Sentence,class,file
"Tel: +82-2-2290-8390, Fax:+82-2-2297-2380, E-mail: kyjoo@hanyang .ac.kr Copyright ⓒ 2012 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permit s unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　The prevalence of pediat ric nonalcoholic fatty liver disease (NAFLD) differs according to the  method of diagnosis, but in the United States, it  h a s  b e e n  r e p o r t e d  t o  b e  3 - 1 0 %  i n  a l l  c h i l d r e n ,  a n d",Non-OADS,/arxiv_data1/oa_pdf/47/08/pghn-15-256.PMC3746059.pdf
"As limit-ations of the study by Oh et al., 12 the study was retrospective  and single center experience with relatively small sample size, COMMENTARY Open Access Received: April 24, 2013    Accepted: April 27, 2013 Correspondence:  Ki Baik Hahm Digestive Disease Center, CHA Bundang Medical Center, CHA University,  and CHA Cancer Prevention Research Center, CHA Cancer Institute, 59 Yat - ap-ro, Bundang-gu, Seongnam 463-712, KoreaTel: +82-31-780-5220, Fax: +82-31-780-5219, E-mail:  hahmkb@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.311 Harmony of Duet over Solo: Use of Midazolam or Propofol   for Sedative Endoscopy in Pediatric Patients Kwang Hyun Ko and Ki Baik Hahm Digestive Disease Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea See “Propofol versus Midazolam for Sedation during Esophagogastroduodenoscopy in Children” by Ji Eun Oh, Hae Jeong  Lee, Y oung Hwan Lee, on page 368-372",Non-OADS,/arxiv_data1/oa_pdf/9e/19/ce-46-311.PMC3746132.pdf
"7,8 New - ly developed ProCore needle looks also promising and many endosonographers are trying to figure out its adoptability COMMENTARY Open Access Received: May 29, 2013    Accepted: June 4, 2013 Correspondence:  Eun Y oung Kim Department of Internal Medicine, Catholic University of Daegu School of  Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea Tel: +82-53-650-4092, Fax: +82-53-624-3281, E-mail:  kimey@cu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.313 Diagnosis of Subepithelial Lesion: Still “Tissue Is the Issue” Eun Young Kim Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea See “Concordance of Endoscopic Ultrasonography-Guided Fine Needle Aspiration Diagnosis with the Final Diagnosis in  Subepithelial Lesions” by Erkan Çağlar, İbrahim Hatemi, Deniz Atasoy, et al., on page 379-383",Non-OADS,/arxiv_data1/oa_pdf/0e/f7/ce-46-313.PMC3746133.pdf
"Only vital surgery should be performed when the pati-ents are still taking aspirin and clopidogrel; unless the hem - orrhage risk is excessive, dual antiplatelet therapy should not COMMENTARY Open AccessPrint ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.315 Continue or Discontinue Dual Antiplatelet Therapy   in Major Surgical or Endoscopic Procedures Young Koog Cheon Digestive Disease Center, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea See “Biliary-Pancreatic Endoscopic and Surgical Procedures in Patients under Dual Antiplatelet Therapy: A Single-Center  Study” by Ahmed Abdel Samie, Michael Stumpf, Rui Sun, et al., on page 395-398 Received: April 8, 2013    Revised: May 15, 2013 Accepted: May 17, 2013 Correspondence:  Y oung Koog Cheon Digestive Disease Center, Department of Internal Medicine, Konkuk Univer - sity Medical Center, Konkuk University School of Medicine, 120 Neungdong- ro, Gwangjin-gu, Seoul 143-729, KoreaTel: +82-2-2030-7490, Fax: +82-2-2030-5029, E-mail:  yksky001@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/f4/ce-46-315.PMC3746134.pdf
"Key Words :  Endoscopy; Inflammatory bowel diseases; Crohn disease; Colitis, ulcerativeOpen Access Received: June 20, 2013    Revised: June 26, 2013 Accepted: July 16, 2013 Correspondence:  Byung Ik Jang Department of Internal Medicine, Y eungnam University College of Medicine,  170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea Tel: +82-53-620-3830, Fax: +82-53-654-8386, E-mail:  jbi@med.yu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.317FOCUSED REVIEW SERIES:  A Perspective: Endoscopy and Imaging in Inflammatory Bowel Disease",Non-OADS,/arxiv_data1/oa_pdf/a2/fe/ce-46-317.PMC3746135.pdf
"Key Words :  Crohn disease; Capsule endoscopy; Balloon assisted endoscopy; Endoscopic balloon dilationOpen Access Received: May 31, 2013    Accepted: July 5, 2013 Correspondence:  Hirokazu Yamagami Department of Gastroenterology, Osaka City University Graduate School of  Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan Tel: +81-6-6645-3811, Fax: +81-6-6645-3813 E-mail:  yamagami@med.osaka-cu.ac.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.321FOCUSED REVIEW SERIES:  A Perspective: Endoscopy and Imaging in Inflammatory Bowel Disease",Non-OADS,/arxiv_data1/oa_pdf/45/c3/ce-46-321.PMC3746136.pdf
"Key Words :  Computed tomography enterography; Inflammatory bowel diseases; Crohn disease; Intestinal tuberculosis; Behcet syndromeOpen Access Received: June 11, 2013    Revised: June 27, 2013 Accepted: June 27, 2013 Correspondence:  Joon Seok Lim Department of Radiology, Y onsei University Health System, Y onsei University  College of Medicine, 50 Y onsei-ro, Seodaemun-gu, Seoul 120-749, Korea Tel: +82-2-2228-2380, Fax: +82-2-393-3035, E-mail:  jslim1@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.327FOCUSED REVIEW SERIES:  A Perspective: Endoscopy and Imaging in Inflammatory Bowel Disease",Non-OADS,/arxiv_data1/oa_pdf/de/de/ce-46-327.PMC3746137.pdf
"Key Words :  Endoscopy, gastrointestinal; Disinfectants; ReprocessingOpen Access Received: February 2, 2013    Accepted: Februry 26, 2013 Correspondence:  Jae Y oung Jang Division of Gastroenterology, Department of Internal Medicine, Kyung Hee  University School of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul  130-872, Korea Tel: +82-2-958-8150, Fax: +82-2-968-1848, E-mail:  jyjang@khu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.337",Non-OADS,/arxiv_data1/oa_pdf/0a/fc/ce-46-337.PMC3746138.pdf
Available from: http://www.fda.gov/MedicalDevices/DeviceRegula - tionandGuidance/ReprocessingofSingle-UseDevices/ucm133514.htm.,Non-OADS,/arxiv_data1/oa_pdf/0a/fc/ce-46-337.PMC3746138.pdf
"Key Words :  Stents; Upper gastrointestinal tract; Malignancy; ObstructionOpen Access Received: October 18, 2012    Revised: January 2, 2013 Accepted: January 3, 2013 Correspondence:  Joo Y oung Cho Institute for Digestive Research, Digestive Disease Center, Soonchunhyang Uni - versity Hospital, Soonchunhyang University College of Medicine, 59 Daesag - wan-ro, Y ongsan-gu, Seoul 140-743, Korea Tel: +82-2-709-9202, Fax: +82-2-709-9696, E-mail:  cjy6695@dreamwiz.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.342",Non-OADS,/arxiv_data1/oa_pdf/7d/95/ce-46-342.PMC3746139.pdf
"Key Words :  Colorectal obstruction; Colorectal stenting; Recommendation; Self-expandable metallic stentsOpen Access Received: September 19, 2012    Revised: October 13, 2012 Accepted: October 29, 2012 Correspondence:  Chang Heon Yang Department of Internal Medicine, Dongguk University Gyeongju Hospital, Dong- guk University College of Medicine, 87 Dongdae-ro, Gyeongju 780-350, Korea Tel: +82-54-770-8206, Fax: +82-54-770-8378, E-mail:  chhyang@dongguk.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.355",Non-OADS,/arxiv_data1/oa_pdf/9a/a5/ce-46-355.PMC3746140.pdf
"Key Words :  Propofol; Midazolam; Endoscopy, digestive system; ChildOpen Access Received: August 21, 2012    Revised: November 15, 2012 Accepted: November 22, 2012 Correspondence:  Hae Jeong Lee Department of Pediatrics, Samsung Changwon Hospital, Sungkyunkwan Uni - versity School of Medicine, 158 Paryong-ro, Masanhoewon-gu, Changwon 630- 723, KoreaTel: +82-55-290-6159, Fax: +82-55-290-6044, E-mail:  okii1004@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.368 INTRODUCTION Endoscopic procedures for diagnostic and therapeutic pur - poses in children are increasing.",Non-OADS,/arxiv_data1/oa_pdf/51/74/ce-46-368.PMC3746141.pdf
"Key Words :  Upper gastrointestinal tract; Obstruction; Ultrathin endoscopeOpen Access Received: July 4, 2012    Revised: October 15, 2012 Accepted: November 27, 2012 Correspondence:  Byung-Wook Kim Division of Gastroenterology, Department of Internal Medicine, Incheon St.  Mary’s Hospital, The Catholic University of Korea College of Medicine, 56  Dongsu-ro, Bupyeong-gu, Incheon 403-720, KoreaTel: +82-32-280-5052, Fax: +82-32-280-5987, E-mail:  gastro@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.373 INTRODUCTION The need for endoscopic management of gastrointestinal  obstruction has been increased due to recent increase in de - tection rate of gastrointestinal cancer and increased survival  of patients with improved therapeutic strategies.",Non-OADS,/arxiv_data1/oa_pdf/21/2b/ce-46-373.PMC3746142.pdf
"Key Words :  Endosonography; Biopsy, fine-needle; Subepithelial lesionOpen Access Received: August 15, 2012    Revised: December 10, 2012 Accepted: January 16, 2013 Correspondence:  Erkan Çağlar Division of Gastroenterology, Istanbul University Cerrahpaşa Medical Faculty,  Fatih, Istanbul 34098, Turkey Tel: +90-212-414-3000, Fax: +90-212-212-1700 E-mail:  dr_erkan799@yahoo.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 See commentary on page 313-314http://dx.doi.org/10.5946/ce.2013.46.4.379",Non-OADS,/arxiv_data1/oa_pdf/d6/a8/ce-46-379.PMC3746143.pdf
"Key Words :  Self-expandable metal stent; Colonic neoplasms; Intestinal perforationOpen Access Received: November 10, 2012    Revised: January 22, 2013 Accepted: April 4, 2013 Correspondence:  Sung Pyo Hong Digestive Disease Center, CHA Bundang Medical Center, CHA University, 59  Yatap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5214, Fax: +82-31-780-5219, E-mail:  sphong@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.384",Non-OADS,/arxiv_data1/oa_pdf/f0/8f/ce-46-384.PMC3746144.pdf
"Key Words :  Photodynamic therapy; Cholangiocarcinoma; Single operator choledochoscopyOpen Access Received: October 17, 2012    Revised: January 10, 2013 Accepted: February 28, 2013 Correspondence:  Michel Kahaleh Division of Gastroenterology and Hepatology, Department of Medicine, Weill  Cornell Medical College, 4th Floor, 1305 Y ork Ave, New Y ork, NY 10021, USA Tel: +1-646-962-4000, Fax: +1-646-962-0110, E-mail:  mkahaleh@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.390",Non-OADS,/arxiv_data1/oa_pdf/3e/8f/ce-46-390.PMC3746145.pdf
"Key Words :  Dual antiplatelet therapy; Sphincterotomy, endoscopic; General surgeryOpen Access Received: October 18, 2012    Revised: November 18, 2012 Accepted: November 29, 2012 Correspondence:  Ahmed Abdel Samie Department of Gastroenterology, Pforzheim Hospital, Kanzler St 2-6, 75175  Pforzheim, Germany Tel: +49-7231-969-3656, Fax: +49-7231-969-2682 E-mail:  abdelsamie@ngi.de cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.395 INTRODUCTION Despite the widespread use of dual antiplatelet therapy after  coronary interventions, the optimal management of these dr- ugs in patients undergoing surgical or endoscopic procedures is still unclear.",Non-OADS,/arxiv_data1/oa_pdf/91/af/ce-46-395.PMC3746146.pdf
"Key Words :  Endoscopy; Gastrectomy; PhytobezoarOpen Access Received: May 9, 2012    Revised: May 31, 2012 Accepted: June 15, 2012 Correspondence:  Ji Y ong Ahn Department of Gastroenterology, Asan Digestive Disease Research Institute,  Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro  43-gil, Songpa-gu, Seoul 138-736, KoreaTel: +82-2-3010-5667, Fax: +82-2-476-0824, E-mail:  ji110@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.399",Non-OADS,/arxiv_data1/oa_pdf/ad/f0/ce-46-399.PMC3746147.pdf
"Key Words :  Gastrointestinal bleeding; Duodenal varix; Endoscopic clippingOpen Access Received: May 27, 2012    Revised: July 2, 2012 Accepted: July 3, 2012 Correspondence:  Sang Ho Lee Department of Internal Medicine, Busan Medical Center, 359 Worldcup-dae - ro, Y eonje-gu, Busan 611-706, Korea Tel: +82-51-507-3000, Fax: +82-51-607-2807, E-mail:  skylsh@kornet.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.403 INTRODUCTION Variceal bleeding is a common cause of upper gastrointesti - nal bleeding in patients with liver cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/48/8f/ce-46-403.PMC3746148.pdf
"Key Words :  Stomach; Squamous metaplasia; Lugol’s iodine solutionOpen Access Received: July 16, 2012    Revised: September 17, 2012 Accepted: September 24, 2012 Correspondence:  Gwang Ha Kim Department of Internal Medicine and Biomedical Research Institute, Pusan  National University Hospital, Pusan National University School of Medicine,  179 Gudeok-ro, Seo-gu, Busan 602-739, KoreaTel: +82-51-240-7869, Fax: +82-51-244-8180, E-mail:  doc0224@pusan.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.407",Non-OADS,/arxiv_data1/oa_pdf/e0/5c/ce-46-407.PMC3746149.pdf
"Key Words :  Linear endosonography; Superior mesenteric artery syndrome; Body mass indexOpen Access Received: July 18, 2012    Revised: October 4, 2012 Accepted: October 13, 2012 Correspondence:  Tae Hee Lee Institute for Digestive Research, Digestive Disease Center, Soonchunhyang Uni - versity Hospital, Soonchunhyang University College of Medicine, 59 Daesag - wan-ro, Y ongsan-gu, Seoul 140-743, Korea Tel: +82-2-709-9691, Fax: +82-2-709-9696, E-mail:  iman0825@naver.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.410",Non-OADS,/arxiv_data1/oa_pdf/86/62/ce-46-410.PMC3746150.pdf
"3, Supplementary Video 1 [available online at http://www.e-ce.org/]).",Non-OADS,/arxiv_data1/oa_pdf/86/62/ce-46-410.PMC3746150.pdf
"Key Words :  Lipoma; Intussusception; Ileum; Endoscopic treatment; Cap-assisted colonoscopyOpen Access Received: August 2, 2012    Revised: September 27, 2012 Accepted: October 11, 2012 Correspondence:  Kang Nyeong Lee Department of Internal Medicine, Hanyang University College of Medicine,  222 Wangsimni-ro, Seongdong-gu, Seoul 133-791, Korea Tel: +82-2-2290-8637, Fax: +82-2-2298-9183, E-mail:  drkangmd@naver.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.414",Non-OADS,/arxiv_data1/oa_pdf/dc/9b/ce-46-414.PMC3746151.pdf
"Key Words :  Pancreatic neoplasms; Stents; Cholangiopancreatography, endoscopic retrograde; Argon plasma coagulationOpen Access Received: May 25, 2012    Revised: June 19, 2012 Accepted: June 23, 2012 Correspondence:  Tae Hoon Lee Division of Gastroenterology, Department of Internal Medicine, Soonchun - hyang University Cheonan Hospital, Soonchunhyang University College of  Medicine, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-930, KoreaTel: +82-41-570-3662, Fax: +82-41-574-5762, E-mail:  thlee9@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.418",Non-OADS,/arxiv_data1/oa_pdf/58/f1/ce-46-418.PMC3746152.pdf
"LETTER TO THE EDITOR Image-Enhanced Endoscopy for Diagnosis and   Treatment of Gastrointestinal TumorOpen Access Received: June 18, 2013    Accepted: July 23, 2013     Correspondence:  Viroj Wiwanitkit, Wiwanitkit House, Bangkhae, Bangkok 10160, Thailand Tel: +66-24-132436, Fax: +66-24-132436, E-mail:  wviroj@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.4.423",Non-OADS,/arxiv_data1/oa_pdf/bf/bd/ce-46-423.PMC3746153.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):249-255 http://dx.doi.org/10.4162/nrp.2013.7.4.249 pISSN 1976-1457 eISSN 2005-6168 Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells Myung-Yul Lee1, Eun Joo Choi2, Myung-Koo Lee3 and Jae-Joon Lee1§ 1Department of Food and Nutrition, College of Natural Scie nce, Chosun University, 301, Pilmun-daero, Dong-gu, Gwangju  501-759, Korea 2College of Pharmacy, Chosun University, Gwangju 501-759, Korea 3College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk 361-763, Korea Abstract In this study, the protective effects of EGCG on L-3,4-dihydroxyphenylalanine (L-DOPA)-induced oxidative cell death in catechol aminergic PC12 cells, the in vitro  model of Parkinson’s disease, were investigated.",Non-OADS,/arxiv_data1/oa_pdf/69/22/nrp-7-249.PMC3746157.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):256-261 http://dx.doi.org/10.4162/nrp.2013.7.4.256 pISSN 1976-1457 eISSN 2005-6168 Effects of perilla oil on plasma concentrations of cardioprotective (n-3) fatty acids an d  lipid profiles in mice Keun Hee Chung1§, Hyo Jeong Hwang2, Kyung Ok Shin1, Woo Min Jeon3 and Kyung Soon Choi1 1Department of Food and Nutrition, Sahmyook Universi ty, 815, Hwarang-ro, Nowon-gu, Seoul 139-742, Korea 2Department of Food and Nutrition, Kyunghee University, Seoul 130-701, Korea 3Division of Animal Science, Sahmyook University, Seoul 139-742, Korea Abstract The aim of this study was to examine the effects of perilla oil as well as several vegetable oils, including flaxseed oil, cano la oil, and rice  bran oil on plasma levels of cardioprotective (n-3) polyunsaturated fatty acids in mice by feeding each vegetable oil for a per iod of eight weeks.",Non-OADS,/arxiv_data1/oa_pdf/34/10/nrp-7-256.PMC3746158.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):262-266 http://dx.doi.org/10.4162/nrp.2013.7.4.262 pISSN 1976-1457 eISSN 2005-6168 Laxative effect of peanut sprout extract Ji Yeon Seo1, Seong Soon Kim1, Hyo Jung Kim2, Kwang-Hyeon Liu3, Hak-Yong Lee4 and Jong-Sang Kim1§ 1School of Food Science and Biotechnology, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 702-701, Korea 2Reseacrh Institute for Biological Functions, Chubu University, Aichi 487-8501, Japan 3College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 702-701, Korea 4Huvet Co. Ltd, Iksan, Jeonbuk 570-749, Korea Abstract Certain phenolic compounds are known to exhibit laxative properties.",Non-OADS,/arxiv_data1/oa_pdf/f6/8d/nrp-7-262.PMC3746159.pdf
Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):267-272 http://dx.doi.org/10.4162/nrp.2013.7.4.267 pISSN 1976-1457 eISSN 2005-6168 Anti-obesity effects of hot water extract from Wasabi ( Wasabia japonica Matsum. ),Non-OADS,/arxiv_data1/oa_pdf/63/ae/nrp-7-267.PMC3746160.pdf
"Three histological specimens were made from each liver sample, and the area percentages of fat droplets were calculated using Image J version 1.6.0 (http://rsbweb.nih.gov/ij/ download.html).",OADS,/arxiv_data1/oa_pdf/63/ae/nrp-7-267.PMC3746160.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):273-280 http://dx.doi.org/10.4162/nrp.2013.7.4.273 pISSN 1976-1457 eISSN 2005-6168 Bamboo salt attenuates CCl 4-induced hepatic damage in Sprague-Dawley rats Xin Zhao1,2, Jia-Le Song1, Jeung-Ha Kil1 and Kun-Young Park1§ 1Department of Food Science and Nutrition, Pusan National  University, 30 Jangjun-dong, Geumjung-gu, Busan 609-735, Korea 2Department of Biological and Chemical Engineering, Chongqing University of Education, Chongqing 400067, PR China Abstract Bamboo salt, a Korean folk medicine, is prepared with solar salt (sea salt) and baked several times at high temperatures in a b amboo case.",Non-OADS,/arxiv_data1/oa_pdf/67/1b/nrp-7-273.PMC3746161.pdf
Available from: http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm078932.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/1b/nrp-7-273.PMC3746161.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):281-286 http://dx.doi.org/10.4162/nrp.2013.7.4.281 pISSN 1976-1457 eISSN 2005-6168 Effects of parental folate deficiency on the folate content, global DNA methylation,  and expressions of FR α, IGF-2 and IGF-1R in the postnatal rat liver Karen Kay Mejos, Hye Won Kim, Eun Mi Lim and Namsoo Chang§ Department of Nutritional Science and Food Management, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul  120-750, Korea Abstract We examined the effect of parental folate deficiency on the folate content, global DNA methylation, folate receptor-alpha (FR α), insulin-like-growt h factor-2 (IGF-2) and -1 receptor (IGF-1R) in the liver and plasma homocysteine in the postnatal rat.",Non-OADS,/arxiv_data1/oa_pdf/1c/5f/nrp-7-281.PMC3746162.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):287-293 http://dx.doi.org/10.4162/nrp.2013.7.4.287 pISSN 1976-1457 eISSN 2005-6168 The effect of fucoxanthin rich power on the lipid metabolism in rats with a high fat die t Ae Wha Ha and Woo Kyoung Kim§ Department of Food Science and Nutrition, Dankook University , 126, Jukjeon-dong, Suji-gu, Yongin-si, Gyunggi 448-701, Korea Abstract This study determined the effects of fucoxanthin on gene expressions related to lipid metabolism in rats with a high-fat diet.",Non-OADS,/arxiv_data1/oa_pdf/0a/f9/nrp-7-287.PMC3746163.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):294-301 http://dx.doi.org/10.4162/nrp.2013.7.4.294 pISSN 1976-1457 eISSN 2005-6168 Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic  fatty acid metabolism in high-fat diet-fed mice Mi-Young Park1 and Seong Taek Mun2§ 1Functional Food and Nutrition Division, Department of Agrofood Resources, Rural Development Administration, Suwon 441-707, Korea 2Department of Obstetrics and Gynecology, Soonchunhyang University Cheonan Hospital, 23-20, Byeongmyeong-dong,  Dongnam-gu, Cheonan 330-721, Korea Abstract In this study, we examined the hepatic anti-steatosis activity of carnosic acid (CA), a phenolic compound of rosemary ( Rosmarinus officinalis )  leaves, as well as its possible mechanism of action, in a high-fat diet (HFD)-fed mice model.",Non-OADS,/arxiv_data1/oa_pdf/cb/2d/nrp-7-294.PMC3746164.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):302-308 http://dx.doi.org/10.4162/nrp.2013.7.4.302 pISSN 1976-1457 eISSN 2005-6168 Glycemic index of dietary formula may not be predictive of postprandial endothelial  inflammation: a double-blinded, randomized, crossover study in non-diabetic subjects Eun Ju Lee1, Ji Yeon Kim2,3, Do Ram Kim1,3, Kyoung Soo Kim4, Mi Kyung Kim3 and Oran Kwon1,3§ 1Department of Nutritional Science and Food Management, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu, Seou l  120-750, Korea 2Department of Food Science and Technology, Seoul National Un iversity of Science and Technology, Seoul 139-743, Korea 3Biofood Network, Seoul 120-160, Korea 4Department of Family Medicine, Seoul St Mary’s Hospital, Seoul 137-701, Korea Abstract The emerging role of endothelial inflammation in diabetes has stimulated research interest in the effects of nutrition on relat ed indices.",Non-OADS,/arxiv_data1/oa_pdf/18/58/nrp-7-302.PMC3746165.pdf
"Currently GI values of 2,487 foods were complied to form the international GI table, and are available in the online appendix at http://dx.doi.org/10.2337/dc08-1239 [3].",Non-OADS,/arxiv_data1/oa_pdf/18/58/nrp-7-302.PMC3746165.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):309-314 http://dx.doi.org/10.4162/nrp.2013.7.4.309 pISSN 1976-1457 eISSN 2005-6168 Effect of milk and milk products consumption on physical growth and bone mineral  density in Korean adolescents Sun Hyo Kim1, Woo Kyoung Kim2 and Myung-Hee Kang3§ 1Department of Technology and Home Economics Education, Kongju National University, Gongju, Chungnam 314-701, Korea  2Department of Food Science and Nutrition, Dank ook University, Yongin, Gyunggi 448-701, Korea,  3Department of Food and Nutrition, College of Life Science and Nano Technonogy, Hannam University, 461-6 Jeonmin-dong,  Yuseong-gu, Daejeon 305-811, Korea Abstract This study was conducted to investigate the relationship among the current status of calcium intake from milk and milk products , physical growt h and bone mineral density in 664 male and female middle school and high school students aged 15-17 years.",Non-OADS,/arxiv_data1/oa_pdf/9e/06/nrp-7-309.PMC3746166.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):315-325 http://dx.doi.org/10.4162/nrp.2013.7.4.315 pISSN 1976-1457 eISSN 2005-6168 Determinants of neural tube defect (NTD)-protective circulating concentrations o f  folate in women of child-bearing age in the US post-folic acid fortification era Chandrika Piyathilake1§, Sang Yong Eom2, Taisun Hyun3, Suguna Badiga1, Constance Robinson1, Nuzhat Rahman1,  Heon Kim2 and Gary L Johanning4 1Department of Nutrition Sciences, University of Alabama at Birmingham, 1675 University Blvd, Birmingham, AL 35294, USA 2Department of Preventive Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea 3Department of Food and Nutrition, Chungbuk National University, Cheongju 361-763, Korea 4Department of Veterinary Sciences, University of Texas MD Anderson Cancer Center, Bastrop, TX 78602, USA Abstract We evaluated folate status of child-bearing age women diagnosed with abnormal pap smear in the US post-folic acid (FA) fortific ation era an d  assessed the determinants of NTD-protective and supra-physiologi c (SP) concentrations of folate.",Non-OADS,/arxiv_data1/oa_pdf/71/4b/nrp-7-315.PMC3746167.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):326-329 http://dx.doi.org/10.4162/nrp.2013.7.4.326 pISSN 1976-1457 eISSN 2005-6168 Validation of self-reported height and weight in fifth-grade Korean children Bora Lee1, Sang-Jin Chung1§, Soo-Kyung Lee2 and Jihyun Yoon3 1Department of Foods and Nutrition, Kookmin Universi ty, 861-1, Jeongneung-dong, Seongbuk-gu, Seoul 136-702, Korea 2Department of Food and Nutrition, Inha University, Incheon 402-751, Korea 3Department of Food and Nutrition, Seoul National University, Seoul 151-742, Korea Abstract Height and weight are important indicators to calculate Body Mass Index (BMI); measuring height and weight directly is the most  exact method  to get this information.",Non-OADS,/arxiv_data1/oa_pdf/e3/0d/nrp-7-326.PMC3746168.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):330-335 http://dx.doi.org/10.4162/nrp.2013.7.4.330 pISSN 1976-1457 eISSN 2005-6168 Associations between dietary patterns and screen time among Korean adolescents Jae Yeon Lee, Nuri Jun and Inkyung Baik§ Department of Foods and Nutrition, College of Natural Sciences, Kookmin University, 861-1 Jeongnung-dong, Songbuk-gu, Seoul  136-702, Korea Abstract Data are limited on the association between dietary patterns and screen time among Korean adolescents.",Non-OADS,/arxiv_data1/oa_pdf/71/ea/nrp-7-330.PMC3746169.pdf
Available from: http://www.oecd.org/interne t/ieconomy/48255770.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/71/ea/nrp-7-330.PMC3746169.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(4):336-341 http://dx.doi.org/10.4162/nrp.2013.7.4.336 pISSN 1976-1457 eISSN 2005-6168 Effects of sensory education based on classroom activities for lower grade school  children Taejung Woo1,2 and Kyung-Hea Lee1§ 1Deprtment of Food and Nutrition, Changwon National University,   20 Changwondaehak-ro, Uichang-gu, Changwon-si, Gyeongnam  641-773, Korea 2Daebang elementary school, Changwon, Gyeongnam 641-100, Korea Abstract This study is to verify the effects of sensory education based on classroom activities for 2nd and 3rd grade children.",Non-OADS,/arxiv_data1/oa_pdf/84/2d/nrp-7-336.PMC3746170.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Novak RM, Donoval BA, Graham PJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/ac/18/sextrans-2013-051052.PMC3746192.pdf
http://www.sony.net/Products/SC-HP/ datasheet/01/data/E01409A3Z.pdf (accessed 02 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/eb/a9/srep02460.PMC3746203.pdf
http://www.mathworks.,Non-OADS,/arxiv_data1/oa_pdf/eb/a9/srep02460.PMC3746203.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/eb/a9/srep02460.PMC3746203.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2460 | DOI: 10.1038/srep02460 6",Non-OADS,/arxiv_data1/oa_pdf/eb/a9/srep02460.PMC3746203.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/66/12/srep02461.PMC3746206.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2461 | DOI: 10.1038/srep02461 7",Non-OADS,/arxiv_data1/oa_pdf/66/12/srep02461.PMC3746206.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/78/a1/srep02465.PMC3746207.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2465 | DOI: 10.1038/srep02465 6",Non-OADS,/arxiv_data1/oa_pdf/78/a1/srep02465.PMC3746207.pdf
"21Statistical power was estimated using the software Quanto v1.2.4 (http://hydra.usc.edu/gxe/) with a log-additive model, a two-sided type I error rate of 0.05 and SLE prevalence of 0.068% inSweden, 0.028% in Finland and 0.053% in the United States.",OADS,/arxiv_data1/oa_pdf/64/99/ejhg2012277a.PMC3746253.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Investigation of Asian SLEgenes in Caucasians CW a n g et al 999 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/64/99/ejhg2012277a.PMC3746253.pdf
"Using the data from the human genome(http://genome.ucsc.edu/cgi-bin/hgGateway, NCBI36/hg18), 135 000 oligonu- cleotide probes covering all genomic regions plus 2 kb at each extremity of the 26 genes were designed for each subarray.",OADS,/arxiv_data1/oa_pdf/25/d6/ejhg2012279a.PMC3746255.pdf
Oligonucleotide primer pairs were designed with the help of the Primer3Plus online tool (http://www.bioinfor- matics.nl/cgi-bin/primer3plus/primer3plus.cgi).,OADS,/arxiv_data1/oa_pdf/25/d6/ejhg2012279a.PMC3746255.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/CGH array for diagnosis of heterogeneous diseases AV a s s o n et al 987 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/25/d6/ejhg2012279a.PMC3746255.pdf
http://www.ukbiobank.ac.uk/newsletter/.,Non-OADS,/arxiv_data1/oa_pdf/77/c8/ejhg2012282a.PMC3746258.pdf
Newsletter from the Norwegian Mother and ChildCohort Study; Folkehelseinstituttet 2012 available at http://www.fhi.no/eway/default.,Non-OADS,/arxiv_data1/oa_pdf/77/c8/ejhg2012282a.PMC3746258.pdf
"European Commission, Directorate General for Research, 2010; Vol 176, available at http://ec.europa.eu/public_opinion/archives/ebs/ebs_341_winds_en.",Non-OADS,/arxiv_data1/oa_pdf/77/c8/ejhg2012282a.PMC3746258.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Broad versus dynamic consent in biobank research KS Steinsbekk et al 902 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/77/c8/ejhg2012282a.PMC3746258.pdf
Available at: http://evs.gs.washington.edu/EVS/.,Non-OADS,/arxiv_data1/oa_pdf/08/24/ejhg2012283a.PMC3746259.pdf
Available at: http://www.biobase-international.com/product/ hgmd.,Non-OADS,/arxiv_data1/oa_pdf/08/24/ejhg2012283a.PMC3746259.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Questioning cardiomyopathy-associated genetic variants CA n d r e a s e n et al 928 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/08/24/ejhg2012283a.PMC3746259.pdf
"17 Patty A: Gene test results to be passed on without consent .S y d n e y ,A u s t r a l i a :T h e Sydney Morning Herald, 2012 available at: http://www.smh.com.au.",Non-OADS,/arxiv_data1/oa_pdf/81/bc/ejhg2012286a.PMC3746262.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Resources for family communication of cancer risk KA McClellan et al 910 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/81/bc/ejhg2012286a.PMC3746262.pdf
Available from: http://www.mciindia.org/tools/announcement/MCI_ booklet.pdf [Last accessed on 2013 May 07].,Non-OADS,/arxiv_data1/oa_pdf/c7/37/JPP-4-171.PMC3746298.pdf
Available from:  http://www.mciindia.org/Rules‑and‑Regulation/Gazette%20Notifications%20 ‑%20Amendments/TEQ‑03.11.2010.pdf [Last accessed on 2013 May 15].,Non-OADS,/arxiv_data1/oa_pdf/c7/37/JPP-4-171.PMC3746298.pdf
Available from: http://www.icmje.,Non-OADS,/arxiv_data1/oa_pdf/c7/37/JPP-4-171.PMC3746298.pdf
Available from: http://www.nlm.nih.gov/pubs/factsheets/jsel.html [Last  accessed on 2013 May 15].,Non-OADS,/arxiv_data1/oa_pdf/c7/37/JPP-4-171.PMC3746298.pdf
Available from: http://en.wikipedia.org/wiki/ Impact_factor [Last accessed on 2013 May 15].,OADS,/arxiv_data1/oa_pdf/c7/37/JPP-4-171.PMC3746298.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/be/39/JPP-4-176.PMC3746300.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/be/39/JPP-4-176.PMC3746300.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/5b/52/JPP-4-187.PMC3746301.pdf
Available from: http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trial id=3671&EncHid=&userName=ranolazine.,Non-OADS,/arxiv_data1/oa_pdf/50/6e/JPP-4-220.PMC3746310.pdf
Available from: http://www.cardiosource.org/News‑Media/Media‑Center/ News‑Releases/2013/03/TERISA‑T rial.aspx.,Non-OADS,/arxiv_data1/oa_pdf/47/6d/JPP-4-221.PMC3746311.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/18/115874 Access this article online Quick Response Code: Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.115874,Non-OADS,/arxiv_data1/oa_pdf/53/79/JPI-4-18.PMC3746412.pdf
"J Pathol Inform 2013, 1:18  http://www.jpathinformatics.org/content/4/1/18trained to use the digital image viewing software.",Non-OADS,/arxiv_data1/oa_pdf/53/79/JPI-4-18.PMC3746412.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/20/115880,Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/20changes associated with specific pathologic processes,  didactic instruction, and critically, the extraction of  new information derived from experimental studies as  reported in the literature.",Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/20of regular expressions to identify sentences of interest  and narrow the amount of text to be further interrogated  using a variety of NLP techniques.",Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/20proteins.",Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/20but utilizes a different grammatical linkage, S + P +  MV + J, retrieving the bit of knowledge, “caspase‑3” and  “expressed.” To be more specific, the “S” link leads the  subject (Caspase‑3) to find the be verb (was).",Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/20is separated by a comma and the former by a preposition.",Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/201.",Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/20 These keywords may provide convincing evidence of  expression based upon experimental techniques other  than immunohistochemistry and includes terms such  as polymerase chain reaction, and fluorescent in‑situ   hybridization.",Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/20name.",Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/20can provide analytical data such as range, distribution  and average that may generate useful visualization and  comparison over different abstracts.",OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
"J Pathol Inform 2013, 1:20  http://www.jpathinformatics.org/content/4/1/2016.",Non-OADS,/arxiv_data1/oa_pdf/61/33/JPI-4-20.PMC3746413.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/19/115879,Non-OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"J Pathol Inform 2013, 1:19  http://www.jpathinformatics.org/content/4/1/19indexing and retrieval of cases, and the use of automated  image analysis.",Non-OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"J Pathol Inform 2013, 1:19  http://www.jpathinformatics.org/content/4/1/19slides have been described by Masmoudi et al.",OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
Table 1 summarizes some  basic scanner characteristics for the three systems  (Information source for Aperio CS: http://www.aperio.,OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"com/lifescience/capture/cs, Information source for Aperio  T2: http://web.archive.org/web/20040412140041/http:/ www.aperio.com/products‑ScanScope_T2.asp, Information  source for Hamamatsu NanoZoomer 2.0HT : http://www.",OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"J Pathol Inform 2013, 1:19  http://www.jpathinformatics.org/content/4/1/19was used to classify the ROIs in each of the datasets  acquired with the three WSI systems in terms of  HER2/neu expression.",OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"J Pathol Inform 2013, 1:19  http://www.jpathinformatics.org/content/4/1/19The mean score from the pathologist panel (1‑100) was  used as ground truth from the pathologist panel was used  during the training process.",Non-OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"J Pathol Inform 2013, 1:19  http://www.jpathinformatics.org/content/4/1/19is shown, as well as percent correct agreement for each  of the 1+, 2+, and 3+ categories.",OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"J Pathol Inform 2013, 1:19  http://www.jpathinformatics.org/content/4/1/19as 1+ whereas Algorithm 2 scored that case as 2+ [Figure 2a],  and another where the majority of pathologists (six out of  seven) scored it as 2+ whereas Algorithm 2 scored it as a  1+.",Non-OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"J Pathol Inform 2013, 1:19  http://www.jpathinformatics.org/content/4/1/19that of all cases classified as 2+ using images from  one system (Hamamatsu), 23.3% and 33.3% of them  were classified as 1+ when using images from the  Aperio‑CS and Aperio‑ T2 systems respectively.",OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"J Pathol Inform 2013, 1:19  http://www.jpathinformatics.org/content/4/1/19to account for differences in image properties between  WSI systems.",OADS,/arxiv_data1/oa_pdf/87/9f/JPI-4-19.PMC3746414.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ),  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/13/met007.PMC3746458.pdf
Available from: http://www.crimiquotes.,Non-OADS,/arxiv_data1/oa_pdf/68/63/JFDS-5-1.PMC3746465.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/72/02/JFDS-5-35.PMC3746471.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/72/02/JFDS-5-35.PMC3746471.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/4a/a3/JFDS-5-47.PMC3746473.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/02/10/JFDS-5-60.PMC3746476.pdf
"Amirthaa Priyadharscini R, Sabarinath TR Department of Oral and Maxillofacial Pathology and   Microbiology, Meenakshi Ammal Dental College and Hospital,  Maduravoyal, Tamil Nadu, India   E‑mail: amirthaa87@gmail.com For Instructions for Authors refer to http://www.jfds.org/contributors.asp",Non-OADS,/arxiv_data1/oa_pdf/37/2c/JFDS-5-64.PMC3746477.pdf
"(COM;748).Availablefrom:http://ec.eur opa.eu/dgs/ health_consumer/docs/communication_amr_20 11_748_en.pdf 5.OtterJA,YezliS,FrenchGL.Theroleplayedbycontaminat ed surfacesinthetransmission ofnosocomial pathogens.",Non-OADS,/arxiv_data1/oa_pdf/92/6f/HIC-08-10.PMC3746601.pdf
"Curriculum füreinenGrundkursfürhygienebeauf tragte Pflegekräfte(Link-Nurse).Availablefrom:http://dgkh.de/ pdfdata/weiterbildung/curriculum_grundk urs_ hygienebeauf tragte_pflegekraef te.pdf 11.KramerA,SchillingM,HeideckeCD.Infektionspräv entions-Check - inundInfektionspräv entions-Check -outzurPrävention nosokomialerInfektionen[Infectionpreventioncheck-inand infectionpreventioncheck-outtopreventnosocomial infections].",Non-OADS,/arxiv_data1/oa_pdf/ae/be/HIC-08-11.PMC3746605.pdf
"Antimicrobialresistance surveillanceinEurope2011.Annual ReportoftheEuropeanAntimicrobialResistance Surveillance Network(EARS-Ne t).Stockholm: ECDC;2012.Availablefrom: http://ecdc.eur opa.eu/en/publications/Publications/ antimicrobial-resistance-sur veillance-eur ope-2011.pdf 2.GouldI.Costsofhospital-acq uiredmethicillin-resistant Staphylococcus aureus(MRSA)anditscontrol.International J AntimicrobAg.2006;28(5):3 79-84.DOI: 10.1016/j.ijantimicag.2006.09.00 1 3.HaeckerA.MRSAimKrankenhaus,KonsequenzenundLösungen fürdasKlinikmanagement.",OADS,/arxiv_data1/oa_pdf/05/26/HIC-08-12.PMC3746607.pdf
"Imaging data were processed and analyzed using Statistical Parametric Mapping 8 (SPM, http://www.fil.ion.ucl.ac.uk/spm/).",OADS,/arxiv_data1/oa_pdf/ae/1d/npp201390a.PMC3746700.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Neural correlates of inhibition in SDI and unaffected siblings S Morein-Zamir et al 1953 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/ae/1d/npp201390a.PMC3746700.pdf
The  full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ijn-8-2961.PMC3746734.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to request  permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 2961–2973International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2961OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4492 4Process optimization and evaluation of novel  baicalin solid nanocrystals Peng-Fei Yue1,2 Yu li1 Jing Wan1 Y ong Wang1 Ming Yang1 Wei-Feng Zhu1 chang-hong Wang2 hai-long Yuan3 1Key lab of Modern Preparation of  TcM, Jiangxi University of Traditional  chinese Medicine, Nanchang,   2Institute of chinese Materia Medica,   shanghai University of Traditional  chinese Medicine, shanghai, 3302  hospital of P la Institute of chinese  Materia Medica, Beijing, People’s  republic of china correspondence: Peng-Fei Yue; Ming Yang   Key lab of Modern Preparation of TcM,  Jiangxi University of Traditional chinese  Medicine, rD 818 Xingwan, Nanchang,  People’s republic of china   Tel +86 791 8711 8108   Fax +86 791 8711 8658   email p.f.yuejxtcmi@gmail.co m;  yangming16@126.co mAbstract:  The objective of this study was to prepare baicalin solid nanocrystals (BCN-SNS) to  enhance oral bioavailability of baicalin.",Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ijn-8-2961.PMC3746734.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ijn-8-2961.PMC3746734.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/0d/ijn-8-2961.PMC3746734.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/dddt-7-767.PMC3746782.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 767–770Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  767Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4771 8Valproic acid-associated low fibrinogen   and delayed intracranial hemorrhage:   case report and mini literature review Hai-Fei Chen1,2 Li-Ping Xu1 Zhi-Y ong Luo1 Zi-Qiang Yu2 Zheng-Yang Li1 Qing-Ya Cui1 Long-Mei Qin1 Y ong-Ya Ren1 Hong-Shi Shen1 Jie-Qing Tang1 Ling-Juan Jin1 Jing-Jing Zhu1 Jing wang1 Ke-Yuan wang1 Tian-Qin wu1 Zhao-Yue wang2 1Department of Hematology,    100th Hospital of People’s Liberation  Army, 2Jiangsu institute of Hematology,   First Affiliated Hospital of Soochow  University, Suzhou, People’s   Republic of China Correspondence: Tian-Qin wu   Department of Hematology,  100th Hospital of People’s Liberation  Army, Suzhou, 215007, People’s  Republic of China   Tel +86 0512 65063541   email chhf1224@163.co m;    Zhao-Yue wang   Jiangsu institute of Hematology, First  Affiliated Hospital of Soochow University,  Suzhou, 215006, Jiangsu Province,  People’s Republic of China,   Tel +86 0512 67780460   email zwang11@sina.co mAbstract:  A 41-year-old male had suffered from gradual hearing loss in his right ear for 2 years.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/dddt-7-767.PMC3746782.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/dddt-7-767.PMC3746782.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/dddt-7-767.PMC3746782.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1063–1069Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1063CAse serIesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4980 2Axial lumbar interbody fusion: a 6-year   single-center experience Dick J Zeilstra1 Larry e Miller2,3 Jon e Block3 1Bergman Clinics, Naarden   and Ned spine, ede, The Netherlands;   2Miller scientific Consulting, Inc,   Arden, NC, UsA; 3The Jon Block  Group, san Francisco, CA, UsA Correspondence: Jon e Block   The Jon Block Group, 2210 Jackson  street, suite 401, san Francisco,   CA 94115, UsA   Tel +1 415 775 7947   Fax +1 415 928 0765   email jonblock@jonblockgroup.co mIntroduction:  The aim of this study is to report our 6-year single-center experience with L5–S1  axial lumbar interbody fusion (AxiaLIF).",Non-OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
"Rockville, MD:  Food and Drug Administration; 1996. http://www.accessdata.fda.gov/ cdrh_docs/pdf/P950019a.pd f. Accessed June 3, 2013.",OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
"Rockville, MD:  Food and Drug Administration; 1999. http://www.accessdata.fda.gov/ cdrh_docs/pdf/P970015b.pd f. Accessed June 3, 2013.",OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
"Rock - ville, MD: Food and Drug Administration; 2002. http://www.accessdata.",OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
"Rockville, MD:  Food and Drug Administration; 2006. http://www.accessdata.fda.gov/ cdrh_docs/pdf5/P050010b.pd f. Accessed June 3, 2013.",OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
"Rockville, MD: Food and  Drug Administration; 2004. http://www.accessdata.fda.gov/cdrh_docs/ pdf4/P040006b.pd f. Accessed June 3, 2013.",OADS,/arxiv_data1/oa_pdf/2e/c8/cia-8-1063.PMC3746784.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/42/cmar-5-235.PMC3746785.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2013:5 235–242Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  235Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S3578 9Samarium-153-ethylene diamine tetramethylene  phosphonate, a beta-emitting bone-targeted  radiopharmaceutical, useful for patients   with osteoblastic bone metastases John Longo1 Stephen Lutz2 Candice Johnstone1 1Department of Radiation Oncology,   Medical College of wisconsin,   Milwaukee, wi, USA; 2Department   of Radiation Oncology, Blanchard  valley Regional Cancer Center,    Findlay, OH, USA Correspondence: Stephen Lutz   Department of Radiation Oncology,   Blanchard valley Regional Cancer Center,   15990 Medical Drive South, Findlay,   OH 45840, USA   Tel +1 419 423 3703   Fax +1 419 427 0212   email slutz@bvha.or gAbstract:  Bone metastases are prevalent among cancer patients and frequently cause  significant  morbidity.",Non-OADS,/arxiv_data1/oa_pdf/66/42/cmar-5-235.PMC3746785.pdf
"Available  from: http://www.nccn.org/professionals/physician_gls/f_guidelines.as p.  Accessed July 1 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/66/42/cmar-5-235.PMC3746785.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/66/42/cmar-5-235.PMC3746785.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/42/cmar-5-235.PMC3746785.pdf
"Available from: http://www.cancer.gov/cancertopics/druginfo/ fda-radium-223-dichlorid e. Accessed June 15 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/66/42/cmar-5-235.PMC3746785.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/73/ijwh-5-495.PMC3746788.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 495–499International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  495OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S4817 9High maternal and neonatal mortality rates in  northern nigeria: an 8-month observational study gilles guerrier1 Bukola Oluyide2 Maria Keramarou1 rebecca grais1 1epicentre, Paris, France;    2Médecins sans   Frontières, Paris, France correspondence: gilles guerrier   epicentre, 8 rue saint sabin,   75011 Paris, France   email guerriergilles@gmail.co mBackground:  Despite considerable efforts to reduce the maternal mortality ratio, numerous  pregnant women continue to die in many developing countries, including Nigeria.",Non-OADS,/arxiv_data1/oa_pdf/50/73/ijwh-5-495.PMC3746788.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/50/73/ijwh-5-495.PMC3746788.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/73/ijwh-5-495.PMC3746788.pdf
Available from: http://www.un.org/millennium/declaration/ares552e.,Non-OADS,/arxiv_data1/oa_pdf/50/73/ijwh-5-495.PMC3746788.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/80/ijwh-5-487.PMC3746789.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 487–494International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  487OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S4771 0HPV infection, cervical abnormalities,   and cancer in HIV-infected women   in Mumbai, India: 12-month follow-up Petros Isaakidis1,2 sharmila Pimple3 Bhanumati Varghese1 samsuddin Khan1 Homa Mansoor1 Joanna ladomirska1 neelakumari sharma1 esdras Da silva1 carol Metcalf4 severine caluwaerts4 Petra alders4 evangelia e ntzani2 T ony reid4 1Médecins sans Frontières, Mumbai,  India; 2clinical and Molecular  epidemiology Unit, Department of  Hygiene and epidemiology, University  of Ioannina school of Medicine,  Ioannina, greece; 3Preventive  Oncology Department, Tata Memorial  Hospital, Mumbai, India; 4Médecins  sans Frontières, Brussels, Belgium correspondence: Petros Isaakidis   Médecins sans Frontières, chandni  Bungalow, Union Park, Off carter road,  Khar (W), Mumbai 400 052, India   Tel +91 9930 534211   email msfocb-asia-epidemio@brussels.",Non-OADS,/arxiv_data1/oa_pdf/72/80/ijwh-5-487.PMC3746789.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/72/80/ijwh-5-487.PMC3746789.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/80/ijwh-5-487.PMC3746789.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commer- cial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/74/fws031.PMC3746797.pdf
"See further here: ,http://ethicsblog.crb.uu.se/2011/12/ 20/the-swedish-data-inspection-board-stops-large-biobank/ .accessed 11 August 2012.",Non-OADS,/arxiv_data1/oa_pdf/06/74/fws031.PMC3746797.pdf
"The judgment indicates that this might be particularly 39For an example of such an interpretation of an instance in which a consent form speciﬁed samples would be used for ‘medical research studies’ see P Burton,‘Policy for use and oversight of samples and data arising from the 1958 birthcohort (National Child Development Study)’ (Unpublished, Access Committee for CLS Cohorts, 2009) 14, available here ,http://www2.le.ac.uk/projects/ birthcohort/document-downloads/POLICY.DOCUMENT.120609.pdf .. 40Gillberg v Sweden , Application no 41723/06, 3 April 2012.41Ibid at [37].42Ibid at [97].43Ibid at [87] The participants’ data were held to be the property of the Univer- sity by whom the applicant was employed and as such were held to be publicdocuments subject to subject to the principle of public access under the Swedish Freedom of the Press Act and the Secrecy Act.",Non-OADS,/arxiv_data1/oa_pdf/06/74/fws031.PMC3746797.pdf
"To proceed without consent requires conformity with 68DPA 1998, s 33(1) and (4).69Proposal for a new Regulation of the European Parliament and of the Council on the protection of individuals with regard to the processing of personaldata and on the free movement of such data (General Data Protection Regulation) Brussels, 25 January 2012 COM(2012) 11 ﬁnal accessible at ,http://ec.europa.eu/justice/data-protection/document/review2012/com_ 2012_11_en.pdf .. 70Draft Recital 23 and draft Art 83(1).71Draft Recital 26.72Draft Art 4.8.",Non-OADS,/arxiv_data1/oa_pdf/06/74/fws031.PMC3746797.pdf
"109General Medical Council, Good Practice in Research and Consent to Research: Supplementary Guidance (GMC, 4 May 2010); British Medical Association, Conﬁdentiality and Disclosure of Health Information Tool kit available at ,http://bma.org.uk/practical-support-at-work/ethics/ conﬁdentiality-tool-kit .accessed 11 August 2012; Royal College of Physi- cians, Royal College of Pathologists and British Society for Human Genetics.Consent and Conﬁdentiality in Clinical Genetic Practice: Guidance on Genetic Testing and sharing genetic Information , 2nd edn, Report of the Joint Committee on Medical Genetics (RCP, RCPath, London 2011).Med.",Non-OADS,/arxiv_data1/oa_pdf/06/74/fws031.PMC3746797.pdf
"Supreme Court, 29 June 2012) online report available here ,http://www.supreme.courts.state.tx.us/ historical/2012/jun/110519.pdf ..154It is sufﬁcient that the person in possession of the goods acts in such a way as to deprive the claimant of their property rights in the goods, this must be through action not omission, but harm need not be intended.",Non-OADS,/arxiv_data1/oa_pdf/06/74/fws031.PMC3746797.pdf
"There is precedent law for extending the doctrine of speciﬁcation to include living organisms,albeit not human tissue ( Kinloch Damph Ltd v Nordvik Salmon Farms Ltd(Outer House, Court of Session, 30 June 1999) unreported—available here,http://www.scotcourts.gov.uk/opinions/ca291499.html .—cited in Hardcastle, above, n156 at 166).Med.",Non-OADS,/arxiv_data1/oa_pdf/06/74/fws031.PMC3746797.pdf
"This is an Open Access article dis- tributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/c2/agt052.PMC3746805.pdf
"http://www.dh.gov.uk/prod_consum_dh/groups/dh_ digitalassets/@dh/@en/documents/digitalasset/dh_075219.pdf/(February 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/4d/c2/agt052.PMC3746805.pdf
"http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_104854.pdf (February 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/4d/c2/agt052.PMC3746805.pdf
"http://www.communities.gov.uk/documents/local government/pdf/englishLSPssurvey.pdf (February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/4d/c2/agt052.PMC3746805.pdf
"http://www.nwph.net/nwpho/publications/AlcoholAtt ributableFractions.pdf/ (February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/4d/c2/agt052.PMC3746805.pdf
"https://owa.mdx.ac.uk/ CookieAuth.dll?GetLogon?reason=0&formdir=1&curl=Z2Fowa Z2F(May 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/4d/c2/agt052.PMC3746805.pdf
"http://www.nta.nhs.uk/uploads/ nta_review_of_the_effectiveness_of_treatment_for_alcohol_ problems_fullreport_2006_alcohol2.pdf/ (February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/4d/c2/agt052.PMC3746805.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/cd/agt061.PMC3746807.pdf
"ESENSE 1 : ClinicalTrials.gov: Nalmefene Efficacy Study I: Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy Study of 20 mg Nalmefene, as needed use, in patients with alcohol dependence;http://clinicaltrial.gov/ct2/show/NCT00811720?Term=NCT00811720&rank=1 ; NCT008 11720.",Non-OADS,/arxiv_data1/oa_pdf/fb/cd/agt061.PMC3746807.pdf
"ESENSE 2 : ClinicalTrials.gov: Nalmefene Efficacy Study II: Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy Study of 20 mg Nalmefene,as needed use, in patients with alcohol dependence; http://clinicaltrials.gov/ct2/show/ NCT00812461?Term=esense+2&rank=1 ; NCT00812461 REFERENCES Alonso J, Angermeyer MC, Bernert S et al.",Non-OADS,/arxiv_data1/oa_pdf/fb/cd/agt061.PMC3746807.pdf
"Available at: http://www.ema.europa.eu/ema/index.jsp?Curl=pages/medicines/human/medicines/002583/human_med_001620.jsp&mid=WC0b 01ac058001d124 (4 April 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/fb/cd/agt061.PMC3746807.pdf
"Available at: http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_ R1/Step4/E6_R1__Guideline.pdf (4 April 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/fb/cd/agt061.PMC3746807.pdf
"Available at: http://www.wma.net/en/30publications/ 10policies/b3/ (4 April 2013, date last accessed).578 van den Brink et al.",Non-OADS,/arxiv_data1/oa_pdf/fb/cd/agt061.PMC3746807.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journa l, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced o r disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/51/bc/hft052.PMC3746839.pdf
"Full report of this project is available in  http://www.icrc.ir/images_/selfcare.pdf  Acknowledgements  The study was supported by the Health Education  and Promotion Bureau of the Iranian Ministry of  Health and Medical Education, and a grant from the  office of WHO in Iran.",Non-OADS,/arxiv_data1/oa_pdf/ef/2b/ARYA-09-232.PMC3746943.pdf
2006; Available from:  URL:  http://selfmanagementsupport.health.org.uk/media_  manager/public/179/SMS_resource- centre_publications/Self care - a guide to  developing local strategies and good practice.pdf /   17.,Non-OADS,/arxiv_data1/oa_pdf/ef/2b/ARYA-09-232.PMC3746943.pdf
2013; Available  from: URL: http://www.dafne.uk.com/  18.,Non-OADS,/arxiv_data1/oa_pdf/ef/2b/ARYA-09-232.PMC3746943.pdf
2012; Available from: URL:  http://www.sci.org.ir/  16.,Non-OADS,/arxiv_data1/oa_pdf/1c/e0/ARYA-09-217.PMC3746944.pdf
2010; Available from: URL:  http://www.theheart.org/article/1040987.do/,Non-OADS,/arxiv_data1/oa_pdf/18/3b/ARYA-09-241.PMC3746947.pdf
2012; Available from: URL:  http://emedicine.medscape.com/article/892489- overview/  5.,Non-OADS,/arxiv_data1/oa_pdf/40/30/ARYA-09-254.PMC3746948.pdf
2003; Available from:   URL: https://www.orpha.net/data/patho/GB/uk- TA05.pdf/  9.,OADS,/arxiv_data1/oa_pdf/40/30/ARYA-09-254.PMC3746948.pdf
2006; Available from: URL:   http://www.orpha.net/consor/cgi- bin/Disease_Search.php?lng=EN&data_id=1888/  32.,OADS,/arxiv_data1/oa_pdf/40/30/ARYA-09-254.PMC3746948.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/8f/cvt128.PMC3746952.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/83/8a/amep-4-135.PMC3746973.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 135–136Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  135LEttEropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S5164 6Publishing medical schools’ USMLE Step 1 scores:  increase preclinical education accountability and  national standards Adam EM Eltorai Brown University, Warren Alpert  Medical School, Providence, rI, USA Correspondence: Adam EM Eltorai   Brown University,   Warren Alpert Medical School,   Box G-9247, Providence, rI 02903, USA   tel +1 401 863 2149   Fax +1 401 863 5096   Email aeltorai@gmail.co mDear Editor Medical education innovation is a field of active investigation.1,2 Whether it is problem- based learning, lectures, discussion groups, systems-based blocks, integrated courses,  video-captured, pass-fail, or iPad-requiring, every medical school approaches preclini - cal education differently.",Non-OADS,/arxiv_data1/oa_pdf/83/8a/amep-4-135.PMC3746973.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  healthcare professional education.",Non-OADS,/arxiv_data1/oa_pdf/83/8a/amep-4-135.PMC3746973.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/8a/amep-4-135.PMC3746973.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/6e/ndt-9-1159.PMC3747020.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1159–1162Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1159OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4815 2a comparison of complex sleep behaviors   with two short-acting Z-hypnosedative   drugs in nonpsychotic patients li-Fen chen1 ching-en lin1–3 Yu-ching chou4 Wei-chung Mao1,5 Yi-chyan chen1–3 Nian-sheng Tzeng1,6 1Department of Psychiatry, Tri- service general hospital, school of  Medicine, National Defense Medical  center, Taipei city, Taiwan; 2Taipei Tzu  chi hospital, The Buddhist Medical  Foundation, Taipei, Taiwan; 3school of  Medicine, Tzu chi University, hualien,   Taiwan; 4school of Public health,   National Defense Medical center,   Taipei city, Taiwan; 5institute of Brain  science, school of Medicine, National  Yang-Ming University, Taipei city,   Taiwan; 6student counseling center,   National Defense Medical center,   Taipei city, Taiwan correspondence: Nian-sheng Tzeng   Department of Psychiatry,   Tri-service general hospital, 325,   sec 2, chenggong road, Nei-hu District,  114, Taipei, Taiwan   T el +886 2 8792 7299   Fax +886 2 8792 7221   email pierrens@mail.ndmctsgh.edu.t w Objective:  Complex sleep behaviors (CSBs) are classified as “parasomnias” in the  International Classification of Sleep Disorders, Second Edition  (ICSD-2).",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/ndt-9-1159.PMC3747020.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/ndt-9-1159.PMC3747020.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/6e/ndt-9-1159.PMC3747020.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/6a/ndt-9-1163.PMC3747021.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1163–1170Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1163OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4908 0Psychiatrists’ awareness of partial   and nonadherence to antipsychotic medication   in schizophrenia: results from an Asia–Pacific survey Jose Manuel Olivares1 Manickam Thirunavukarasu2 Jayashri Kulkarni3 hong Yan Zhang4 Mingyuan Zhang5 Fan Zhang6 1Department of Psychiatry, hospital  Meixoeiro, complejo hospitalario  Universitario de Vigo, Vigo, spain;   2Department of Psychiatry, srM  Medical college hospital and  research center, Tamil Nadu, india;   3Department of Psychiatry, Monash  University and the alfred hospital,   Prahran, Vic, australia; 4Department of  Psychiatry, Peking University institute  of Mental health, Beijing, People’s  republic of china; 5Department of  Psychiatry, shanghai Mental health  center, shanghai, People’s republic of  china; 6Medical affairs, Xian Janssen  Pharmaceutical, Beijing, People’s  republic of china correspondence: José Manuel Olivares   Department of Psychiatry, hospital  Meixoeiro, complejo hospitalario  Universitario de Vigo, avda.",Non-OADS,/arxiv_data1/oa_pdf/90/6a/ndt-9-1163.PMC3747021.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/90/6a/ndt-9-1163.PMC3747021.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/6a/ndt-9-1163.PMC3747021.pdf
"Available at: http://www.who.int/mental_health/evidence/atlas/profiles/ en/index.htm l. Accessed June 19, 2013.",Non-OADS,/arxiv_data1/oa_pdf/90/6a/ndt-9-1163.PMC3747021.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/d7/ndt-9-1171.PMC3747023.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1171–1174Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1171Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5024 4increased biogenic catecholamine and metabolite  levels in two patients with malignant catatonia Koichi Nisijima Department of Psychiatry, Jichi  Medical University, T ochigi, Japan Correspondence: Koichi Nisijima   Department of Psychiatry, Yakushiji   shimotuke- shi Tochigi-Ken,   329-0498, Japan   Tel +812 8558 7364   Fax +812 8544 6198   email midorin@jichi.ac.j pAbstract:  The pathophysiology of malignant catatonia, a rare life-threatening psychiatric  syndrome, has not yet been elucidated.",Non-OADS,/arxiv_data1/oa_pdf/19/d7/ndt-9-1171.PMC3747023.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/19/d7/ndt-9-1171.PMC3747023.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/d7/ndt-9-1171.PMC3747023.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/jpr-6-635.PMC3747026.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 635–639Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  635ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S4372 9Protocols for treating the postoperative pain   of fractures in Dutch hospitals Rikkert Ossendorp1 Tymour Forouzanfar2 claire e ashton-James2,3 Frank Bloemers1 1Department of surgery, VU  University Medical center,   2Department of Oral and Maxillofacial  surgery, VU University Medical  center, 3Department of social   and Organizational Psychology,    VU University, amsterdam,    The netherlands correspondence: FW Bloemers   Department of surgery, VU University  Medical center, PO Box 7057, 1007 MB,  amsterdam, The netherlands   Tel +31 20 444 1150   Fax +31 20 444 1024   email fw.bloemers@vumc.n lIntroduction:  Every year, over 260,000 patients in the Netherlands are diagnosed with a trau - matic fracture.",Non-OADS,/arxiv_data1/oa_pdf/25/1b/jpr-6-635.PMC3747026.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/25/1b/jpr-6-635.PMC3747026.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/1b/jpr-6-635.PMC3747026.pdf
"J Cell Biol 2012; 198:1011–23; PMID:22965908; http://dx.doi.org/10.1083/jcb.201203075Keywords:  epithelial cell polarity,  MDCK, lumen formation, mechano - transduction, ciliogenesis, Rho, Rab Submitted: 01/21/13Accepted: 03/14/13http://dx.doi.org/10.4161/sgtp.24303 *Correspondence to: Fernando Martín-Belmonte;  Email: fmartin@cbm.uam.es Epithelial cells differentiate and polar - ize to build complete epithelial organs  during development.",Non-OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Curr Opin Cell Biol 2011; 23:540- 6; PMID:21807488; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Cell  1996; 84:335-44; PMID:8608587; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Rev Mol Cell Biol  2009; 10:75-82; PMID:19197334; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
J Cell Sci 2012; 125:3061-73;  PMID:22797927; http://dx.doi.org/10.1242/ jcs.093005.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Rev Mol Cell Biol 2012; 13:591-600;  PMID:22895435; http://dx.doi.org/10.1038/ nrm3416.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nature 2011; 474:179- 83; PMID:21654799; http://dx.doi.org/10.1038/ nature10137.,Non-OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Science  2007; 316:1749-52; PMID:17588931; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Cell 2003; 113:329-42;  PMID:12732141; http://dx.doi.org/10.1016/S0092- 8674(03)00278-2.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Rev Mol Cell Biol 2011; 12:308-19;  PMID:21508987; http://dx.doi.org/10.1038/ nrm3112.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Rev Nephrol 2010; 6:530-8; PMID:20625375; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Rev Cancer 2009; 9:108-22; PMID:19165226; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Curr Opin Cell Biol 2011; 23:523-30;  PMID:21890337; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Proc Natl Acad Sci U S  A 2013; 110:163-8; PMID:23248267; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Cell Biol 2013; 15:17- 27; PMID:23263281; http://dx.doi.org/10.1038/ ncb2646.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Cell Biol 2012; 14:1235-43; PMID:23196841;  http://dx.doi.org/10.1038/ncb2635.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Cell Biol 2012;  14:838-49; PMID:22820376; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Cell Biol 2010; 12:1035- 45; PMID:20890297; http://dx.doi.org/10.1038/ ncb2106.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Cell 2007; 128:383- 97; PMID:17254974; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
J Cell Biol 2010; 189:725-38; PMID:20479469;  http://dx.doi.org/10.1083/jcb.201002047.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
J Cell Biol 2012; 199:1083-101; PMID:23253480;  http://dx.doi.org/10.1083/jcb.201202126.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Science 2009; 324:1673-7; PMID:19556500;  http://dx.doi.org/10.1126/science.1171643.3.,Non-OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Cell  1990; 62:309-16; PMID:2164888; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Annu Rev  Cell Dev Biol 2006; 22:287-309; PMID:16824016;  http://dx.doi.org/10.1146/annurev.cell - bio.22.010305.104315.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Annu Rev  Biomed Eng 2012; 14:129-54; PMID:22524386;  http://dx.doi.org/10.1146/annurev-bio - eng-071811-150043.,Non-OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
J Cell Sci 2010; 123:4201-13; PMID:21123618; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nature 2011; 471:99-103; PMID:21368832;  http://dx.doi.org/10.1038/nature09765.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Trends Cell Biol 2011; 21:745-54; PMID:22033488; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
J Cell Biol 2010; 191:303-12;  PMID:20956379; http://dx.doi.org/10.1083/ jcb.201004003.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
J Cell Biol 2012; 198:1011-23; PMID:22965908; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Mol Biol Cell 2005; 16:433-45;  PMID:15574881; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Nat Cell Biol 2001; 3:831-8; PMID:11533663; http://dx.doi.org/10.1038/ ncb0901-831.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
Dev Cell  2011; 20:526-39; PMID:21396893; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/30/e0/sgtp-4-136.PMC3747256.pdf
"www.landesbioscience.com Small GTPases 61 EDITOR’S CAORNER RETRACTION Small GTPases 4:2, 61–61; April/May/June 2013; © 2013 Landes Bioscience The following article from Small GTPases, “Scientific Yellow Journalism” by Anica Klockars and Michael J. Williams, published  online on 20 September 2012 (doi: 10.4161/sgtp.22289; PMID: 22995950; http://www.landesbioscience.com/journals/smallgt - pases/article/22289) by Landes Bioscience and subsequently published in print in Small GTPases 2012 3(4):201 has been retracted  in whole by agreement between the authors and the journal’s Editor-in-Chief, Michael J. Williams (also an author of the paper).",Non-OADS,/arxiv_data1/oa_pdf/e0/ab/sgtp-4-61.PMC3747257.pdf
"Retracted manuscript Scientific yellow journalism Anica Klockars and Michael J. Williams  Department of Neuroscience; Uppsala University; Uppsala, Sweden *Correspondence to: Michael J. Williams; Email: mwdros@gmail.com http://dx.doi.org/10.4161/sgtp.24294",Non-OADS,/arxiv_data1/oa_pdf/e0/ab/sgtp-4-61.PMC3747257.pdf
"Levine; Email: tim.levine@ucl.ac.uk Submitted: 01/17/13; Revised: 03/05/13; Accepted: 03/11/13 http://dx.doi.org/10.4161/sgtp.24262modules, but the range of their interac - tions is highly restricted.",Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
J Biol  Chem 2011; 286:13791-800; PMID:21330364;  http://dx.doi.org/10.1074/jbc.R110.217067 19.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Open  Biol 2012; 2:120071; PMID:22977732; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
J Natl Cancer Inst 2008; 100:140- 54; PMID:18182616; http://dx.doi.org/10.1093/jnci/ djm288 21.,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
J Biol Chem 2010; 285:19705- 9; PMID:20457610; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
J  Biol Chem 2008; 283:16915-27; PMID:18397879;  http://dx.doi.org/10.1074/jbc.M802550200 23.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
PLoS Biol 2012; 10:e1001438;  PMID:23226104; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Nucleic Acids Res 2005; 33(Web  Server issue):W244-8; PMID:15980461; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Front Genet 2012;  3:283; PMID:23248642; http://dx.doi.org/10.3389/ fgene.2012.00283 27.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Bioinformatics 2013; 29:499-503;  PMID:23329412; http://dx.doi.org/10.1093/bioinfor - matics/bts725 28.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Curr Neurol Neurosci Rep 2012; 12:243-50;  PMID:22477152; http://dx.doi.org/10.1007/s11910- 012-0268-5 29.,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Protein Sci  2006; 15:2669-74; PMID:17075139; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Curr Biol 2010; 20:1654-9;  PMID:20797862; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Biochim Biophys Acta 2013; 1833:468- 78; PMID:23103514; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Nat Struct Mol Biol 2012; 19:1300-9;  PMID:23104059; http://dx.doi.org/10.1038/ nsmb.2414 6.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Cell Motil Cytoskeleton 2008; 65:183- 96; PMID:18044744; http://dx.doi.org/10.1002/ cm.20254 8.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Biochem Biophys Res Commun  2001; 287:688-95; PMID:11563850; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Proc Natl Acad Sci U S A  2004; 101:10984-9; PMID:15263099; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
EMBO  J 2011; 30:4185-97; PMID:21847100; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
J Biol Chem  2006; 281:8898-906; PMID:16439358; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Cell  2008; 133:1202-13; PMID:18585354; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Proc Natl Acad Sci U S A 2011; 108:18672- 7; PMID:22065758; http://dx.doi.org/10.1073/ pnas.1110415108 14.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Genes Dev 2011; 25:1668- 73; PMID:21816923; http://dx.doi.org/10.1101/ gad.16968011 15.,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
J Biol Chem  2012; 287:29648-53; PMID:22807443; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Structure 2012; 20:2151- 60; PMID:23123112; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
"Science 2008; 320:1496-501; PMID:18497260;  http://dx.doi.org/10.1126/science.1157535top, with two helices, that interacts with  specific partners involved in membrane  traffic – either GTPases or SNAREs.5 The  overall fold of LD/RDs is preserved with  very little obvious sequence conservation,11  so it is necessary to use remote homology  searches that include secondary structure  predictions to find new domains.25 Such  searches identified two RD-only proteins  in yeast that are homologous to Ragulator  subunits.",OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Supplemental Material Supplemental material may be found  here: http://www.landesbioscience.com/ journals/smallgtpases/article/24262/ References 1.,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
J Cell Biol  2010; 191:367-81; PMID:20937701; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Curr Biol 2012; 22:2135-9; PMID:23084991;  http://dx.doi.org/10.1016/j.cub.2012.09.020 3.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
BMC  Biol 2012; 10:71; PMID:22873208; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Proc Natl Acad Sci U S A  2003; 100:9011-6; PMID:12853575; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
PLoS One 2011; 6:e23350;  PMID:21858081; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Nat Struct Mol Biol 2010; 17:1298- 304; PMID:20972447; http://dx.doi.org/10.1038/ nsmb.1914 50.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Genetics 2012; 191:451-60;  PMID:22426882; http://dx.doi.org/10.1534/genet - ics.112.139378 52.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
J Cell Biol  2000; 151:289-96; PMID:11038176; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Biochem Biophys Res Commun  2009; 378:338-43; PMID:18466758; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Nat Rev Mol Cell Biol  2010; 11:759-63; PMID:20966969; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Mol Biol Cell 2011; 22:2083- 93; PMID:21525244; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
BMC Evol Biol 2007; 7:29; PMID:17319956;  http://dx.doi.org/10.1186/1471-2148-7-29 44.,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
T raffic 2011; 12:715-25;  PMID:21453443; http://dx.doi.org/10.1111/j.1600- 0854.2011.01181.x 45.,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
PLoS One 2010; 5:e10646; PMID:20498720;  http://dx.doi.org/10.1371/journal.pone.0010646 47.,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Science  2012; 337:1668-72; PMID:23019651; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Mamm Genome 2012; 23:404-15; PMID:22538705;  http://dx.doi.org/10.1007/s00335-012-9398-y 33.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
PLoS Genet  2009; 5:e1000515; PMID:19521502; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
"Mol Cell Proteomics 2011; 10:M110, 006478;  PMID:21454883; http://dx.doi.org/10.1074/mcp.",OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Mol Biol Cell 2011; 22:4124- 33; PMID:21900499; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Cell 2010; 141:290- 303; PMID:20381137; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Cell 2012; 150:1196- 208; PMID:22980980; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
Northeast  Structural Genomics Consortium Target YT727/ Ontario Center for Structural Proteomics Target  yst6499; http://www.ncbi.nlm.nih.gov/Structure/ mmdb/mmdbsrv.cgi?uid=2GRG,Non-OADS,/arxiv_data1/oa_pdf/e2/2f/sgtp-4-62.PMC3747258.pdf
"*Correspondence to: Dusanka Deretic; Email: dderetic@salud.unm.edu Submitted: 01/24/13; Revised: 03/18/13; Accepted: 03/21/13 http://dx.doi.org/10.4161/sgtp.24396Small GTPases are versatile temporal and spatial regulators of  virtually all cellular processes including signal transduction,  cytoskeleton dynamics and membrane trafficking.",OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Small GTPases 2012; 3:80- 90; PMID:22790194; http://dx.doi.org/10.4161/ sgtp.19842 2.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
EMBO J 2009; 28:183-92; PMID:19153612;  http://dx.doi.org/10.1038/emboj.2008.267 4.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Regulation of sorting and post-Golgi  trafficking of rhodopsin by its C-terminal sequence  QVS(A)PA. Proc Natl Acad Sci U S A 1998; 95:10620- 5; PMID:9724753; http://dx.doi.org/10.1073/ pnas.95.18.10620 5.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Proc Natl Acad Sci U S A 2005; 102:3301- 6; PMID:15728366; http://dx.doi.org/10.1073/ pnas.05000951026.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Curr Biol  2006; 16:1211-6; PMID:16782012; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Mol Biol Cell 2011; 22:3289-305;  PMID:21775626; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Cell Signal 2004; 16:401-13;  PMID:14709330; http://dx.doi.org/10.1016/j.cell - sig.2003.09.012 11.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Proc Natl Acad Sci U S A 2010; 107:6346- 51; PMID:20308558; http://dx.doi.org/10.1073/ pnas.1002401107 13.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Proc Natl Acad Sci U S A  2011; 108:2759-64; PMID:21273506; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Biol Chem 2001; 276:39067-75; PMID:11495908;  http://dx.doi.org/10.1074/jbc.M104831200 15.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Biol Chem  2004; 279:33430-7; PMID:15173169; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nat Struct Mol Biol  2008; 15:373-80; PMID:18376416; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Cell Biol 2010; 189:1039- 51; PMID:20530210; http://dx.doi.org/10.1083/ jcb.200912001 50.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Science  2004; 303:495-9; PMID:14645856; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Cell Signal 2005; 17:1276-88;  PMID:16038802; http://dx.doi.org/10.1016/j.cell - sig.2005.01.007 52.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Semin Cell Dev Biol 2010; 21:391-8; PMID:20083215;  http://dx.doi.org/10.1016/j.semcdb.2010.01.010 53.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Biol Chem 2009; 284:1652-63;  PMID:19017632; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nature 2001; 411:215-9; PMID:11346801;  http://dx.doi.org/10.1038/35075620 55.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Cell 2004; 116:445-56;  PMID:15016378; http://dx.doi.org/10.1016/S0092- 8674(04)00117-5 56.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Arfaptin 1 forms a complex with ADP-ribosylation  factor and inhibits phospholipase D. FEBS Lett  1999; 454:85-9; PMID:10413101; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Proc Natl Acad Sci U S A 2006; 103:15416-21;  PMID:17030804; http://dx.doi.org/10.1073/ pnas.0605357103 58.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Annu Rev Biochem  2012; 81:637-59; PMID:22463690; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nat Cell Biol 2010; 12:1035-45;  PMID:20890297; http://dx.doi.org/10.1038/ncb2106 61.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Biochem Soc T rans 2006; 34:683-6; PMID:17052174;  http://dx.doi.org/10.1042/BST034068332.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Cell 2007; 129:1201- 13; PMID:17574030; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Cell Biol 2007; 178:363- 9; PMID:17646400; http://dx.doi.org/10.1083/ jcb.200703047 35.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Hum Mol Genet 2010; 19:3591-8; PMID:20631154;  http://dx.doi.org/10.1093/hmg/ddq275 36.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
EMBO J 1999; 18:1071- 80; PMID:10022848; http://dx.doi.org/10.1093/ emboj/18.4.1071 37.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Biol Chem 2012; 287:15602-9; PMID:22433857;  http://dx.doi.org/10.1074/jbc.M111.333245 38.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
EMBO J 2013; 32:874- 85; PMID:23435566; http://dx.doi.org/10.1038/ emboj.2013.32 39.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Cell Biol 2006; 172:645-50; PMID:16505163;  http://dx.doi.org/10.1083/jcb.200512057 40.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Biochem Soc T rans 2005; 33:1276- 8; PMID:16246097; http://dx.doi.org/10.1042/ BST20051276 41.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Curr Opin Cell Biol 2003; 15:396-404;  PMID:12892779; http://dx.doi.org/10.1016/S0955- 0674(03)00071-1 43.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nat Rev Mol Cell Biol  2011; 12:362-75; PMID:21587297; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Annu Rev Cell Dev Biol 2004; 20:87-123;  PMID:15473836; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nature 2005; 437:1018- 21; PMID:16136078; http://dx.doi.org/10.1038/ nature04117 18.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Science  2000; 289:739-45; PMID:10926528; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Mol Biol  2006; 364:121-35; PMID:17007872; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Mol Cell  2007; 25:455-62; PMID:17289591; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nat Struct Mol Biol  2006; 13:577-81; PMID:16826234; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
EMBO J 2007; 26:3484-93; PMID:17581628;  http://dx.doi.org/10.1038/sj.emboj.7601771 23.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Cell 2008; 132:286- 98; PMID:18243103; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nat Rev Mol Cell Biol  2010; 11:759-63; PMID:20966969; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Cell 2010; 141:812- 21; PMID:20510928; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J  Biol Chem 2012; 287:40996-1006; PMID:23055524;  http://dx.doi.org/10.1074/jbc.M112.349803 27.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Cell Sci 2007; 120:3929- 40; PMID:17956946; http://dx.doi.org/10.1242/ jcs.010769 28.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Curr  Biol 2006; 16:130-9; PMID:16431365; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Mol Biol Cell 2008; 19:4224-37; PMID:18685082;  http://dx.doi.org/10.1091/mbc.E08-03-0290 30.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Mol Biol Cell 2002; 13:3268-80; PMID:12221131;  http://dx.doi.org/10.1091/mbc.E02-03-0143 31.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Genomics 2010; 96:362- 8; PMID:20887780; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nature 2007; 445:941- 4; PMID:17287728; http://dx.doi.org/10.1038/ nature05527 80.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nature  2011; 473:181-6; PMID:21532587; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Cell  2003; 114:497-509; PMID:12941277; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Mol Biol Cell 2003; 14:2116-27;  PMID:12802079; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Small GTPases 2012; 3:107-10; PMID:22790198;  http://dx.doi.org/10.4161/sgtp.19380.71.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Dev Cell 2010; 18:828-40;  PMID:20493815; http://dx.doi.org/10.1016/j.dev - cel.2010.03.016 72.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Cell Biol  1997; 137:1495-509; PMID:9199166; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Biol Chem 2004; 279:43027- 34; PMID:15292201; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nat Struct Mol Biol  2005; 12:879-85; PMID:16155582; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Cell Sci  2009; 122:2003-13; PMID:19454479; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Biochem Biophys  Res Commun 2004; 319:138-43; PMID:15158452;  http://dx.doi.org/10.1016/j.bbrc.2004.04.165 77.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Mol Biol Cell  2004; 15:359-70; PMID:13679519; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Int Rev Cytol  2004; 233:243-65; PMID:15037366; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
T rends Cell Biol  2011; 21:383-6; PMID:21550243; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
T raffic 2012; 13:898-907; PMID:22420621;  http://dx.doi.org/10.1111/j.1600-0854.2012.01353.x 65.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Mol Biol Cell 2006; 17:2757-69;  PMID:16611746; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Neuroreport  2008; 19:1643-7; PMID:18845944; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
Nat Rev Mol Cell Biol 2001;  2:107-17; PMID:11252952; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
J Cell Biol 2002; 157:1005- 15; PMID:12045183; http://dx.doi.org/10.1083/ jcb.200201003,OADS,/arxiv_data1/oa_pdf/59/9a/sgtp-4-70.PMC3747259.pdf
"Small GTPases 4:2, 90–101; April/May/June 2013; © 2013 Landes Bioscience RESEARCH PAPER 90 Small GTPases Volume 4 Issue 2*Correspondence to: Erzsébet Ligeti; Email: ligeti@puskin.sote.hu Submitted: 10/10/12; Revised: 11/25/12; Accepted: 01/22/13 http://dx.doi.org/10.4161/sgtp.23708Introduction Reorganization of the actin cytoskeleton, focal adhesions, vesicle  trafficking, cell movement and immunological processes such  as phagocytosis or production of reactive oxygen species have  fine temporal and spatial regulation by Rho family GTPases.1-3  As molecular switches, small G-proteins are able to bind GTP,  which turns them to an active state.",Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
The amino acid sequences of 65 human  RhoGAP domains from UniProt/Swissprot (http://www.uni - prot.org) were aligned and edited applying the ClustalW program  incorporated to MEGA5 software using Gonnet protein weight  matrix.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
EST profiles of 54 human  Rho family GAP genes (http://www.ncbi.nlm.nih.gov/unigene) were searched and analyzed.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
"98 Small GTPases Volume 4 Issue 2experiments GDS1209 (http://www.ncbi.nlm.nih.gov/sites/ GDSbrowser?acc=GDS1209)37,38 and GSE3982 (http://www.",Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE3982)39 were  performed with Affymetrix Human Genome U133A array  and were obtained from PubMed GEO DataSets database   (http://www.ncbi.nlm.nih.gov/gds).,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
"Sources of abbreviations and aliases of human Rho/Rac GAPs Original source (abbreviation) Link Approved symbol HUGO Gene Nomencature Committee (HGNC) http://www.genenames.org/ Approved name HUGO Gene Nomencature Committee (HGNC) http://www.genenames.org/ Previous symbols HUGO Gene Nomencature Committee (HGNC) http://www.genenames.org/ Sequence lenght (amino acids) UniProt Protein Knowledgebase (UniProt KB) http://www.uniprot.org/ Chromosomal location HUGO Gene Nomencature Committee (HGNC) http://www.genenames.org/ RefSeq Transcript ID National Center for Biotechnology Information (NCBI) http://www.ncbi.nlm.nih.gov/gene/ Ensembl Gene ID Ensembl Genome Browser http://www.ensembl.org/index.html Entrez Gene ID National Center for Biotechnology Information (NCBI) http://www.ncbi.nlm.nih.gov/gene KIAA Number Kazusa cDNA Sequencing Project http://www.ihop-net.org/UniPub/iHOP/ FLJ Number NEDO Human cDNA Sequencing Project http://www.ihop-net.org/UniPub/iHOP/ Other aliasesInformation Hyperlinked Over Proteins (iHOP) HUGO  Gene Nomenclature Committee (HGNC), GeneCardshttp://www.ihop-net.org/UniPub/iHOP/   http:// www.genenames.org/Table 4.",Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
100 Small GTPases Volume 4 Issue 2Supplemental Materials Supplemental material may be downloaded here:  http://www.landesbioscience.com/journals/smallgtpases/ article/23708and Spearman Rank Order Correlation.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
T rends Cell  Biol 2006; 16:522-9; PMID:16949823; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
T rends Cell Biol 2005; 15:163-71;  PMID:15752980; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Nature 1993; 366:643-54;  PMID:8259209; http://dx.doi.org/10.1038/366643a0 5.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Biol  Cell 2007; 99:67-86; PMID:17222083; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Curr Opin Cell Biol 1996; 8:216-22; PMID:8791419;  http://dx.doi.org/10.1016/S0955-0674(96)80068-8 7.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Cell Signal  1999; 11:545-54; PMID:10433515; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
T rends Biochem Sci 1998; 23:257-62;  PMID:9697416; http://dx.doi.org/10.1016/S0968- 0004(98)01224-9 9.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Physiol Rev 2012; 92:237-72;  PMID:22298657; http://dx.doi.org/10.1152/phys - rev.00045.2010 10.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
J Biol Chem 2003; 278:14599-602;  PMID:12637568; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Nat Struct  Biol 1998; 5:1047-52; PMID:9846874; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
T rends Cell Biol 2003; 13:13-22;  PMID:12480336; http://dx.doi.org/10.1016/S0962- 8924(02)00004-1 15.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Gene Expr Patterns 2003; 3:219-23;  PMID:12711552; http://dx.doi.org/10.1016/S1567- 133X(02)00073-X 17.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Prog Neurobiol 2011; 94:133-48;  PMID:21530608; http://dx.doi.org/10.1016/j.pneuro - bio.2011.04.011 18.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Cell Struct Funct 2001; 26:645-51;  PMID:11942621; http://dx.doi.org/10.1247/csf.26.645 20.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
J Cell Biol 2008; 182:1039-44; PMID:18809720;  http://dx.doi.org/10.1083/jcb.200806041 22.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
J Neurosci  2012; 32:2824-34; PMID:22357865; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Biochem Biophys Res Commun 2003; 306:151- 5; PMID:12788081; http://dx.doi.org/10.1016/ S0006-291X(03)00923-9 24.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Mol Biol Cell 2003;  14:2921-34; PMID:12857875; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
J Neurosci 2010; 30:14134- 44; PMID:20962234; http://dx.doi.org/10.1523/ JNEUROSCI.1711-10.2010 26.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Dev Dyn  2002; 223:517-25; PMID:11921339; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Cell  1995; 80:719-28; PMID:7889565; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Cancer Res 2005; 65:5881-9; PMID:15994966;  http://dx.doi.org/10.1158/0008-5472.CAN-04-4078 38.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
J Surg Res 2006; 135:282- 90; PMID:16603191; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Nat Immunol 2006; 7:274-83;  PMID:16474395; http://dx.doi.org/10.1038/ni131033.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Curr Protein Pept Sci 2006;  7:355-65; PMID:16918449; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Cell 2008; 135:510- 23; PMID:18984162; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Oncogene 2003; 22:445- 50; PMID:12545165; http://dx.doi.org/10.1038/ sj.onc.1206064 36.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Oncogene 2004; 23:1405-11; PMID:14661059;  http://dx.doi.org/10.1038/sj.onc.120729129.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Mol Cell Biol  2007; 27:899-911; PMID:17116687; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Blood 2012; 119:573-82; PMID:22096251;  http://dx.doi.org/10.1182/blood-2010-12-324053 31.,Non-OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Science 1991; 252:1651- 6; PMID:2047873; http://dx.doi.org/10.1126/sci - ence.2047873 32.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Oncogene  2011; 30:1032-45; PMID:21042277; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/de/sgtp-4-90.PMC3747261.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201302075/DC1.,Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201302075.dv.,OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1172/JCI3801 9 Akhmanova, A., and C.C.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/j.ceb.2004.11.00 1 Akhmanova, A., C.C.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10   .1016/S0092-8674(01)00288- 4 Al-Bassam, J., H. Kim, G. Brouhard, A. van Oijen, S.C. Harrison, and F.  Chang.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/   10.1016/j.devcel.2010.07.01 6 Alev, C., Y. Wu, T. Kasukawa, L.M.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1242/dev.05346 2 Alev, C., M. Nakano, Y .",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/j.cell.2008.10.01 8 Bacallao, R., C. Antony, C. Dotti, E. Karsenti, E.H. Stelzer, and K. Simons.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"109:2817– 2832. http://dx.doi.org/10.1083/jcb.109.6.281 7 Bozzi, M., S. Morlacchi, M.G.",Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10   .1016/0092-8674(95)90344- 5 Carvalho, P., J.S.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/S0962-   8924(03)00074- 6et al., 2005).",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/   10.1126/science.267233 0 Rowe, R.G., and S.J.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.24.110707.17531 5 Schmidt, A., and A.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/   10.1074/jbc.M11110820 0 Söderberg, O., M. Gullberg, M. Jarvius, K. Ridderstråle, K.J.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/   10.1146/annurev-cellbio-092910-15404 3 Stern, C.D.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/S0070-   2153(08)60505- 0 Teng, J., T. Rai, Y. Tanaka, Y. Takei, T. Nakata, M. Hirasawa, A.B.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/j.cell.2009.11.00 7 Wen, Y., C.H.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1038/ncb116 0 Wickström, S.A., A. Lange, M.W.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/   10.1016/j.devcel.2010.09.00 7 Williams, M., C. Burdsal, A. Periasamy, M. Lewandoski, and A. Sutherland.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1002/dvdy.2371 1 Yu, H., and J.F.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi   .org/10.1042/BJ2002150 0Cerecedo, D., B. Cisneros, R. Suárez-Sánchez, E. Hernández-González, and I.  Galván.",Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
141:517– 528. http://dx.doi.org/10.1111/j.1365-2141.2008.07048.,Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/   0092-8674(91)90035- W Hagedorn, E.J., and D.R.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.05.00 2 Henry, M.D., and K.P.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/S0955-0674(99)   00024- 1 Hotta, A., T. Kawakatsu, T. Nakatani, T. Sato, C. Matsui, T. Sukezane, T.  Akagi, T. Hamaji, I. Grigoriev, A. Akhmanova, et al.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi   .org/10.1083/jcb.20091009 5 Ibraghimov-Beskrovnaya, O., J.M.",Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1038/355696a 0 Kalluri, R., and R.A. Weinberg.",Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1172/   JCI3910 4 Kerosuo, L., and M. Bronner-Fraser.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/j.semcdb.2012.03.01 0 Lansbergen, G., I. Grigoriev, Y. Mimori-Kiyosue, T. Ohtsuka, S. Higa, I.  Kitajima, J. Demmers, N. Galjart, A.B.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi   .org/10.1016/j.devcel.2006.05.01 2 Levayer, R., and T. Lecuit.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"10:757– 759. http://dx.doi.org/10.1038/ncb0708-75 7 Lim, J., and J.P. Thiery.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10   .1242/dev.07120 9 Meng, W., Y. Mushika, T. Ichii, and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/j.cell.2008.09.04 0 Mimori-Kiyosue, Y.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1002/cm.2054 0 Mimori-Kiyosue, Y ., I. Grigoriev, G. Lansbergen, H. Sasaki, C. Matsui, F. Severin,  N. Galjart, F. Grosveld, I. V orobjev, S. Tsukita, and A. Akhmanova.",Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/   10.1083/jcb.20040509 4 Moreno-Bueno, G., F. Portillo, and A. Cano.",Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi   .org/10.1038/onc.2008.34 6 Müsch, A.",Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
http://dx.doi.org/10.1111/j.1600-0854.2003.00149.,Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
http://dx.doi.org/10.1111/j.1440-169X.2008.01070.,Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10.1016/j.canlet.2013.02.03 7 Nakaya, Y., E.W.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
"http://dx.doi.org/10   .1038/ncb173 9 Nakaya, Y., E.W.",OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
http://dx.doi.org/10.1083/jcb.20090504 8,Non-OADS,/arxiv_data1/oa_pdf/29/50/JCB_201302075.PMC3747297.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de - scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1038/1476 4 Blum, H., H. Beier, and H.J.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1002/elps.115008020 3 Bückers, J., D. Wildanger, G. Vicidomini, L. Kastrup, and S.W.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1364/   OE.19.00313 0 Bucurenciu, I., A. Kulik, B. Schwaller, M. Frotscher, and P. Jonas.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1016/j.neuron.2007   .12.02 6 Clements, J.D., and R.A. Silver.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1038/   nrn312 5 Fiala, J.C. 2005.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
http://dx.doi.org/10.1111/j.1365-2818.2005.01466.,Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"186:129– 145. http://dx.doi.org/10.1083/jcb.20081215 0 Gundelfinger, E.D., M.M.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1038/nrm101 6 Hallermann, S., R.J. Kittel, C. Wichmann, A. Weyhersmüller, W. Fouquet,   S. Mertel, D. Owald, S. Eimer, H. Depner, M. Schwärzel, et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2495-10.201 0 Harlow, M.L., D. Ress, A. Stoschek, R.M.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1038/3505400 0 Haucke, V ., E. Neher, and S.J.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1038/nrn294 8 Hell, S.W.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"148:131– 137. http://dx.doi.org/10.1093/jb/mvq06 5 Holderith, N., A. Lorincz, G. Katona, B. Rózsa, A. Kulik, M. Watanabe, and Z.  Nusser.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1038/nn.313 7 Hou, J., T. Tamura, and Y .",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1152/jn.90342.200 8 Jiao, W., S. Masich, O. Franzén, and O. Shupliakov.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi   .org/10.1016/j.jsb.2010.07.00 7 Jin, Y ., and C.C.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1146/ annurev.cellbio.23.090506.12341 7 Kawasaki, F., S.C. Collins, and R.W.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
Online supple - mental material is available at http://www.jcb.org/cgi/content/full/ jcb.201301072/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
Additional data are available in the JCB Data - Viewer at http://dx.doi.org/10.1083/jcb.201301072.dv.,OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10   .1038/nn.212 2 Sheng, J., L. He, H. Zheng, L. Xue, F. Luo, W. Shin, T. Sun, T. Kuner, D.T.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1038/nn.312 9 Sheridan, D.L., C.H.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"3:7. http://dx.doi.org/10.1186/1471-2202-3- 7 Sigrist, S.J., and D. Schmitz.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi   .org/10.1016/j.conb.2010.08.01 2 Silver, R.A. 2003.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1016/j.jneumeth   .2003.09.03 0 Spangler, S.A., and C.C.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1042/BST035127 8 Stewart, B.A., H.L.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1007/BF0021511 4 Südhof, T.C.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi   .org/10.1016/j.neuron.2012.06.01 2 Venken, K.J., Y .",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1126/   science.113442 6 Venken, K.J., J. Kasprowicz, S. Kuenen, J. Yan, B.A.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1093/nar/gkn48 6 Wagh, D.A., T.M.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.02.00 8 Weyhersmüller, A., S. Hallermann, N. Wagner, and J. Eilers.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.6698-10.201 1 Wojcik, S.M., and N. Brose.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"55:11– 24. http://dx.doi.org/10.1016/j.neuron.2007.06.01 3Kawasaki, F., B. Zou, X. Xu, and R.W.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.3553-03.200 4 Kittel, R.J., C. Wichmann, T.M.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1126/science.112630 8 Kremer, J.R., D.N.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1006/jsbi.1996.001 3 Laemmli, U.K. 1970.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/   10.1038/227680a 0 Liu, K.S., M. Siebert, S. Mertel, E. Knoche, S. Wegener, C. Wichmann, T. Matkovic,  K. Muhammad, H. Depner, C. Mettke, et al.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1126/science.121299 1 Matz, J., A. Gilyan, A. Kolar, T. McCarvill, and S.R.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/   10.1016/j.neuron.2011.10.01 0 Mittelstaedt, T., E. Alvaréz-Baron, and S. Schoch.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi   .org/10.1515/bc.2010.06 4 Müller, M., K.S.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0981-   12.201 2 Murthy, V .N., and P. De Camilli.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1146/annurev   .neuro.26.041002.13144 5 Neher, E., and T. Sakaba.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10   .1016/j.neuron.2008.08.01 9 Owald, D., W. Fouquet, M. Schmidt, C. Wichmann, S. Mertel, H. Depner, F.  Christiansen, C. Zube, C. Quentin, J. Körner, et al.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1083/jcb.20090805 5 Pawlu, C., A. DiAntonio, and M. Heckmann.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1016/S0896-   6273(04)00269- 7 Peled, E.S., and E.Y .",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1038/nn.276 7 Qin, G., T. Schwarz, R.J. Kittel, A. Schmid, T.M.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.4194-04.200 5 Rasse, T.M., W. Fouquet, A. Schmid, R.J. Kittel, S. Mertel, C.B.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"8:898– 905. http://dx.doi.org/10.1038/nn148 4 Reiff, D.F., P.R.",Non-OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1126/   science.107537 5 Rizo, J., and T.C.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-   101011-15581 8 Sakaba, T., R. Schneggenburger, and E. Neher.",OADS,/arxiv_data1/oa_pdf/a6/24/JCB_201301072.PMC3747298.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"Phos - phorylation sites were determined by manually comparing datasets of prod - uct ions acquired from Orbitrap MS/MS spectra, and theoretical fragment  ions were estimated using the MS-product tool on the ProteinProspector web  site (http://prospector.ucsf.edu/prospector/mshome.htm).",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/full/ jcb.201302067/DC1.,Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
Additional data are available in the JCB DataViewer  at http://dx.doi.org/10.1083/jcb.201302067.dv.,OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1105/tpc.108.06099 6 Baskaran, S., M.J. Ragusa, E. Boura, and J.H.",Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1016/j.molcel.2012.05.02 7Lipid dot blot analysis PIP strip and PIP array assays were performed according to the protocols  of Echelon Bioscience, Inc. For the PIP strip, membranes were incubated  with 0.5 µg/ml purified proteins for 1 h. For the PIP array, membranes  were incubated with 1.0 µg/ml protein for 3 h. Anti-GST antibody diluted  1:5,000 was incubated for 1 h and anti–goat-HRP diluted 1:10,000 was  incubated for 1 h. For both PIP strip and PIP array experiments, the signals  were acquired using the same exposure time.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi   .org/10.1242/jcs.11572 5 Suzuki, K., Y. Kubota, T. Sekito, and Y. Ohsumi.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
12:209– 218. http://dx.doi.org/10.1111/j.1365-2443.2007.01050.,Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1242/jcs.07004 5 Watanabe, Y., T. Kobayashi, H. Yamamoto, H. Hoshida, R. Akada, F. Inagaki,  Y. Ohsumi, and N.N.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1074/jbc.M112.39757 0 Weisman, L.S.",Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1038/   nrm189 2 Yamashita, S., H. Yurimoto, D. Murakami, M. Yoshikawa, M. Oku, and Y.  Sakai.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1111/j.1365- 2443.2009.01316. xCabrera, M., C.W.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1091/mbc.E08-09-094 3 Cabrera, M., L. Langemeyer, M. Mari, R. Rethmeier, I. Orban, A. Perz, C.  Bröcker, J. Griffith, D. Klose, H.J.",Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1038/   nature0518 5 Dove, S.K., F.T.",Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1038/3661 3 Dove, S.K., R.C.",Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1038/sj.emboj.760020 3 Dove, S.K., K. Dong, T. Kobayashi, F.K.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10   .1042/BJ2008195 0 Efe, J.A., R.J. Botelho, and S.D.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1091/mbc.E07-04-030 1 Farré, J.-C., R. Manjithaya, R.D.",Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"14:365– 376. http://dx.doi.org/10.1016/j.devcel.2007.12.01 1 Guan, J., P.E.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10   .1371/journal.pone.002525 7 Kobayashi, T., K. Suzuki, and Y. Ohsumi.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10   .1016/j.febslet.2012.06.00 8 Krick, R., J. Tolstrup, A. Appelles, S. Henke, and M. Thumm.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1016/j.febslet.2006.07.04 1 Krick, R., R.A. Busse, A. Scacioc, M. Stephan, A. Janshoff, M. Thumm, and  K. Kühnel.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10   .1073/pnas.120512810 9 LaGrassa, T.J., and C. Ungermann.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1083/jcb.20040714 1 Lemmon, M.A.",Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1038/nrm232 8 Li, S.C., and P.M. Kane.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10   .1016/j.bbamcr.2008.08.00 3 Manjithaya, R., T.Y.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"584:1367– 1373. http://dx.doi.org/10.1016/j.febslet.2010.01.01 9 Mizushima, N., T. Yoshimori, and Y. Ohsumi.",OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
"http://dx.doi.org/10.1111/j.1742- 4658.2010.07741. x Powell, D.J., E. Hajduch, G. Kular, and H.S.",Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
http://dx.doi.org/10.1128/MCB   .23.21.7794-7808.200 3,Non-OADS,/arxiv_data1/oa_pdf/66/83/JCB_201302067.PMC3747300.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1371/journal.pone.000804 5 Amagai, M., and J.R. Stanley.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/   jid.2011.39 0 Angst, B.D., L.A. Nilles, and K.J.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1016/j.ceb.2009.07.00 2 Benitah, S.A., M. Frye, M. Glogauer, and F.M.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi   .org/10.1126/science.111357 9 Bishop, A.L., and A.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1042/0264-6021:348024 1 Boulter, E., R. Garcia-Mata, C. Guilluy, A. Dubash, G. Rossi, P.J.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi   .org/10.1038/ncb204 9 Braga, V .M., L.M.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi   .org/10.1083/jcb.137.6.142 1 Burridge, K., and K. Wennerberg.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1016/S0092-8674(04)00003- 0 Busche, S., A. Descot, S. Julien, H. Genth, and G. Posern.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1242/jcs.01445 6 Calautti, E., M. Grossi, C. Mammucari, Y .",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"156:137– 148. http://dx.doi.org/10.1083/jcb.20010514 0 Chardin, P. 2006.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/nrm178 8 Cho, Y .J., J.M.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1128/MCB.00756-0 6 Chrzanowska-Wodnicka, M., and K. Burridge.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
http://dx.doi.org/10.1083/jcb.133.6.140 3University Cell Imaging Facility.,OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201304133/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi   .org/10.1091/mbc.E09-10-085 9 Jaffe, A.B., and A.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1146/annurev   .cellbio.21.020604.15072 1 Jaffe, A.B., A.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10   .1016/j.cub.2004.12.08 2 Kaartinen, V., A. Nagy, I. Gonzalez-Gomez, J. Groffen, and N. Heisterkamp.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1002/dvdy.1007 1 Kalaji, R., A.P.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/   10.1111/boc.20110009 3 Koegel, H., L. von Tobel, M. Schäfer, S. Alberti, E. Kremmer, C. Mauch, D.  Hohl, X.J.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1172/JCI3777 1 Kottke, M.D., E. Delva, and A.P.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi   .org/10.1242/jcs.0288 8 Liebig, T., J. Erasmus, R. Kalaji, D. Davies, G. Loirand, A. Ridley, and V.M.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1091/mbc   .E07-11-119 7 Liu, B.P., and K. Burridge.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1128/MCB.20.19.7160-7169.200 0 Lock, F.E., and N.A.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/ncb216 3 McCaffrey, L.M., and I.G.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/   10.1016/j.tcb.2011.06.00 5 McGrath, J.A.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
http://dx.doi.org/10.1111/j.1440-0960.2005.00188.,Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/ng1097-24 0 McMullan, R., S. Lax, V.H.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1016/j.cub.2003.11.05 0 Meyers, C., and L.A. Laimins.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1007/978-3-642-78487-3_1 1 Moon, S.Y ., and Y .",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1016/S0962-   8924(02)00004- 1 Müller, E.J., L. Williamson, C. Kolly, and M.M.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/sj.jid.570124 8 Nikolova, E., V .",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1002/jcb.2145 5 Noren, N.K., B.P.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1083/jcb.150.3.56 7 Oh, D., S. Han, J. Seo, J.R. Lee, J. Choi, J. Groffen, K. Kim, Y.S.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1711-10.201 0Chuang, T.H., X. Xu, V .",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/ncb207 4 Cunnick, J.M., S. Schmidhuber, G. Chen, M. Yu, S.J.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1128/MCB.00357-0 9 Daley, G.Q., R.A. Van Etten, and D. Baltimore.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1126/science.240690 2 Delva, E., D.K.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1101/cshperspect   .a00254 3 Dubash, A.D., K. Wennerberg, R. García-Mata, M.M.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1242/jcs.00380 6 Dusek, R.L., L.M.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1016/j.jdermsci.2006.10.00 6 Ehrenreiter, K., F. Kern, V .",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1016/   j.ccr.2009.06.00 8 Etienne-Manneville, S., and A.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/nature0114 8 Evelyn, C.R., S.M.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi   .org/10.1158/1535-7163.MCT-06-078 2 Ferone, G., M.R.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi   .org/10.1093/hmg/dds46 4 García-Mata, R., and K. Burridge.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1016/j.tcb.2006.11.00 4 García-Mata, R., A.D. Dubash, L. Sharek, H.S.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10   .1128/MCB.00157-0 7 Getsios, S., C.L.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1083/jcb.20080904 4 Godsel, L.M., A.D. Dubash, A.E.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1091/mbc.E10-02-013 1 Green, K.J., and C.L.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/   sj.jid.570101 5 Halbert, C.L., G.W.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/ncb1201-e27 0 Hatzfeld, M. 2007.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/315758a 0 Heisterkamp, N., V. Kaartinen, S. van Soest, G.M.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
http://dx.doi.org/10.1016/   0092-8674(80)90406- 7,OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/nrm289 0 Park, G.T., S.E.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1074/jbc   .M20538020 0 Posern, G., and R. Treisman.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"16:588– 596. http://dx.doi.org/10.1016/j.tcb.2006.09.00 8 Rossman, K.L., C.J.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/nrm158 7 Simpson, C.L., D.M.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/nrm317 5 Sugai, M., K. Hashimoto, A. Kikuchi, S. Inoue, H. Okumura, K. Matsumoto, Y.  Goto, H. Ohgai, K. Moriishi, B. Syuto, et al.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1042/BJ2010056 7 Tunggal, J.A., I. Helfrich, A. Schmitz, H. Schwarz, D. Günzel, M. Fromm, R.  Kemler, T. Krieg, and C.M.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/sj.emboj.760060 5 Vaezi, A., C. Bauer, V. Vasioukhin, and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1016/S1534-5807(02)00259- 9 Vaughan, E.M., A.L.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.01.01 4 Verdoni, A.M., S. Ikeda, and A. Ikeda.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"21:64– 76. http://dx.doi.org/10.1007/s00335-009-9245- y Waschke, J., V. Spindler, P. Bruggeman, D. Zillikens, G. Schmidt, and  D. Drenckhahn.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10   .1083/jcb.20060512 5 Wilanowski, T., J. Caddy, S.B.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"27:886– 897. http://dx.doi.org/10.1038/emboj.2008.2 4 Wolf, A., and M. Hatzfeld.",OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.4161/cc.9.15.1244 6 Zheng, X., S. Güller, T. Beissert, E. Puccetti, and M. Ruthardt.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
6:262. http://dx.doi.org/10.1186/1471-2407-6-26 2,Non-OADS,/arxiv_data1/oa_pdf/6d/f3/JCB_201304133.PMC3747303.pdf
"http://dx.doi.org/10.1038/ncb203 3 Andrews, P.D., Y. Ovechkina, N. Morrice, M. Wagenbach, K. Duncan, L.  Wordeman, and J.R. Swedlow.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/   S1534-5807(04)00025- 5 Bieling, P., I.A.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.cell.2010.06.03 3 Brust-Mascher, I., G. Civelekoglu-Scholey, M. Kwon, A. Mogilner, and J.M.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/   10.1038/nrm347 4 Charras, G., and E. Paluch.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/   10.1038/nrm245 3 Douglas, M.E., and M. Mishima.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.semcdb.2010.08.00 5 Douglas, M.E., T. Davies, N. Joseph, and M. Mishima.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.cub.2010.03.05 5 Ems-McClung, S.C., and C.E.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.semcdb.2010.01.01 6 Fededa, J.P., and D.W. Gerlich.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1038/ncb248 2 Frenette, P., E. Haines, M. Loloyan, M. Kinal, P. Pakarian, and A. Piekny.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1371/   journal.pone.003488 8 Fuller, B.G., M.A.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/   10.1038/nature0692 3 Gaetz, J., and T.M.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1083/jcb.20040401 5 Ganem, N.J., and D.A.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1083/jcb.20040401 2 Ganem, N.J., K. Upton, and D.A.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.cub.2005.08.06 5 Gardner, M.K., D.J.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"18:307– 310. http://dx.doi.org/10.1016/j.tcb.2008.05.00 3 Ghosh, M., I. Ichetovkin, X.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
http://dx.doi.org/10.1021/ja017592 lDynamic instability.,OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201302123/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.cub.2007.04.05 7 Rankin, K.E., and L. Wordeman.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"118:187– 202. http://dx.doi.org/10.1016/j.cell.2004.06.02 6 Sedzinski, J., M. Biro, A. Oswald, J.Y.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1038/   nature1028 6 Sprague, B.L., C.G.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi   .org/10.1016/S0006-3495(03)75087- 5 Steigemann, P., C. Wurzenberger, M.H.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10   .1016/j.cell.2008.12.02 0 Tan, L., and T.M.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1073/   pnas.110674810 8 Uehara, R., and G. Goshima.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10   .1083/jcb.20100415 0 Uehara, R., R.S.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi   .org/10.1073/pnas.090158710 6 van der Waal, M.S., R.C.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.yexcr.2012.03.01 5 Varga, V., J. Helenius, K. Tanaka, A.A. Hyman, T.U.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1038/ncb146 2 Wang, C.Q., X. Qu, X.Y.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.oraloncology.2009.11.00 3 Wang, H., I. Brust-Mascher, D. Cheerambathur, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"67:715– 728. http://dx.doi.org/10.1002/cm.2048 2Goshima, G., and J.M.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-   100109-10400 6 Goshima, G., and R.D.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"16:3896– 3907. http://dx.doi.org/10.1091/mbc.E05-02-011 8 Goshima, G., R. Wollman, N. Stuurman, J.M.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.cub.2005.09.05 4 Gregory, S.L., S. Ebrahimi, J. Milverton, W.M.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi   .org/10.1083/jcb.20040308 4 Guizetti, J., L. Schermelleh, J. Mäntler, S. Maar, I. Poser, H. Leonhardt, T.  Müller-Reichert, and D.W. Gerlich.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1126/science.120184 7 Gupta, M.L., Jr., P. Carvalho, D.M.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1038/ncb145 7 Hu, C.K., M. Coughlin, C.M.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.04.01 9 Hu, C.K., N. Ozlü, M. Coughlin, J.J. Steen, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1091/ mbc.E12-01-005 8 Hutchins, J.R., Y. Toyoda, B. Hegemann, I. Poser, J.K. Hériché, M.M.",Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1126/   science.118134 8 Kimura, K., N. Nozaki, M. Saijo, A. Kikuchi, M. Ui, and T. Enomoto.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1126/science.106462 9 Kinoshita, E., E. Kinoshita-Kikuta, K. Takiyama, and T. Koike.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1016/j.cub.2009.03.01 8 Lan, W., X. Zhang, S.L.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10   .1091/mbc.01-10-050 4 McIntosh, J.R., and S.C. Landis.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1038/nature0276 7 Noy, P., A. Sawasdichai, P.S.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
"http://dx.doi.org/10.1093/nar/gks68 7 Ohi, R., T. Sapra, J. Howard, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
http://dx.doi   .org/10.1091/mbc.E04-02-008 2,Non-OADS,/arxiv_data1/oa_pdf/6d/73/JCB_201302123.PMC3747305.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201301094/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201301094.d v.were acquired for 60 time points every second and then a further 60 time  points every 2 s. Quantification and analysis of the FRAP data were per - formed using the Volocity FRAP plug-in.,OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.devcel.2005.09.00 3 Friel, C.T., and J. Howard.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1007/s10974-012-9289- 6 Fuller, B.G., M.A.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1038/nature0692 3 Gell, C., V .",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/   10.1016/S0091-679X(10)95013- 9 Glotzer, M. 2009.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10   .1038/nrm260 9 Gruneberg, U., R. Neef, R. Honda, E.A.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10   .1083/jcb.20051106 1 Guse, A., M. Mishima, and M. Glotzer.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.cub.2005.03.04 1 Hackney, D.D.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi   .org/10.1083/jcb.20061108 2 Howard, J., and A.A. Hyman.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/   10.1038/nrm271 3 Hu, C.K., M. Coughlin, C.M.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.04.01 9 Hu, C.K., N. Ozlü, M. Coughlin, J.J. Steen, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1091/ mbc.E12-01-005 8 Hümmer, S., and T.U.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.cub.2009.02.04 6 Jiang, W., G. Jimenez, N.J. Wells, T.J. Hope, G.M.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1126/science.120482 4 Kettenbach, A.N., D.K.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1126/scisignal.200149 7 Klein, U.R., E.A.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"17:2547– 2558. http://dx.doi.org/10.1091/mbc.E05-12-113 3 Kurasawa, Y., W.C. Earnshaw, Y. Mochizuki, N. Dohmae, and K. Todokoro.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1083/   jcb.20100309 5 Lee, Y.M., and W. Kim.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
http://dx.doi.org/10.1038/emm.2004.1 3We thank Ian Dobbie (Micron Advanced Bioimaging Unit) for technical assis - tance with TIRF microscopy.,Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1038/nrm236 9 Akhmanova, A., and M.O.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1242/jcs.06241 4 Alexander, J., D. Lim, B.A.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1126/scisignal.200179 6 Andrews, P.D., Y .",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/   S1534-5807(04)00025- 5 Bastos, R.N., and F.A.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1083/jcb.20100810 8 Bastos, R.N., X. Penate, M. Bates, D. Hammond, and F.A.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10 .1083/   jcb.20120410 7 Bayliss, R., T. Sardon, I. Vernos, and E. Conti.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.cell.2010.06.03 3 Blangy, A., H.A.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/0092-8674(95)90142- 6 Bringmann, H., G. Skiniotis, A. Spilker, S. Kandels-Lewis, I. Vernos, and T.  Surrey.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1126/science.109483 8 Castoldi, M., and A.V.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/S1046-   5928(03)00218- 3 Cox, J., and M. Mann.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/   10.1038/nbt.151 1 Cox, J., I. Matic, M. Hilger, N. Nagaraj, M. Selbach, J.V.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi   .org/10.1038/nprot.2009.3 6 Desai, A., and T.J. Mitchison.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1146/annurev   .cellbio.13.1.8 3 Douglas, M.E., T. Davies, N. Joseph, and M. Mishima.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.cub.2010.03.05 5 Eggert, U.S., T.J. Mitchison, and C.M.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi   .org/10.1146/annurev.biochem.74.082803.13342 5 Elad, N., S. Abramovitch, H. Sabanay, and O. Medalia.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
http://dx.doi.org/10.1242/jcs   .07348 6,Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.cub.2011.07.01 7 Vázquez-Novelle, M.D., and M. Petronczki.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.cub.2010.06.03 6 Walczak, C.E., T.J. Mitchison, and A. Desai.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)80991- 5 Walczak, C.E., E.C.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/S0960-9822(02)01227- 7 Wandke, C., M. Barisic, R. Sigl, V. Rauch, F. Wolf, A.C. Amaro, C.H.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1083/jcb.20111006 0 Wilm, M., A. Shevchenko, T. Houthaeve, S. Breit, L. Schweigerer, T. Fotsis, and  M. Mann.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1038/379466a 0 Wittmann, T., A. Hyman, and A. Desai.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi   .org/10.1038/3505066 9 Wolfe, B.A., T. Takaki, M. Petronczki, and M. Glotzer.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi   .org/10.1371/journal.pbio.100011 0 Zhu, C., and W. Jiang.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10   .1073/pnas.040843810 2 Zhu, C., J. Zhao, M. Bibikova, J.D.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi   .org/10.1091/mbc.E05-02-016 7 Zhu, C., E. Lau, R. Schwarzenbacher, E. Bossy-Wetzel, and W. Jiang.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi   .org/10.1073/pnas.050692610 3Mirchenko, L., and F. Uhlmann.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.cub.2010.06.02 3 Mishima, M., S. Kaitna, and M. Glotzer.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/   S1534-5807(01)00110- 1 Mishima, M., V. Pavicic, U. Grüneberg, E.A.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1083/jcb.20011105 2 Neef, R., C. Preisinger, J. Sutcliffe, R. Kopajtich, E.A.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1083/jcb.20030600 9 Neef, R., U.R.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.cub.2005.12.03 0 Neef, R., U. Gruneberg, R. Kopajtich, X. Li, E.A.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1038/ncb155 7 Niiya, F., T. Tatsumoto, K.S.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1038/sj.onc.120912 4 Nislow, C., V.A.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1038/359543a 0 Ohi, R., T. Sapra, J. Howard, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi   .org/10.1091/mbc.E04-02-008 2 Ozlü, N., F. Monigatti, B.Y.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1074/mcp.M900308-MCP20 0 Pavicic-Kaltenbrunner, V., M. Mishima, and M. Glotzer.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/   10.1091/mbc.E07-05-046 8 Petronczki, M., M. Glotzer, N. Kraut, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.03.01 3 Samejima, K., I. Samejima, P. Vagnarelli, H. Ogawa, G. Vargiu, D.A.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/   10.1083/jcb.20120215 5 Santamaria, A., R. Neef, U. Eberspächer, K. Eis, M. Husemann, D. Mumberg,  S. Prechtl, V. Schulze, G. Siemeister, L. Wortmann, et al.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1083/jcb.127.1.18 7 Sellitto, C., and R. Kuriyama.",OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
"http://dx.doi.org/10.1083/jcb.106.2.43 1 Sessa, F., M. Mapelli, C. Ciferri, C. Tarricone, L.B.",Non-OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
http://dx.doi   .org/10.1016/j.cell.2010.07.01 2,OADS,/arxiv_data1/oa_pdf/d1/6e/JCB_201301094.PMC3747307.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1111/j   .1742-4658.2009.06956. x Bird, G.S., W.I.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1126/science.194804 8 Bultynck, G., S. Kiviluoto, N. Henke, H. Ivanova, L. Schneider, V .",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1074/jbc.M111   .27535 4 Carrara, G., N. Saraiva, C. Gubser, B.F. Johnson, and G.L.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1074/jbc.M111.33614 9 Chan, K.T., D.A.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1074/jbc.M109   .09074 6 Chen, Y .F., W.T.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1038/sj.emboj.760093 1 Cohen, D.M., H. Chen, R.P.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1074/jbc   .M41470420 0 Demaison, C., K. Parsley, G. Brouns, M. Scherr, K. Battmer, C. Kinnon, M. Grez,  and A.J.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1089/1043034025289898 4 de Mattia, F., C. Gubser, M.M.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1091/mbc   .E09-05-038 5 Dolman, N.J., and A.V.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1016/j.ceca.2006.08.01 2 English, A.R., and G.K. Voeltz.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1101/cshperspect.a01322 7 Feng, M., D.M.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1016/j.cell.2010.08.04 0using the ImageJ Manual Tracking plugin, and tracks were analyzed using   an in house–written Mathematica 7 notebook (provided by G. Dunn,  King’s College London, London, England, UK) to calculate migration rates  and persistence.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201301016/DC1.,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10   .1161/CIRCRESAHA.111.24335 2 Marks, P.W., and F.R.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1083/jcb.110.1.4 3 McHugh, B.J., R. Buttery, Y. Lad, S. Banks, C. Haslett, and T. Sethi.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi   .org/10.1242/jcs.05642 4 Mitra, S.K., and D.D.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi   .org/10.1016/j.ceb.2006.08.01 1 Orlando, K., and W. Guo.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/   10.1101/cshperspect.a00132 1 Parkinson, J.E., and G.L.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1006/viro.1994.154 2 Parnaud, G., E. Hammar, D.G.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/   10.1152/ajpendo.00006.200 5 Petrie, R.J., A.D. Doyle, and K.M.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1038/3800 1 Prevarskaya, N., R. Skryma, and Y. Shuba.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi   .org/10.1038/nrc310 5 Putney, J.W.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1111/j.1600-065X.2009   .00810. x Reimers, K., C.Y.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"8:148– 156. http://dx.doi.org/10.2174/15665240878376956 2 Rock, M.T., A.R.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1006/excr.2000.504 8 Roszik, J., D. Lisboa, J. Szöllosi, and G. Vereb.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1016/j.jmb.2004.11.03 9 Tang, S., H.C. Wong, Z.M.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1038/415530 a Várnai, P., L. Hunyady, and T. Balla.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1016/j.tips.2008.11.00 5 Vicente-Manzanares, M., and A.R.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1242/jcs.09565 3 Webb, D.J., K. Donais, L.A. Whitmore, S.M.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi   .org/10.1038/nature0757 7 Worth, D.C., K. Hodivala-Dilke, S.D.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1083/jcb.20091201 4 Xu, C., W. Xu, A.E.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1074/jbc.M70838520 0Franco, S.J., and A. Huttenlocher.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1242/jcs   .0256 2 Franco, S.J., M.A.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/   10.1038/ncb117 5 Frisch, S.M., and H. Francis.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/   10.1083/jcb.124.4.61 9 Giannone, G., P. Rondé, M. Gaire, J. Haiech, and K. Takeda.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1074/jbc   .M20395220 0 Gilmore, A.P., T.W.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1016/j   .ceb.2009.05.00 9 Groden, D.L., Z. Guan, and B.T.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1016/0143-4160(91)90002- V Grzmil, M., S. Kaulfuss, P. Thelen, B. Hemmerlein, S. Schweyer, S. Obenauer,  T.W.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1002/path.190 2 Gubser, C., D. Bergamaschi, M. Hollinshead, X. Lu, F.J. van Kuppeveld, and  G.L.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1371/journal   .ppat.003001 7 Holt, M.R., Y. Calle, D.H. Sutton, D.R.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
http://dx.doi   .org/10.1111/j.1365-2818.2008.02069.,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi   .org/10.1016/j.bbrc.2003.09.14 2 Hood, J.L., W.H.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi   .org/10.1074/jbc.M40810020 0 Hu, L., T.F.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1007/   s10495-009-0402- 2 Hynes, R.O.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)00971- 6 Igney, F.H., and P.H.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1038/   nrc77 6 Katz, F.N., J.E.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi   .org/10.1002/jss.40007030 8 Kim, H.R., G.H.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1074/jbc.M80007520 0 Lee, G.H., T. Ahn, D.S.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1128/   MCB.01357-0 9 Lee, G.H., C. Yan, S.J.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1038/onc.2009.49 1 Lee, J., A. Ishihara, G. Oxford, B. Johnson, and K. Jacobson.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1038/2257 8 Lee, S., M. Jo, J. Lee, S.S. Koh, and S. Kim.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.5483/BMBRep   .2007.40.2.22 6 Lewis, R.S.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1016/j.ccr.2008.12.01 9 Ying, Z., F.R.",OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"http://dx.doi.org/10.1161/ATVBAHA.109.19089 2 Yun, C.H., H.J.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/JCB_201301016.PMC3747308.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2013 |  76  | e4225 | Page 1 of 13Video Article Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit Brianna L. Armour*1, Steve R. Barnes*2, Spencer O. Moen2, Eric Smith3, Amy C. Raymond4, James W. Fairman5, Lance J. Stewart6, Bart L. Staker7, Darren W. Begley5, Thomas E. Edwards8, Donald D. Lorimer9 1Protein Crystallization Lab, Emerald Bio 2Molecular Biology Lab, Emerald Bio 3Scientific Sales Representative, Emerald Bio 4Group Leader II, Emerald Bio 5Group Leader I, Emerald Bio 6Chair of Advisory Board, Emerald Bio 7Director of Multi-Target Services, Emerald Bio 8Senior Project Leader, Emerald Bio 9Project Leader II & SSGCID Site Manager, Emerald Bio *These authors contributed equally Correspondence to: Bart L. Staker at bstaker@embios.com URL: http://www.jove.com/video/4225 DOI: doi:10.3791/4225 Keywords: Infection, Issue 76, Structural Biology, Virology, Genetics, Medicine, Biomedical Engineering, Molecular Biology, Infectious Diseases, Microbiology, Genomics, high throughput, multi-targeting, structural genomics, protein crystallization, purification, protein production, X-ray crystallography, Gene Composer, Protein Maker, expression, E. coli , fermentation, influenza, virus, vector, plasmid, cell, cell culture, PCR, sequencing Date Published: 6/28/2013 Citation: Armour, B.L., Barnes, S.R., Moen, S.O., Smith, E., Raymond, A.C., Fairman, J.W., Stewart, L.J., Staker, B.L., Begley, D.W., Edwards, T.E., Lorimer, D.D.",Non-OADS,/arxiv_data1/oa_pdf/b9/50/jove-76-4225.PMC3747311.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4225/ Protocol An overview of the protocol is presented in Figure 1 .,Non-OADS,/arxiv_data1/oa_pdf/b9/50/jove-76-4225.PMC3747311.pdf
Available at http://www.cdc.gov/nchs/nhanes/ nhanes_questionnaires.htm .,OADS,/arxiv_data1/oa_pdf/7a/52/12325_2013_Article_45.PMC3747322.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Journal of Human Hypertension website (http://www.nature.com/jhh)Achieving target blood pressure in elderly EK Chowdhury et al 551 &2013 Macmillan Publishers Limited Journal of Human Hypertension (2013) 545 – 551",Non-OADS,/arxiv_data1/oa_pdf/be/d6/jhh201311a.PMC3747330.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/HSV-NIS for prostate cancer radiovirotherapy HL i et al 485 &2013 Nature America, Inc. Cancer Gene Therapy (2013), 478 – 485",Non-OADS,/arxiv_data1/oa_pdf/77/18/cgt201343a.PMC3747331.pdf
"WHO: Geneva, 2009http://www.who.int/ healthinfo/global_burden_disease/global_health_risks/en/index.html(accessed 26 January 2012.",Non-OADS,/arxiv_data1/oa_pdf/c4/5e/jhh201318a.PMC3747332.pdf
"17 US Census Bureau: International Data Base (IDB),Yemen 2008. http://www.cen- sus.gov/ipc/www/idb/groups.php (accessed 8 November 2012).",OADS,/arxiv_data1/oa_pdf/c4/5e/jhh201318a.PMC3747332.pdf
"31,World Health Organization, 2001 http://www.who.int/healthinfo/paper31.pdf(accessed 8 November 2012).",Non-OADS,/arxiv_data1/oa_pdf/c4/5e/jhh201318a.PMC3747332.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Journal of Human Hypertension website (http://www.nature.com/jhh)Proteinuria in urban and rural Yemen dwellers PA Modesti et al 579 &2013 Macmillan Publishers Limited Journal of Human Hypertension (2013) 572 – 579",Non-OADS,/arxiv_data1/oa_pdf/c4/5e/jhh201318a.PMC3747332.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8c/d2/srep02473.PMC3747506.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2473 | DOI: 10.1038/srep02473 9",Non-OADS,/arxiv_data1/oa_pdf/8c/d2/srep02473.PMC3747506.pdf
"During a search for rRNA genes in the assembled contigs, we identified two nearly complete rRNA operons classified as actinobacterial by the 16S rRNA Ribosomal Database Project (RDP, http://rdp.cme.msu.edu) classifier21and the 23S rRNA SILVA large subunit (L SU, http://www.arb-silva.de) database22(MedDCM-OCT-S38-C68 and MedDCM-OCT-S40-C95).Surprisingly, the GC content of bot h of these rRNA containing contigs (33% and 32%), was far lower even than the recently described low GCfreshwater Actinobacteria (GC% 42) 11,12,15.",Non-OADS,/arxiv_data1/oa_pdf/b9/d9/srep02471.PMC3747508.pdf
Functional annotation was performed by comparison of predicted protein sequences against the NCBI NR database (available from ftp://ftp.ncbi.nih.gov/blast/db/) and domain predictions for the fosmids described in this work were performed manually using NCBI-CDsearch 57and the HHpred server58.,OADS,/arxiv_data1/oa_pdf/b9/d9/srep02471.PMC3747508.pdf
"Phylogenetic analysis .Reference 16S rRNA sequences for all major actinobacterial lineages defined using 178 type strains, all known lineages of uncultured freshwaterActinobacteria (72 sequences), the closest BLAST hits to the Mediterranean actinobacterial sequences to the RDP database (available from http:// rdp.cme.msu.edu/) (27 sequences) and the GOS dataset (available from http://camera.calit2.net/) (255 sequences) were collected to examine the phylogenetic relatedness of the low GC actinobacterial sequences.",OADS,/arxiv_data1/oa_pdf/b9/d9/srep02471.PMC3747508.pdf
"In the second method, 4203 TIGRFAMs (available from ftp://ftp.jcvi.org/ pub/data/TIGRFAMs/) were searched in all known complete actinobacterial genomes (n 5232).",OADS,/arxiv_data1/oa_pdf/b9/d9/srep02471.PMC3747508.pdf
Images from FISH were analyzed using NIH ImageJ Software to determine cell dimensions for a minimum of 500 cells (http://rsb.info.-nih.gov/ij/index.html).,OADS,/arxiv_data1/oa_pdf/b9/d9/srep02471.PMC3747508.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b9/d9/srep02471.PMC3747508.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2471 | DOI: 10.1038/srep02471 8",Non-OADS,/arxiv_data1/oa_pdf/b9/d9/srep02471.PMC3747508.pdf
"Bioinformatic analysis .GO terms related to angiotensin were found using amiGO (http://amigo.geneontology.org/cgi-bin/amigo/go.cgi), all the gene namesin these GO terms were also collected.",OADS,/arxiv_data1/oa_pdf/93/6e/srep02467.PMC3747509.pdf
Additionally the GO terms were also used in Uniprot directly (http://www.uniprot.,Non-OADS,/arxiv_data1/oa_pdf/93/6e/srep02467.PMC3747509.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/93/6e/srep02467.PMC3747509.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2467 | DOI: 10.1038/srep02467 7",Non-OADS,/arxiv_data1/oa_pdf/93/6e/srep02467.PMC3747509.pdf
The gene encoding SptRNALeu(CAA isoacceptor in this study) was chemically synthesized using the sequence from the genomic tRNA database (http://gtrnad-b.ucsc.edu) and inserted between the EcoR Ia n d PstI sites of the pTrc99B vector.,OADS,/arxiv_data1/oa_pdf/1e/25/srep02475.PMC3747510.pdf
All the molecular graphics were generated using PyMOL (DeLano Scientific; http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/1e/25/srep02475.PMC3747510.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1e/25/srep02475.PMC3747510.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2475 | DOI: 10.1038/srep02475 8",Non-OADS,/arxiv_data1/oa_pdf/1e/25/srep02475.PMC3747510.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2232 | DOI: 10.1038/srep02232 7",Non-OADS,/arxiv_data1/oa_pdf/da/28/srep02232.PMC3747511.pdf
The signal intensity in immunoblot analysis was quantified using ImageJ software(http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/a8/5f/srep02474.PMC3747512.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a8/5f/srep02474.PMC3747512.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2474 | DOI: 10.1038/srep02474 13",Non-OADS,/arxiv_data1/oa_pdf/a8/5f/srep02474.PMC3747512.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/,Non-OADS,/arxiv_data1/oa_pdf/e0/b1/ARD-69-01-0088.PMC3747519.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/heartjnl-2013-303927).,Non-OADS,/arxiv_data1/oa_pdf/dd/ce/heartjnl-2013-303927.PMC3747520.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Nkomo VT, Gardin JM, Skelton TN, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/ce/heartjnl-2013-303927.PMC3747520.pdf
Nucleotide distribution and quality scores of raw reads were assessedand ﬁltered for quality using the FASTX toolkit ( http://hannonlab.cshl .edu/fastx_toolkit/index.html ) (genome assembly metrics are provided in Table S4 in the supplemental material).,OADS,/arxiv_data1/oa_pdf/df/1c/mBio.00356-13.PMC3747577.pdf
"Forcomparisons of gene content, de novo assemblies of short reads was carried out using Velvet v1.0.15 (32) and the VelvetOptimiser.pl script within VelvetOptimiser v-2.1.7 ( http://bioinformatics.net.au/software .velvetoptimiser.shtml ).",OADS,/arxiv_data1/oa_pdf/df/1c/mBio.00356-13.PMC3747577.pdf
"The Illumina sequences generated and used in this study are deposited and available in the Se-quence Read Archive (SRA) ( http://www.ncbi.nlm.nih.gov/sra ) under the study accession number PRJEB1411, located at http://www.ebi.ac.uk/ena /data/view/PRJEB1411 .",OADS,/arxiv_data1/oa_pdf/df/1c/mBio.00356-13.PMC3747577.pdf
"Since the beginning of the 20th century, tiger populations have collapsed from an estimated 100,000 tigers among 9 subspe- cies to fewer than 3,500 individuals (1, 2), and all extant subspeciesare currently listed as endangered or critically endangered by theInternational Union for the Conservation of Nature (http://www.iucn.org/).",Non-OADS,/arxiv_data1/oa_pdf/bc/4c/mBio.00410-13.PMC3747579.pdf
"To determine the phylogenetic relationships of tiger CDVs to each other and to other CDV viruses and morbilliviruses, nucleo-tide sequences for the P and H genes from the tigers and represen-tative CDV strains were aligned (GenBank, National Center forBiotechnology Information; http://www.ncbi.nlm.nih.gov) (Ge-neious Pro 5.1.7 software; Biomatters Ltd., Auckland, New Zea-land).",OADS,/arxiv_data1/oa_pdf/bc/4c/mBio.00410-13.PMC3747579.pdf
"Treeswere ﬁnalized and labeled (FigTree v1.3.1 software [Andrew Ram-baut, Institute of Evolutionary Biology, University of Edinburgh,2006 to 2009; http://tree.bio.ed.ac.uk/]).",OADS,/arxiv_data1/oa_pdf/bc/4c/mBio.00410-13.PMC3747579.pdf
Vaccination with recombinant vectored vaccines has been safely used and isthe recommendation for captive tigers in Association of Zoosand Aquariums (AZA)-accredited zoos (http://www.aazv.org/displaycommon.cfm?an /H110051&subarticlenbr /H11005273) and for nondo- mestic canid and other wildlife species (modiﬁed-live vaccines caninduce disease and should not be used).,Non-OADS,/arxiv_data1/oa_pdf/bc/4c/mBio.00410-13.PMC3747579.pdf
2013:571939. http://dx.doi.org/10.1155 /2013/571939 .,Non-OADS,/arxiv_data1/oa_pdf/bc/4c/mBio.00410-13.PMC3747579.pdf
"In the United Kingdom, concern about increasingVRE incidence led to mandatory reporting of rates of VRE bacte-remia, and more than 500 cases per year have been reported since2004 ( http://www.hpa.org.uk/ ; accessed, 3 December 2012).",Non-OADS,/arxiv_data1/oa_pdf/0a/e1/mBio.00412-13.PMC3747580.pdf
Estimate of the divergence date for ST17 and ST252 isolates by branch-to-tip analysis using Path-O-Gen and branch lengths inferred by maximum-likelihood analysis(http://tree.bio.ed.ac.uk/software/pathogen/ ).Howden et al.,OADS,/arxiv_data1/oa_pdf/0a/e1/mBio.00412-13.PMC3747580.pdf
"Single nucleotide polymorphisms (SNPs) in the E. faecium core ge- nome were identiﬁed using Nesoni v0.93, which aligns the read of eachgenome to that of the reference to construct a tally of putative differencesat each position ( http://www.bioinformatics.net.au ).",OADS,/arxiv_data1/oa_pdf/0a/e1/mBio.00412-13.PMC3747580.pdf
The temporal sig-nals in the sequence data were analyzed using Path-O-Gen ( http://tree.bioGenomics of VREfm July/August 2013 Volume 4 Issue 4 e00412-13®mbio.asm.org 7,OADS,/arxiv_data1/oa_pdf/0a/e1/mBio.00412-13.PMC3747580.pdf
"Un-aligned contigs were appended to the AUS0085 genome to construct a pangenome, which was annotated using Prokka ( http://bioinformatics.net .au/).",OADS,/arxiv_data1/oa_pdf/0a/e1/mBio.00412-13.PMC3747580.pdf
http://www.eurosurveillance.org /ViewArticle.aspx?ArticleId /H1100519046 .,Non-OADS,/arxiv_data1/oa_pdf/0a/e1/mBio.00412-13.PMC3747580.pdf
"For the identiﬁcation of GGDEF, EAL, and HD-GYP domains, we searched the CyanoBase data-base ( http://genome.kazusa.or.jp/cyanobase ), which contains genome se- quences of cultured cyanobacteria (63).",OADS,/arxiv_data1/oa_pdf/c8/73/mBio.00451-13.PMC3747582.pdf
The statistically signiﬁcant effects of light conditions on c-di-GMP levels were determined using one-way analysis of variance (ANOVA) witha Fisher post hoc test using OpenStat statistical software (version 10.01.08; http://www.Statprograms4U.com [W. G. Miller]).,OADS,/arxiv_data1/oa_pdf/c8/73/mBio.00451-13.PMC3747582.pdf
S25 in the supplementary appendix availableathttp://gasp.med.harvard.edu/journals /traxler_2013_SI_nanodesi.pdf ).,OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
"The results of this analysis (providedin Table S5 in the supplemental appendixathttp://gasp.med.harvard.edu/journals /traxler_2013_SI_nanodesi.pdf ) showed that none of the initiator strains containsgenes for production of either actino-rhodin or prodiginines, and accordingly,all compounds of these families associ-ated with these interactions are presumedto originate with S. coelicolor .",OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
"The fragmentation patterns for these known acyl-desferrioxamines provided the basis for annotation of more mol-ecules in these subnetworks, ultimately showing that S. coelicolor made at least 12 analogs of the acyl-desferrioxamines, with ap-pendages ranging from C7 to C17 fatty acids (summarized in Ta-ble S1 at http://gasp.med.harvard.edu/journals/traxler_2013_SI _nanodesi.pdf ).",OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
S2 and S3 at http://gasp.med.harvard.edu/journals/traxler_2013_SI_nanodesi.pdf .,OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
S3 at http://gasp.med.harvard.edu /journals/traxler_2013_SI_nanodesi.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
Activity in sub- networks a2 to -4 also mirrors this pattern (see the supplementalappendix at http://gasp.med.harvard.edu/journals/traxler_2013 _SI_nanodesi.pdf ).,OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
"6A, listed in Table S3 at http://gasp.med.harvard.edu/journals/traxler_2013_SI_nanodesi.pdf).Amycolatopsis sp.AA4 strains with mutations in the amcG locus are unable to make amychelin (13).",Non-OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
An appendix containing supplemental ﬁgures and chemical annotations for the molecules detected in this study can be ac-cessed at http://gasp.med.harvard.edu/journals/traxler_2013_SI _nanodesi.pdf .,OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
Strains used in this study are listed in Table S4 in the supplemental appendix at http://gasp.med.harvard.edu/journals/traxler_2013_SI_nanodesi.pdf .,OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
http://dx.doi.org/doi:10.1371/journal.pbio.1001184 .,Non-OADS,/arxiv_data1/oa_pdf/a2/b7/mBio.00459-13.PMC3747584.pdf
http://dx.doi.org /10.1371/journal.ppat.1002331 .,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/mBio.00524-13.PMC3747587.pdf
http://dx.doi.org/10.1128/mBio.00002-13 .,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/mBio.00524-13.PMC3747587.pdf
http://dx.doi.org/10.1128/mBio.00473-12 .,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/mBio.00524-13.PMC3747587.pdf
http://dx.doi.org/10.1128/mBio.00165-13 .,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/mBio.00524-13.PMC3747587.pdf
http://dx.doi.org/10 .1371/journal.ppat.0010039 .,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/mBio.00524-13.PMC3747587.pdf
http://dx.doi.org/10.1371 /journal.ppat.1000054 .,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/mBio.00524-13.PMC3747587.pdf
http://dx.doi.org/10.1371/journal.pbio .0060226 .,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/mBio.00524-13.PMC3747587.pdf
http://dx.doi.org/10.1371/journal.pone.0003299 .,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/mBio.00524-13.PMC3747587.pdf
http://dx.doi.org/10.1371/journal.ppat .1000088 .,Non-OADS,/arxiv_data1/oa_pdf/b4/7f/mBio.00524-13.PMC3747587.pdf
"Therefore, mutation FIG 1 goeBURST analysis of 2,273 E. faecium entries in the E. faecium MLST database ( http://efaecium.mlst.net ), which can be grouped into 773 sequence types (STs) (brown circles), based upon MLST relatedness.",OADS,/arxiv_data1/oa_pdf/3e/98/mBio.00534-13.PMC3747589.pdf
"(see https://olive.broadinstitute.org/projects/work_package_1 /downloads) , we were able to quantify and determine the rate of occurrence and location of IS elements.",OADS,/arxiv_data1/oa_pdf/3e/98/mBio.00534-13.PMC3747589.pdf
"Methods for DNA se-quencing, genome assembly, and bioinformatic analysis are provided inSupplemental Methods at https://olive.broadinstitute.org/projects/work _package_1/downloads , along with details of the genome sequences.",OADS,/arxiv_data1/oa_pdf/3e/98/mBio.00534-13.PMC3747589.pdf
http://www.phe.gov/s3/dualuse /Documents/us-policy-durc-032812.pdf .,Non-OADS,/arxiv_data1/oa_pdf/25/ca/mBio.00547-13.PMC3747591.pdf
Available from: http://www.hira.or.kr/ .2.,Non-OADS,/arxiv_data1/oa_pdf/d7/10/EPHRP1-03-94.PMC3747640.pdf
"E-mail: cchu@cdc.go.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2012 3(4), 191 http://dx.doi.org/10.1016/j.phrp.2012.11.004 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2012 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/cf/d5/EPHRP1-3-191.PMC3747656.pdf
"E-mail: keemk60@yahoo.co.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2012 3(4), 245 e249 http://dx.doi.org/10.1016/j.phrp.2012.11.001 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2012 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/5d/43/EPHRP1-3-245.PMC3747657.pdf
"E-mail: carotene@korea.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2012 3(4), 199 e205 http://dx.doi.org/10.1016/j.phrp.2012.10.005 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2012 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/6b/c9/EPHRP1-3-199.PMC3747660.pdf
"BMC Geriatr 2010;10:31, http://dx.doi.org/ 10.1186/1471-2318-10-31 .",Non-OADS,/arxiv_data1/oa_pdf/6b/c9/EPHRP1-3-199.PMC3747660.pdf
"E-mail: slowpc@daum.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2012 3(4), 222 e228 http://dx.doi.org/10.1016/j.phrp.2012.10.002 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2012 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/05/5c/EPHRP1-3-222.PMC3747661.pdf
"Gene clustering by gene function was per-formed at the National Center for Biotechnology Infor-mation website by clusters of orthologous groups (COGs)of proteins, http://www.ncbi.nlm.nih.gov/COG [18] .",OADS,/arxiv_data1/oa_pdf/05/5c/EPHRP1-3-222.PMC3747661.pdf
Supplementary material Supplementary data associated with this article can be found in online version at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/5c/EPHRP1-3-222.PMC3747661.pdf
"E-mail: shuh@hallym.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2012 3(4), 192 e198 http://dx.doi.org/10.1016/j.phrp.2012.11.003 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2012 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/EPHRP1-3-192.PMC3747662.pdf
"Populations in each city or county in a yearwere obtained from the webs site of Statistics Korea, available from: http://kostat.go.kr .",OADS,/arxiv_data1/oa_pdf/b0/1e/EPHRP1-3-192.PMC3747662.pdf
Available from: http://CRAN.R-project.org/packageZ dhglm .,Non-OADS,/arxiv_data1/oa_pdf/b0/1e/EPHRP1-3-192.PMC3747662.pdf
"E-mail: kkingsh@chol.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2012 3(4), 239 e244 http://dx.doi.org/10.1016/j.phrp.2012.11.002 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2012 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/aa/69/EPHRP1-3-239.PMC3747663.pdf
"E-mail: prvhong@konyang.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2012 3(4), 206 e212 http://dx.doi.org/10.1016/j.phrp.2012.10.001 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2012 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e0/83/EPHRP1-3-206.PMC3747664.pdf
"1These authors equally contributed as the ﬁrst authors.Osong Public Health Res Perspect 2013 4(1), 21 e26 http://dx.doi.org/10.1016/j.phrp.2012.12.002 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/80/41/phrp-4-1-21.PMC3747674.pdf
"The number of patientsinfected tsutsugamushi (based on patient reports) grewsharply from 2637 in 2001 to 6780 in 2005, after whichthe number fell moderately over next several years but E-mail: rheehc@skku.edu ,rheehc@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(1), 16 e20 http://dx.doi.org/10.1016/j.phrp.2012.12.003 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/d7/a1/phrp-4-1-16.PMC3747675.pdf
"E-mail: shuh@hallym.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(1), 39 e44 http://dx.doi.org/10.1016/j.phrp.2013.01.002 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/62/a1/phrp-4-1-39.PMC3747676.pdf
"Populations in each city or county were obtained from the website of Statistics Korea,available from: http://kostat.go.kr .",OADS,/arxiv_data1/oa_pdf/62/a1/phrp-4-1-39.PMC3747676.pdf
Avail-able from: http://CRAN.R-project.org/packageZdhglm ; 2012.,Non-OADS,/arxiv_data1/oa_pdf/62/a1/phrp-4-1-39.PMC3747676.pdf
"The This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(1), 1 e3 http://dx.doi.org/10.1016/j.phrp.2013.01.001 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/08/e7/phrp-4-1-1.PMC3747677.pdf
Available from: http://www.searo.,Non-OADS,/arxiv_data1/oa_pdf/08/e7/phrp-4-1-1.PMC3747677.pdf
http://dx.doi.org/10.1016/j.jtbi.2010.06.015.,OADS,/arxiv_data1/oa_pdf/08/e7/phrp-4-1-1.PMC3747677.pdf
http://dx.doi.org/10.1038/415710a.,Non-OADS,/arxiv_data1/oa_pdf/08/e7/phrp-4-1-1.PMC3747677.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/e7/phrp-4-1-1.PMC3747677.pdf
http://dx.doi.org/10.1016/ j.actatropica.2011.05.018.,OADS,/arxiv_data1/oa_pdf/08/e7/phrp-4-1-1.PMC3747677.pdf
"E-mail: bracstu3@konkuk.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(1), 27 e33 http://dx.doi.org/10.1016/j.phrp.2012.12.005 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/7e/b6/phrp-4-1-27.PMC3747678.pdf
"For PCR reac- tions, 0.5 mM DNA template was added to 50 mL PCR mixture consisting of Pyrobest DNA polymerase (5 U/ mL, 0.5mL), 10 /C2Pyrobest buffer II (Takara Bio Inc.), 1 mMo f each primer ( http://mlst.ucc.ie/mlst/dbs/Senterica ), and dNTP mixture (2.5 mM each).",OADS,/arxiv_data1/oa_pdf/7e/b6/phrp-4-1-27.PMC3747678.pdf
Allele numbers were assigned anMLST type after the distinct allele sequences weresubmitted via the Internet to the dedicated database(http://mlst.ucc.ie/mlst/dbs/Senterica ).,OADS,/arxiv_data1/oa_pdf/7e/b6/phrp-4-1-27.PMC3747678.pdf
"All isolates were assigned to MLST 11 in the dedicated database ( http://mlst.ucc.ie/mlst/dbs/ Senterica ), resulting in the Simpson’s index ( D) of zero (Table 1 ).",OADS,/arxiv_data1/oa_pdf/7e/b6/phrp-4-1-27.PMC3747678.pdf
"In this study, all isolates of S. Enteritidis tested were assigned to MLST 11, according to the MLST database(http://mlst.ucc.ie/mlst/dbs/Senterica ).",OADS,/arxiv_data1/oa_pdf/7e/b6/phrp-4-1-27.PMC3747678.pdf
"E-mail: yunki7777@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(1), 52 e56 http://dx.doi.org/10.1016/j.phrp.2012.12.001 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/27/93/phrp-4-1-52.PMC3747679.pdf
"E-mail: rnpadhy54@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(1), 45 e51 http://dx.doi.org/10.1016/j.phrp.2012.12.004 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/2e/00/phrp-4-1-45.PMC3747680.pdf
http://dx.doi.org/10.1007/s10389-012-0517-8.,Non-OADS,/arxiv_data1/oa_pdf/2e/00/phrp-4-1-45.PMC3747680.pdf
"E-mail: hjwoo@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http:// creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(1), 57 e66 http://dx.doi.org/10.1016/j.phrp.2012.12.008 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/38/81/phrp-4-1-57.PMC3747681.pdf
"BSE has occurred in European countries that import MBM from the UK; according to statistics from theWorld Organization for Animal Health (Ofﬁce Interna-tional des Epizooties; OIE), there have been 190,628BSE cases in 25 countries worldwide as of August 30,2012 ( http://www.oie.int ).",Non-OADS,/arxiv_data1/oa_pdf/38/81/phrp-4-1-57.PMC3747681.pdf
"1These authors contributed equally to this article.Osong Public Health Res Perspect 2013 4(1), 34 e38 http://dx.doi.org/10.1016/j.phrp.2012.12.006 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/2a/2c/phrp-4-1-34.PMC3747682.pdf
"E-mail: hozilla@chonnam.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Osong Public Health Res Perspect 2013 4(1), 4 e15 http://dx.doi.org/10.1016/j.phrp.2012.12.007 pISSN 2210-9099 eISSN 2233-6052 Copyright ª2013 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/10/77/phrp-4-1-4.PMC3747683.pdf
Available from: http://www.searo.who.int/LinkFiles/ CDS_faq_Scrub_Typhus.pdf ; 2009.,Non-OADS,/arxiv_data1/oa_pdf/10/77/phrp-4-1-4.PMC3747683.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/77/phrp-4-1-4.PMC3747683.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/77/phrp-4-1-4.PMC3747683.pdf
http://dx.doi.org/10.1038/415710a.,Non-OADS,/arxiv_data1/oa_pdf/10/77/phrp-4-1-4.PMC3747683.pdf
http://dx.doi.org/10.1016/S0169- 2046(00)00119-5.,OADS,/arxiv_data1/oa_pdf/10/77/phrp-4-1-4.PMC3747683.pdf
"Myeong-Chan Cho, MD, PhD, Director General Korea National Institute of Health E-mail: mcho@korea.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Public Health Res Perspect 2011 2(S1), S2 doi:10.1016/j.phrp.2011.11.036 pISSN 2210-9099 eISSN 2233-6052 ª2011, Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/3a/a2/EPHRP1-02-S2.PMC3747694.pdf
"E-mail: cchu@cdc.go.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Public Health Res Perspect 2011 2(S1), S1 doi:10.1016/j.phrp.2011.11.035 pISSN 2210-9099 eISSN 2233-6052 ª2011, Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/e2/e8/EPHRP1-02-S1.PMC3747698.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Public Health Res Perspect 2011 2(S1), S3 eS10 pISSN 2210-9099 eISSN 2233-6052 ª2011, Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/91/dd/EPHRP1-02-S3.PMC3747710.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/e0/opth-7-1647.PMC3747847.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1647–1649Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1647Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S4744 8Retinal vein occlusion during flare of multicentric  Castleman’s disease Igor Kozak1,2 erin G reid3 1King Khaled eye specialist Hospital,   Riyadh, Kingdom of Saudi Arabia;   2University of California San Diego,   Jacobs Retina Center at the Shiley Eye  Center, La Jolla, CA, USA; 3University  of California San Diego, Moores  Cancer Center, AIDS Malignancy  Consortium, La Jolla, C a, Usa Correspondence: Igor Kozak   Vitreoretinal Division, King Khaled Eye  specialist Hospital, pO Box 7191,   Riyadh 11462, Kingdom of Saudi Arabia   tel +966 482 1234 ext 3772   email ikozak@kkesh.med.s aAbstract:  We report a case of successive bilateral retinal vein occlusion in a human  immunodeficiency virus (HIV)-positive male with multicentric Castleman’ s disease treated  successfully with a single injection of intravitreal bevacizumab.",Non-OADS,/arxiv_data1/oa_pdf/93/e0/opth-7-1647.PMC3747847.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/93/e0/opth-7-1647.PMC3747847.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/e0/opth-7-1647.PMC3747847.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/7c/ijn-8-3107.PMC3747848.pdf
Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3107–3118International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3107OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4832 1Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/07/7c/ijn-8-3107.PMC3747848.pdf
"Or use: http://dvpr.es/16FOGd RDelivery system for DNazymes using arginine- modified hydroxyapatite nanoparticles   for therapeutic application in a nasopharyngeal  carcinoma model Yan Chen1 lifang Yang1,2 suping huang3 Zhi Li1 Lu Zhang1 Jiang he1 Zhijie Xu2 liyu liu2 Ya cao2 lunquan sun1 1Center for Molecular Medicine, Xiangya  hospital, 2Cancer Research Institute, 3state  Key laboratory of Powder Metallurgy,   Central South University, Changsha,   People’s Republic of China correspondence: lifang Yang,   lunquan sun   center for Molecular Medicine,   Xiangya Hospital, Central South University,  Changsha 410008, People’s Republic of China   Tel +86 731 8432 7646   Fax +86 731 8432 7212   email yanglifang@csu.edu.c n; lunquansun@csu.",Non-OADS,/arxiv_data1/oa_pdf/07/7c/ijn-8-3107.PMC3747848.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/07/7c/ijn-8-3107.PMC3747848.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/7c/ijn-8-3107.PMC3747848.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/43/ott-6-1097.PMC3747849.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1097–1110OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1097Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3486 9Future directions in combined modality therapy  for rectal cancer: reevaluating the role of total  mesorectal excision after chemoradiotherapy Abhishek A Solanki1 Daniel T Chang2 Stanley L Liauw1 1Department of Radiation and Cellular  Oncology, University of Chicago,   Chicago, iL, USA; 2Department  of Radiation Oncology, Stanford  University, Stanford, CA, USA Correspondence: Stanley L Liauw   Department of Radiation and Cellular   Oncology, 5758 S Maryland Avenue,   MC 9006, Chicago, iL 60637, USA   Tel +1 773 702 6870   Fax +1 773 834 7340   email sliauw@radonc.uchicago.ed uAbstract:  Most patients who develop rectal cancer present with locoregionally advanced (T3  or node-positive) disease.",Non-OADS,/arxiv_data1/oa_pdf/b2/43/ott-6-1097.PMC3747849.pdf
Available from: http://www.nccn.org/professionals/ physician_gls/pdf/rectal.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b2/43/ott-6-1097.PMC3747849.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b2/43/ott-6-1097.PMC3747849.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/43/ott-6-1097.PMC3747849.pdf
Available from: http://pathways.nice.org.uk/ pathways/colorectal-cancer#pat h=view%3A/pathways/colorectal- cancer/managing-local-colorectal-tumours.xml&content =view- node%3Anodes-deciding-whether-to-offer-further-treatment.,Non-OADS,/arxiv_data1/oa_pdf/b2/43/ott-6-1097.PMC3747849.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/53/1d/ijwh-5-501.PMC3747850.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 501–507International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  501OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S4990 9retrospective cohort study of the effects   of obesity in early pregnancy on maternal   weight gain and obstetric outcomes   in an obstetric population in africa chukwuemeka a Iyoke1 george O Ugwu1 Frank O ezugwu2 Osaheni l lawani3 azubuike K Onyebuchi3 1Departments of Obstetrics  and gynaecology, University of  nigeria Teaching Hospital, enugu,  2Departments of Obstetrics  and gynaecology, enugu state  University Teaching Hospital, enugu,  3Departments of Obstetrics and  gynaecology, Federal Medical centre,  abakaliki, ebonyi state, nigeria correspondence: chukwuemeka Iyoke   Department of Obstetrics and  gynaecology, University of   nigeria Teaching Hospital,   Ituku-Ozalla, PO Box 4998, enugu   Headquarters, enugu, nigeria   T el +234 8085 831 167   email caiyoke@yahoo.co.u kObjective:  The purpose of this study was to compare maternal weight gain in pregnancy and  obstetric outcomes between women with obesity in early pregnancy and those with a normal  body mass index (BMI) in early pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/53/1d/ijwh-5-501.PMC3747850.pdf
Available from: http://www.who.int/dietphysicalactivity/ publications /trs916/kit/en /.,Non-OADS,/arxiv_data1/oa_pdf/53/1d/ijwh-5-501.PMC3747850.pdf
Available  from: http://www.ahrq.gov/research/findings/evidence-based-reports/ er168-abstract.html .,OADS,/arxiv_data1/oa_pdf/53/1d/ijwh-5-501.PMC3747850.pdf
Available from:  http://www.measuredhs.com/pubs/pdf/FR222/FR222.pdf .,Non-OADS,/arxiv_data1/oa_pdf/53/1d/ijwh-5-501.PMC3747850.pdf
Available from: http://apps.who.int/bmi/index.jsp .,OADS,/arxiv_data1/oa_pdf/53/1d/ijwh-5-501.PMC3747850.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/53/1d/ijwh-5-501.PMC3747850.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/1d/ijwh-5-501.PMC3747850.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/ijn-8-3093.PMC3747852.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3093–3105International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3093OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4808 4Dual effects and mechanism of TiO2 nanotube  arrays in reducing bacterial colonization and  enhancing c3h10T1/2 cell adhesion Zhaoxiang Peng1,2,* Jiahua Ni3,* Kang Zheng2 Yandong shen2 Xiaoqing Wang1 guo he3 sungho Jin4 Tingting Tang1 1shanghai Key laboratory of Orthopaedic  Implants, Department of Orthopaedic  surgery, shanghai Ninth People’s hospital,   shanghai Jiaotong University school of  Medicine, shanghai, People’s republic  of china; 2Department of Orthopaedic  surgery, Ningbo Medical Treatment center  lihuili hospital, Ningbo, People’s republic  of china; 3state Key lab of Metal Matrix  composites, school of Materials science  and engineering, shanghai Jiao Tong  University, shanghai, People’s republic of  china; 4Materials science and engineering,   University of california, san Diego,    la Jolla, ca, Usa *These authors contributed equally to this  work correspondence: Tingting Tang   shanghai Key laboratory of Orthopaedic  Implants, Department of Orthopaedic surgery,  shanghai Ninth People’s hospital,   shanghai Jiaotong University school of Medicine,   639 Zhizaoju road, shanghai 200011,   People’s republic of china   Tel +86 21 2327 1133   Fax +86 21 6313 7020   email tingtingtang@hotmail.co m    guo he   state Key lab of Metal Matrix composites,  school of Materials science and engineering,  shanghai Jiao T ong University,   80 Dongchuan road,   Minhang District, shanghai 200240,   People’s republic of china   T el +86 21 3420 2643   Fax +86 21 3420 2643   email ghe@sjtu.edu.c nAbstract:  Competition occurs between the osteoblasts in regional microenvironments and  pathogens introduced during surgery, on the surface of bone implants, such as joint prostheses.",Non-OADS,/arxiv_data1/oa_pdf/9c/41/ijn-8-3093.PMC3747852.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9c/41/ijn-8-3093.PMC3747852.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/41/ijn-8-3093.PMC3747852.pdf
"Corresponding author: Chao-Qiang Lai, chaoqiang.lai@ars.usda.gov, or Duo Li, duoli@zju.edu.cn.Received 14 December 2012 and accepted 25 February 2013.DOI: 10.2337/dc12-2607 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2607/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/2b/22/2621.PMC3747864.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2b/22/2621.PMC3747864.pdf
Available from http://www.saladeimprensa.IBGE.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/13/eb/e139.PMC3747865.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8f/38/2566.PMC3747866.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/aa/5e/2551.PMC3747867.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a9/63/2787.PMC3747869.pdf
†Anxiety was measured using a one-item scale from the China National Health Services Survey (http://www.moh.gov.cn/mohwsbwstjxxzx/s8211/200809/37880.shtm).,OADS,/arxiv_data1/oa_pdf/6e/68/e159.PMC3747870.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/fc/b5/2523.PMC3747872.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ee/b3/2843.PMC3747873.pdf
Available fromhttp://www.health.gov /paguidelines/pdf/ paguide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/b3/2843.PMC3747873.pdf
"ACTRN12610000409077, www.anzctr.org.au.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2617/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/8e/8a/2822.PMC3747874.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8e/8a/2822.PMC3747874.pdf
DOI: 10.2337/dc12-2190This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2190/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ef/49/2697.PMC3747875.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ef/49/2697.PMC3747875.pdf
Available from http://www.adips.org/downloads/ADIPS%20consensus %20guidelines%20GDM%20140213.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/b0/e164.PMC3747876.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/58/65/2862.PMC3747877.pdf
"Corresponding author: Jeffrey F. Horowitz, jeffhoro@umich.edu.Received 14 December 2012 and accepted 23 February 2013.DOI: 10.2337/dc12-2606This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2606/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/81/d6/2516.PMC3747878.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/81/d6/2516.PMC3747878.pdf
Available from http://www.heart.org/HEARTORG/GettingHealthy/PhysicalActivity/StartWalking/American- Heart-Association-Guidelines_UCM_307976_ Article.jsp#.T2epchEgcTY.,Non-OADS,/arxiv_data1/oa_pdf/81/d6/2516.PMC3747878.pdf
Available from http://www.cdc.gov/physicalactivity/everyone/guidelines/adults.html.,Non-OADS,/arxiv_data1/oa_pdf/81/d6/2516.PMC3747878.pdf
"Corresponding author: David M. Maahs, david.maahs@ucdenver.edu.Received 5 December 2012 and accepted 19 February 2013.DOI: 10.2337/dc12-2538This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2538/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/33/75/2607.PMC3747879.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/33/75/2607.PMC3747879.pdf
"Corresponding author: Christina Ellervik, christina@ellervik.dk.Received 5 October 2012 and accepted 25 February 2013.DOI: 10.2337/dc12-2032This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2032/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/77/96/2646.PMC3747880.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/77/96/2646.PMC3747880.pdf
Received 24 October 2012 and accepted 26 February 2013.DOI: 10.2337/dc12-2173This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2173/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/45/3e/2720.PMC3747882.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/45/3e/2720.PMC3747882.pdf
Available from http://smokefree.gov.,Non-OADS,/arxiv_data1/oa_pdf/45/3e/2720.PMC3747882.pdf
Received 30 August 2012 and accepted 8 February 2013.DOI: 10.2337/dc12-1759This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1759/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/5a/ff/2628.PMC3747883.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/5a/ff/2628.PMC3747883.pdf
Information available at: http://www.idf.org/di abetesatlas/5e/the- global-burden4.,Non-OADS,/arxiv_data1/oa_pdf/5a/ff/2628.PMC3747883.pdf
"Corresponding author: Todd M. Brown, tmbrown@uab.edu.Received 8 November 2012 and accepted 2 March 2013.DOI: 10.2337/dc12-2318This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2318/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/63/5c/2734.PMC3747886.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/63/5c/2734.PMC3747886.pdf
Available from http://www.cdc.gov/nchs/nhanes.htm.Accessed 10 August 2012 8.,Non-OADS,/arxiv_data1/oa_pdf/63/5c/2734.PMC3747886.pdf
Available from http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/labdoc_e.htm.,OADS,/arxiv_data1/oa_pdf/63/5c/2734.PMC3747886.pdf
"Corresponding author: Chittaranjan S. Yajnik, diabetes@kemdiabetes.org.Received 23 November 2012 and accepted 19 March 2013.DOI: 10.2337/dc12-2445This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2445/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/d8/10/2706.PMC3747887.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d8/10/2706.PMC3747887.pdf
Available fromhttp://www.nhlbi.nih.gov/guidelines/ cholesterol/atp3full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/10/2706.PMC3747887.pdf
Available from http://iom.edu/reports/2009/weight-gain-during- pregnancy-reexamining-the-guidelines.,Non-OADS,/arxiv_data1/oa_pdf/d8/10/2706.PMC3747887.pdf
"NCT00069784, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2129/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/69/ec/2466.PMC3747889.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/69/ec/2466.PMC3747889.pdf
New drug application (NDA) [Internet].Available from http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/HowDrug sareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/default.htm.,OADS,/arxiv_data1/oa_pdf/df/d0/2453.PMC3747890.pdf
Available from http://www.novonordisk.com/include/asp/exe_ news_attachment.asp?sAttachmentGUID= 83700060-0ce3-4577-a35a-f3e57801637d.Accessed 20 April 2013 4.,Non-OADS,/arxiv_data1/oa_pdf/df/d0/2453.PMC3747890.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/41/fd/2810.PMC3747891.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/35/ee/2815.PMC3747892.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/40/f8/2748.PMC3747893.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6c/e1/2663.PMC3747895.pdf
Available from http://diabeticeye.screening.nhs.uk/standards.Accessed 15 February 2013 17.,Non-OADS,/arxiv_data1/oa_pdf/6c/e1/2663.PMC3747895.pdf
Avail-able from http://diabeticeye.screening.,Non-OADS,/arxiv_data1/oa_pdf/6c/e1/2663.PMC3747895.pdf
"Corresponding author: Marcus D. Säemann, marcus.saemann@meduniwien.ac.at.Received 22 November 2012 and accepted 26 February 2013.DOI: 10.2337/dc12-2441This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2441/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/4f/52/2763.PMC3747896.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4f/52/2763.PMC3747896.pdf
Available fromhttp://www.srtr.org/annual_reports/2010/ pdf/2010_SRTR_ADR.pdf.,OADS,/arxiv_data1/oa_pdf/4f/52/2763.PMC3747896.pdf
Availablefrom http://www.usrds.org/adr.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4f/52/2763.PMC3747896.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7c/dc/2504.PMC3747897.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/cb/49/2726.PMC3747898.pdf
Available from http://www.acponline.org/advo cacy/where_we_ stand/medical_home/approve_jp.pdf.Accessed 16 December 2011 6.,Non-OADS,/arxiv_data1/oa_pdf/cb/49/2726.PMC3747898.pdf
Available from http://www.ncqa.org/tabid/78/Default.,OADS,/arxiv_data1/oa_pdf/cb/49/2726.PMC3747898.pdf
DOI: 10.2337/dc13-0425 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0425/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/62/1f/2615.PMC3747899.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/62/1f/2615.PMC3747899.pdf
"NCT00975286, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2462/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/4f/29/2497.PMC3747901.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4f/29/2497.PMC3747901.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c4/7b/2756.PMC3747902.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/88/0e/2741.PMC3747905.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/51/66/2475.PMC3747907.pdf
Available from http://www.pewinternet.org/static-pages/ trend-data-for-teens/whos-online.aspx.Accessed 3 June 201111.,Non-OADS,/arxiv_data1/oa_pdf/51/66/2475.PMC3747907.pdf
Available from http://www.useit.com/alertbox/20050131.html.,Non-OADS,/arxiv_data1/oa_pdf/51/66/2475.PMC3747907.pdf
"Corresponding author: Stephanie N. DuBose, sdubose@jaeb.org.Received 25 October 2012 and accepted 21 February 2013.DOI: 10.2337/dc12-2192This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2192/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/71/14/2639.PMC3747908.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/71/14/2639.PMC3747908.pdf
Received 27 September 2012 and accepted 8 March 2013.DOI: 10.2337/dc12-1986This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1986/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/eb/8c/2794.PMC3747909.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/eb/8c/2794.PMC3747909.pdf
DOI: 10.2337/dc12-2553 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-2553/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8a/db/2836.PMC3747911.pdf
Statistical methods Statistical analyses were performed using PLINK (http://pngu.mgh.harvard.edu/~purcell/plink/) and SAS (version 9.1.3; SAS Institute).,OADS,/arxiv_data1/oa_pdf/8a/db/2836.PMC3747911.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/75/35/2597.PMC3747912.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4a/03/2677.PMC3747916.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7a/91/2536.PMC3747917.pdf
Availablefrom: http://www.obesity.org/resources- for/your-weight-and-diabetes.htm.,Non-OADS,/arxiv_data1/oa_pdf/7a/91/2536.PMC3747917.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/09/b2/2591.PMC3747918.pdf
Available from http://www.dmi.dk/dmi/tr00-08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/39/e157.PMC3747919.pdf
"Corresponding author: Kathryn Backholer, kathryn.backholer@bakeridi.edu.au.Received 3 December 2012 and accepted 22 March 2013.DOI: 10.2337/dc12-2501This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2501/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/78/04/2714.PMC3747920.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/78/04/2714.PMC3747920.pdf
"Corresponding authors: Insa Feinkohl, i.feinkohl@sms.ed.ac.uk, and Jackie F. Price, jackie.price@ed.ac.uk.Received 31 October 2012 and accepted 21 February 2013.DOI: 10.2337/dc12-2241This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2241/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/f9/8d/2779.PMC3747922.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f9/8d/2779.PMC3747922.pdf
Avail-able from http://www.sciencedirect.com/ science/article/pii/S0160289603000679.,Non-OADS,/arxiv_data1/oa_pdf/f9/8d/2779.PMC3747922.pdf
"NCT01137812, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2491/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/59/53/2508.PMC3747923.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/59/53/2508.PMC3747923.pdf
Received 18 September 2012 and accepted 21 February 2013.DOI: 10.2337/dc12-1906This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1906/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/4a/95/2830.PMC3747924.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4a/95/2830.PMC3747924.pdf
The free web-based calculator is available at http://www.operapadrepio.,Non-OADS,/arxiv_data1/oa_pdf/4a/95/2830.PMC3747924.pdf
"Fi- nally, we have provided a user-friendlyweb-based risk engine (http://www.operapadrepio.it/rca lc/rcalc.php) that may serve the important function of test- ing our model in different sets of diabeticindividuals in order to address its gener- alizability.",Non-OADS,/arxiv_data1/oa_pdf/4a/95/2830.PMC3747924.pdf
Avail-able from http://www.eatlas.idf.org/index2983.html.,Non-OADS,/arxiv_data1/oa_pdf/4a/95/2830.PMC3747924.pdf
"NCT007715624, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2454/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/10/26/2489.PMC3747925.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/10/26/2489.PMC3747925.pdf
Available at http://ec.europa.eu/health/documents/community-register/html/ alfregister.htm.,Non-OADS,/arxiv_data1/oa_pdf/10/26/2489.PMC3747925.pdf
"Corresponding author: Anders Grøntved, agroentved@health.sdu.dk.Received 1 November 2012 and accepted 9 February 2013.DOI: 10.2337/dc12-2252This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2252/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/7c/08/2575.PMC3747926.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7c/08/2575.PMC3747926.pdf
Available from http://www.health.,Non-OADS,/arxiv_data1/oa_pdf/7c/08/2575.PMC3747926.pdf
Received 27 August 2012 and accepted 9 March 2013.DOI: 10.2337/dc12-1738This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1738/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/5f/5e/2683.PMC3747928.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/5f/5e/2683.PMC3747928.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/40/4c/2456.PMC3747929.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2a/5c/2573.PMC3747930.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/80/eb/2772.PMC3747932.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/1f/e5/2530.PMC3747933.pdf
Available from http://sucralose.org/ques-tions/default.asp.,OADS,/arxiv_data1/oa_pdf/1f/e5/2530.PMC3747933.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/32/9e/2582.PMC3747934.pdf
Available from http://www5.statcan.gc.ca/cansim/a01?lang=eng.,OADS,/arxiv_data1/oa_pdf/32/9e/2582.PMC3747934.pdf
"NCT00943917, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2410/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/cd/fb/2559.PMC3747935.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/cd/fb/2559.PMC3747935.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6c/97/2483.PMC3747936.pdf
"NCT00712673, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2006/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/50/71/2543.PMC3747937.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/50/71/2543.PMC3747937.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/27/76/e143.PMC3747938.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/52/6b/2690.PMC3747941.pdf
Available from http://www.cdc.gov/nchs/ nhanes/nhanes_questionnaires.htm.,OADS,/arxiv_data1/oa_pdf/52/6b/2690.PMC3747941.pdf
Avail- able from http://www.cdc.gov/nchs/data/ nhanes/nhanes_07_08/manual_an.pdf.Accessed 10 January 2012 8.,Non-OADS,/arxiv_data1/oa_pdf/52/6b/2690.PMC3747941.pdf
Available from http://www.cdc .gov/nchs/nhanes/nhanes2003-2004/analytical_guidelines.htm.,OADS,/arxiv_data1/oa_pdf/52/6b/2690.PMC3747941.pdf
Availablefrom http://www.cdc.gov/diabetes/statis-tics/incidence/ ﬁg2.htm.,Non-OADS,/arxiv_data1/oa_pdf/52/6b/2690.PMC3747941.pdf
"Corresponding author: Baiju R. Shah, baiju.shah@ices.on.ca.Received 15 October 2012 and accepted 17 March 2013.DOI: 10.2337/dc12-2105This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2105/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/f8/00/2670.PMC3747942.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f8/00/2670.PMC3747942.pdf
"Ottawa, Ontario, Canada, Statistics Can- ada, 2 April 2008 (97-562-XWE2006002) Available from http://www12.statcan.gc.ca/census-recensement/2006/rt-td/eth-eng .cfm.",OADS,/arxiv_data1/oa_pdf/f8/00/2670.PMC3747942.pdf
"Ottawa, Ontario, Canada, Statistics Canada,4 December 2007 (97-557-XWE2006002).Available from http://www12.statcan.gc.ca/ census-recensement/2006/rt-td/immcit- eng.cfm.",OADS,/arxiv_data1/oa_pdf/f8/00/2670.PMC3747942.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/76/dd/2850.PMC3747944.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ed/34/2600.PMC3747945.pdf
Diabetic medica- tions were recorded at every study visit by direct visual inspection of medications andclassi ﬁed using the Centers for Disease Control and Prevention Ambulatory Care Drug Database (http://www2.cdc.gov/ drugs/).,OADS,/arxiv_data1/oa_pdf/ed/34/2600.PMC3747945.pdf
Available from http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ed/34/2600.PMC3747945.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8a/f7/2655.PMC3747946.pdf
"Available from http://www.cdc.gov/nchs/nhanes.htm [Internet], 2012.",OADS,/arxiv_data1/oa_pdf/8a/f7/2655.PMC3747946.pdf
Available from http://www.cnpp.usda.gov/Publications/ HEI/HEI-2005/HEI-2005TechnicalReport.pdf.,OADS,/arxiv_data1/oa_pdf/8a/f7/2655.PMC3747946.pdf
Available from http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/ DIETARY_MEC.pdf.,OADS,/arxiv_data1/oa_pdf/8a/f7/2655.PMC3747946.pdf
Available from http://pages.gseis.ucla.edu/faculty/muthen/articles/Arti-cle_075.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/f7/2655.PMC3747946.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e0/cc/2857.PMC3747947.pdf
"For morphometric analysis, digital microscopy images were analyzed using ImageJ software (http://rsb.info.nih.gov/ ij/) as described.33All images were coded and assessed blindly.",OADS,/arxiv_data1/oa_pdf/98/5c/mi2012141a.PMC3747980.pdf
"All quanti- tative PCR primers used were designed using Primer3 software (http://primer3plus.com), 34and their details are provided in Supplementary Table S1 online.",OADS,/arxiv_data1/oa_pdf/98/5c/mi2012141a.PMC3747980.pdf
"SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/miACKNOWLEDGEMENTS We thank Simon Cumming, Megan Davey, Bob Fleming, Fraser Laing, and the Pathology Services Group (University of Edinburgh, UK) for excellent technical support, Helen Brown (University of Edinburgh, UK) for statisticaladvice, and Gaku Nakato (RCAI-RIKEN, Yokohama, Japan) for excellent technical advice and helpful discussion.",Non-OADS,/arxiv_data1/oa_pdf/98/5c/mi2012141a.PMC3747980.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/77/ndt-9-1193.PMC3748052.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1193–1202Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1193OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4896 5Quality of life and personality traits in patients  with malignant pleural mesothelioma and their  first-degree caregivers antonella granieri1 stella Tamburello2 antonino Tamburello2 silvia casale3 chiara cont1 Fanny guglielmucci1 Marco innamorati2 1Università degli studi di T orino, T urin,   italy; 2Università europea di roma,   rome, italy; 3Università di Firenze,   Firenze, italy correspondence: antonella granieri   Department of Psychology,   University of Turin, Via Po 14,   10123 Turin, italy   Tel +39 011 091 3062   Fax +39 011 814 6231   email antonella.granieri@unito.i tAbstract:  Asbestos exposure causes significant pleural diseases, including malignant pleural  mesothelioma (MPM).",Non-OADS,/arxiv_data1/oa_pdf/e4/77/ndt-9-1193.PMC3748052.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e4/77/ndt-9-1193.PMC3748052.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/77/ndt-9-1193.PMC3748052.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/03/ndt-9-1187.PMC3748055.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1187–1192Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1187OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5045 8T emperamental characteristics in childhood  migraine without aura: a multicenter study Maria esposito1 rosa Marotta2 Beatrice gallai3 lucia Parisi4 giuseppina Patriciello1 serena Marianna lavano2 giovanni Mazzotta5 Michele roccella4 Marco carotenuto1 1center for childhood headache,   clinic of child and adolescent  Neuropsychiatry, Department   of Mental health, Physical and  Preventive Medicine, second  University of Naples, Naples, italy;   2Department of Psychiatry, “Magna  graecia” University of catanzaro,   catanzaro, italy; 3Unit of child  and adolescent Neuropsychiatry,   University of Perugia, Perugia, italy;   4child Neuropsychiatry, Department  of Psychology, University of Palermo,   Palermo, italy; 5Unit of child and  adolescent Neuropsychiatry, aUsl  Umbria 2, T erni, italy correspondence: Beatrice gallai   Unit of child and adolescent  Neuropsychiatry, University of Perugia,   Via enrico dal Pozzo, 06100, Perugia, italy   Tel +39 744 204 506   Fax +39 744 204 506   email beagallai@gmail.co mBackground:  Children with migraine seem to be more anxious, sensitive, deliberate, cautious,  fearful, vulnerable to frustration, tidy, and less physically enduring than comparisons.",Non-OADS,/arxiv_data1/oa_pdf/bd/03/ndt-9-1187.PMC3748055.pdf
"Available from: http://www.moityca.com.br/pdfs/ Cloninger2003.PD F. Accessed July 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/bd/03/ndt-9-1187.PMC3748055.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/bd/03/ndt-9-1187.PMC3748055.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/03/ndt-9-1187.PMC3748055.pdf
Available at: http://www.wma.,Non-OADS,/arxiv_data1/oa_pdf/bd/03/ndt-9-1187.PMC3748055.pdf
"www.landesbioscience.com  Autophagy  1167Aut ophagy 9:8, 1167–1171; August 2013; © 2013 Landes Bioscience BAsiC BriEF rEPor t BAsiC Bri EF rEP or t *Correspondence to: Tomohiro Kabuta; Email: kabuta@ncnp.go.jp Submitted: 12/05/12; Revised: 04/25/13; Accepted: 04/30/13http://dx.doi.org/10.4161/auto.24880Introduction Lysosomes contain various hydrolases that can degrade proteins,  lipids, nucleic acids and carbohydrates,1,2 as well as organelles.3  Despite such a diversity of hydrolases observed within lysosomes, studies on selective autophagy have been mainly focused on its protein-targeting machineries.",Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
J Biophys Biochem Cytol 1956; 2(Suppl):179-84; PMID:13357540; http://dx.doi.org/10.1083/jcb.2.4.179 3.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Cell 2011; 147:728-41; PMID:22078875; http://dx.doi.org/10.1016/j.cell.2011.10.026 4.,OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Autophagy 2011; 7:279-96; PMID:21189453; http://dx.doi.org/10.4161/auto.7.3.14487 5.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Dev Cell 2011; 20:131-9; PMID:21238931; http://dx.doi.org/10.1016/j.dev-cel.2010.12.003 6.,OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Autophagy 2013; 9:403-9; PMID:23291500; http://dx.doi.org/10.4161/auto.23002 8.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
T raffic 2005; 6:1058-61; PMID:16190986; http://dx.doi.org/10.1111/j.1600-0854.2005.00337.x 9.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Science 1996; 273:501-3; PMID:8662539; http://dx.doi.org/10.1126/science.273.5274.501 10.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
J Biol Chem 2008; 283:23731-8; PMID:18550537; http://dx.doi.org/10.1074/jbc.M80191820011.,OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Nature 2000; 406:902-6; PMID:10972293; http://dx.doi.org/10.1038/35022595 12.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Nat Immunol 2011; 12:222-30; PMID:21151103; http://dx.doi.org/10.1038/ni.1980 13.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Nature 2012; 485:251-5; PMID:22535248; http://dx.doi.org/10.1038/nature10992 14.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Nature 2010; 464:104-7; PMID:20203610; http://dx.doi.org/10.1038/nature08780 15.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Cell 2009; 136:763-76; PMID:19239894; http://dx.doi.org/10.1016/j.cell.2009.01.019 16.,OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Nat Cell Biol 2008; 10:602-10; PMID:18391941; http://dx.doi.org/10.1038/ncb1723 18.,OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Nature 2000; 408:740-5; PMID:11130078; http://dx.doi.org/10.1038/35047123 19.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Nature 2001; 413:732-8; PMID:11607032; http://dx.doi.org/10.1038/3509956020.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Science 2004; 303:1526-9; PMID:14976262; http://dx.doi.org/10.1126/science.1093620 21.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Science 2004; 303:1529-31; PMID:14976261; http://dx.doi.org/10.1126/science.1093616 22.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Int Immunol 2005; 17:1-14; PMID:15585605; http://dx.doi.org/10.1093/intimm/dxh186 23.,Non-OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Immunity 2005; 22:571-81; PMID:15894275; http://dx.doi.org/10.1016/j.immuni.2005.03.009 26.,OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Immunity 2012; 37:986-97; PMID:23219390; http://dx.doi.org/10.1016/j.immu-ni.2012.09.014 27.,OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
Nucleic Acids Res 1987; 15:529-42; PMID:2881260; http://dx.doi.org/10.1093/nar/15.2.529,OADS,/arxiv_data1/oa_pdf/d8/9f/auto-9-1167.PMC3748189.pdf
"Thus, we examined the current status of  Received: July 23, 2012 Accepted: October 3, 2012 Correspondence: Dr. Tatsuhiko Urakami, Department of  Pediatrics, Nihon University School of Medicine, 1-8-13 Kandasurugadai, Chiyoda-ku, Tokyo 101-8309, Japan E-mail: urakami.tatsuhiko@nihon-u.ac.jpClin Pediatr Endocrinol 2013; 22 (1), 1–8 Copyright© 2013 by The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-ncnd) License  <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/5e/f9/cpe-22-001.PMC3748280.pdf
"Characteristic X-ray findings such as cupping, flaring, and fraying strongly suggest Received: June 22, 2012 Accepted: October 22, 2012 Correspondence: Dr. Keiichi Ozono, Department of Pe- diatrics, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan E-mail: keioz@ped.med.osaka-u.ac.jp * Member list of the Department of Molecular Endocrinology,  National Research Institute for Child Health and Develop- ment: Osamu Arisaka, Susumu Yokoya, Shin Amemiya,  Toshiaki Tanaka, Tomonobu Hasegawa, Hiroyuki Tanaka, Syohei Harada.Clin Pediatr Endocrinol 2013; 22 (1), 9–14 Copyright© 2013 by The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-ncnd) License  <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/cpe-22-009.PMC3748281.pdf
"To date, over 200 mutations have been found  in the PHEX gene and listed in the PHEXdb,  PHEX Locus Database (http://www.phexdb.mcgill.ca).",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/cpe-22-009.PMC3748281.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permi ts non-commercial re-use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/b9/mst104.PMC3748350.pdf
[cited 2012 July 24] Available from: http://www.who.int/malaria/ world_malaria_report_2011/en .,Non-OADS,/arxiv_data1/oa_pdf/7c/b9/mst104.PMC3748350.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permi ts non-commercial re-use, distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/1f/mst108.PMC3748351.pdf
http://beast.bio.ed.ac.uk/ Tracer .,Non-OADS,/arxiv_data1/oa_pdf/d3/1f/mst108.PMC3748351.pdf
"2012 )f r o m http://medinalab.org/zoox (last accessed October 3, 2012).",Non-OADS,/arxiv_data1/oa_pdf/e0/69/mst109.PMC3748352.pdf
"Subsequently, proteinsequences were analyzed for the presence of signal peptides with Signal IP 4.0 ( http://www.cbs.dtu.dk/services/SignalP/ , last accessed February 15, 2013), TM domains withTMHMM v. 2.0 ( http://www.cbs.dtu.dk/services/TMHMM/ , last accessed February 15, 2013) and further characterized for homologous domains, and regions using theInterproScan platform ( http://www.ebi.ac.uk/Tools/pfa/iprs- can/ , last accessed February 15, 2013).",OADS,/arxiv_data1/oa_pdf/e0/69/mst109.PMC3748352.pdf
"Homology Analysis and Protein Comparisons at the Domain Level Homology analysis were performed using the 36 A. millepora sequences involved in biomineralization (transcripts and proteins) against the predicted coding genes of Acropora digitifera (http://marinegenomics.oist.jp/genomes/gallery , last accessed November 2, 2011), N. vectensis (http://www.",OADS,/arxiv_data1/oa_pdf/e0/69/mst109.PMC3748352.pdf
"uniprot.org/ , last accessed February 14, 2013), and H. magni- papillata (ftp://ftp.jgi-psf.org/pub/JGI_data/Hydra_magnipa- pillata/ , last accessed February 14, 2013).",OADS,/arxiv_data1/oa_pdf/e0/69/mst109.PMC3748352.pdf
Supplementary Material Supplementary tables S1–S6 and ﬁgures S1–S8 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/e0/69/mst109.PMC3748352.pdf
Supplementary Material Supplementary ﬁgures S1–S9 and table S1 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/7b/e8/mst110.PMC3748353.pdf
"(2005) implemented their method in SweepFinder ( http://people.binf.ku.dk/ rasmus/webpage/sf.html , last accessed June 29, 2013).",OADS,/arxiv_data1/oa_pdf/a3/93/mst112.PMC3748355.pdf
"Nowaday s, samples that comprise hun- dreds or even thousands (e.g., The 1000 Genomes Project Consortium 2012 ;http://www.1000genomes.org ,l a s t accessed June 29, 2013) of sequences are becoming available.Hence, selective sweep detection is expected to become moreaccurate.",Non-OADS,/arxiv_data1/oa_pdf/a3/93/mst112.PMC3748355.pdf
"The modiﬁed versions ofboth, mssel and msms are available at http://exelixis-lab.org/ software.html (last accessed June 29, 2013).",OADS,/arxiv_data1/oa_pdf/a3/93/mst112.PMC3748355.pdf
Scripts that used to generate and analyze simulated data can be downloaded athttp://exelixis-lab.org/software.html .,OADS,/arxiv_data1/oa_pdf/a3/93/mst112.PMC3748355.pdf
"Usage Example To demonstrate the capability o f SweeD to handle real-world genomic data, we downloaded and analyzed the chromosome 1 data set from the 1000 Genome Project (http://ftp.1000genomes.ebi.ac.",OADS,/arxiv_data1/oa_pdf/a3/93/mst112.PMC3748355.pdf
For more examples and a detailed description of allsupported command line parameters please refer to the manual ( http://exelixis-lab.org/software.html ).,Non-OADS,/arxiv_data1/oa_pdf/a3/93/mst112.PMC3748355.pdf
All topologies obtained are available for download from http://dx.doi.org/10.5061/dryad.vh49j .T h er e m o v a lo f compositionally heterogeneous taxa (identiﬁed in 39TaxonSet_aa through Posterior Predictive simulationsand highlighted in ﬁg.,OADS,/arxiv_data1/oa_pdf/a0/fa/mst117.PMC3748356.pdf
"The Ensembl unique identiﬁers for all 27 genes are available in supplementary table S5 ,Supple- mentary Material online, and the complete set of multiple sequence alignments are available at http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/a0/fa/mst117.PMC3748356.pdf
Topologies obtained from heterogeneous models in P4are available for download from http://dx.doi.org/10.5061/ dryad.vh49j .,OADS,/arxiv_data1/oa_pdf/a0/fa/mst117.PMC3748356.pdf
Supplementary Material Supplementary tables S1–S7 and ﬁgure S1 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/a0/fa/mst117.PMC3748356.pdf
"GigaScience [cited 2013 July 23]; Available from: http://dx.do i.org/10.5524/100008 Li WH, Ellsworth DL, Krushkal J, Chang BH, Hewett-Emmett D. 1996.",OADS,/arxiv_data1/oa_pdf/a0/fa/mst117.PMC3748356.pdf
"Available from: http://tree.bio.ed.ac.uk/software/seal/ Rokas A, Kruger D, Carroll SB.",OADS,/arxiv_data1/oa_pdf/a0/fa/mst117.PMC3748356.pdf
Associate editor: Rasmus Nielsen The sequences reported in this paper have been deposited in the N ational Center for Biotechnology Information (NCBI) dbSNP Short Genetic Variations database: http://www.ncbi.nlm.nih.gov/SN P/snp_viewBatch.cgi?sbid=1055441 .,OADS,/arxiv_data1/oa_pdf/34/b8/mst125.PMC3748359.pdf
"Estimated true heterozy-gosity indicates that on average we would expect to ﬁnd oneheterozygous base pair every 1,070 bp: that is, approximately 2.47 million heterozygous SNP across all autosomes assuming a total length of 2,545,896,661 bp based on the Btau 4.0 ref-erence genome ( http://www.ncbi.nlm.nih.gov/assembly/ GCF_000003205.2/ , last accessed July 23, 2013).",OADS,/arxiv_data1/oa_pdf/34/b8/mst125.PMC3748359.pdf
"This assumption is justiﬁedbecause within the pedigree of each bull there are severalinbreeding loops to recent common ancestors three to sixgenerations ago ( https://www.holstein.ca/ , last accessed July 23, 2013).",Non-OADS,/arxiv_data1/oa_pdf/34/b8/mst125.PMC3748359.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Heart Journal (2013) 34, 2557–2565 doi:10.1093/eurheartj/ehs056",Non-OADS,/arxiv_data1/oa_pdf/cd/21/ehs056.PMC3748368.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2483 | DOI: 10.1038/srep02483 6",Non-OADS,/arxiv_data1/oa_pdf/f2/73/srep02483.PMC3748424.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: AstraZeneca (Spain) provided partial financial support for the present study via an educational grant to Dr. Javier A. Menendez and Dr. JoaquimBosch-Barrera.,Non-OADS,/arxiv_data1/oa_pdf/7c/18/srep02459.PMC3748425.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2459 | DOI: 10.1038/srep02459 10",Non-OADS,/arxiv_data1/oa_pdf/7c/18/srep02459.PMC3748425.pdf
Available from: http://www.hips.,Non-OADS,/arxiv_data1/oa_pdf/1c/b6/IJNMR-18-237.PMC3748545.pdf
Available from: http://apps.who.int/rhl/ pregnancy_childbirth/childbirth/2 nd_stage/jlcom/en/index.html  [Last revised on 2003 Oct 20].,Non-OADS,/arxiv_data1/oa_pdf/1c/b6/IJNMR-18-237.PMC3748545.pdf
Available from: http://www.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/e0/65/IJNMR-18-14.PMC3748549.pdf
; http://www.usdoctor.com/2011.,Non-OADS,/arxiv_data1/oa_pdf/e0/65/IJNMR-18-14.PMC3748549.pdf
Available from:  http://www.usdoctor.com/2011/Jun PMS.htmArticle.,OADS,/arxiv_data1/oa_pdf/e0/65/IJNMR-18-14.PMC3748549.pdf
Available from: http://www.irrodl.org/index.php/irrodl/article/ view/192/274 [Last accessed on 2004 May 01].,OADS,/arxiv_data1/oa_pdf/8f/f1/IJNMR-18-20.PMC3748550.pdf
Available from: http://www.amstat.org/publications/jse/v11n3/ utts.html [Last accessed on 2003 Jun 01].,OADS,/arxiv_data1/oa_pdf/8f/f1/IJNMR-18-20.PMC3748550.pdf
Available from:  http://www.wisconsin.edu/ttt/articles/garnham2.htm  [Last  accessed on 2002 Mar 20].,Non-OADS,/arxiv_data1/oa_pdf/8f/f1/IJNMR-18-20.PMC3748550.pdf
Available from: http://www.geteducated.com/ vug/june02/vug0602.htm [Last accessed on 2002 Jun 05].,OADS,/arxiv_data1/oa_pdf/8f/f1/IJNMR-18-20.PMC3748550.pdf
2009;2:131‑56.Available from: http://ravanshenasi.nashriyat.ir 7.,Non-OADS,/arxiv_data1/oa_pdf/b9/9f/IJNMR-18-38.PMC3748553.pdf
Available from: http://www.stigmaconference.nih.gov/ FinalLinkPaper.html 17.,Non-OADS,/arxiv_data1/oa_pdf/bb/6a/IJNMR-18-65.PMC3748558.pdf
Available from: http://www.citizen‑news.org.,Non-OADS,/arxiv_data1/oa_pdf/bb/6a/IJNMR-18-65.PMC3748558.pdf
Available from: http://alzahrahosp.tbzmed.,Non-OADS,/arxiv_data1/oa_pdf/27/36/IJNMR-18-71.PMC3748559.pdf
Available from: http://www.mums.ac.ir/nurse/ fa/pos_gr_ms_at_sp_int.,Non-OADS,/arxiv_data1/oa_pdf/27/36/IJNMR-18-71.PMC3748559.pdf
J  Health Inf Manag 2008;5: Available from:  http://www.him.mui.ac.ir/index.php/him/issue/view/9.,Non-OADS,/arxiv_data1/oa_pdf/1d/b7/IJNMR-18-79.PMC3748560.pdf
"2011: Available from: http://www.mdconsult.com/books/page.do?eid=4‑u1.0‑B978‑1‑4377‑0755‑7.00090‑7‑sc0015 and isbn=978‑1‑4377‑0755‑7 and sid=1372916832 and  uniqId=376673885‑17#4‑u1.0‑B978‑1‑4377‑0755‑7.00090‑7‑ sc0015, [Last retrieved on 2012 Sep 07].",Non-OADS,/arxiv_data1/oa_pdf/ab/61/IJNMR-18-112.PMC3748565.pdf
Available from: http://www.mdconsult.com/books/page.do?eid=4‑u1.0‑B978‑1‑4377‑ 1935‑2.00031‑4‑s0130 and isbn=978‑1‑4377‑1935‑2 and sid=1372913339 and uniqId=376673885‑4#4‑u1.0‑B978‑1‑ 4377‑1935‑2.00031‑4‑s0130 [Last retrieved on 2012 Sep 07].,Non-OADS,/arxiv_data1/oa_pdf/ab/61/IJNMR-18-112.PMC3748565.pdf
Available from: http://www.anesthesia‑analgrsia.org/content/99/3/886.full.,Non-OADS,/arxiv_data1/oa_pdf/9a/6d/IJNMR-18-117.PMC3748566.pdf
Available from: http://www.rtmagazine.com/issues/articles/2010‑07‑06.asp.,Non-OADS,/arxiv_data1/oa_pdf/9a/6d/IJNMR-18-117.PMC3748566.pdf
Available from: http://www.mehrnews.,Non-OADS,/arxiv_data1/oa_pdf/08/f3/IJNMR-18-123.PMC3748567.pdf
Available  from: http://www.ispub.com/journal/the ‑internet‑jour nal‑of‑gynecology‑and‑obstetrics/volume‑7‑number‑1/ management‑of‑dysmenorrrhoea‑among‑medical‑students.,Non-OADS,/arxiv_data1/oa_pdf/99/86/IJNMR-18-128.PMC3748568.pdf
Available from: http://www.sci.,Non-OADS,/arxiv_data1/oa_pdf/94/fe/IJNMR-18-140.PMC3748570.pdf
Available  from: http://www.iranmedex.com/issues.asp?journalID=57  [Last accessed on 2010 Dec].,Non-OADS,/arxiv_data1/oa_pdf/67/a7/IJNMR-18-94.PMC3748577.pdf
Available from: http://www.shakercg.com/hr/ Objective%20Evaluation%20Methods.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/a7/IJNMR-18-94.PMC3748577.pdf
Available from: http://www.hopkinsmedicine.org/about/ history/history5.html.,Non-OADS,/arxiv_data1/oa_pdf/87/57/JFCM-20-123.PMC3748647.pdf
"Saudi Board: Saudi specialty  certificate [Internet], 2011 Available from: http://english.scfhs.org.",Non-OADS,/arxiv_data1/oa_pdf/87/57/JFCM-20-123.PMC3748647.pdf
Available from: http://www.sacre.,Non-OADS,/arxiv_data1/oa_pdf/87/57/JFCM-20-123.PMC3748647.pdf
Available  from: http://www.acgme.org/acWebsite/resident_survey/General  SampleSurvey2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/87/57/JFCM-20-123.PMC3748647.pdf
Available from: http://www.cfpc.,Non-OADS,/arxiv_data1/oa_pdf/87/57/JFCM-20-123.PMC3748647.pdf
Available  from: http://arabic.scfhs.org.sa/new/pdf/2008_Trn‑cen‑regn_2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/87/57/JFCM-20-123.PMC3748647.pdf
"Future of Medical Education in Canada: White Paper  Series [Internet], 2011 Available from: http://www.royalcollege.ca/ shared/documents/fmec/resident_dual_role.pdf.",Non-OADS,/arxiv_data1/oa_pdf/87/57/JFCM-20-123.PMC3748647.pdf
Available from: http://www.idf.org/diabetesatlas/news/fifth‑  edition‑release.,Non-OADS,/arxiv_data1/oa_pdf/a1/89/JFCM-20-77.PMC3748651.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/a1/89/JFCM-20-77.PMC3748651.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/a1/89/JFCM-20-77.PMC3748651.pdf
Conflict of Interest:  None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d3/2b/JFCM-20-83.PMC3748652.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/2d/9d/JFCM-20-90.PMC3748653.pdf
MATERIALS AND METHODS The data presented in first figure of earlier report  http://llmpp.nih.gov/lymphoma/data.,OADS,/arxiv_data1/oa_pdf/60/99/ABR-2-26.PMC3748669.pdf
"Pediatric Anesthesia and Neurodevelopment Assessment (PANDA), Available from: http://www.kidspandastudy.org/index.html [Last accessed on 2013 May 7].",Non-OADS,/arxiv_data1/oa_pdf/cd/b5/IJA-57-221.PMC3748673.pdf
Available from: http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/4f/8b/IJA-57-236.PMC3748676.pdf
"Source of Support:  Nil, Conflict of Interest:  None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/8a/b4/IJA-57-282.PMC3748684.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/ca/c8/IJA-57-292.PMC3748687.pdf
Available from: http://www.WHO‑UMC.org/graphics/4409.pdf [Last accessed on   2012 Dec 16].,Non-OADS,/arxiv_data1/oa_pdf/30/a2/IJA-57-325.PMC3748705.pdf
"28,29 Associations between hospitalizations and the exposure vari- ables (i.e., percentage of downwind hours per day; daily means and hourly peaks of SO 2and PM 2.5) were assessed by conditional logistic regression analyses using the R statistical software(http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/9d/94/jes201327a.PMC3748758.pdf
2011; Available from http://www.who.int/mediacentre/factsheets/fs313/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9d/94/jes201327a.PMC3748758.pdf
2008 (updated November 6 2012) Available from: http://www.ec.gc.ca/pdb/websol/querysite/facility_substance_summary_e.cfm?opt_ npri_id=0000003057&opt_report_year=2008.21 Statistique-Canada.,OADS,/arxiv_data1/oa_pdf/9d/94/jes201327a.PMC3748758.pdf
"National Climate Data and Information Archive 2011, Available from http://climate.weatherofﬁce.gc.ca/c limateData/menu_e.htm l?Prov=QC&StationID =9999&Year=2011&Month=9&Day=29&timeframe=1.",OADS,/arxiv_data1/oa_pdf/9d/94/jes201327a.PMC3748758.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ APPENDIX Table A1 .Associations between hospitalizations for asthma or bronchiolitis in children aged 0–4 years versus percentage of hours per day that their residence was found downwind from the aluminum smelter (A) lagged for lag 1 day; (B) for the average of lags 0 and1 day; (C) excluding repeat hospitalizations of kids that occurred within 30 days.",Non-OADS,/arxiv_data1/oa_pdf/9d/94/jes201327a.PMC3748758.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/92/kft137.PMC3748763.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/cb/opth-7-1471.PMC3748793.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1471–1476Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1471Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S4587 5Influence of sclerotomy use on vitreous  incarceration in an experimental model   of vitrectomized eye Javier Benitez-Herreros1 Lorenzo Lopez-Guajardo1,2 Cristina Camara-Gonzalez1 Aurora Perez-Crespo1 Agustin Silva-Mato3 Miguel A T eus1,2 1Department of Ophthalmology,   University hospital Príncipe de  Asturias, Madrid, Spain; 2Department  of Surgery, Medical and Social  Sciences, Faculty of Medicine, Alcalá  University, Madrid, Spain; 3Department  of Health and Sociomedical Sciences,   Alcalá University, Madrid, Spain Correspondence: Lorenzo Lopez- Guajardo   Department of Ophthalmology,  University hospital Príncipe de asturias,  Carretera Alcalá-Meco, Alcalá de  Henares, Madrid 28805, Spain   email llguajardo@icam.e sPurpose:  To evaluate the influence of sclerotomy use during vitrectomy (vitreous cutter,  illumination probe, or infusion-line entrance) on postoperative vitreous incarceration using an  experimental model of vitrectomized eye.",Non-OADS,/arxiv_data1/oa_pdf/2e/cb/opth-7-1471.PMC3748793.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2e/cb/opth-7-1471.PMC3748793.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/cb/opth-7-1471.PMC3748793.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/13/opth-7-1535.PMC3748794.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1535–1537Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1535CASE REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4926 4Spontaneous corneal perforation in an eye   with Peters’ anomaly Moosang Kim Seung-Chan Lee Seung-Jun Lee Department of Ophthalmology,   School of Medicine, Kangwon  National University, Chuncheon,   South Korea Correspondence: Seung-Jun Lee   Department of Ophthalmology,   Hospital 200-722, School of   Medicine, Kangwon National   University, Baengnyeong-ro 156,   Chuncheon-Si, Gangwon-Do   Kangwon National University   Chuncheon, South Korea   Tel +82 33 258 2014   Fax +82 2 258 2191   Email ophkimmoo@gmail.comAbstract:  A premature female infant underwent her first ophthalmologic examination at the  age of 4 weeks.",Non-OADS,/arxiv_data1/oa_pdf/e3/13/opth-7-1535.PMC3748794.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e3/13/opth-7-1535.PMC3748794.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/13/opth-7-1535.PMC3748794.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2476 | DOI: 10.1038/srep02476 6",Non-OADS,/arxiv_data1/oa_pdf/b9/25/srep02476.PMC3748842.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/93/39/srep02477.PMC3748843.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2477 | DOI: 10.1038/srep02477 6",Non-OADS,/arxiv_data1/oa_pdf/93/39/srep02477.PMC3748843.pdf
http://www.pepfarwatch.org/about_pepfar/ [Accessed 12 April 2013].,Non-OADS,/arxiv_data1/oa_pdf/13/7f/aids-27-2003.PMC3748855.pdf
http://www.who.int/tb/country/ data/download/en/index.html [Accessed 12 April 2013].,OADS,/arxiv_data1/oa_pdf/13/7f/aids-27-2003.PMC3748855.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2482 | DOI: 10.1038/srep02482 6,Non-OADS,/arxiv_data1/oa_pdf/d9/63/srep02482.PMC3748856.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2482 | DOI: 10.1038/srep02482 7",Non-OADS,/arxiv_data1/oa_pdf/d9/63/srep02482.PMC3748856.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/3d/det235.PMC3748858.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"The RLP can be used both in counselling and in a written form, as booklets or worksheet(http://www.cdc.gov/preconception /documents/ReproductiveLifePlan- Worksheet.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"Hela livet: 50 a ˚r med sex- och samlevnadsundervisning, 2005. http://www.skolverket.se/polopoly_fs/ 1.95608!Menu/article/attachment/hela%2520livet.pdf (3 January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"Information fra ˚nL a¨kemedelsverket, 2005, 7. http://www.lakemedelsverket.",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"Demographic Reports 2011, 3. http://www.scb.se/statistik/_publikationer/BE0701_ 2011A01_BR_BE51BR1103.pdf (4 April 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"Pohjoismaiset raskaudenkeskeytykset 2009—Aborter i Norden 2009—Inducedabortions in the Nordic countries 2009 Statistikrapport 9/2011, 2011.http://www.thl.ﬁ/tilastoliite/tilastoraportit/2011/Tr09_11.pdf (3 January 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"2009-06-15. http://www.regeringen.se/content/1/c6/12/83/30/ 018247a0.pdf (3 January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
2008-131-26. http://www.socialstyrelsen.,Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"2009-9-18. http://www.socialstyrelsen.se/Lists/Artikelkatalog/ Attachments/17742/2009-9-18.pdf (3 January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"http://www.socialstyrelsen.se/Lists/ Artikelkatalog/Attachments/18877/2012-11-6.pdf (3 January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"http://www.socialstyrelsen.se/Lists/ Artikelkatalog/Attachments/18669/2012-4-2.pdf (3 January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"Kunskaper om folsyra, 2010. http://www.slv.",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"Take folic acid before you get pregnant/A ¨t folsyra innan du blir gravid, 2013. http://www.slv.se/en-gb/Folic-acid/ (3 January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"ISSN 1103-2421. http://www.skolverket.se/ 2F%2Fwww5.skolverket.se%2Fwtpub%2Fws%2Fskolbok%2Fwpubext%2Ftrycksak%2FRecord%3Fk%3D605 (3 January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
"Sexualitet, genus och relationer i grundskolans styrdokument, 2011. http://www.skolverket.se/polopoly_ fs/1.162740!/Menu/article/attachment/Sex_och_samlevnad_grundskolans_styrdokument_2.pdf (3 January 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/da/10/det279.PMC3748861.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/6b/ijn-8-3051.PMC3748904.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3051–3060International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3051OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4674 8enhanced transdermal bioavailability of testosterone  propionate via surfactant-modified ethosomes shu Meng1 Zaixing chen2 liqun Yang1 Wei Zhang1 Danhua liu1 Jing guo1 Yanmin guan1 Jianxin li1 1liaoning research Institute of Family  Planning, shenyang, liaoning Province,   People’s republic of china; 2school of  Pharmacy, china Medical University,   shenyang, liaoning Province, People’s  republic of china correspondence: Jianxin li   liaoning research Institute of Family  Planning, 10 Puhe street, shenyang,  liaoning Province, People’s republic   of china, 110031   Tel +88 60 242 611 2802   Fax +88 60 248 680 6307   email jxinl@vip.sina.co mAbstract:  The current investigation aimed to evaluate the transdermal potential of novel  testosterone propionate (TP) ethosomes and liposomes prepared by surfactant modification.",Non-OADS,/arxiv_data1/oa_pdf/e1/6b/ijn-8-3051.PMC3748904.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e1/6b/ijn-8-3051.PMC3748904.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/6b/ijn-8-3051.PMC3748904.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/2d/not054.PMC3748912.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercialreproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/f4/jit267.PMC3749006.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/9e/jpr-6-589.PMC3749058.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 589–593Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  589PeRsPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JPR.S4769 3A comparison between acute pressure block of  the sciatic nerve and acupressure: methodology,  analgesia, and mechanism involved Danping Luo1,2 Xiaolin Wang1 Jiman He1,3 1Pain Medicine Program, Nanfang  Hospital, southern Medical University,   Guangzhou, People’s Republic of  china; 2the First Affiliated Hospital  of Guangdong college of Pharmacy,   Guangzhou, People’s Republic of  china; 3Department of Medicine,   Brown University, Providence, Ri, UsA correspondence: Jiman He   Pain Medicine Program, Nanfang Hospital,  southern Medical University, People’s  Republic of china   tel +86 20 62786221   Fax +86 20 87280770   email jiman_he@brown.ed uAbstract:  Acupressure is an alternative medicine methodology that originated in ancient China.",Non-OADS,/arxiv_data1/oa_pdf/b6/9e/jpr-6-589.PMC3749058.pdf
Available at  http://consensus.nih.gov/1997/1997acupuncture107html.htm .,OADS,/arxiv_data1/oa_pdf/b6/9e/jpr-6-589.PMC3749058.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/b6/9e/jpr-6-589.PMC3749058.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/9e/jpr-6-589.PMC3749058.pdf
Available from http://aapm.con - fex.com/aapm/2008am/techprogram/P2949.HTM.,Non-OADS,/arxiv_data1/oa_pdf/b6/9e/jpr-6-589.PMC3749058.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/3b/dddt-7-635.PMC3749059.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 635–643Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  635Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S4919 7glyphosate and aMPa inhibit cancer cell growth  through inhibiting intracellular glycine synthesis Qingli li1,2 Mark J lambrechts1 Qiuyang Zhang1 sen liu1 Dongxia ge1 rutie Yin2 Mingrong Xi2 Zongbing Y ou1 1Departments of structural and  cellular Biology and Orthopaedic  surgery, Tulane cancer center  and louisiana cancer research  consortium, T ulane center for stem  cell research and regenerative  Medicine, and Tulane center for  aging, Tulane University health  sciences center, new Orleans, la,   Usa; 2Department of Obstetrics  and gynecology, West china  second University hospital, sichuan  University, chengdu, People’s republic  of china correspondence: Zongbing You,  Department of structural and cellular  Biology, Tulane University, 1430 Tulane  ave sl 49, new Orleans, la 70112, Usa   Tel +1 504 988 0467   Fax +1 504 988 1687   email zyou@tulane.ed uAbstract:  Glycine is a nonessential amino acid that is reversibly converted from serine  intracellularly by serine hydroxymethyltransferase.",Non-OADS,/arxiv_data1/oa_pdf/68/3b/dddt-7-635.PMC3749059.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/68/3b/dddt-7-635.PMC3749059.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/3b/dddt-7-635.PMC3749059.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/1d/dddt-7-691.PMC3749060.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 691–698Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  691Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S4863 6synthesis and evaluation of mutual azo   prodrug of 5-aminosalicylic acid linked   to 2-phenylbenzoxazole-2-yl-5-acetic   acid in ulcerative colitis Jamal a Jilani1 Maha shomaf2 Karem h alzoubi3 1Department of Medicinal chemistry  and Pharmacognosy, Jordan University  of science and Technology, irbid,  Jordan; 2Department of Pathology,  Jordan University, amman, Jordan;  3Department of clinical Pharmacy,  Jordan University of science and  Technology, irbid, Jordan correspondence: Jamal a Jilani   Department of Medicinal chemistry   and Pharmacognosy, Faculty of Pharmacy,  Jordan University of science and  Technology, PO box 3030, irbid, Jordan   Tel +962 2 720 1000   Fax +962 2 720 1075   email jilanij@just.edu.j oAbstract:  In this study, the syntheses of 4-aminophenylbenzoxazol-2-yl-5-acetic acid,  (an analogue of a known nonsteroidal anti-inflammatory drug [NSAID]) and 5-[4-(benzo - xazol-2-yl-5-acetic acid)phenylazo]-2-hydroxybenzoic acid (a novel mutual azo prodrug of  5-aminosalicylic acid [5-ASA]) are reported.",Non-OADS,/arxiv_data1/oa_pdf/34/1d/dddt-7-691.PMC3749060.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/34/1d/dddt-7-691.PMC3749060.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/1d/dddt-7-691.PMC3749060.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/06/6f/ppa-7-777.PMC3749061.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 777–785Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  777Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S3694 8Role of the levonorgestrel intrauterine system   in effective contraception Abdelhamid M Attia1 Magdy M ibrahim1 Ahmed M Abou-Setta2 1Department of Obstetrics and  Gynecology, Cairo University, Cairo,  egypt; 2George and Fay Yee Centre  for Healthcare innovation,   University of Manitoba/ winnipeg  Regional Health Authority,   winnipeg, MB, Canada Correspondence: Ahmed M Abou-Setta   George and Fay Yee Center for  Healthcare innovation, University of  Manitoba/winnipeg Regional Health  Authority, GH-714 – 820 Sherbrook  Street, winnipeg, MB R3A 1R9, Canada   Tel +1 204 787 8707   Fax +1 204 787 7567   email ahmed_abou-setta@umanitoba.c aAbstract:  Norgestrel, a synthetic progestin chemically derived from 19-nortestosterone, is six  times more potent than progesterone, with variable binding affinity to various steroid receptors.",Non-OADS,/arxiv_data1/oa_pdf/06/6f/ppa-7-777.PMC3749061.pdf
"Available from: http://www.uptodate.com/contents/overview-of- intrauterine-contraception?source=see_lin k. Accessed July 19, 2013.",Non-OADS,/arxiv_data1/oa_pdf/06/6f/ppa-7-777.PMC3749061.pdf
Available from: http://www.uptodate.,Non-OADS,/arxiv_data1/oa_pdf/06/6f/ppa-7-777.PMC3749061.pdf
"Available  from: http://www.berlex.com/html/products/pi/Mirena_PI.pd f.  Accessed July 19, 2013.",Non-OADS,/arxiv_data1/oa_pdf/06/6f/ppa-7-777.PMC3749061.pdf
"Available from: http://www.pharmacoepi.org/meetings/27thconf/ presentations/Risk%20Factors%20for%20Uterine%20Perforations%20 during%20IUD%20Insertion-%20Interim%20Results%20from%20 the%20EURAS-IUD%20Study.pd f. Accessed July 19, 2013.",Non-OADS,/arxiv_data1/oa_pdf/06/6f/ppa-7-777.PMC3749061.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/06/6f/ppa-7-777.PMC3749061.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/6f/ppa-7-777.PMC3749061.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/0f/ijgm-6-613.PMC3749082.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 613–616International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  613Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S4951 0Comorbidity of Kawasaki disease and   group a streptococcal pleural effusion   in a healthy child: a case report ahmed H alhammadi Mohamed a Hendaus General pediatrics section,   Department of pediatrics, Hamad  Medical Corporation, Doha, Qatar Correspondence: ahmed H alhammadi   General pediatrics section, Department  of pediatrics, Hamad Medical  Corporation, po Box 3050, Doha, Qatar   tel +974 4439 2239   Fax +974 4443 9571   email aalhammadi@hmc.org.q aBackground:  Kawasaki disease is an acute self-limiting vasculitis that affects children.",Non-OADS,/arxiv_data1/oa_pdf/f0/0f/ijgm-6-613.PMC3749082.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/f0/0f/ijgm-6-613.PMC3749082.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/0f/ijgm-6-613.PMC3749082.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/97/ppa-7-771.PMC3749083.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 771–775Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  771Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S4813 5issues surrounding end-of-life decision-making vickram T ejwani1,* YiFan wu1,* Sabrina Serrano2 Luis Segura2 Michael Bannon3 Qi Qian1 1Department of Medicine, Division   of Nephrology and Hypertension,   2Mayo Graduate School, 3Department  of Trauma, Critical Care, and General  Surgery, Mayo Clinic College of  Medicine, Rochester, MN, USA *These authors contributed equally   to this work Correspondence: Qi Qian   Department of Nephrology   and Hypertension, Mayo Clinic,   200 First Street Sw, Rochester,   MN 55905, USA   Tel +1 507 266 7960   Fax +1 507 266 7891   email qian.qi@mayo.ed uAbstract:  End-of-life decision-making is a complex process that can be extremely challenging.",Non-OADS,/arxiv_data1/oa_pdf/6a/97/ppa-7-771.PMC3749083.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6a/97/ppa-7-771.PMC3749083.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/97/ppa-7-771.PMC3749083.pdf
Available from: http://assets.aarp.org/rgcenter/il/ getting_ready .pdf.,OADS,/arxiv_data1/oa_pdf/6a/97/ppa-7-771.PMC3749083.pdf
Available from: http://www.yale.edu/bioethics/publications/Medical  Futility.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6a/97/ppa-7-771.PMC3749083.pdf
Available from:  http://parklandhospital.com/patients_visitors/pdf/lifesupportadult.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6a/97/ppa-7-771.PMC3749083.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/48/84/dddt-7-711.PMC3749085.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 711–722Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  711Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4021 5Aflibercept in wet AMD: specific role   and optimal use F Semeraro1 F Morescalchi1 S Duse1 F Parmeggiani2 E Gambicorti1 C Costagliola3 1Department of Medical and Surgical  Specialties, Radiological Specialties  and Public Health, Ophthalmology  Clinic, University of Brescia, Brescia,   italy; 2Department of Ophthalmology,   University of Ferrara, Ferrara, italy;   3Department of Health Science,   Ophthalmology Clinic, University   of Molise, Campobasso, Italy Correspondence: Francesco Semeraro   Ophthalmology Clinic, Spedali Civili di   Brescia, Piazzale Spedali Civili 1,   25123 Brescia, italy   Tel +39 030 399 5308   Fax +39 030 338 8191   email semeraro@med.unibs.i tBackground:  Vascular endothelial growth factor (VEGF) is a naturally occurring glycoprotein  in the body that acts as a growth factor for endothelial cells.",Non-OADS,/arxiv_data1/oa_pdf/48/84/dddt-7-711.PMC3749085.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/48/84/dddt-7-711.PMC3749085.pdf
Available from:  http://newsroom.regeneron.com/releasedetail.cfm?releasei d=532099.,Non-OADS,/arxiv_data1/oa_pdf/48/84/dddt-7-711.PMC3749085.pdf
Available from: http://www.clinicaltrials.gov /.,Non-OADS,/arxiv_data1/oa_pdf/48/84/dddt-7-711.PMC3749085.pdf
Available  from http://investor.regeneron.com/releasedetail.cfm?releaseid=70883 5.,Non-OADS,/arxiv_data1/oa_pdf/48/84/dddt-7-711.PMC3749085.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/48/84/dddt-7-711.PMC3749085.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/84/dddt-7-711.PMC3749085.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs /label/2012/125387s004lbl.pd f. Accessed June 27,  2013.",Non-OADS,/arxiv_data1/oa_pdf/48/84/dddt-7-711.PMC3749085.pdf
Biomatter 2013; 3:e24281; http://dx.doi.org/10.4161/biomatter.24281Nanotechnology based p harma has emerged significantly  and has influenced the pharma industry up to a considerable  extent.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Control Release 2005; 102:203- 22; PMID:15653146; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Polymers 2011; 3:131-49; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Biomaterials 2004; 25:2019- 27; PMID:14741616; http://dx.doi.org/10.1016/j.bio- materials.2003.08.050.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Funct Biomater 2010;  1:22-107; http://dx.doi.org/10.3390/jfb1010022.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Aerosol Sci 1998; 29:561-74; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Pharm  Res 2004; 21:372-81; PMID:15032321; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Eur J Pharm Sci 2003; 20:149-71;  PMID:14550882; http://dx.doi.org/10.1016/S0928- 0987(03)00147-7.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Aerosol Sci 1999; 30:825-6; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Int J Nanomedicine  2008; 3:133-49; PMID:18686775; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Control Release 2007; 121:3-9;  PMID:17544538; http://dx.doi.org/10.1016/j.jcon-rel.2007.03.022.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Powder Technol 2007; 176:18-35;  http://dx.doi.org/10.1016/j.powtec.2007.01.035.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Langmuir  2012; 28:8216-23; PMID:22568862; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Carbohydr Polym 2011; 84:1329-36;  http://dx.doi.org/10.1016/j.carbpol.2011.01.029.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Arch Pharm Res 2011; 34:583-92;  PMID:21544723; http://dx.doi.org/10.1007/s12272- 011-0408-5.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Mol Pharm  2009; 6:1371-9; PMID:19499922; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Biomaterials  2012; 33:4069-77; PMID:22386922; http://dx.doi.org/10.1016/j.biomaterials.2012.02.024.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Biomaterials 2012; 33:5914-23; PMID:22656447; http://dx.doi.org/10.1016/j.bio- materials.2012.05.012.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Electrost  2012; 70:428-37; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Nanotechnology 2011; 22:305307; PMID:21719963; http://dx.doi.org/10.1088/0957-4484/22/30/305307.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
http://nextbigfuture.com/2008/01/silicon-electronics- providing-early.html 2.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
"Cientifica Ltd., 2007. http://www.cientifica.com/ WhitePapers/054_Drug%20Delivery%20White%20 Paper.pdf 3.",Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
http://www.fd.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/ EnforcementActivitiesbyFDA/WarningLetters   andNoticeofViolationLetterstoPharmaceuticalCompa-nies/UCM289191.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
American Pharmaceutical Review  2012; 126889 http://www.americanpharmaceutical- review.com/Featured-Articles/126889-Implementing- Nanotechnology-and-Novel-Drug-Delivery-Systems-to-Improve-Dissolution-and-Solubilization.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Expert Opin Drug Deliv 2010;  7:145-58; PMID:20095939; http://dx.doi.org/10.1517/17425240903436479.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Colloids  Surf B Biointerfaces 2003; 30:225; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Control Release 2000; 66:115-26;  PMID:10742573; http://dx.doi.org/10.1016/S0168-3659(99)00223-0.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Control Release 2002; 82:189-212;  PMID:12175737; http://dx.doi.org/10.1016/S0168- 3659(02)00009-3.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Pharm Sci 2012; 101:1178- 88; PMID:22189503; http://dx.doi.org/10.1002/ jps.23024.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Int J Pharm 2011; 414:1-5; PMID:21536114;  http://dx.doi.org/10.1016/j.ijpharm.2011.04.045.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Drug Dev Ind Pharm 2010;  36:431-8; PMID:19788405; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Mater  Chem 2011; 21:15957; http://dx.doi.org/10.1039/ c1jm12720a.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J coll and interface Sci 2009; 334: 22-8;  http://dx.doi.org/10.1016/j.jcis.2009.02.044.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Aerosol  Sci 2010; 41:790-804; http://dx.doi.org/10.1016/j.jaerosci.2010.04.010.48.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Small 2011; 7:1149- 56; PMID:21480519; http://dx.doi.org/10.1002/ smll.201002002.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Biomacromolecules  2009; 10:19-24; PMID:19072041; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Colloid  Interface Sci 2011; 358:73-80; PMID:21421221;  http://dx.doi.org/10.1016/j.jcis.2011.02.047.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
J Tissue Eng  Regen Med 2009; 3:562-6; PMID:19557729; http://dx.doi.org/10.1002/term.185.53.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Biotechnol J 2006; 1:86-94; PMID:16892229;  http://dx.doi.org/10.1002/biot.200500025.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Analyst  2011; 136:878-90; PMID:21271004; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Small 2012; 8:2495- 500; PMID:22648794; http://dx.doi.org/10.1002/ smll.201200138.,Non-OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
Biotechnol Bioeng 2010; 106:690- 8; PMID:20229515; http://dx.doi.org/10.1002/ bit.22734.,OADS,/arxiv_data1/oa_pdf/35/e8/biom-3-e24281.PMC3749275.pdf
"Biomatter 2013; 3:e24630; http://dx.doi.org/10.4161/biom.24630Breast reconstruction is a type of surgery for women who  have had a mastectomy, and involves using autologous tissue or prosthetic material to construct a natural-looking breast.",Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Cell Physiol 2001; 189:54-63; PMID:11573204;  http://dx.doi.org/10.1002/jcp.1138.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Mol Biol Cell 2002; 13:4279- 95; PMID:12475952; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue  Eng 2001; 7:211-28; PMID:11304456; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Cell Metab 2006; 4:263-73; PMID:17011499;  http://dx.doi.org/10.1016/j.cmet.2006.07.001.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Clin Invest 1989; 84:1663-70; PMID:2681273; http://dx.doi.org/10.1172/JCI114345.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biochimie  2005; 87:9-13; PMID:15733730; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biochem Biophys Res Commun 2004; 319:511- 7; PMID:15178436; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue  Eng 2001; 7:729-41; PMID:11749730; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Cell Biochem  2001; 81:312-9; PMID:11241671; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biomaterials 2007; 28:3834-42; PMID:17544502; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
World J Urol 2000; 18:2-9; PMID:10766037; http://dx.doi.org/10.1007/s003450050002.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng Part B Rev 2010; 16:413-26; PMID:20166810; http://dx.doi.org/10.1089/ten.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng 2004a; 10:215-29; PMID:15009947;  http://dx.doi.org/10.1089/107632704322791862.17.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Clin Endocrinol Metab  1996; 81:2443-7; PMID:8675558; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng 1995;  1:3-13; PMID:19877911; http://dx.doi.org/10.1089/ ten.1995.1.3.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Anat Rec 2001; 263:361-6;  PMID:11500812; http://dx.doi.org/10.1002/ar.1113.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Plast Reconstr  Aesthet Surg 2010; 63:1886-92; PMID:19969517;  http://dx.doi.org/10.1016/j.bjps.2009.10.028.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biomaterials 2006; 27:6052-63;  PMID:16973213; http://dx.doi.org/10.1016/j.bioma- terials.2006.07.033.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Cell 2006; 126:663- 76; PMID:16904174; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Nature 2011; 474:225-9; PMID:21654807;  http://dx.doi.org/10.1038/nature10106.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Circ Res 2007;  100:1249-60; PMID:17495232; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Sex Med 2009; 6(Suppl 3):320- 7; PMID:19267855; http://dx.doi.org/10.1111/ j.1743-6109.2008.01190.x.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Cell T ransplant 2010;  19:1217-23; PMID:20444320; http://dx.doi.org/10.3727/096368910X507187.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
T rends Biotechnol 2006; 24:150-4; PMID:16488036; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Stem Cell Rev 2011; 7:269-91; PMID:20853072; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Hum Lact  2005; 21:126-30; PMID:15886338; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Mammary Gland Biol Neoplasia 2000;  5:119-37; PMID:11149569; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Annu Rev  Biomed Eng 2004; 6:109-30; PMID:15255764; http://dx.doi.org/10.1146/annurev.bioeng.6.040803.140032.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Sex Relationship Ther 2006; 21:237-49;  http://dx.doi.org/10.1080/14681990600674674.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Br J Surg 2000; 87:1455-72; PMID:11091232;  http://dx.doi.org/10.1046/j.1365-2168.2000.01593.x.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Breast J 2010; 16:169-75; PMID:19912236; http://dx.doi.org/10.1111/j.1524-4741.2009.00873.x.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Ann Chir Plast Esthet  2008; 53:169-77; PMID:17959298; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
"Plast Reconstr Surg 2007;  119:775-85, discussion 786-7; PMID:17312477;  http://dx.doi.org/10.1097/01.prs.0000252001.59162.c9.",OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Plast Reconstr Surg 2005; 116:1300-5; PMID:16217471; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
"Aesthetic Plast Surg 2008; 32:48- 55, discussion 56-7; PMID:17763894; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Semin Surg Oncol 2000; 19:302-11;  PMID:11135487; http://dx.doi.org/10.1002/1098- 2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S. 13.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Clin Endocrinol Metab 2004; 89:2548-56; PMID:15181022; http://dx.doi.org/10.1210/jc.2004- 0395.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Gerontology  2012; 58:15-23; PMID:21135534; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Cell 2007; 131:242- 56; PMID:17956727; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Plast  Reconstr Surg 2009; 124:1087-97; PMID:19935292;  http://dx.doi.org/10.1097/PRS.0b013e3181b5a3f1.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Circulation  2004; 109:656-63; PMID:14734516; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biochem Biophys Res Commun 2005; 330:142- 50; PMID:15781243; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Arterioscler Thromb  Vasc Biol 2009; 29:503-10; PMID:19201690; http://dx.doi.org/10.1161/ATVBAHA.108.178962.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Nat Protoc 2008; 3:674- 8; PMID:18388950; http://dx.doi.org/10.1038/ nprot.2008.35.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Curr  Opin Biotechnol 2006; 17:518-23; PMID:16971111;  http://dx.doi.org/10.1016/j.copbio.2006.08.011.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Am Chem Soc  2003; 125:12988-9; PMID:14570447; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng Part A 2010; 16:3719- 26; PMID:20649458; http://dx.doi.org/10.1089/ten.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
EMBO J  2011; 30:2662-74; PMID:21610693; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Science 2006; 314:298-300; PMID:17038622;  http://dx.doi.org/10.1126/science.1131000.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Integr Biol (Camb) 2010; 2:424-34;  PMID:20717570; http://dx.doi.org/10.1039/ c0ib00040j.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biophys J  2012; 103:152-62; PMID:22828342; http://dx.doi.org/10.1016/j.bpj.2012.05.048.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Mammary Gland  Biol Neoplasia 2010; 15:365-76; PMID:20835885;  http://dx.doi.org/10.1007/s10911-010-9192-y.64.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng 2006; 12:1475-87; PMID:16846345;  http://dx.doi.org/10.1089/ten.2006.12.1475.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biomaterials 2003; 24:2513-21;  PMID:12695078; http://dx.doi.org/10.1016/S0142- 9612(03)00049-8.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Cell T ransplant  2008; 17:977-86; PMID:19069639; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biomaterials 2003; 24:3125-32;  PMID:12895585; http://dx.doi.org/10.1016/S0142- 9612(03)00156-X.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biomaterials 2008; 29:3712- 9; PMID:18571717; http://dx.doi.org/10.1016/j.bio-materials.2008.05.028.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Pathol Biol (Paris) 2009; 57:309-17; PMID:18534784; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biomaterials 2007; 28:2850-60;  PMID:17374391; http://dx.doi.org/10.1016/j.bioma- terials.2007.02.030.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Biomed  Mater Res A 2006; 79:359-69; PMID:16883587;  http://dx.doi.org/10.1002/jbm.a.30762.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
J Biomed  Mater Res A 2009; 89:929-41; PMID:18465826;  http://dx.doi.org/10.1002/jbm.a.32044.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Cell Prolif  2009; 42:29-37; PMID:19143761; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Circulation 2004; 110:349-55; PMID:15238461; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Exp Cell Res 2004b; 300:54- 64; PMID:15383314; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Ann Plast  Surg 2003; 50:610-7; PMID:12783012; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biomaterials 2007; 28:5280-90; PMID:17765303; http://dx.doi.org/10.1016/j.bioma- terials.2007.08.017.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng Part  A 2008; 14:275-84; PMID:18333780; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Cell 1974; 3:127- 33; PMID:4426090; http://dx.doi.org/10.1016/0092- 8674(74)90116-0.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng  2005; 11:458-68; PMID:15869424; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng 2002; 8:283-93; PMID:12031117;  http://dx.doi.org/10.1089/107632702753725049.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Plast Reconstr Surg  1999; 104:1732-8; PMID:10541176; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng 2005; 11:556-66; PMID:15869434; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Biomaterials  2008; 29:573-9; PMID:17980905; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Appl Microbiol Biotechnol 2004;  65:1-8; PMID:15221227; http://dx.doi.org/10.1007/ s00253-004-1580-z.,Non-OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
Tissue Eng  2006; 12:3035-43; PMID:17518619; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/fd/biom-3-e24630.PMC3749276.pdf
"Biomatter 2013; 3:e24647; http://dx.doi.org/10.4161/biom.24647.endothelial plasticity, the ability of endothelial cells to alter  their lineage commitment to generate other cell types, is  involved in many developmental and pathological processes.",Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Tissue  Eng 2001; 7:211-28; PMID:11304456; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Proc Natl Acad Sci U S A  2000; 97:13625-30; PMID:11087820; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Science  1999; 284:143-7; PMID:10102814; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Arthritis Rheum 2001;  44:1928-42; PMID:11508446; http://dx.doi.org/10.1002/1529-0131(200108)44:8<1928::AID- ART331>3.0.CO;2-P .,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Blood  2002; 99:1995-2001; PMID:11877271; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Curr Opin  Biotechnol 2011; 22:715-20; PMID:21646011; http://dx.doi.org/10.1016/j.copbio.2011.05.001.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Nat Med 2010; 16:1400-6; PMID:21102460; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Biomaterials 2008; 29:3703-11; PMID:18556062;  http://dx.doi.org/10.1016/j.biomaterials.2008.05.034.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Biochem  J 2011; 437:515-20; PMID:21585337; http://dx.doi.org/10.1042/BJ20101500.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
J Cell Biol 2004; 166:359- 67; PMID:15289495; http://dx.doi.org/10.1083/ jcb.200403050.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Circ  Res 2006; 99:861-9; PMID:16973908; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Curr Opin Cell Biol  2003; 15:740-6; PMID:14644200; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
J Clin Invest 2009; 119:1420- 8; PMID:19487818; http://dx.doi.org/10.1172/ JCI39104.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
J Clin Invest 2009; 119:1438- 49; PMID:19487820; http://dx.doi.org/10.1172/JCI38019.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
J Pathol 2008; 214:199-210; PMID:18161745;  http://dx.doi.org/10.1002/path.2277.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Semin Cancer Biol 2012; 22:379-84;  PMID:22554794; http://dx.doi.org/10.1016/j.sem- cancer.2012.04.004.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Dev Biol  1975; 42:160-80; PMID:1112439; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Cells Tissues Organs 2007; 185:146-56; PMID:17587820; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Am J Respir Cell Mol Biol 2010; 43:161- 72; PMID:19767450; http://dx.doi.org/10.1165/ rcmb.2009-0031OC.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Cancer Res  2007; 67:10123-8; PMID:17974953; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Nat Genet  2006; 38:525-7; PMID:16642017; http://dx.doi.org/10.1038/ng1783.30.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Cancer Cell 2008; 14:201- 11; PMID:18772110; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Cell Metab 2012; 15:222-9;  PMID:22326223; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
In Vitro Cell Dev Biol Anim 1995; 31:447-55; PMID:8589888; http://dx.doi.org/10.1007/ BF02634257.,Non-OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Blood  2005; 105:659-69; PMID:15374877; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Science 1997; 275:964- 7; PMID:9020076; http://dx.doi.org/10.1126/sci- ence.275.5302.964.,OADS,/arxiv_data1/oa_pdf/a5/0e/biom-3-e24647.PMC3749277.pdf
Biomatter 2013; 3:e24648; PMID: 23628871; http://dx.doi.org10.4161/biom.24648.Introduction Abdominal aortic aneurysm (AAA) is currently a leading cause  of death in developed countries with occurrence rates expected to increase with aging populations.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Am  J Physiol Heart Circ Physiol 2009; 296:H1660-5;  PMID:19252100; http://dx.doi.org/10.1152/ajp- heart.00028.2009.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Lab Invest 2009; 89:315-26; PMID:19153555; http://dx.doi.org/10.1038/labinvest.2008.167.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Atherosclerosis  2010; 212:181-7; PMID:20542274; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Ultrason Imaging 2007; 29:137-54; PMID:18092671; http://dx.doi.org/10.1177/016173460702900301.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Biomech Eng 2004; 126:815-22; PMID:15796340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
PLoS One 2012; 7:e33523;  PMID:22448249; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Biomech Eng 2011;  133:121008; PMID:22206425; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Magn Reson Imaging 2010; 32:847- 58; PMID:20882615; http://dx.doi.org/10.1002/ jmri.22331.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Med Eng Phys 2011; 33:1262- 9; PMID:21742539; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Biomech 2012; 45:772-9;  PMID:22196971; http://dx.doi.org/10.1016/j.jbio-mech.2011.11.017.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Cardiovasc Res 2012;  94:30-7; PMID:22293851; http://dx.doi.org/10.1093/ cvr/cvs076.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Can J Cardiol  2013; PMID:23395513; http://dx.doi.org/10.1016/j.cjca.2012.11.012.References 1.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Eur J Vasc Endovasc Surg 2009; 38:278- 84; PMID:19540779; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Biomech 2006; 39:1324- 34; PMID:15885699; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Biomech 2007; 40:1887-902; PMID:17254589; http://dx.doi.org/10.1016/j.jbiomech.2006.09.003.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Clin Invest  2000; 105:1605-12; PMID:10841519; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Arterioscler Thromb Vasc Biol 2012; 32:3012- 23; PMID:23087364; http://dx.doi.org/10.1161/ ATVBAHA.112.254219.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
PLoS One 2012; 7:e49642;  PMID:23226500; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Am J Physiol Heart Circ Physiol 2012;  303:H1067-75; PMID:22904155; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Biomech 2007; 40:766-76;  PMID:16750537; http://dx.doi.org/10.1016/j.jbio- mech.2006.03.018.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Biomech 2009; 42:1-8;  PMID:19070860; http://dx.doi.org/10.1016/j.jbio- mech.2008.11.011.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Proc Natl Acad Sci U S A 1995; 92:2169- 73; PMID:7892241; http://dx.doi.org/10.1073/ pnas.92.6.2169.28.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Biomech Eng 2011;  133:075001; PMID:21823753; http://dx.doi.org/10.1115/1.4004495.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Microsc Microanal 2011; 17:167- 75; PMID:21226989; http://dx.doi.org/10.1017/ S1431927610094341.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Microsc Microanal 2011; 17:167- 75; PMID:21226989; http://dx.doi.org/10.1017/ S1431927610094341.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Biomed Opt 2006;  11:054021; PMID:17092170; http://dx.doi.org/10.1117/1.2360516.22.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Biophys J  2004; 87:2778-86; PMID:15454469; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Ann Biomed Eng 2009; 37:1093- 104; PMID:19350391; http://dx.doi.org/10.1007/ s10439-009-9686-1.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J R Soc Interface 2006; 3:15- 35; PMID:16849214; http://dx.doi.org/10.1098/ rsif.2005.0073.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Arterioscler Thromb Vasc Biol 2003; 23:1621-6; PMID:12855482; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
J Vasc  Surg 2006; 44:372-6; PMID:16890871; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/a8/biom-3-e24648.PMC3749278.pdf
Biomatter 2013; 3:e24650; http://dx.doi.org/10.4161/biomatter.24650Introduction Many cell types are sensitive to their mechanical environment.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
FASEB J 2006; 20:811-27;  PMID:16675838; http://dx.doi.org/10.1096/fj.05- 5424rev.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Ann Biomed Eng  2007; 35:1156-64; PMID:17578668; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Am J Physiol  Cell Physiol 2010; 299:C345-53; PMID:20519449;  http://dx.doi.org/10.1152/ajpcell.00379.2009.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Science 1990; 250:1266-9; PMID:2173861;  http://dx.doi.org/10.1126/science.2173861.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Am J Physiol Lung Cell Mol Physiol  2009; 296:L574-81; PMID:19136581; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Biomech Model  Mechanobiol 2008; 7:323-34; PMID:17701064; http://dx.doi.org/10.1007/s10237-007-0099-5.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Ann Biomed Eng 2011; 39:1390-402;  PMID:21298345; http://dx.doi.org/10.1007/s10439- 010-0243-8.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
J Appl Physiol  2005; 98:1892-9; PMID:15829722; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Cell Mol Life Sci 2006; 63:2304-16; PMID:16909208; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Cell  Tissue Res 2010; 339:269-80; PMID:19693543; http://dx.doi.org/10.1007/s00441-009-0834-6.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Biochem J 2002; 368:1- 15; PMID:12241528; http://dx.doi.org/10.1042/ BJ20021228.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Annu Rev Cell Dev Biol 1998; 14:305-38;  PMID:9891786; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Matrix Biol 2003; 22:73-80; PMID:12714044; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Arterioscler Thromb Vasc Biol  2002; 22:61-8; PMID:11788462; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
J  R Soc Interface 2011; 8:1217-32; PMID:21632610;  http://dx.doi.org/10.1098/rsif.2011.0157.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
PLoS  One 2009; 4:e5262; PMID:19370157; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Chaos 1998; 8:557-66; PMID:12779759;  http://dx.doi.org/10.1063/1.166337.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Phys Rev Lett 2002; 89:238101; PMID:12485044;  http://dx.doi.org/10.1103/PhysRevLett.89.238101.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
BMC Neurosci  2006; 7(Suppl 1):S10; PMID:17118154; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Biochem Biophys Res Commun  1997; 239:372-6; PMID:9344837; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Phys Rev A 1992;  46:R1713-6; PMID:9908367; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Clin Neurophysiol  2004; 115:267-81; PMID:14744566; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Nature 1995; 378:362-4; PMID:7477370;  http://dx.doi.org/10.1038/378362a0.,Non-OADS,/arxiv_data1/oa_pdf/f6/a0/biom-3-e24650.PMC3749279.pdf
Biomatter 2013; 3:e24651; PMID: 23628869; http://dx.doi.org10.4161/biom.24651.Introduction Collagen is the most abundant protein in the body.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biochim Biophys Acta 1998; 1381:37-48;  PMID:9659370; http://dx.doi.org/10.1016/S0304- 4165(97)00158-X.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Mol Graph Model  2002; 21:209-13; PMID:12463639; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biochemistry 1991; 30:2372-7; PMID:2001367;  http://dx.doi.org/10.1021/bi00223a011.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Proc Natl Acad Sci U S A  1997; 94:11312-7; PMID:9326606; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Philos T rans R Soc Lond B Biol Sci  2002; 357:191-7; PMID:11911776; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Mech Behav Biomed Mater 2008;  1:51-8; PMID:19627771; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Struct Biol  2010; 169:183-91; PMID:19822213; http://dx.doi.org/10.1016/j.jsb.2009.10.002.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Matrix Biol 2012; 31:141-9; PMID:22204879; http://dx.doi.org/10.1016/j.mat- bio.2011.11.005.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Mech Ageing Dev 2001; 122:735-55; PMID:11322995; http://dx.doi.org/10.1016/S0047- 6374(01)00225-1.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Biomech 2002; 35:1411-5;  PMID:12231287; http://dx.doi.org/10.1016/S0021- 9290(02)00166-5.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Biomech Eng  2003; 125:719-25; PMID:14618931; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biotechnol Bioeng  2009; 102:632-43; PMID:18767187; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Ann Biomed Eng  2001; 29:908-14; PMID:11764321; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Cereal Sci 2010; 52:100-5; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Biomed Mater Res  A 2008; 87:308-20; PMID:18181104; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biomaterials 2001; 22:1713-9;  PMID:11396874; http://dx.doi.org/10.1016/S0142- 9612(00)00315-X.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biophys J 2007; 92:2212-22;  PMID:17172303; http://dx.doi.org/10.1529/bio- physj.106.097998.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biophys J 2009; 97:2051- 60; PMID:19804737; http://dx.doi.org/10.1016/j.bpj.2009.07.035.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biomaterials 2003; 24:759-67; PMID:12485794; http://dx.doi.org/10.1016/S0142- 9612(02)00412-X.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biomaterials 2008; 29:3278-88;  PMID:18472155; http://dx.doi.org/10.1016/j.bioma- terials.2008.04.028.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Biomed Mater Res 1999; 47:116- 26; PMID:10449623; http://dx.doi.org/10.1002/ (SICI)1097-4636(199911)47:2<116::AID- JBM2>3.0.CO;2-J.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Food Hydrocoll 2010; 24:512-7; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Food Sci 2000; 65:374-81; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Int J Biomater  2011; 2011:172389; PMID:21876695; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biomech Model Mechanobiol  2011; 10:613-25; PMID:20963623; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Int J Biol Macromol 1997;  20:23-33; PMID:9110182; http://dx.doi.org/10.1016/ S0141-8130(97)01148-3.References 1.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Int J Pharm 2001; 221:1-22; PMID:11397563;  http://dx.doi.org/10.1016/S0378-5173(01)00691-3.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Cell Motil Cytoskeleton  2000; 45:1-9; PMID:10618162; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Curr Opin Cell  Biol 2002; 14:633-9; PMID:12231360; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Periodontol 2001; 72:215-29;  PMID:11288796; http://dx.doi.org/10.1902/ jop.2001.72.2.215.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Odontology 2008; 96:1-11;  PMID:18661198; http://dx.doi.org/10.1007/s10266- 008-0087-y.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biochim Biophys Acta 2009; 1793:893-902;  PMID:19027042; http://dx.doi.org/10.1016/j.bbam - cr.2008.10.012.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Biomech Eng  2004; 126:152-66; PMID:15179845; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Proc R Soc Lond B Biol Sci  1971; 178:465-76; PMID:4398681; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Connect Tissue Res  1978; 6:11-23; PMID:149646; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Biomech Eng 2002; 124:214-22; PMID:12002131; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biomaterials 2006; 27:4608-17; PMID:16713624;  http://dx.doi.org/10.1016/j.biomaterials.2006.04.022.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Mater Sci Mater Med 1995; 6:460-72; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biophys J 2009; 96:1566- 85; PMID:19217873; http://dx.doi.org/10.1016/j.bpj.2008.10.063.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Ann Biomed Eng  2009; 37:1572-83; PMID:19484387; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Comput  Phys Commun 1982; 27:229-42; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Biomed Mater Res  A 2007; 82:160-8; PMID:17269147; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Mol Biol 2005; 346:551-6; PMID:15670603;  http://dx.doi.org/10.1016/j.jmb.2004.12.001.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Eur J Pharm Biopharm 2001; 51:259-65;  PMID:11343891; http://dx.doi.org/10.1016/S0939- 6411(01)00136-9.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Carbohydr Polym 2009; 76:567-77; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Osteoporos Int 2010; 21:195-214; PMID:19760059;  http://dx.doi.org/10.1007/s00198-009-1066-z.,Non-OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
J Card Fail 2005; 11:196-9; PMID:15812747;  http://dx.doi.org/10.1016/j.cardfail.2005.02.001.,OADS,/arxiv_data1/oa_pdf/68/26/biom-3-e24651.PMC3749280.pdf
Biomatter 2013; 3:e24717; PMID: 23628868; http://dx.doi.org10.4161/biom.24717.Biomaterials are being used for the healthcare applications  from ancient times.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
This will be marketed under the trade name of Glybera by an Amsterdam based company called unique (http://blogs.nature.com/news/2012/11/gene-therapy-hits-euro - pean-market.html).,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Technol Soc  2004; 26:415-31; http://dx.doi.org/10.1016/j.tech- soc.2004.01.008.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Adv Cardiol 2002; 39:189-94; PMID:12060918;  http://dx.doi.org/10.1159/000058927.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Am Coll Cardiol 2003; 41:893-904;  PMID:12651032; http://dx.doi.org/10.1016/S0735- 1097(02)02965-0.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Chest  1978; 73:193-7; PMID:620581; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
JAMA 2003; 289:2685-94; PMID:12771115;  http://dx.doi.org/10.1001/jama.289.20.2685.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
N  Engl J Med 2002; 346:1845-53; PMID:12063368;  http://dx.doi.org/10.1056/NEJMoa013168.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Neurosurg 1999; 91:733-6; PMID:10541228; http://dx.doi.org/10.3171/ jns.1999.91.5.0733.8.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Spine (Phila Pa 1976)  2002; 27:2662-73; PMID:12461392; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Compos Sci Technol 2001; 61:1189-224;  http://dx.doi.org/10.1016/S0266-3538(00)00241-4.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Biosens Bioelectron 2008;  23:1083-100; PMID:18063356; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Biomacromolecules 2009; 10:1697- 703; PMID:19425549; http://dx.doi.org/10.1021/ bm8014736.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Curr Opin Biotechnol 2011; 22:492- 501; PMID:21676609; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Autoimmun Rev 2012; PMID:23219952;  http://dx.doi.org/10.1016/j.autrev.2012.11.005.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Adv Drug Deliv Rev  2012; 64:1547-68; PMID:22575858; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Ocul Pharmacol Ther 2011; 27:151-6; PMID:21323470; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Pharm Sci 1998; 87:1387- 94; PMID:9811495; http://dx.doi.org/10.1021/ js980085q.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Chem Eng News 2000; 78:33- 41; http://dx.doi.org/10.1021/cen-v078n026.p033.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Science 1999; 286:2244-5;  PMID:10636774; http://dx.doi.org/10.1126/sci- ence.286.5448.2244.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Bioconjug Chem 2003; 14:311- 9; PMID:12643741; http://dx.doi.org/10.1021/ bc025623b.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Acta Mater 2013; 61:931-44; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Acta Ophthalmol 2009; 87:433-7;  PMID:19016660; http://dx.doi.org/10.1111/j.1755- 3768.2008.01404.x.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Curr  Opin Biotechnol 2005; 16:100-7; PMID:15722022;  http://dx.doi.org/10.1016/j.copbio.2004.12.007.31.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Br Med Bull 2008; 86:7-22; PMID:18424445;  http://dx.doi.org/10.1093/bmb/ldn016.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Orthop Res 2007; 25:11- 22; PMID:17048259; http://dx.doi.org/10.1002/ jor.20305.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Cell  2006; 126:677-89; PMID:16923388; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Expert Rev Med Devices  2004; 1:21-31; PMID:16293007; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Wound Repair Regen 2013;  21:1-16; PMID:23126632; http://dx.doi.org/10.1111/ j.1524-475X.2012.00861.x.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Dermatol Sci 2007; 48:15-24;  PMID:17643966; http://dx.doi.org/10.1016/j.jderm-sci.2007.05.018.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Prog Polym Sci 2012; 37:237-80; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Biotechnol Adv  2012; 30:321-8; PMID:21756992; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Lancet 2003; 361:247-9; PMID:12547552;  http://dx.doi.org/10.1016/S0140-6736(03)12275-1.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Eur Heart J 2010; 31:1032- 5; PMID:20064819; http://dx.doi.org/10.1093/eur- heartj/ehp591.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Int J Pharm 2013; 441:665- 79; PMID:23117022; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Adv Drug Deliv Rev  2006; 58:350-7; PMID:16546288; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
"ISBN: 978-953-307-443-6, InTech 2011:  71-86; http://dx.doi.org/10.5772/17103.",Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Adv Healthc Mater 2013;  2:57-71; PMID:23184739; http://dx.doi.org/10.1002/ adhm.201200197.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Biomaterials  2005; 26:7425-35; PMID:16023714; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Biomaterials 2013; 34:2902-10; PMID:23375953; http://dx.doi.org/10.1016/j.bioma- terials.2013.01.035.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Science 1980; 208:826-31; PMID:6246576; http://dx.doi.org/10.1126/sci- ence.6246576.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J R Soc Interface 2010;  7(Suppl 4):S379-91; PMID:20484227; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Science 2002; 295:1014-7; PMID:11834817;  http://dx.doi.org/10.1126/science.1067404.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Cardiovasc  Res 2008; 80:88-95; PMID:18539631; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Mol Cell Cardiol 2011; 50:312- 9; PMID:20709074; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Cell Biochem 2008; 105:612- 23; PMID:18661483; http://dx.doi.org/10.1002/ jcb.21862.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Mater Sci  Eng Rep 2008; 59:38-71; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Biomaterials 2009; 30:2816-25; PMID:19232714; http://dx.doi.org/10.1016/j.bioma- terials.2009.01.031.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Mol Ther 2011; 19:53-9; PMID:20859259;  http://dx.doi.org/10.1038/mt.2010.190.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
T rends Biotechnol  2012; 30:546-54; PMID:22939815; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Mater Sci Mater Med 2013; 24:447-59;  PMID:23124526; http://dx.doi.org/10.1007/s10856- 012-4795-z.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Biosci Bioeng  2012; 114:663-70; PMID:22884715; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Biotechnol Prog 2011; 27:170-80;  PMID:20865749; http://dx.doi.org/10.1002/btpr.497.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Macromol Biosci  2011; 11:22-35; PMID:21077225; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Mater Sci Mater  Med 2009; 20(Suppl 1):S173-9; PMID:18597161;  http://dx.doi.org/10.1007/s10856-008-3504-4.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Nat Protoc  2010; 5:1737-47; PMID:21030950; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J R Soc Interface 2011; 8:540-54; PMID:20943683;  http://dx.doi.org/10.1098/rsif.2010.0455.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Biomater  Sci Polym Ed 2011; 22:2107-26; PMID:21067655;  http://dx.doi.org/10.1163/092050610X534230.64.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Mater Today 2010;  13:14-22; http://dx.doi.org/10.1016/S1369- 7021(10)70013-4.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Adv Drug Deliv Rev 2002; 54:37- 51; PMID:11755705; http://dx.doi.org/10.1016/ S0169-409X(01)00242-3.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Stem Cells 2012; 30:1196- 205; PMID:22438013; http://dx.doi.org/10.1002/ stem.1089.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
J Polym Sci Pol Chem 2010; 48:3229-35; http://dx.doi.org/10.1002/pola.24087.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
Biomaterials 2010; 31:1-8; PMID:19788947;  http://dx.doi.org/10.1016/j.biomaterials.2009.09.025.,OADS,/arxiv_data1/oa_pdf/ff/08/biom-3-e24717.PMC3749281.pdf
"Biomatter 2013; 3:e24926 ; http://dx.doi.org/10.4161/biom.24926organogenesis, such as long tubule self-organization, requires  long-range coordination of cell mechanics to arrange cell  positions and to remodel the extracellular matrix.",OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Nat Rev Mol Cell Biol 2007; 8:633-44;  PMID:17643125; http://dx.doi.org/10.1038/ nrm2222.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Semin Cell Dev Biol 2008; 19:213-4;  PMID:18316214; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
PLoS Comput Biol  2011; 7:e1001088; PMID:21390276; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
"Horowitz A, Murakami M, Gao Y, Simons M. Phosphatidylinositol-4,5-bisphosphate mediates the  interaction of syndecan-4 with protein kinase C.  Biochemistry 1999; 38:15871-7; PMID:10625452;  http://dx.doi.org/10.1021/bi991363i.",OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Development 2004; 131:1449-62; PMID:15023929;  http://dx.doi.org/10.1242/dev.01089.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Mech Dev 2000; 92:55-81;  PMID:10704888; http://dx.doi.org/10.1016/S0925- 4773(99)00325-1.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
T rends Cell Biol 2003; 13:86-91; PMID:12559759;  http://dx.doi.org/10.1016/S0962-8924(02)00031-4.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Nature  2007; 447:316-20; PMID:17507982; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Breast Cancer Res 2005; 7:245-51; PMID:16280048;  http://dx.doi.org/10.1186/bcr1331.,Non-OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Science 1999; 285:1028-32; PMID:10446041; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Nat Rev Cancer  2003; 3:422-33; PMID:12778132; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
J Cell Biol  1997; 139:1873-84; PMID:9412479; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Mol Biol Cell  2008; 19:2051-8; PMID:18321993; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Int J Dev Biol  2006; 50:255-66; PMID:16479493; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Cancer Cell 2005; 8:175- 6; PMID:16169461; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Cell  Motil Cytoskeleton 2005; 60:24-34; PMID:15573414;  http://dx.doi.org/10.1002/cm.20041.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Cancer Cell  2005; 8:241-54; PMID:16169468; http://dx.doi.org/10.1016/j.ccr.2005.08.010.26.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Nat Rev Mol  Cell Biol 2009; 10:831-42; PMID:19888266; http://dx.doi.org/10.1038/nrm2797.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Differentiation  2006; 74:349-64; PMID:16916374; http://dx.doi.org/10.1111/j.1432-0436.2006.00088.x.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Dev Cell 2010; 18:698-712; PMID:20493806; http://dx.doi.org/10.1016/j.dev- cel.2010.04.008.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Differentiation 2003; 71:171-205; PMID:12694202; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Science 2012; 338:210-2; PMID:23066071; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Tissue Eng 2007; 13:721- 35; PMID:17341161; http://dx.doi.org/10.1089/ ten.2006.0123.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Int J Oral Sci 2010; 2:117-26; PMID:21125789;  http://dx.doi.org/10.4248/IJOS10042.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Science 2006; 314:1447- 50; PMID:17082421; http://dx.doi.org/10.1126/sci- ence.1130088.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Cell  2007; 128:239-40; PMID:17254962; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Nat Cell  Biol 2007; 9:36-44; PMID:17173042; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Dev Biol  1988; 127:304-15; PMID:3259938; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Wiley Interdiscip Rev Syst Biol  Med 2010; 2:734-41; PMID:20890968; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Birth Defects Res C Embryo Today 2010; 90:193- 202; PMID:20860059; http://dx.doi.org/10.1002/ bdrc.20185.,Non-OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Science 2006; 314:298-300; PMID:17038622;  http://dx.doi.org/10.1126/science.1131000.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Integr Biol (Camb) 2010; 2:424-34;  PMID:20717570; http://dx.doi.org/10.1039/ c0ib00040j.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Nature 2011; 474:179- 83; PMID:21654799; http://dx.doi.org/10.1038/ nature10137.39.,Non-OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Pediatr Nephrol 2009; 24:1611-9;  PMID:19083023; http://dx.doi.org/10.1007/s00467- 008-1048-y.,Non-OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Dev Biol 1989; 135:20-30;  PMID:2767334; http://dx.doi.org/10.1016/0012- 1606(89)90154-1.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Biophys J 1997; 73:2798-808;  PMID:9370474; http://dx.doi.org/10.1016/S0006-3495(97)78309-7.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Dev Cell 2002; 3:367-81;  PMID:12361600; http://dx.doi.org/10.1016/S1534- 5807(02)00259-9.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
Dev Dyn  2005; 232:268-81; PMID:15614768; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/38/6c/biom-3-e24926.PMC3749282.pdf
"Cytotoxicity of cultured macrophages exposed to antimicrobial zinc oxide (ZnO) coatings on nanoporous aluminum oxide membranes; Biomatter 2013; 3:e25528; http://dx.doi.org/10.4161/biomatter.25528Introduction Zinc oxide (ZnO) is a widely utilized commercial material that  has recently garnered interest by medical and nanotechnology researchers due to its considerable antimicrobial 1 and UV pro - tection properties.2 In a review by Lansdown et al., the authors  emphasize the importance of numerous Zn materials that have good clinical evidence showing anti-infective activity, improved wound healing, and higher epithelialization rates.",Non-OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
PLoS Pathog  2011; 7:e1002357; PMID:22072971; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Exp Biol Med (Maywood) 2010; 235:741- 50; PMID:20511678; http://dx.doi.org/10.1258/ebm.2010.009258 28.,Non-OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
"Arch Toxicol 2011; 85:695-704; PMID:20938647;  http://dx.doi.org/10.1007/s00204-010-0608-7 29. von Bülow V, Dubben S, Engelhardt G, Hebel S,  Plümäkers B, Heine H, et al.",OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Biomaterials  2006; 27:3195-200; PMID:16487585; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Exp Mol Pathol 1973; 19:186-96;  PMID:4754789; http://dx.doi.org/10.1016/0014-4800(73)90078-6 32.,Non-OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Agents Actions 1985; 16:580-4; PMID:4072834;  http://dx.doi.org/10.1007/BF01983665 34.,Non-OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Br J Radiol 1986; 59:597-602; PMID:3518853;  http://dx.doi.org/10.1259/0007-1285-59-702-597 35.,Non-OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Int J Dermatol 2002; 41:606-11;  PMID:12358835; http://dx.doi.org/10.1046/j.1365- 4362.2002.01567.x12.,Non-OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Eur J Pharm Biopharm 2013; 84:297- 308; PMID:23454052; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
J Nanopart Res 2009; 11:251-7;  PMID:21170129; http://dx.doi.org/10.1007/s11051- 008-9579-5 14.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Biosens Bioelectron 2013; 42:5- 11; PMID:23208085; http://dx.doi.org/10.1016/j.bios.2012.10.003 15.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Mater Sci Eng B 2012; 177:992-8; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
J Nanosci Nanotechnol  2011; 11:6698-704; PMID:22103070; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
J Nanosci  Nanotechnol 2010; 10:5602-11; PMID:21133080;  http://dx.doi.org/10.1166/jnn.2010.2478 19.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Nanoscale Res Lett 2011; 6:568;  PMID:22040295; http://dx.doi.org/10.1186/1556-276X-6-568 21.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
ACS Appl Mater Interfaces  2012; 4:6185-94; PMID:23088303; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Toxicology 2010; 267:125-31; PMID:19897006;  http://dx.doi.org/10.1016/j.tox.2009.10.034References 1.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Nanotechnology 2012; 23:475703;  PMID:23103840; http://dx.doi.org/10.1088/0957- 4484/23/47/475703 2.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Carbohydr Polym  2013; 92:400-6; PMID:23218312; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Wound Repair  Regen 2007; 15:2-16; PMID:17244314; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
J Biomed Nanotechnol 2012; 8:891-900; PMID:23029997; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Nanomedicine  2011; 7:184-92; PMID:21034861; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Toxicol Lett 2010; 199:389-97; PMID:20934491;  http://dx.doi.org/10.1016/j.toxlet.2010.10.003 8.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Toxicol Appl Pharmacol  2012; 264:94-103; PMID:22842014; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Am J Respir Crit Care Med 2010; 182:1398- 409; PMID:20639441; http://dx.doi.org/10.1164/ rccm.201002-0185OC 10.,Non-OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
Chem Biol Interact  2012; 198:29-37; PMID:22640810; http://dx.doi.org/10.1016/j.cbi.2012.04.007 11.,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
ACS Appl Mater Interfaces 2012; 4:2618- 29; PMID:22489770; http://dx.doi.org/10.1021/ am300292v,OADS,/arxiv_data1/oa_pdf/ac/53/biom-3-e25528.PMC3749283.pdf
"Biomatter 2013; 3:e25597; http://dx.doi.org/10.4161/biom.25597Burns, chronic wounds, osteoarthritis, and uveitis are examples  of conditions characterized by local, intense inflammatory responses that can impede healing or even further tissue  degradation.",Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Expert Opin  Investig Drugs 2010; 19:195-213; PMID:20050823; http://dx.doi.org/10.1517/13543780903418452 2.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Nature 2007; 445:866-73; PMID:17314973; http://dx.doi.org/10.1038/ nature05663 4.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Lancet 2007; 370:272-84;  PMID:17658398; http://dx.doi.org/10.1016/S0140- 6736(07)61129-5 5.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Immunol Res 1991; 10:122- 40; PMID:1717618; http://dx.doi.org/10.1007/ BF029181607.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Cytokine Growth Factor Rev 2007; 18:335-43; PMID:17493863; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
FASEB J 2000; 14:2525- 31; PMID:11099471; http://dx.doi.org/10.1096/fj.00-0073com 9.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Ann Surg 1996; 224:647-64; PMID:8916880; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Annu Rev Immunol 1995; 13:251-76;  PMID:7612223; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
N Engl J Med 2004; 351:2069- 79; PMID:15537905; http://dx.doi.org/10.1056/ NEJMoa03340212.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
N Engl J Med  2007; 356:580-92; PMID:17287478; http://dx.doi.org/10.1056/NEJMoa062382 13.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
J Surg Res 2010; 158:112-20; PMID:19394637; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Proc Natl Acad Sci U S A 1997; 94:12258- 62; PMID:9356436; http://dx.doi.org/10.1073/ pnas.94.23.12258 15.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
J Biol Chem 2006; 281:2945-50; PMID:16321974;  http://dx.doi.org/10.1074/jbc.M510085200 16.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
J Surg  Res 1998; 80:69-74; PMID:9790817; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Ann Plast Surg  2007; 59:109-15; PMID:17589272; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
J Biomed Mater Res A 2013; In press; PMID:23765644; http://dx.doi.org/10.1002/ jbm.a.34829.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Clin Immunol 2009; 131:308-16; PMID:19188093; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Annu Rev Cell Dev Biol 2007; 23:435-61; PMID:17506690; http://dx.doi.org/10.1146/ annurev.cellbio.23.090506.12333724.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
J Control Release 2001; 73:121-36;  PMID:11516493; http://dx.doi.org/10.1016/S0168- 3659(01)00248-6 25.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
J Mater  Chem 2008; 18:1873-80; http://dx.doi.org/10.1039/ b718277e 26.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Mol Pharm 2010; 7:1769-77; PMID:20726535;  http://dx.doi.org/10.1021/mp100150z 27.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Wound Repair Regen 2010; 18:302-10;  PMID:20412551; http://dx.doi.org/10.1111/j.1524- 475X.2010.00591.x 28.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Acta Biomater  2010; 6:4708-15; PMID:20601239; http://dx.doi.org/10.1016/j.actbio.2010.06.029 29.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
J  Invest Dermatol 2007; 127:514-25; PMID:17299434; http://dx.doi.org/10.1038/sj.jid.5700701 30.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Best Pract Res Clin Rheumatol 2006; 20:879-96; PMID:16980212; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
J Pharm Sci  1995; 84:1144-6; PMID:8537898; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
J Control Release 1989; 10:167-75; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Adv Drug Deliv  Rev 1996; 20:113-5; http://dx.doi.org/10.1016/0169- 409X(95)00114-M 22.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Pharm Res 2002;  19:403-10; PMID:12033371; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
Adv  Drug Deliv Rev 2012; 64:72-82; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/biom-3-e25597.PMC3749284.pdf
"Biomatter 2013; 3:e25887; http://dx.doi.org/10.4161/biom.25887of disease, damaged and/or aging tissues  or organs.",Non-OADS,/arxiv_data1/oa_pdf/78/ea/biom-3-e25887.PMC3749285.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/14/da/3017.PMC3749325.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b1/bb/3282.PMC3749326.pdf
"Complete QC reports are available through dbGaP, http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/b1/bb/3282.PMC3749326.pdf
"ADDENDUM Web Resources: BEAGLE, http://faculty.washi ngton.edu/browning/beagle/ beagle.html; dbGaP HAPO Study, http://www.ncbi.nlm.nih.gov/projects/ gap/cgi-bin/study.cgi?study_id=phs000096.v4.p1; EIGENSTRAT, http://genepath.med.harvard.edu/~reich/ Software.htm; METAL, http://www.sph.umich.ed u/csg/abecasis/ metal/index.",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/3282.PMC3749326.pdf
"omim.org; PLINK, http://pngu.mgh.har vard.edu/~purcell/plink/; SNPTEST, https://mathgen.stats.ox.ac.uk/genetics_software/ snptest/snptest.html ACKNOWLEDGMENTS This study was supported by National Institutes of Health(NIH) grants HD-34242, HD-34243, HG-004415, and CA- 141688, Institutes of Health Research –INMD (Funding Ref- erence Number 110791), and by the American Diabetes Association.",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/3282.PMC3749326.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/bf/27/3261.PMC3749327.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/07/15/3014.PMC3749328.pdf
"Haptoglobin (HP) (http://www.ncbi.nlm.nih .gov/gene/3240, 16q22.2), an abundant serum protein whose primary function is to protect against the pro-oxidative activity of extracorpuscular hemoglobin (Hb), is one po- tential determinant of susceptibility to DN (4).",Non-OADS,/arxiv_data1/oa_pdf/ac/31/3218.PMC3749329.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ac/31/3218.PMC3749329.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/30/01/3081.PMC3749330.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a0/ba/3005.PMC3749331.pdf
A trial using a novel device that electrically alters the vagal nerve ﬁring as a treatment for morbid obesity reports a fast decrease infasting plasma glucose within the ﬁrst week in patients with type 2 diabetes (ENABLE trial; http://ir.enteromedics.com/ releasedetail.cfm?ReleaseID=610191).,Non-OADS,/arxiv_data1/oa_pdf/a0/ba/3005.PMC3749331.pdf
Likewise a tube de- vice that is endoscopically inserted in the gut extendingfrom the duodenum to the proximal jejunum to prevent nutrients being absorbed within this region also reports rapid changes in glucose (http://www.gidynamics.com/endobarrier-overview.php).,Non-OADS,/arxiv_data1/oa_pdf/a0/ba/3005.PMC3749331.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f1/08/3224.PMC3749332.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/66/41/3024.PMC3749333.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/47/30/2997.PMC3749334.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c2/ed/3120.PMC3749335.pdf
"For pathwayanalysis, GenBank accession numbers were mapped to the Ingenuity database(IPA, http://www.ingenuity.com) to retrieve relevant biological processes (microarray data accession number: E-MEXP-3789).",OADS,/arxiv_data1/oa_pdf/c2/ed/3120.PMC3749335.pdf
"For consistency, all study subjects, including newly collected samples, samples from blood cards, and samples received from theNational Institute of Diabetes and Digestive and Kidney Diseases repository(https://www.niddkrepository.org) were genotyped in the laboratory at Child-ren’s Hospital and Research Center Oakland using PCR sequence-speci ﬁco l i - gonucleotide probe methodology with “linear arrays ”as previously described for the Type 1 Diabetes Genetics Consortium (T1DGC) (6,7).",Non-OADS,/arxiv_data1/oa_pdf/d7/6f/3292.PMC3749336.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d7/6f/3292.PMC3749336.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c3/38/3232.PMC3749337.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/87/bc/3189.PMC3749338.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/27/5a/3180.PMC3749340.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/77/d4/3064.PMC3749341.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/5b/e3/3132.PMC3749342.pdf
"A clinical study evaluating safety for treatment of rheuma- toid arthritis with autologous DCs generated with dexa- methasone and vitamin D3 and loaded with synovial ﬂuid (http://www.clinical trials.gov/ct2/sho w/NCT01352858) is ongoing in Newcastle, U.K. At the University of Pitts- burgh (Pittsburgh, PA), the ﬁrst trial for the treatment of type 1 diabetic patients with autologous DCs treated ex vivo with antisense phosphorothioate-modi ﬁed oligonucleotides targeting the primary transcripts of the CD40, CD80, and CD86 has passed an initial phase I trial for safety (63).",Non-OADS,/arxiv_data1/oa_pdf/5b/e3/3132.PMC3749342.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7d/ca/3093.PMC3749343.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/65/14/3170.PMC3749344.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d7/11/3103.PMC3749345.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/3053.PMC3749346.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a6/05/3251.PMC3749347.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/90/c0/2995.PMC3749348.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/46/7e/3114.PMC3749349.pdf
"Simple and multiple regressions were carried out using the linearmodel function in R, version 2.10 (http://www.r-project.org).RESULTS Transfection of isolated human adipose cells.",OADS,/arxiv_data1/oa_pdf/46/7e/3114.PMC3749349.pdf
"See  http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.DIGESTS Keep up with the latest research and   information from the journals of the  American Diabetes Association A free podcast hosted by   Neil Skolnik, MD,  and John Russell, MD Diabetes Core Update http://diabetesjournals.org/site/podcasts.xhtml",Non-OADS,/arxiv_data1/oa_pdf/96/98/3302.PMC3749350.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d6/33/3027.PMC3749351.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/94/f0/3151.PMC3749352.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/fd/4d/3268.PMC3749353.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/63/aa/3275.PMC3749354.pdf
Islets from cadaver donors ( n= 45) were provided by the Nordic Islet Transplantation Program (http://www.nordicislets.org).,OADS,/arxiv_data1/oa_pdf/63/aa/3275.PMC3749354.pdf
The htseq countscript (http://www-huber.embl.de/users/anders/HTSeq/doc/count.html) was used by counting uniquely mapped reads in each exon using the mode “in- tersection-nonempty.,OADS,/arxiv_data1/oa_pdf/63/aa/3275.PMC3749354.pdf
Available from http://www.ncbi .nlm.nih.gov/projects/gap/cgi-bin/ana lysis.cgi?study_id=phs000206.v3.p2&pha=2889.,Non-OADS,/arxiv_data1/oa_pdf/63/aa/3275.PMC3749354.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ac/9c/3163.PMC3749355.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/95/7f/3022.PMC3749356.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/bf/89/3207.PMC3749357.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/13/cc/3075.PMC3749358.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c4/33/3044.PMC3749359.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/85/5b/3019.PMC3749360.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/df/1c/3033.PMC3749361.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/55/0d/3143.PMC3749362.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/16/eb/3194.PMC3749364.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f1/c3/3241.PMC3749365.pdf
"T o select the most appropriaterestriction enzy me for vector preparation, comprehensive information on restriction enzy mes from the REBASE database (http://rebase.neb.com) was examined with the following criteria in mind: 1) the enzy me produces a T overhang at the 3' end, 2) the enzy me does not digestcommonly used vectors in molecular biology , such as pBluescript II and pUC vectors, and 3) the enzy me is available at a low price.",Non-OADS,/arxiv_data1/oa_pdf/1a/66/mb-37-240.PMC3749396.pdf
ITS rDNA sequence information on KACC43556 and 43557 was downloaded from  the W ebsite of KoreanAgriculture Culture Collection (http://kacc.rda.go.kr/).,OADS,/arxiv_data1/oa_pdf/80/74/mb-37-251.PMC3749414.pdf
"The AMF spores were identified on the basis of morphology (i.e., shape, surfaceornamentation, color , contents, and wall structure) (Schenck and Perez, 1990) and were compared to the morphologi- cal descriptions of species presented on the International Culture Collection of V esicular -Arbuscular My corrhizal Fungi (INV AM) webpage (http://invam.caf.wvu.edu).",OADS,/arxiv_data1/oa_pdf/ad/27/mb-37-272.PMC3749417.pdf
"Based on the sequence of the T.  m a t s u t a k e  ITS region, a specific primer set (DTmF-DTmR) was designed usinga multiple sequence alignment program (http://prodes.tou- louse.inra.fr/multalin/multalin.html, T able 2).",OADS,/arxiv_data1/oa_pdf/50/b2/mb-37-317.PMC3749427.pdf
"After 24 hrs, five fields were randomly selected from each culture and images of tube formation were captured andanalyzed by an inverted microscope (Oly mpus Co., Japan) using a 10 × objective lens and by Image J tool program (by NIH; http://rsb.info.nih.gov/ij/), respectively .",OADS,/arxiv_data1/oa_pdf/e7/d8/mb-37-21.PMC3749450.pdf
Our diversity predictions and range maps withsupporting data are publicly available through an interactive web-portal at http://docpollard.org/ marine_diversity.,OADS,/arxiv_data1/oa_pdf/8d/a2/ismej201337a.PMC3749493.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Th e ISME Journal website (http://www.nature.com/ismej)Global marine bacterial diversity J Ladau et al 1677 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/8d/a2/ismej201337a.PMC3749493.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Invasive genetic elements in marine microbial eukaryotes A Monier et al 1774 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/b3/45/ismej201370a.PMC3749507.pdf
"See: http://creativecommons.org/ licenses/by/3.0/ REFERENCES 1 Hobbs MM, Sena AC, Swygard H, et al .Trichomonas vaginalis and trichomoniasis.",Non-OADS,/arxiv_data1/oa_pdf/a3/80/sextrans-2013-051105.PMC3749517.pdf
"Indeed, chloroquine and its deri- vatives are currently the only inhibitors used for treatment of cancerpatients, and more than 20 clinical trials using chloroquine or hydro-xychloroquine are now testing whether the pharmacological inhibi-tion of autophagy in a clinical setting can increase the effectiveness of existing cancer therapies (http://clinicaltrials.gov/ct2/results?term 5 autophagy 1and1cancer&Search 5Search) 21,22.",Non-OADS,/arxiv_data1/oa_pdf/27/27/srep02469.PMC3749547.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/27/27/srep02469.PMC3749547.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2469 | DOI: 10.1038/srep02469 13",Non-OADS,/arxiv_data1/oa_pdf/27/27/srep02469.PMC3749547.pdf
Available from URL: http://www.fifthdimension.jp/(2010).,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/srep02491.PMC3749548.pdf
"and did morphological observations, molecular phylogeny, culture experiments andwrote the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/c4/d8/srep02491.PMC3749548.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2491 | DOI: 10.1038/srep02491 7",Non-OADS,/arxiv_data1/oa_pdf/c4/d8/srep02491.PMC3749548.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2493 | DOI: 10.1038/srep02493 7",Non-OADS,/arxiv_data1/oa_pdf/4c/29/srep02493.PMC3749549.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2492 | DOI: 10.1038/srep02492 5",Non-OADS,/arxiv_data1/oa_pdf/fb/3b/srep02492.PMC3749550.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a0/e7/srep02489.PMC3749551.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2489 | DOI: 10.1038/srep02489 6",Non-OADS,/arxiv_data1/oa_pdf/a0/e7/srep02489.PMC3749551.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/31/9c/srep02487.PMC3749552.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2487 | DOI: 10.1038/srep02487 8",Non-OADS,/arxiv_data1/oa_pdf/31/9c/srep02487.PMC3749552.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)DUSP6 regulates apoptosis and DDR BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.353 1071,Non-OADS,/arxiv_data1/oa_pdf/0a/38/bjc2013353a.PMC3749559.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Immune prognostic biomarkers in colorectal cancer 1022 www.bjcancer.com | DOI:10.1038/bjc.2013.362,Non-OADS,/arxiv_data1/oa_pdf/ca/42/bjc2013362a.PMC3749560.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Phase I study of RO4929097 and cediranib BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.380 949,Non-OADS,/arxiv_data1/oa_pdf/93/4e/bjc2013380a.PMC3749563.pdf
"Medical records were reviewed to detail carboplatin HSR documented before enrolment, and to characterise carboplatin HSR occurring on trial.BRCA1/2mutstatus was obtained as part of the clinical trial enrolment, and sources included the patient’s genetic test results, and in one case, deleterious mutation risk outcome estimates using the BRCAPro model (BayesMendel Lab, http://bcb.dfci.harvard.",Non-OADS,/arxiv_data1/oa_pdf/a9/a9/bjc2013389a.PMC3749564.pdf
"DHM was funded through the NIH Medical Research Scholars Program, a public–private partnership supported jointly by the NIH and through the Foundation for the NIH (details on program and donors: http://www.fnih.org/ work/programs-development/medical-research-scholars-program).",Non-OADS,/arxiv_data1/oa_pdf/a9/a9/bjc2013389a.PMC3749564.pdf
All TMA cores were screened and evaluated with a computerised image analysis platform constructed using the TMAJ Image application (http://tmaj.pathology.jhmi.edu).,OADS,/arxiv_data1/oa_pdf/1c/61/bjc2013390a.PMC3749565.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)TAA expression and HCC progression BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.390 1039,Non-OADS,/arxiv_data1/oa_pdf/1c/61/bjc2013390a.PMC3749565.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Glycolysis inhibitors enhance photodynamic therapy 982 www.bjcancer.com | DOI:10.1038/bjc.2013.391,Non-OADS,/arxiv_data1/oa_pdf/77/83/bjc2013391a.PMC3749566.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Gene fusions in malignant meningioma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.395 1055,Non-OADS,/arxiv_data1/oa_pdf/cd/9f/bjc2013395a.PMC3749567.pdf
"Patients were monitored monthly, and assessed for treatment toxicity according to the National Cancer Institute-Common Terminology Criteria for Adverse Events version 4.03 (CTCAE v.4.03, 2010; http://evs.nci.nih.gov/ftp1/CTCAE/ CTCAE_4.03_2010-06-14_QuickR eference_8.5x11.pdf), and for treatment activity according to the recent ‘(PCWG2)’ guidelines (Scher et al, 2008).",Non-OADS,/arxiv_data1/oa_pdf/80/65/bjc2013398a.PMC3749570.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER UGT1A loss allows for androgen ablation survival 956 www.bjcancer.com | DOI:10.1038/bjc.2013.399,Non-OADS,/arxiv_data1/oa_pdf/6d/a2/bjc2013399a.PMC3749571.pdf
"Comprehensive Cancer Centers, the Netherlands (2011) Dataset Breast Cancer from http://www.cijfersoverkanker.nl/selecties/Dataset_1/img4f3ba09dec237.",Non-OADS,/arxiv_data1/oa_pdf/f7/21/bjc2013401a.PMC3749573.pdf
"Manual update ,from http://guidance.nice.org.uk/CSGBC/Guidance/pdf/English.",Non-OADS,/arxiv_data1/oa_pdf/f7/21/bjc2013401a.PMC3749573.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Locoregional recurrence and breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.401 871,Non-OADS,/arxiv_data1/oa_pdf/f7/21/bjc2013401a.PMC3749573.pdf
"Johnson CD, Aaronson NK, Blazeby J, Bottomley A, Fayers P, Koeller M, Kulis D, Ramage J, Sprangers MA, Velkova G, Young T. EORTC Qualityof Life Group (2011) Guidelines for developing questionnaire modules.Available at http://groups.eortc.be/qol/documentation_manuals.htm.",Non-OADS,/arxiv_data1/oa_pdf/70/a5/bjc2013407a.PMC3749575.pdf
Sorafenib for the treatment of advanced hepatocellularcarcinoma http://www.nice.org.uk/nicemedia/live/12019/46312/46312.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/90/bjc2013410a.PMC3749577.pdf
website http://www.scottishmedicines.org.uk/ files/sorafenib__Nexavar___FINAL_JUNE_2008_for_website.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/90/bjc2013410a.PMC3749577.pdf
Cancer Research UK (2012b) Vulval cancer statistics http://www.cancerresearch uk.org/cancer-info/cancerstats/types/vulva/Accessed 18 September 2012.,Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
Cancer Research UK (2013a) UK Cancer Incidence (2010) by Country Summary http://publications.cancerresearchuk.org/cancerstats/ statsincidence/dtinccountries.htmlAccessed 13 June 2013.,Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
Cancer Research UK (2013b) Uterine cancer statistics http://www.cancer researchuk.org/cancer-info/cancerstats/types/uterus/Accessed 6 February 2013.,Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
Cancer Research UK (2013c) Cervical cancer statistics http://www.cancer researchuk.org/cancer-info/cancerstats/types/cervix/Accessed 6 February 2013.,Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
Cancer Research UK (2013d) Ovarian cancer statistics http://www.cancer researchuk.org/cancer-info/cancerstats/types/ovary/Accessed 6 February 2013.,Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
http://www.nrs.co.uk/lifestyle.html (Accessed 19 September 2012).,Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
http://www.nhs.uk/conditions/ Cancer/Pages/Introduction.aspx (Accessed 5 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
http://www.ons.gov.uk/ons/rel/cancer-unit/cancer-incidence-and-mortality/2007-2009/stb-cancer-incidence-and-mortality.html(Accessed 22 November 2012).,Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
"Office for National Statistics (2012b) Cancer Registrations in England, 2010. http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-257416 (Accessed 5 June 2013).",Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
"Population, Ethnicity, Religion and Migration (PERM) (2009) The non-White ethnic population: by ethnic group, 2009. http://www.ethnicity.ac.uk/ population/size.html (Accessed 31 May 31 2013).",OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
Target Ovarian Cancer (2013) Target Ovarian Cancer Pathfinder Study 2012. http://www.targetovariancancer.org.uk/page.asp?section=538&sectionTitle=The þ2012þTargetþOvarian þCancer þPathfinder þStudy#.UYvDUMqS9CN (Accessed 1 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/04/ff/bjc2013412a.PMC3749578.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Stromal targeting in PDA BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.415 933,Non-OADS,/arxiv_data1/oa_pdf/f2/54/bjc2013415a.PMC3749580.pdf
"CANCER-SPECIFIC CONSIDERATIONS IN NGS AND DATA ANALYSIS Next-generation sequencing has been utilised to characterise numerous cancers and large-scale projects such as The Cancer Genome Atlas (http://cancergenome.nih.gov/) and InternationalCancer Genome Consortium (http://icgc.org) now exist to comprehensively profile hundreds of cancers of any type using genome–exome sequencing, gene and protein expression profiling, RNA sequencing, methylome analysis, and copy number assess- ment.",Non-OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
The other two algorithms are designed for longer sequences ranging from 70 bp to 1 Mbp.http://bio-bwa.sourceforge.net/ Li and Durbin (2009a) Li and Durbin (2010) Eland Eland is a commercially based software program designed by Illumina to map Illumina reads to a reference genome as part of their genome analysis pipeline.http://www.illumina.com MAQ Maps short reads to a reference genome.,OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
Produces ungapped alignment of reads.http://maq.sourceforge.net/ Liet al (2008) Stampy Maps short reads to a reference genome using Illumina reads.,OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
Can be used incombination with BWA.http://www.well.ox.ac.uk/project-stampy Lunter and Goodson (2011) Variant callers GATK Structured software library that has programs to analyse NGS data.,OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
Can be used for variant calling and identification of indels.http://www.broadinstitute.org/gsa/wiki/ index.php/Home_Page Developers-Broad Institute JointSNVMix Analyses tumour and normal genome pairs simultaneously so that germline and somatic mutations can be distinguished.http://code.google.com/p/joint-snv-mix/ Roth et al (2012) MuTect A variant caller to identify somatic point mutations from tumour normal paired sequencing data.,OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
"The program can determine from the depth of coverage in tumour and normal whether there is sufficient sensitivity to call a somatic mutation.http://www.broadinstitute.org/cancer/ cga/mutect Cibulskis et al (2013) Samtools This is a software program that can align and manipulate NGS data, which is stored in the SAM format, a generic format for storing large nucleotide sequence data.",OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
It is not specific to cancer genomes but can be used to identify variant calls in the tumour distinct from the reference and can also be used to identify short range indels.http://samtools.sourceforge.net/ Liet al (2009b) Somatic SniperThe program compares tumour and normal data to produce a Phred-based probability score to determine the likelihood of the tumour and normal genotypes being different.http://gmt.genome.wustl.edu/ somatic-sniper/current/ Larson et al (2012) Varscan2 Can be used to identify somatic and germline variants and LOH events in tumour normal pairs.,OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
"Detectslarge insertions, deletions, inversions, inter/intra chromosomal translocations.BreakDancer Mini – used to detect small indels 10–100 bp, which are not routinely identified by BreakDancer Max.http://breakdancer.sourceforge.net Chen et al (2009) Dindel This can identify small indels in NGS data.",OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
With deeper coverage the number of false positives can be reduced by filtering the data to ensurethat each indel is present more than twice.http://www.sanger.ac.uk/resources/ software/dindel/Albers et al (2011) Genome STRiPDesigned to detect structural variations shared by multiple individuals.,OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
Its current use is limited to uncovering and genotyping deletions relativeto a reference sequence.http://www.broadinstitute.org/software/ genomestrip/genome-stripHandsaker et al (2011) Pindel Can be used to identify simple deletions and insertions.,OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
It uses BAMfiles generated from Illumina read data.https://trac.nbic.nl/pindel/ Yeet al (2009) CNV analysis CNAseg Uses NGS data to estimate copy number states using the depth of coverage and variability in coverage in the cancer and normal to try and control false-positive rate.Ivakhno et al (2010) SegSeq Uses NGS data to detect CNVs of a given size using tumour- normal pairs and can be used to map breakpoints.Chiang et al (2009) Abbreviations: BWA ¼Burrows Wheeler Aligner; BWA-SW ¼Burrows Wheeler Aligner’s Smith-Waterman Alignment; CNV ¼copy number variant; LOH ¼loss of heterozygosity; MAQ¼mapping and assembly with quality; NGS ¼next-generation sequencing; SAM ¼sequence alignment/map.BRITISH JOURNAL OF CANCER NGS of cancers in clinical practice 832 www.bjcancer.com | DOI:10.1038/bjc.2013.416,Non-OADS,/arxiv_data1/oa_pdf/40/31/bjc2013416a.PMC3749581.pdf
Eur Radiol 18(2): 351–354.How CONSORT began (2008) Available from http://www.consort-statement.,Non-OADS,/arxiv_data1/oa_pdf/5c/7c/bjc2013417a.PMC3749582.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER TKIs induce cytotoxicity in bladder cancer cells 1050 www.bjcancer.com | DOI:10.1038/bjc.2013.420,Non-OADS,/arxiv_data1/oa_pdf/c7/34/bjc2013420a.PMC3749583.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognostic role of CIMP in bowel subsite 1012 www.bjcancer.com | DOI:10.1038/bjc.2013.430,Non-OADS,/arxiv_data1/oa_pdf/12/d0/bjc2013430a.PMC3749584.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Notch targets predict colorectal cancer chemoresponse 1030 www.bjcancer.com | DOI:10.1038/bjc.2013.431,Non-OADS,/arxiv_data1/oa_pdf/f1/21/bjc2013431a.PMC3749585.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Predictors of weight gain in breast cancer patients BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.441 881,Non-OADS,/arxiv_data1/oa_pdf/3f/1c/bjc2013441a.PMC3749587.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Activity of panobinostat in soft tissue sarcoma 914 www.bjcancer.com | DOI:10.1038/bjc.2013.442,Non-OADS,/arxiv_data1/oa_pdf/b7/77/bjc2013442a.PMC3749588.pdf
"This is an Open Access article distributed underthe terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/bc/cit404.PMC3749748.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/54/1a/srep02472.PMC3749795.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2472 | DOI: 10.1038/srep02472 6",Non-OADS,/arxiv_data1/oa_pdf/54/1a/srep02472.PMC3749795.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2432 | DOI: 10.1038/srep02432 6",Non-OADS,/arxiv_data1/oa_pdf/1d/02/srep02432.PMC3749796.pdf
Biomatter 2013; 3:e24922; http://dx.doi.org/10.4161/biom.24922Introduction Designed porous materials have been proposed as scaffolds for  regenerative medicine applications.,Non-OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Biomaterials 2002; 23:3919-26;  PMID:12162324; http://dx.doi.org/10.1016/S0142- 9612(02)00126-6.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
J Mater Sci Mater Med  2008; 19:2015-21; PMID:17952564; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Acta Biomater 2010; 6:2189-99; PMID:20040387; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Mater Res  2012; 15:151-8; http://dx.doi.org/10.1590/S1516- 14392011005000099.,Non-OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Tissue Eng Part B  Rev 2011; 17:263-80; PMID:21495897; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
T rends Biotechnol 2004; 22:80-6; PMID:14757042; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Tissue Eng 2003;  9:549-54; PMID:12857422; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Biomaterials 2006; 27:315-23; PMID:16125223;  http://dx.doi.org/10.1016/j.biomaterials.2005.07.044.9.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Biomaterials 2009; 30:4533-8;  PMID:19500837; http://dx.doi.org/10.1016/j.bioma- terials.2009.05.020.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Tissue Eng Part C Methods  2011; 17:505-16; PMID:21171934; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Tissue Eng Part C Methods 2011; 17:337- 48; PMID:20929287; http://dx.doi.org/10.1089/ten.,Non-OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Tissue Eng 2003; 9:1205-14; PMID:14670108;  http://dx.doi.org/10.1089/10763270360728116.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Biomaterials 2003; 24:2277-86; PMID:12699664;  http://dx.doi.org/10.1016/S0142-9612(03)00039-5.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
J Mater Sci Mater Med  2008; 19:269-75; PMID:17597360; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Tissue Eng Part A 2008; 14:1331-40;  PMID:18601588; http://dx.doi.org/10.1089/ten.,Non-OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Ann Biomed Eng 2004; 32:112-22; PMID:14964727; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Tissue Eng Part A 2008; 14:1809- 20; PMID:18620487; http://dx.doi.org/10.1089/ten.,Non-OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Arch Oral Biol 1992; 37:15-21;  PMID:1596204; http://dx.doi.org/10.1016/0003- 9969(92)90147-Z.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Calcif Tissue Int 1992; 51:438- 42; PMID:1451011; http://dx.doi.org/10.1007/ BF00296677.,Non-OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Bone 2002; 31:296-302; PMID:12151082; http://dx.doi.org/10.1016/S8756- 3282(02)00821-9.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Front Biosci  2012; 17:1891-903; PMID:22201843; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/4d/biom-3-e24922.PMC3749797.pdf
Biomatter 2013; 3:e23705; http://dx.doi.org/10.4161/biom.23705Introduction RP technologies are gaining importance as fabrication tech - niques for preparation of 3D scaffolds used in various tissue  engineering applications.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Biomed Mater  Res 2001; 55:203-16; PMID:11255172; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2005; 26:4817- 27; PMID:15763261; http://dx.doi.org/10.1016/j.biomaterials.2004.11.057.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2009; 30:3801-9; PMID:19406467; http://dx.doi.org/10.1016/j.bioma- terials.2009.03.055.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2008; 29:2608- 15; PMID:18358527; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2002; 23:4739-51; PMID:12361612; http://dx.doi.org/10.1016/S0142- 9612(02)00223-5.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Biomed  Mater Res A 2005; 75:957-65; PMID:16118789;  http://dx.doi.org/10.1002/jbm.a.30499.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Tissue Eng 2005; 11:1297- 311; PMID:16259586; http://dx.doi.org/10.1089/ ten.2005.11.1297.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Polymer (Guildf)  2007; 48:6823-33; http://dx.doi.org/10.1016/j.poly-mer.2007.09.037.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Electrost  1995; 35:151-60; http://dx.doi.org/10.1016/0304-3886(95)00041-8.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2006; 27:3115-24;  PMID:16458961; http://dx.doi.org/10.1016/j.bioma-terials.2006.01.022.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Tissue Eng Part C Methods  2009; 15:11-21; PMID:18844601; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials  2008; 29:2996-3003; PMID:18423584; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2005; 26:2603-10;  PMID:15585263; http://dx.doi.org/10.1016/j.bioma- terials.2004.06.051.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Macromolecules 2004;  37:573-8; http://dx.doi.org/10.1021/ma0351975.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Mater Sci 2009;  44:1357-62; http://dx.doi.org/10.1007/s10853-008- 3010-6.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Polymer (Guildf)  2001; 42:261-72; http://dx.doi.org/10.1016/S0032-3861(00)00250-0.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials  2006; 27:4911-22; PMID:16762409; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Adv Funct Mater 2008; 18:53-60; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Acta Orthop Scand  2000; 71:337-53; PMID:11028881; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Biomed Mater Res 2001; 56:208-15;  PMID:11340590; http://dx.doi.org/10.1002/1097-4636(200108)56:2<208::AID-JBM1085>3.0.CO;2-R. 24.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Nature 1962; 196:1048; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Curr Opin Solid  St M. 2003; 7:309-18; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Tissue Eng 2004; 10:101-8; PMID:15009935; http://dx.doi.org/10.1089/107632704322791745.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
"Ca,P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater  Res 1990; 24:331-43; PMID:2156869; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials  2002; 23:1921-30; PMID:11996032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Acta Biomater  2009; 5:1626-38; PMID:19188103; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2002; 23:4649-56;  PMID:12322986; http://dx.doi.org/10.1016/S0142-9612(02)00214-4.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials  2004; 25:4149-61; PMID:15046905; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
PLoS One 2008; 3:e3032;  PMID:18716660; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Biomed Mater Res  2002; 59:535-46; PMID:11774312; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Biomed Mater Res  A 2006; 78:605-14; PMID:16758454; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Bone 2006; 39:431-3; PMID:16581322;  http://dx.doi.org/10.1016/j.bone.2006.02.058.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Langmuir  2010; 26:7380-7; PMID:20039599; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Macromol  Rapid Commun 2008; 29:1577-81; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Biomed  Mater Res 1997; 34:247-59; PMID:9029305; http://dx.doi.org/10.1002/(SICI)1097- 4636(199702)34:2<247::AID-JBM14>3.0.CO;2-F .,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2005; 26:3631-8; PMID:15621253;  http://dx.doi.org/10.1016/j.biomaterials.2004.09.035.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Biol Chem 2003; 278:41921- 9; PMID:12920127; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Oncogene 2004; 23:4315- 29; PMID:15156188; http://dx.doi.org/10.1038/ sj.onc.1207676.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2006; 27:974-85;  PMID:16055183; http://dx.doi.org/10.1016/j.bioma-terials.2005.07.023.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Tissue Eng 2007; 13:3-9; PMID:17518576;  http://dx.doi.org/10.1089/ten.2005.0513.51.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Tissue  Eng Part A 2010; 16:2467-73; PMID:20214455;  http://dx.doi.org/10.1089/ten.tea.2009.0337.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Bone 2010; 46:479-86;  PMID:19782780; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2012; 33:3205-15;  PMID:22285104; http://dx.doi.org/10.1016/j.bioma-terials.2012.01.020.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Proc Natl Acad Sci U S A 2010; 107:13614- 9; PMID:20643969; http://dx.doi.org/10.1073/ pnas.1003600107.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Proc Natl Acad Sci U S A 2000; 97:8352- 7; PMID:10890885; http://dx.doi.org/10.1073/ pnas.140021997.45.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Biomed Mater Res A 2004; 69:145- 54; PMID:14999762; http://dx.doi.org/10.1002/ jbm.a.20131.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Mater Sci Mater Med 2001;  12:259-65; PMID:15348310; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomaterials 2005; 26:285-95; PMID:15262470; http://dx.doi.org/10.1016/j.biomaterials.2004.02.030.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Mater Sci Mater Med 2008; 19:2261-8;  PMID:18058196; http://dx.doi.org/10.1007/s10856- 007-3335-8.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
J Biomed Mater Res A 2003; 64:378- 87; PMID:12522826; http://dx.doi.org/10.1002/ jbm.a.10291.,Non-OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biochem Biophys Res Commun 2010; 394:1093-7; PMID:20346918; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/b1/biom-3-e23705.PMC3749798.pdf
Biomatter 2013; 3:e25103; http://dx.doi.org/10.4161/biomatter.25103Calcium phosphate materials have been used increasingly in  the past 40 years as bone graft substitutes in the dental and orthopedic fields.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Eur Spine  J 2009; 18:449-64; PMID:19152011; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Mater Today 2010; 13:24-30; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Orthop T rauma 1989; 3:192-5; PMID:2809818; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Spine (Phila Pa 1976) 1995;  20:1055-60; PMID:7631235; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Clin Orthop Relat Res  1996; 300-9; PMID:8769465; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J  Biomed Mater Res 1970; 4:433-56; PMID:5469185;  http://dx.doi.org/10.1002/jbm.820040309.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Biomed Mater Res Symp 1971; 2:161- 229; http://dx.doi.org/10.1002/jbm.820050613.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Tissue Eng Regen Med 2007; 1:245-60;  PMID:18038415; http://dx.doi.org/10.1002/term.24.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Clin Mater  1994; 17:35-67; PMID:10150176; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Acta Biomater  2008; 4:773-82; PMID:18348912; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Acta Biomater 2010; 6:1680-92;  PMID:20172057; http://dx.doi.org/10.1016/j.act- bio.2010.02.028.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Biomed Mater Res 1989; 23:883- 94; PMID:2777831; http://dx.doi.org/10.1002/jbm.820230806.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Proc  Inst Mech Eng H 1998; 212:427-35; PMID:9852738;  http://dx.doi.org/10.1243/0954411981534196.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Clin Orthop Relat  Res 2002; 81-98; PMID:11937868; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Bone 2005; 36:1086- 93; PMID:15869915; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Tissue Eng  Regen Med 2007; 1:25-32; PMID:18038389; http://dx.doi.org/10.1002/term.5.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
"J Biomed Mater Res 1998; 42:368- 75; PMID:9788498; http://dx.doi.org/10.1002/ (SICI)1097-4636(19981205)42:3<368::AID-JBM4>3.0.CO;2-H. 22. van Hemert WL, Willems K, Anderson PG, van  Heerwaarden RJ, Wymenga AB.",Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Knee 2004; 11:451-6; PMID:15581763;  http://dx.doi.org/10.1016/j.knee.2004.08.004.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Eur Spine J 2001;  10(Suppl 2):S132-40; PMID:11716010; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Orthod Craniofac  Res 2005; 8:277-84; PMID:16238608; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Science  1995; 267:1796-9; PMID:7892603; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater  Sci Mater Med 2003; 14:647-53; PMID:15348429;  http://dx.doi.org/10.1023/A:1024035426820.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2005; 26:6423-9; PMID:15964620;  http://dx.doi.org/10.1016/j.biomaterials.2005.03.049.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Spine (Phila Pa 1976) 2008; 33:1284- 90; PMID:18469705; http://dx.doi.org/10.1097/ BRS.0b013e3181714a84.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Eur Spine J 2007; 16:601-10; PMID:17120071;  http://dx.doi.org/10.1007/s00586-006-0258-x.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Cryst Growth Des 2008; 8:2227-34; http://dx.doi.org/10.1021/cg700808h.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Small 2011; 7:2685-702; PMID:21805623;  http://dx.doi.org/10.1002/smll.201002022.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Am Chem Soc 1950; 72:4847-54; http://dx.doi.org/10.1021/ja01167a001.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med  2001; 12:385-90; PMID:15348276; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2005; 26:1553-63; PMID:15522757; http://dx.doi.org/10.1016/j.bioma- terials.2004.05.010.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med 2012; 23:1593-603;  PMID:22528073; http://dx.doi.org/10.1007/s10856- 012-4640-4.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Am Ceram Soc 2004;  87:1126-32; http://dx.doi.org/10.1111/j.1551- 2916.2004.01126.x.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Adv Funct Mater 2007; 17:3940-5; http://dx.doi.org/10.1002/adfm.200700019.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med 2004;  15:13-7; PMID:15338586; http://dx.doi.org/10.1023/ B:JMSM.0000010092.01661.a8.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Cryst Res Technol 2009; 44:336-40;  http://dx.doi.org/10.1002/crat.200800404.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Mater Sci Technol 2008; 24:612- 7; http://dx.doi.org/10.1179/174328407X176974.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Bioact Compat Polym 2009; 24:151-68;  http://dx.doi.org/10.1177/0883911508101554.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Chem  Papers 2010; 64:491-8; http://dx.doi.org/10.2478/ s11696-010-0032-8.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Tissue Eng Part  A 2010; 16:1681-91; PMID:19954329; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Bioceram Dev Appl 2011; 1:1-3; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Eur Ceram Soc 2009; 29:369-75; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Eur Ceram Soc  2012; 32:2673-8; http://dx.doi.org/10.1016/j.jeurce- ramsoc.2012.01.014.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
IEEE T rans Plasma Sci 1997; 25:1066-72;  http://dx.doi.org/10.1109/27.649627.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
JOM 1997; 49:58-62; http://dx.doi.org/10.1007/ BF02915483.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater  Sci Mater Med 2000; 11:523-31; PMID:15348004;  http://dx.doi.org/10.1023/A:1008918110156.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Pharm  Sci 1972; 61:1466-8; PMID:5068953; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Clin Mater 1989; 4:319- 27; http://dx.doi.org/10.1016/0267-6605(89)90012- 7.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med 2008; 19:2231-9; PMID:18049869; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Proc Tech 1997; 63:271-6; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J  Mater Proc Tech 1999; 89-90:373-7; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2002; 23:2623-9;  PMID:12059011; http://dx.doi.org/10.1016/S0142- 9612(01)00393-3.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Nat Mater 2005; 4:518-24; PMID:16003400;  http://dx.doi.org/10.1038/nmat1421.67.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2004; 25:4363-73; PMID:15046927;  http://dx.doi.org/10.1016/j.biomaterials.2003.11.028.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med 2006; 17:455-63;  PMID:16688586; http://dx.doi.org/10.1007/s10856- 006-8473-x.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Mater  Lett 2012; 76:243-6; http://dx.doi.org/10.1016/j.mat- let.2012.02.114.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Ceram Int 2011; 37:2043-9;  http://dx.doi.org/10.1016/j.ceramint.2011.02.012.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med  1999; 10:383-8; PMID:15348122; http://dx.doi.org/10.1023/A:1008918412198.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2002; 23:3449-54; PMID:12099288; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Bull Mater  Sci 2005; 28:383-90; http://dx.doi.org/10.1007/ BF02711223.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Ceram Int  2003; 29:271-8; http://dx.doi.org/10.1016/S0272- 8842(02)00115-3.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2009; 30:4390-400;  PMID:19481798; http://dx.doi.org/10.1016/j.bioma- terials.2009.05.002.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Biomed Mater Res B Appl Biomater  2011; 99:150-7; PMID:21714080; http://dx.doi.org/10.1002/jbm.b.31882.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med 2011; 22:547-55; PMID:21318627; http://dx.doi.org/10.1007/s10856- 011-4232-8.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Control Release  2010; 147:45-53; PMID:20600398; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med 2008; 19:3029-34;  PMID:18389344; http://dx.doi.org/10.1007/s10856-008-3435-0.51.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med  2008; 19:103-10; PMID:17577636; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Mater Sci  Eng C 1995; 3:75-8; http://dx.doi.org/10.1016/0928- 4931(95)00089-5.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Chem  Mater 2005; 17:36-42; http://dx.doi.org/10.1021/cm048776c.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Cryst Growth Des 2009; 9:3154-60; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater  Sci Mater Med 2010; 21:1143-9; PMID:20052521;  http://dx.doi.org/10.1007/s10856-009-3980-1.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Key  Eng Mater 2012; 493-494:215-8; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Chem 2011; 21:13963-72; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Mater Sci Eng  C 2009; 29:1770-5; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Langmuir 2000;  16:955-60; http://dx.doi.org/10.1021/la990590i.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 1994; 15:474-7; PMID:8080940; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 1996; 17:1955-7; PMID:8894087; http://dx.doi.org/10.1016/0142- 9612(95)00301-0.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Biomed  Mater Res A 2008; 86:483-93; PMID:17975824;  http://dx.doi.org/10.1002/jbm.a.31634.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Key Eng Mater 2009; 396-398:691-4; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Cryst Growth Des 2004;  4:141-6; http://dx.doi.org/10.1021/cg034078d.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Ceram  Int 2009; 35:509-13; http://dx.doi.org/10.1016/j.cera- mint.2008.01.012.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials  2004; 25:3569-82; PMID:15020131; http://dx.doi.org/10.1016/j.biomaterials.2003.10.032.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Injury  2000; 31(Suppl 4):37-47; PMID:11270080; http://dx.doi.org/10.1016/S0020-1383(00)80022-4.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Soil Sci Soc Am J 2008; 72:462-70; http://dx.doi.org/10.2136/sssaj2006.0421.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Soil Sci 2009; 174:358-64; http://dx.doi.org/10.1097/SS.0b013e3181a7e716.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Cereal Chem 2000; 77:489-94; http://dx.doi.org/10.1094/CCHEM.2000.77.4.489.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Res 1993; 8:1687- 96; http://dx.doi.org/10.1557/JMR.1993.1687.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2009; 30:2175-9;  PMID:19176246; http://dx.doi.org/10.1016/j.bioma- terials.2009.01.008.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2008; 29:944-53; PMID:18055009; http://dx.doi.org/10.1016/j.bioma- terials.2007.10.023.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med 1993; 4:337- 44; http://dx.doi.org/10.1007/BF00122290.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Liquid Chrom 1988; 11:665- 81; http://dx.doi.org/10.1080/01483918808068336.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 1996; 17:1959-64; PMID:8894088; http://dx.doi.org/10.1016/0142- 9612(96)00019-1.114.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Polyhedron 2009; 28:3036-42; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Liquid Chrom 1986; 9:3543-57; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Ceram Int 2012; 38:561-70; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Solid State Chem 2003; 172:339-50;  http://dx.doi.org/10.1016/S0022-4596(02)00085-3.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Magn Reson Chem  2006; 44:573-80; PMID:16395729; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med 2007;  18:1931-7; PMID:17554596; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J  Am Ceram Soc 2010; 93:3116-23; PMID:21892226;  http://dx.doi.org/10.1111/j.1551-2916.2010.03833.x.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med  2011; 22:579-91; PMID:21290170; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Chem Mater 2007; 19:3081-3;  http://dx.doi.org/10.1021/cm070298t.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Ceram Int 2009;  35:1587-94; http://dx.doi.org/10.1016/j.cera- mint.2008.08.015.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Colloids Surf B Biointerfaces 2010; 76:226-35;  PMID:19939646; http://dx.doi.org/10.1016/j.col- surfb.2009.10.039.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomed Mater  2009; 4:031002; PMID:19372618; http://dx.doi.org/10.1088/1748-6041/4/3/031002.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Acta Biomater 2011; 7:907-20; PMID:20920616; http://dx.doi.org/10.1016/j.actbio.2010.09.039.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Adv Mater 2007; http://dx.doi.org/10.1002/adma.200601370.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Acta Biomater  2012; 8:373-85; PMID:21925623; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Chem 2004;  14:2225-30; http://dx.doi.org/10.1039/b403503h.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Colloids Surf  B Biointerfaces 2006; 49:87-92; PMID:16621478;  http://dx.doi.org/10.1016/j.colsurfb.2006.03.005.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med  2011; 22:349-55; PMID:21222142; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Sci Mater Med  1996; 7:34-9; http://dx.doi.org/10.1007/BF00121187.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater  Sci Mater Med 2012; 23:2631-7; PMID:22903599;  http://dx.doi.org/10.1007/s10856-012-4740-1.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Powder  Technol 2012; 217:581-4; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2008; 29:3400-7; PMID:18495242; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Mater Res Bull  1999; 34:1215-25; http://dx.doi.org/10.1016/S0025- 5408(99)00118-X.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Biomater  Appl 2008; 23:37-50; PMID:18194997; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Bull Chem  Soc Jpn 2008; 81:1567-74; http://dx.doi.org/10.1246/ bcsj.81.1567.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Dent Mater  J 2008; 27:827-34; PMID:19241692; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Am  Ceram Soc 1990; 73:1803-5; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Chem 2008; 18:5900-8; http://dx.doi.org/10.1039/b807920j.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2007; 28:3295-305; PMID:17466366; http://dx.doi.org/10.1016/j.bioma- terials.2007.04.006.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J R Soc Interface 2008; 5:427- 39; PMID:17698476; http://dx.doi.org/10.1098/ rsif.2007.1141.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Colloid Interface Sci 2010; 352:393- 400; PMID:20846664; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Biomed Mater Res A  2013; PMID:23359485; http://dx.doi.org/10.1002/jbm.a.34526.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Acta Biomater 2010; 6:4027-33;  PMID:20451674; http://dx.doi.org/10.1016/j.act- bio.2010.04.027.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Colloid Interface  Sci 1995; 174:224-9; http://dx.doi.org/10.1006/jcis.1995.1385.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Materialwiss  Werkst 2004; 35:203-7; http://dx.doi.org/10.1002/mawe.200400735.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Mater Lett 2011; 65:2043-6; http://dx.doi.org/10.1016/j.mat- let.2011.04.003.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Chem Pharm Bull (Tokyo) 1996;  44:868-70; http://dx.doi.org/10.1248/cpb.44.868.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Key  Eng Mater 2005; 284-286:309-12; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Mater Sci Eng C 2010; 30:610-7; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Nanosci  Nanotechnol 2007; 7:839-43; PMID:17450843;  http://dx.doi.org/10.1166/jnn.2007.526.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Biomed Mater  Res 1994; 28:1455-63; PMID:7876285; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Key Eng Mater 2013; 529-530:34-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Biomed Mater Res B Appl Biomater  2011; 97:156-66; PMID:21290594; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Sci Technol Adv  Mater 2003; 4:503-8; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Mater Sci Eng C 2013; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2004; 25:1439-51;  PMID:14643619; http://dx.doi.org/10.1016/j.bioma-terials.2003.08.073.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 2005; 26:4383-94; PMID:15701367; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Curr Appl Phys 2005; 5:489- 92; http://dx.doi.org/10.1016/j.cap.2005.01.016.148.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Key Eng Mater 2012; 512-515:119-22; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Acta Biomater  2008; 4:1465-71; PMID:18445539; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Cryst Growth 1990; 104:820-32;  http://dx.doi.org/10.1016/0022-0248(90)90108-W. 152.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Dent Mater 1991; 7:124- 9; PMID:1936640; http://dx.doi.org/10.1016/0109-5641(91)90058-7.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Biomaterials 1999; 20:1807-13; PMID:10509191; http://dx.doi.org/10.1016/S0142- 9612(99)00076-9.,OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater Res 2000; 15:2526- 33; http://dx.doi.org/10.1557/JMR.2000.0362.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater  Sci Mater Med 2011; 22:2175-85; PMID:21823030;  http://dx.doi.org/10.1007/s10856-011-4412-6.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Chem Mater 1995; 7:26-32; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
J Mater  Chem 2008; 18:4460-7; http://dx.doi.org/10.1039/ b804314k.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Key Eng Mater 2013;  529-530:66-9; http://dx.doi.org/10.4028/www.scien- tific.net/KEM.529-530.66.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
Key  Eng Mater 2013; 529-530:109-13; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/77/biom-3-e25103.PMC3749799.pdf
"Biomatter 2013; 3:e24610; http://dx.doi.org/10.4161/biom.24610The achievement of this important milestone for the journal  would not have been possible without the help and support of  our Editorial Board members, our reviewers, our authors and our Editorial team.",Non-OADS,/arxiv_data1/oa_pdf/ac/30/biom-3-e24610.PMC3749800.pdf
Biomatter 2013; 3:e23162; http://dx.doi.org/10.4161/biom.23162Introduction The objective of this work was to develop ciprofloxacin releasing  and bioabsorbable bone defect filler material that also contains a ceramic component to aid bone healing.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Dis Mon 2010; 56:6-31; http://dx.doi.org/10.1016/j.dis-amonth.2009.07.001.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Am J Surg 2004; 188(Suppl):57-66;  PMID:15223504; http://dx.doi.org/10.1016/S0002- 9610(03)00292-7.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Eur J Clin Microbiol Infect Dis 2010; 29:217-22;  PMID:20012334; http://dx.doi.org/10.1007/s10096- 009-0842-1.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Int J Infect Dis 2010; 14:e752-8; PMID:20471296; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Crit Rev Ther Drug Carrier Syst 2007; 24:393- 443; PMID:18197780; http://dx.doi.org/10.1615/ CritRevTherDrugCarrierSyst.v24.i5.10.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Injury 2006; 37(Suppl 2):S3-14;  PMID:16651069; http://dx.doi.org/10.1016/j.inju- ry.2006.04.003.9.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Int J Antimicrob Agents 2008; 32:287-93; PMID:18617373; http://dx.doi.org/10.1016/j.ijan - timicag.2008.03.010.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Control Release 2008; 130:202-15; PMID:18687500; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Antimicrob Chemother 2005; 56:1063-8;  PMID:16234335; http://dx.doi.org/10.1093/jac/ dki366.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Mech Behav Biomed Mater 2012; 9:100-12; PMID:22498288;  http://dx.doi.org/10.1016/j.jmbbm.2012.01.003.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Control Release 1998; 55:79-85; PMID:9795018; http://dx.doi.org/10.1016/S0168-3659(98)00021-2.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J  Biomed Mater Res 1999; 48:342-53; PMID:10398040;  http://dx.doi.org/10.1002/(SICI)1097- 4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J  Mater Sci Mater Med 1990; 1:198-206; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Macromolecules 1998; 31:3895-905;  http://dx.doi.org/10.1021/ma971545p.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Biosens Bioelectron 2011; 26:1788-99;  PMID:20951023; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Comb Chem High Throughput Screen  2006; 9:501-14; PMID:16925511; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Biomol  Screen 2007; 12:855-64; PMID:17644773; http://dx.doi.org/10.1177/1087057107304729.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Journal of Biomaterials  Applications 2013; In press; http://dx.doi.org/10.1177/0885328212462258.26.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Biomaterials 2011; 32:3166-77;  PMID:21315446; http://dx.doi.org/10.1016/j.bioma-terials.2011.01.033.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Pharm Res 2006; 23:215-23; PMID:16320000; http://dx.doi.org/10.1007/s11095- 005-9042-6.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Mater Sci  Eng C 2011; 31:1352-6; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Clin Orthop Relat Res 2011; 469:3222-8; PMID:21918801; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Biomed Mater Res 1979; 13:497-507; PMID:438232; http://dx.doi.org/10.1002/ jbm.820130313.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Antimicrob Chemother 1999; 44:661- 7; PMID:10552983; http://dx.doi.org/10.1093/ jac/44.5.661.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J R Soc Interface 2010; 7:209- 27; PMID:19864265; http://dx.doi.org/10.1098/rsif.2009.0379.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Mol Microbiol 1999; 33:1254-66;  PMID:10510239; http://dx.doi.org/10.1046/j.1365- 2958.1999.01577.x.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Biomacromolecules  2004; 5:1303-9; PMID:15244444; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Biomed Mater Res A 2006; 78:532- 40; PMID:16736479; http://dx.doi.org/10.1002/jbm.a.30766.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Bone  2005; 36:292-9; PMID:15780955; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Biomaterials  2008; 29:350-8; PMID:17977596; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Bone 2005; 36:770- 8; PMID:15794930; http://dx.doi.org/10.1016/j.bone.2005.01.008.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Biomed Mater Res B Appl Biomater 2008; 85:93-104; PMID:17696153;  http://dx.doi.org/10.1002/jbm.b.30921.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Craniofac Surg 2009; 20:58- 61; PMID:19164990; http://dx.doi.org/10.1097/ SCS.0b013e318190df48.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Eur J Pharm Biopharm 2005; 60:401- 6; PMID:15996581; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
J Control  Release 2003; 93:341-54; PMID:14644584; http://dx.doi.org/10.1016/j.jconrel.2003.09.004.,OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Antimicrob Agents Chemother  2005; 49:1502-8; PMID:15793132; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Polym Degrad Stabil 2009; 94:438-42; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/biom-3-e23162.PMC3749801.pdf
Biomatter 2013; 3:e25102; http://dx.doi.org/10.4161/biomatter.25102Introduction The design of experiments (DOE) technique was used to provide  an efficient means to optimize the process variables of nanopar - ticles composition.,OADS,/arxiv_data1/oa_pdf/5a/4a/biom-3-e25102.PMC3749802.pdf
AAPS PharmSciTech  2007; 8:E86; PMID:18181547; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/4a/biom-3-e25102.PMC3749802.pdf
Int J Pharm 2004; 275:171-87; PMID:15081148;  http://dx.doi.org/10.1016/j.ijpharm.2004.01.033.,OADS,/arxiv_data1/oa_pdf/5a/4a/biom-3-e25102.PMC3749802.pdf
Curr Drug Deliv  2004; 1:321-33; PMID:16305394; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/4a/biom-3-e25102.PMC3749802.pdf
J Antimicrob Chemother 2006; 57:1146- 52; PMID:16597631; http://dx.doi.org/10.1093/jac/ dkl128.6.,Non-OADS,/arxiv_data1/oa_pdf/5a/4a/biom-3-e25102.PMC3749802.pdf
J Control Release 2006; 116:337-45; PMID:17097180;  http://dx.doi.org/10.1016/j.jconrel.2006.09.015.,OADS,/arxiv_data1/oa_pdf/5a/4a/biom-3-e25102.PMC3749802.pdf
J Microencapsul 2011; 28:21-8; PMID:21171813;  http://dx.doi.org/10.3109/02652048.2010.522257.,OADS,/arxiv_data1/oa_pdf/5a/4a/biom-3-e25102.PMC3749802.pdf
Biomatter 2013; 3:e24288; PMID: 23512012; http://dx.doi.org/10.4161/biomatter.24288Introduction Bioactive glasses are certain glass compositions that are capable  of inducing specific biological activity.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
Biomaterials  2002; 23:4295-302; PMID:12194532; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
Calcif Tissue Int 2000; 67:321-9;  PMID:11000347; http://dx.doi.org/10.1007/s002230001134.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
J Biomed Mater Res 1994; 28:693-8; PMID:8071380; http://dx.doi.org/10.1002/jbm.820280606.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
J Biomed Mater Res 2000; 50:97-100; PMID:10679671;  http://dx.doi.org/10.1002/(SICI)1097- 4636(200005)50:2<97::AID-JBM1>3.0.CO;2-7.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
Biomaterials 1993; 14:359-64; PMID:8507779;  http://dx.doi.org/10.1016/0142-9612(93)90055-7.,OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
J Biomed Mater  Res 2001; 54:608-18; PMID:11426607; http://dx.doi.org/10.1002/1097-4636(20010315)54:4<608::AID- JBM180>3.0.CO;2-U.References 1.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
J Biomed Mater Res 1971; 5:117-41; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
J Am Ceram Soc 1998; 81:1705-28; http://dx.doi.org/10.1111/j.1151-2916.1998.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
J Biomed Mater  Res 1981; 15:805-17; PMID:7309763; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
Key Eng Mater 2003; 240-242:719-24; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
Biomaterials 2004; 25:3013-21;  PMID:14967534; http://dx.doi.org/10.1016/j.bioma- terials.2003.09.081.,OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
J Biomed Mater Res 2001; 55:151-7;  PMID:11255166; http://dx.doi.org/10.1002/1097- 4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D.9.,Non-OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
Biochem Biophys Res Commun  2000; 276:461-5; PMID:11027497; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
Biomaterials 2006; 27:964-73; PMID:16102812;  http://dx.doi.org/10.1016/j.biomaterials.2005.07.017.,OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
J Am Ceram Soc 1992; 75:2094-7; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/bf/biom-3-e24288.PMC3749803.pdf
Biomatter 2013; 3:e24791;; http://dx.doi.org/10.4161/biomatter.24791Introduction Protein adsorption has an important role in modulating cell  response to biomaterials.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Langmuir 2004; 20:9745-54; PMID:15491210;  http://dx.doi.org/10.1021/la049158d.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Colloids Surf B Biointerfaces  2010; 77:181-90; PMID:20185279; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Biomaterials  2009; 30:5541-51; PMID:19595453; http://dx.doi.org/10.1016/j.biomaterials.2009.06.025.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Biomaterials 2009; 30:307-16;  PMID:18952279; http://dx.doi.org/10.1016/j.bio- materials.2008.09.048.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Biomaterials  2009; 30:5465-75; PMID:19615736; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Biomaterials 1997; 18:567-75; PMID:9105597;  http://dx.doi.org/10.1016/S0142-9612(96)00167-6.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Langmuir  1997; 13:3404-13; http://dx.doi.org/10.1021/ la9604341.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Biomed Mater  Res A 2003; 64:20-37; PMID:12483693; http://dx.doi.org/10.1002/jbm.a.10316.13.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Mater Sci Mater Med  2004; 15:387-90; PMID:15332604; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Biomed Mater Res A  2005; 72:228-36; PMID:15625681; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Biomaterials 1998; 19:1275-85; PMID:9720891;  http://dx.doi.org/10.1016/S0142-9612(98)00036-2.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Biomed Mater Res A 2003; 66:247- 59; PMID:12888994; http://dx.doi.org/10.1002/ jbm.a.10537.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Langmuir 2003;  19:8033-40; http://dx.doi.org/10.1021/la034810a.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Biomaterials 2004; 25:5947-54; PMID:15183609;  http://dx.doi.org/10.1016/j.biomateri- als.2004.01.062.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Biomaterials 2002; 23:4803-9; PMID:12361619; http://dx.doi.org/10.1016/S0142-9612(02)00231-4.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Biomed Mater Res  A 2003; 67:538-47; PMID:14566796; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Carbohydr Res 1997; 302:169-77; http://dx.doi.org/10.1016/ S0008-6215(97)00126-2.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Polymer (Guildf) 2001; 42:3569-80;  http://dx.doi.org/10.1016/S0032-3861(00)00713-8.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Microvasc Res 2002; 64:384- 97; PMID:12453433; http://dx.doi.org/10.1006/ mvre.2002.2434.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Appl Polym  Sci 2006; 102:1341-55; http://dx.doi.org/10.1002/ app.24127.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Mater Sci Mater Med 2008; 19:343- 57; PMID:17597372; http://dx.doi.org/10.1007/s10856-006-0024-y.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Mater Sci Mater Med 2011; 22:839- 44; PMID:21431352; http://dx.doi.org/10.1007/ s10856-011-4280-0.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Biomed Mater Res  A 2003; 67:531-7; PMID:14566795; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Biomed Mater Res A 2009; 89:1040- 8; PMID:18478557; http://dx.doi.org/10.1002/ jbm.a.32061.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Biomaterials  2005; 26:3197-206; PMID:15603814; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
J Biomed Mater Res A  2005; 75:824-31; PMID:16138323; http://dx.doi.org/10.1002/jbm.a.30468.36.,Non-OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
Nat Mater 2011; 10:67-73; PMID:21151163;  http://dx.doi.org/10.1038/nmat2904.,OADS,/arxiv_data1/oa_pdf/02/53/biom-3-e24791.PMC3749804.pdf
URL: http://www.anzctr.org.au.Registration number: ACTRN12607000551493.,Non-OADS,/arxiv_data1/oa_pdf/c0/f4/gat029.PMC3749805.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/f4/gat029.PMC3749805.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/e3/e2/tp-96-245.PMC3749815.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/e0/dmso-6-303.PMC3749816.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 303–307Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  303Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S4447 7Treatment outcome and prognostic indices   in patients with hyperglycemic emergencies iU ezeani1 a eregie2 OS Ogedengbe2 1Department of Medicine, Federal  Medical centre, Umuahia, abia State,   nigeria; 2Department of Medicine,   University of Benin T eaching hospital,   Benin city, n igeria correspondence: iU ezeani   Department of Medicine, Federal Medical  center, P.M.B 7001, Umuahia,   abia State, 440, nigeria   Tel +234 80 6069 2131   email ignatiusez@yahoo.co mObjective:  The objective of this study is to assess the treatment outcomes in patients with  hyperglycemic emergencies and to ascertain the factors associated with outcome, with emphasis  on the determinants of outcome.",Non-OADS,/arxiv_data1/oa_pdf/de/e0/dmso-6-303.PMC3749816.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/de/e0/dmso-6-303.PMC3749816.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/e0/dmso-6-303.PMC3749816.pdf
"Available from:  http://pubs.sciepub.com/ajmsm/1/3/1/abstract.html#.UfFN_Bs1ib E.  Accessed July 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/de/e0/dmso-6-303.PMC3749816.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/47/cia-8-1089.PMC3749817.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1089–1095Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1089OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4653 6Minocycline alleviates beta-amyloid protein and  tau pathology via restraining neuroinflammation  induced by diabetic metabolic disorder Zhiyou Cai1 Y ong Yan2 Y onglong Wang2 1Department of n eurology, the lu’an  Affiliated hospital of Anhui Medical  University, lu’an People’s hospital,   lu’an, Anhui Province, People’s  republic of China; 2Department  of neurology, the First Affiliated  hospital of Chongqing Medical  University, Chongqing Key laboratory  of neurology, Chongqing, People’s  republic of China Correspondence: Zhiyou Cai   Department of neurology, the lu’an  Affiliated Hospital of Anhui Medical  University, lu’an People’s hospital   no 21 Wanxi West road, lu’an,   Anhui Province, People’s   republic of China, 237005   Tel +86 564 333 8520   Fax +86 564 333 8520   email c0909@hotmail.co mBackground:  Compelling evidence has shown that diabetic metabolic disorder plays a critical  role in the pathogenesis of Alzheimer’ s disease, including increased expression of β-amyloid  protein (A β) and tau protein.",Non-OADS,/arxiv_data1/oa_pdf/05/47/cia-8-1089.PMC3749817.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/05/47/cia-8-1089.PMC3749817.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/47/cia-8-1089.PMC3749817.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/36/bf/cia-8-1079.PMC3749819.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1079–1088Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1079OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4621 8effects of a complex intervention on fall risk  in the general practitioner setting: a cluster  randomized controlled trial ellen Freiberger1 Wolfgang A Blank2 Johannes salb1 Barbara geilhof3 Christian hentschke1 Peter landendoerfer2 Martin halle3 Monika siegrist3 1Institute of sport science and sport  Universität erlangen-n ürnberg,   nuremberg, germany; 2Institute  of general Practice, Technische  Universität München, Munich,   germany; 3Department of Prevention,   rehabilitation and sports Medicine,   T echnische Universität München,   Munich, germany Correspondence: PD ellen Freiberger   Institute for Biomedicine of Aging   Kobergerstr.",Non-OADS,/arxiv_data1/oa_pdf/36/bf/cia-8-1079.PMC3749819.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/36/bf/cia-8-1079.PMC3749819.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/bf/cia-8-1079.PMC3749819.pdf
Available from: http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/36/bf/cia-8-1079.PMC3749819.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/98/ddt216.PMC3749859.pdf
Available at http://www.cdc.gov/niosh/docket/review/dock et161a/.,OADS,/arxiv_data1/oa_pdf/9e/2b/mes060.PMC3750099.pdf
Current Intelligence Bulletin 63. http://www.cdc.gov/niosh/docs/2011-160/pdfs/2011-160.pdf.,OADS,/arxiv_data1/oa_pdf/9e/2b/mes060.PMC3750099.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/87/85/srep02495.PMC3750536.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2495 | DOI: 10.1038/srep02495 6",Non-OADS,/arxiv_data1/oa_pdf/87/85/srep02495.PMC3750536.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/39/16/srep02497.PMC3750537.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2497 | DOI: 10.1038/srep02497 8",Non-OADS,/arxiv_data1/oa_pdf/39/16/srep02497.PMC3750537.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2498 | DOI: 10.1038/srep02498 5",Non-OADS,/arxiv_data1/oa_pdf/19/98/srep02498.PMC3750538.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2496 | DOI: 10.1038/srep02496 11",Non-OADS,/arxiv_data1/oa_pdf/5e/63/srep02496.PMC3750539.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/24/d2/srep02490.PMC3750616.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2490 | DOI: 10.1038/srep02490 6",Non-OADS,/arxiv_data1/oa_pdf/24/d2/srep02490.PMC3750616.pdf
Available from: http://www.cebm.net/index.aspx?o=5653.,Non-OADS,/arxiv_data1/oa_pdf/0f/99/abd-88-0238.PMC3750887.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/18/TODENTJ-7-62.PMC3750967.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/22/TODENTJ-7-76.PMC3750972.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/17/TODENTJ-7-68.PMC3750973.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/7e/TODENTJ-7-82.PMC3750974.pdf
"Available at: http://www.bio.davi dson.edu/people/sosarafova/Ass- ets/Bio307/meprasse/page06.html  [63] Singh SK, Girschick HJ: Lyme borreliosis: from infection to auto- immunity.",Non-OADS,/arxiv_data1/oa_pdf/07/2b/TONEUJ-6-179.PMC3751012.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licen- ses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution a nd reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/2b/TONEUJ-6-179.PMC3751012.pdf
"CHMP/EWP/225/02, London, 23Jun 2004. http://www.ema.europa.eu/docs/en_GB/document_ library/Scientiﬁc_guideline/2009/09/WC500003123.pdf .",Non-OADS,/arxiv_data1/oa_pdf/03/5a/40261_2013_Article_110.PMC3751212.pdf
"CHMP/ICH/2/2004, November 2005. http://www.ema.europa.eu/docs/en_G B/document_library/Scientiﬁc_ guideline/2009/09/WC500002879.pdf .",Non-OADS,/arxiv_data1/oa_pdf/03/5a/40261_2013_Article_110.PMC3751212.pdf
http://www.towerhamlets.gov.uk/ lgsl/901-950/916_borough_sta tistics/ethnicity.aspx .,Non-OADS,/arxiv_data1/oa_pdf/ee/6c/10067_2013_Article_2286.PMC3751214.pdf
GuideV9_tcm77_169094_1.pdf p42 Table 17.http://www.ons.gov.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/ee/6c/10067_2013_Article_2286.PMC3751214.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org/ Accessed 18 June 2012 24.",Non-OADS,/arxiv_data1/oa_pdf/09/35/414_2013_Article_883.PMC3751225.pdf
http://www.omafra.,Non-OADS,/arxiv_data1/oa_pdf/a0/36/11627_2013_Article_9515.PMC3751267.pdf
http://www.cms.gov/ Research-Statistics-Data-and- Systems/Research/MCBS/index.,OADS,/arxiv_data1/oa_pdf/14/c2/40271_2013_Article_18.PMC3751268.pdf
http://www.cms.gov/ LimitedDataSets/11_MCBS.asp#TopOfPage .,Non-OADS,/arxiv_data1/oa_pdf/14/c2/40271_2013_Article_18.PMC3751268.pdf
http://www.cms.gov/MCBS/Downloads/CNP_ 2003_appendixA.pdf .,OADS,/arxiv_data1/oa_pdf/14/c2/40271_2013_Article_18.PMC3751268.pdf
http://data.bls.gov/cgi-bin/surveymost .,OADS,/arxiv_data1/oa_pdf/14/c2/40271_2013_Article_18.PMC3751268.pdf
http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c033208c22a/?vgnextoid=d6952a2e23264310VgnVCM100000ed152ca2RCRD&vgnextchannel=c03c90916e442310V gnVCM100000ed152ca2RCRD (Accessed 30 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/3f/24/40271_2013_Article_20.PMC3751276.pdf
"Cohort study of pioglitazone and bladder cancer in patients with diabetes: fourth interim analysis (8-year) report, 2012. http://general.takedapharm.com/Trial-Disclosure/01-03- TL-OPI-524-8-year-Interim-Report.pdf .",Non-OADS,/arxiv_data1/oa_pdf/84/a7/40261_2013_Article_106.PMC3751328.pdf
"Fast stats, 2010. http://seer.cancer.gov/faststats/ .",Non-OADS,/arxiv_data1/oa_pdf/84/a7/40261_2013_Article_106.PMC3751328.pdf
http://www.ahrq.,Non-OADS,/arxiv_data1/oa_pdf/6b/9c/40261_2013_Article_102.PMC3751342.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/70/ijgm-6-689.PMC3751378.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 689–691International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  689Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S4965 8spontaneous bacterial peritonitis with a very   high leukocyte count in ascitic fluid caused   by Haemophilus influenzae tarek saadi1,2 safie Khoury3 ella Veitsman1 Yaacov Baruch1,4 ayelet Raz-p asteur3,4 1Liver Unit, 2Department   of Gastroenterology, 3Department   of Internal Medicine a, Rambam  Health Care Campus, Haifa, Israel;   4the Bruce Rappaport Faculty   of Medicine, technion-Israel   Institute of technology, Haifa, Israel Correspondence: t arek s aadi  Liver Unit, Rambam Health Care   Campus, Haifa, Israel, poB 9602,   Haifa, 31096, Israel   tel +972 4 8541415   Fax +972 4 8542477   email t_saadi@rambam.health.gov.i lAbstract:  We report on a case of spontaneous bacterial peritonitis (SBP) due to Haemophilus  influenzae  (H. influenzae ) in an elderly patient with alcoholic cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/44/70/ijgm-6-689.PMC3751378.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/44/70/ijgm-6-689.PMC3751378.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/70/ijgm-6-689.PMC3751378.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/7a/ijwh-5-515.PMC3751381.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 515–521International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  515OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S4967 2ectopic pregnancy: a life-threatening gynecological  emergency Osaheni l lawani Okechukwu B anozie Paul O ezeonu Department of Obstetrics   and gynecology, Federal Teaching  Hospital, abakaliki, nigeria correspondence: Osaheni l lawani   Department of Obstetrics and  gynecology, Federal Teaching Hospital,  abakaliki, ebonyi state, nigeria   Tel +234 803 669 1209   Tel +234 708 900 9130   email l awkins2000 @yahoo.co mBackground:  Ectopic pregnancy is a life-threatening gynecological emergency, and a significant  cause of maternal morbidity and mortality in Nigeria.",Non-OADS,/arxiv_data1/oa_pdf/95/7a/ijwh-5-515.PMC3751381.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/95/7a/ijwh-5-515.PMC3751381.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/7a/ijwh-5-515.PMC3751381.pdf
Available from: http://guidance.nice.org.uk/ cg154.,Non-OADS,/arxiv_data1/oa_pdf/95/7a/ijwh-5-515.PMC3751381.pdf
Avail - able from: http://www.ncbi.nlm.nih.gov/books/NBK2279 /.,Non-OADS,/arxiv_data1/oa_pdf/95/7a/ijwh-5-515.PMC3751381.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/ijgm-6-703.PMC3751382.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 703–706International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  703Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S4965 7Metformin-induced mixed hepatocellular   and cholestatic hepatic injury: case report   and literature review tarek saadi1–3 Matti Waterman1–4 Heba Yassin3 Yaacov Baruch1,4 1Liver Unit, 2Department of  Gastroenterology, 3Department of  Internal Medicine a, Rambam Health  Care Campus, Haifa, Israel; 4the  Bruce Rappaport Faculty of Medicine,   technion-Israel Institute   of technology, Haifa, Israel Correspondence: tarek saadi   Liver Unit, Rambam Health Care  Campus, poB 9602, Haifa, 31096, Israel   tel +972 4 854 1415   Fax +972 4 854 2477   email t_saadi@rambam.health.gov.i lIntroduction:  Metformin is a first-line drug choice for the treatment of type 2 diabetes mellitus  (DM-2).",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/ijgm-6-703.PMC3751382.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/ijgm-6-703.PMC3751382.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/ijgm-6-703.PMC3751382.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/72/aabc-6-037.PMC3751384.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpAdvances and Applications in Bioinformatics and Chemistry 2013:6 37–46Advances and Applications in Bioinformatics and Chemistry Dove press submit your manuscript | www.dovepress.co m Dove press  37OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AABC.S4958 7Antigenic heterogeneity of capsid protein   VP1 in foot-and-mouth disease virus (FMDV)   serotype Asia1 sM sabbir Alam1 ruhul Amin1 Mohammed Ziaur rahman2 M Anwar hossain1 Munawar sultana1 1Department of Microbiology,   University of Dhaka, Dhaka,   Bangladesh; 2international Centre   for Diarrhoeal Disease research,   Dhaka, Bangladesh Correspondence: Munawar sultana   Department of Microbiology, University  of Dhaka, Dhaka-1000, Bangladesh   Tel +880 155 363 6825   email munawar@du.ac.b d; munamicro@ yahoo.co mAbstract:  Foot and mouth disease virus (FMDV), with its seven serotypes, is a highly  contagious virus infecting mainly cloven-hoofed animals.",Non-OADS,/arxiv_data1/oa_pdf/bb/72/aabc-6-037.PMC3751384.pdf
"Advances and Applications in Bioinformatics and Chemistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com /advances-and-applications-in-bioinformatics-and-chemistry-journalAdvances and Applications in Bioinformatics and Chemistry is an inter - national, peer-reviewed open-access journal that publishes articles in the  following fields: Computational biomodeling; Bioinformatics; Compu - tational genomics; Molecular modeling; Protein structure modeling and  structural genomics; Systems Biology; Computational Biochemistry; Computational Biophysics; Chemoinformatics and Drug Design; In silico  ADME/Tox prediction.",Non-OADS,/arxiv_data1/oa_pdf/bb/72/aabc-6-037.PMC3751384.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/72/aabc-6-037.PMC3751384.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/f3/ijgm-6-685.PMC3751385.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 685–687International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  685Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S4970 1Cannabinoid hyperemesis syndrome   with extreme hydrophilia Hilary a enuh1 Julia Chin1 Jay Nfonoyim2 1Department of Medicine, 2Critical  Care Unit, richmond University  Medical Center, staten Island,    NY, Usa Correspondence: Hilary enuh   Department of Medicine, richmond   University Medical Center, 355 Bard   avenue, staten Island, NY 10310, Usa   email enuh2010@yahoo.co mAbstract:  Marijuana is the most widely used recreational drug in the US.",Non-OADS,/arxiv_data1/oa_pdf/a5/f3/ijgm-6-685.PMC3751385.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/a5/f3/ijgm-6-685.PMC3751385.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/f3/ijgm-6-685.PMC3751385.pdf
Available from: http://www.mayoclinic.com/health/ obsessive -compulsive -disorder/DS00189 .,Non-OADS,/arxiv_data1/oa_pdf/a5/f3/ijgm-6-685.PMC3751385.pdf
Female artistic gymnasts; 2008. http://en.beijing2008.cn/ (Accessed 26 Feb 2009).,Non-OADS,/arxiv_data1/oa_pdf/f5/df/40279_2013_Article_58.PMC3751410.pdf
http://www.thedailybeast.com/newsweek/1992/08/09/old- too-soon-wise-too-late.html (Accessed 4 Apr 2013).89.,Non-OADS,/arxiv_data1/oa_pdf/f5/df/40279_2013_Article_58.PMC3751410.pdf
Earlier state media report listed gymnast He’s age as 13; 2008. http://sports.espn.go.com/oly/summer08/ gymnastics/news/story?id=3534544 (Accessed 14 Aug 2008).,Non-OADS,/arxiv_data1/oa_pdf/f5/df/40279_2013_Article_58.PMC3751410.pdf
"Chinese gymnasts cleared, but two from 2000 games still eyed; 2008. http://sports.espn.go.com/oly/ gymnastics/news/story?id=3619325 (Accessed 1 Oct 2008).",Non-OADS,/arxiv_data1/oa_pdf/f5/df/40279_2013_Article_58.PMC3751410.pdf
New York Times; 2008. http://beijing2008.blogs.nytimes.com/2008/08/03/a-visit-to-the- athletes-village-to-see-the-perhaps-underage-chinese-gymnasts/?scp=1&sq=Macur%20A%20visit%20to%20the%20athletes%20village%203%20%22August%202008%22&st=cse (Accessed 12 Aug 2008).,Non-OADS,/arxiv_data1/oa_pdf/f5/df/40279_2013_Article_58.PMC3751410.pdf
http://www.thedailybeast.com/news week/1992/08/10/living-with-training.html (Accessed 4 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/f5/df/40279_2013_Article_58.PMC3751410.pdf
"Time Magazine Asia; 2004. http://www.time.com/time/magazine/article/0,9171,678686-3,00.",Non-OADS,/arxiv_data1/oa_pdf/f5/df/40279_2013_Article_58.PMC3751410.pdf
14 Jan 2013. http://dx.doi.org/10.1016/j.euroneuro.2012.,OADS,/arxiv_data1/oa_pdf/41/92/40263_2013_Article_86.PMC3751426.pdf
Available from URL: http://www.medicines.org.uk/ EMC/medicine/8382/SPC/Concerta ?XL?18?mg?-?36?mg?,Non-OADS,/arxiv_data1/oa_pdf/41/92/40263_2013_Article_86.PMC3751426.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/9e/aabc-6-047.PMC3751451.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpAdvances and Applications in Bioinformatics and Chemistry 2013:6 47–53Advances and Applications in Bioinformatics and Chemistry Dove press submit your manuscript | www.dovepress.co m Dove press  47OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AABC.S4950 3Design of multiligand inhibitors for the swine   flu H1N1 neuraminidase binding site Manoj M narayanan1,2 Chandrasekhar B nair2 shilpa K sanjeeva2 PV subba rao2 Phani K Pullela1,2 Colin J Barrow1 1Centre for Chemistry and  Biotechnology, Deakin University,   geelong, ViC, Australia; 2Bigtec Pvt  ltd, rajajinagar, Bangalore, india Correspondence: Colin J Barrow   Centre for Chemistry and Biotechnology,  Deakin University, locked Bag 20000,  geelong, ViC 3220, Australia   Tel +61 3 5227 1318   Fax +61 3 5227 1040   email cbarrow@deakin.edu.a uAbstract:  Viral neuraminidase inhibitors such as oseltamivir and zanamivir prevent early  virus multiplication by blocking sialic acid cleavage on host cells.",Non-OADS,/arxiv_data1/oa_pdf/b8/9e/aabc-6-047.PMC3751451.pdf
"Advances and Applications in Bioinformatics and Chemistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com /advances-and-applications-in-bioinformatics-and-chemistry-journalAdvances and Applications in Bioinformatics and Chemistry is an inter - national, peer-reviewed open-access journal that publishes articles in the  following fields: Computational biomodeling; Bioinformatics; Compu - tational genomics; Molecular modeling; Protein structure modeling and  structural genomics; Systems Biology; Computational Biochemistry; Computational Biophysics; Chemoinformatics and Drug Design; In silico  ADME/Tox prediction.",Non-OADS,/arxiv_data1/oa_pdf/b8/9e/aabc-6-047.PMC3751451.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/9e/aabc-6-047.PMC3751451.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/65/ceg-6-129.PMC3751460.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2013:6 129–137Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  129REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S4800 5Clinical applications of small bowel   capsule endoscopy Uri Kopylov Ernest G Seidman Division of Gastroenterology, McGill  University Health Center, Montreal,   Quebec, Canada Correspondence: Uri Kopylov   iBD Center, Montreal General Hospital,  C10.145, 1650 Cedar Avenue, Montreal,   QC, Canada, H3G 1A4   Tel +1 514 377 9356   Email ukopylov@gmail.co mAbstract:  Video capsule endoscopy has revolutionized our ability to visualize the entire small  bowel mucosa.",Non-OADS,/arxiv_data1/oa_pdf/64/65/ceg-6-129.PMC3751460.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/64/65/ceg-6-129.PMC3751460.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/65/ceg-6-129.PMC3751460.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/f3/ndt-9-1213.PMC3751461.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1213–1220Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1213OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4542 2intrastriatal injections of KN-93 ameliorates  levodopa-induced dyskinesia in a rat model   of Parkinson’s disease Xinxin Yang Na Wu lu song Zhenguo liu Department of Neurology, Xinhua  hospital affiliated with shanghai Jiao  T ong University school of Medicine,   shanghai, People’s republic of china correspondence: Zhenguo liu   Department of Neurology, Xinhua  Hospital affiliated to the Medical School  of shanghai Jiaotong University,   200092, 1665 Kongjiang road,   shanghai, People’s republic of china   T el +86 21 2507 7501   email zhenguoliu2004@aliyun.co mBackground:  Levodopa remains the most effective drug for the treatment of Parkinson’ s disease  (PD).",Non-OADS,/arxiv_data1/oa_pdf/eb/f3/ndt-9-1213.PMC3751461.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/eb/f3/ndt-9-1213.PMC3751461.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/f3/ndt-9-1213.PMC3751461.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2013:6 55–63Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  55REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S4049 0T ool guide for lifestyle behavior change   in a cardiovascular risk reduction program Nicole D White1 Thomas L Lenz1 Katherine Smith2 1Pharmacy Practice, Creighton  University School of Pharmacy and  Health Professions, Omaha, NE,   USA; 2PharmD Candidate Creighton  University School of Pharmacy and  Health Professions, Omaha, NE, USA Correspondence: Nicole D White   Creighton University School of Pharmacy  and Health Professions, 2500 California  Plaza, Omaha, NE 68178, USA   Tel +1 402 280 2797   Fax +1 402 280 2039   Email nicolewhite@creighton.ed uAbstract:  Lifestyle medicine behaviors such as a healthy diet, physical activity, and tobacco  avoidance, are the cornerstone of treatment in many chronic disease conditions, especially  those related to the cardiovascular system.",Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
"Table  1 describes how physical activity, nutrition, tobacco cessation, alcohol modera - tion, stress reduction, and weight loss play a role in the management of hypertension,  hyperlipidemia, and diabetes.3,4,6–11 Specific definitions regarding each of these lifestyle  behaviors (eg, exercise frequency and Dietary Approach to Stop Hypertension) can  be found on the website “Lifestyle is Medicine” at http://lm-rx.co m.11 Of note, when  combined, these behaviors have additive lowering effects on systolic blood pressure,  low-density lipoprotein cholesterol, and estimated average glucose.",Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
"Available at: http://lm-rx.com /.11  Abbreviations:  DASH, Dietary Approach to Stop Hypertension; LDL, low-density lipoprotein.",Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
Available from: http://www.who.int/chp/ chronic_disease_report/part1/en/index11.html .,Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
Available from:  http://lm-rx.com /.,Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
Available  from: http://www.ncbi.nlm.nih.gov/books/NBK63952 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
Available from: http://www.hindawi.com/journals/apm/2011/215842 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/39/prbm-6-055.PMC3751462.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/ea/vhrm-9-435.PMC3751465.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2013:9 435–456Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  435ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S45704emerging families of biomarkers for coronary   artery disease: inflammatory mediators Josef Yayan Department of internal Medicine,   University Hospital of Saarland,   Homburg/Saar, Germany Correspondence: Josef Yayan   Department of internal Medicine,   University Hospital of Saarland,   Kirrberger Straße,   D-66421 Homburg/Saar, Germany   Tel +49 684116 21620   Fax +49 684116 23602   email josef.yayan@hotmail.co mIntroduction:  Inflammation has been implicated in the development of atherosclerosis in  patients with acute coronary syndrome.",Non-OADS,/arxiv_data1/oa_pdf/56/ea/vhrm-9-435.PMC3751465.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/56/ea/vhrm-9-435.PMC3751465.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/ea/vhrm-9-435.PMC3751465.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/8b/ppa-7-729.PMC3751466.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 729–739Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  729OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S4751 9impact of a pharmaceutical care program   on clinical evolution and antiretroviral   treatment adherence: a 5-year study María Jesús hernández  Arroyo1 salvador enrique cabrera  Figueroa2 rosa sepúlveda correa3 María de la Paz Valverde  Merino1 Alicia iglesias gómez4 Alfonso Domínguez- gil  hurlé5 On behalf of the Tormes  T eam 1Pharmacy service, University  hospital of salamanca, salamanca,   spain; 2Pharmacy institute, University  Austral of chile, Valdivia, chile;   3Department of statistics, University  of salamanca, salamanca, spain;   4infectious Disease service, University  hospital of salamanca, salamanca,   spain; 5Department of Pharmacy and  Pharmaceutical T echnology, University  of salamanca, salamanca, spain correspondence: salvador cabrera  Figueroa   servicio de Farmacia, hospital  Universitario de salamanca, Paseo de san  Vicente 58, 37007 salamanca, spain   Tel +34 923 291 172   Fax +34 923 291 174   email scabrera@uach.c lBackground:  Antiretroviral treatments (ART) form the basis of adequate clinical control in  human immunodeficiency virus-infected patients, and adherence plays a primary role in the  grade and duration of the antiviral response.",Non-OADS,/arxiv_data1/oa_pdf/98/8b/ppa-7-729.PMC3751466.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/98/8b/ppa-7-729.PMC3751466.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/8b/ppa-7-729.PMC3751466.pdf
"Available from: http://aidsinfo.nih.gov/ ContentFiles /AdultandAdolescentGL.pd f. Accessed April 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/98/8b/ppa-7-729.PMC3751466.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/24/copd-8-369.PMC3751499.pdf
Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 369–377International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  369OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S4799 2should chest examination be reinstated   in the early diagnosis of chronic obstructive   pulmonary disease?,Non-OADS,/arxiv_data1/oa_pdf/1a/24/copd-8-369.PMC3751499.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1a/24/copd-8-369.PMC3751499.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/24/copd-8-369.PMC3751499.pdf
"Available from: http://www.goldcopd.org/uploads/users/files/ GOLD_Report_2011_Feb21.pd f. Accessed June 29, 2013.",OADS,/arxiv_data1/oa_pdf/1a/24/copd-8-369.PMC3751499.pdf
"Available  from: http://mkanders.com/CIforLR.ph p. Accessed June 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1a/24/copd-8-369.PMC3751499.pdf
Available from: http://publications.nice.org.uk/chronic-obstructive- pulmonary-disease-cg10 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/24/copd-8-369.PMC3751499.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/d4/ndt-9-1221.PMC3751501.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/41/d4/ndt-9-1221.PMC3751501.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/d4/ndt-9-1221.PMC3751501.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/9a/b6/ppa-7-805.PMC3751505.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 805–811Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  805OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5005 5The influence of symptoms of anxiety   and depression on medication nonadherence   and its causes: a population based survey   of prescription drug users in sweden lena Thunander sundbom1,2 Kerstin Bingefors2 1Faculty of Health and Occupational  studies, Department of health  and Caring Sciences, University  of gävle, gävle, sweden;   2Pharmacoepidemiology and  Pharmacoeconomics, Department   of Pharmacy, Uppsala University,   Uppsala, sweden correspondence: lena Thunander  sundbom   University of Gävle, Faculty of Health  and Occupational studies, 801 76 gävle,  sweden   Tel +46 705 53 6316   email lts@hig.s ePurpose:  The purpose of this study was to evaluate the associations between self-reported  symptoms of anxiety and/or depression, nonadherent (NA) behaviors, and reasons for NA to  medication regimens.",Non-OADS,/arxiv_data1/oa_pdf/9a/b6/ppa-7-805.PMC3751505.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9a/b6/ppa-7-805.PMC3751505.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/b6/ppa-7-805.PMC3751505.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Heart Journal (2012) 33, 1112–1119 doi:10.1093/eurheartj/ehr306",Non-OADS,/arxiv_data1/oa_pdf/47/5f/ehr306.PMC3751966.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Heart Journal (2012) 33, 1142–1149 doi:10.1093/eurheartj/ehs023",Non-OADS,/arxiv_data1/oa_pdf/d7/6c/ehs023.PMC3751967.pdf
"This is an Open Access article distrib uted under the terms of the Creative Co mmons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provide d the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/5e/evs075.PMC3752010.pdf
"Materials and Methods Generation of Whole-Genome Alignments The human (hg19), chimpanzee ( panTro3), gorilla (gorGor3), and orangutan (ponAbe2) gen ome sequences were obtained from the UCSC genome browser ( http://genome.ucsc.edu/ , cited 2012 Sep 18).",OADS,/arxiv_data1/oa_pdf/98/5e/evs075.PMC3752010.pdf
The extension of the evolutionary model and parallel-ization were performed via modiﬁcation of the source code ofMCMCcoal1.2a developed by Yang ( http://abacus.gene.ucl .ac.uk/software/MCMCcoal.html ; cited 2012 Sep 18) (Rannala and Yang 2003 ;Burgess and Yang 2008 ).,OADS,/arxiv_data1/oa_pdf/98/5e/evs075.PMC3752010.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003143).,Non-OADS,/arxiv_data1/oa_pdf/89/1a/bmjopen-2013-003143.PMC3752048.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ APPENDIX: ALGEBRAIC DERIVATION OF THE MODELS Legend:Target = target outcome that the treatment can prevent 10 Marcucci M, Sinclair JC.",Non-OADS,/arxiv_data1/oa_pdf/89/1a/bmjopen-2013-003143.PMC3752048.pdf
http://plus.mcmaster.ca/evidenceupdates 4.,Non-OADS,/arxiv_data1/oa_pdf/89/1a/bmjopen-2013-003143.PMC3752048.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-002923).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
2011. http://ec.europa.eu/taxation_customs/resources/documents/customs/customs_controls/counterfeit_piracy/statistics/2012_ipr_statistics_en.pdf (accessed 23 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
http://www.who.int/ medicines/services/counterfeit/faqs/06/en/ (accessed 23 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
http://www.psi-inc.org/incidentTrends.cfm (accessed 23 May 2013).,OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
2013. http://www.iom.edu/Reports/2013/Countering-the-Problem-of-Falsified-and-Substandard-Drugs.aspx (accessed 23 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
http://data.worldbank.org/ about/country-classifications (accessed 25 May 2013).,OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
http://apps.who.int/medicinedocs/pdf/s2276e/s2276e.pdf (accessed 23 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
http://apps.who.int/medicinedocs/pdf/s4901e/s4901e.pdf (accessed 23 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
WHO/EMP/QSM/ 2011.1. http://www.who.int/medicines/publications/WHO_QAMSA_report.pdf (accessed 23 May 2013).,OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
November 2009. http://apps.who.int/medicinedocs/documents/s17069e/s17069e.pdf (accessed 23 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
http://apps.who.int/medicinedocs/documents/s19053en/s19053en.pdf(accessed 23 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
December 2009. http://www.haiweb.org/medicineprices/29012010/ MPM_6.pdf (accessed 11 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
http://www.interpol.int/content/download/3902/37957/version/17/file/Factsheets_EN_jun2012_DCO04.pdf (accessed 24 May2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
November 2009. http://www.wcoomd.org/en/media/newsroom/2009/november/international-operation-combats-the-online-supply-of-counterfeit-and-illegal-medicines.aspx (accessed 24 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_23-en.pdf(accessed 23 May 2013).,OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
2012. http://www.who.int/medicines/news/TRA-SE_EMP.pdf (accessed 23 May2013).,Non-OADS,/arxiv_data1/oa_pdf/86/23/bmjopen-2013-002923.PMC3752049.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003338).,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/bmjopen-2013-003338.PMC3752050.pdf
Available from: http://www.guild.org.au/ sites/The_Guild/tab-Pharmacy_Services_and_Programs/Research_and_ Development/Fourth Agreement/IIG-003.page.,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/bmjopen-2013-003338.PMC3752050.pdf
PublishedOnline First: 4 March 2013. http://www.ecdc.europa.eu/en/publications/Publications0906_GUI_Chlamydia_Control_in_Europe.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/bmjopen-2013-003338.PMC3752050.pdf
http://www.health.gov.au/nndssdata 4.,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/bmjopen-2013-003338.PMC3752050.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003216).,Non-OADS,/arxiv_data1/oa_pdf/8d/0b/bmjopen-2013-003216.PMC3752051.pdf
2010: http://www.europeristat.com/ (accessed 18 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/8d/0b/bmjopen-2013-003216.PMC3752051.pdf
2012. http://www.nice.org.uk/nicemedia/live/11957/5946/5946.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/47/67/bmjopen-2013-003153.PMC3752052.pdf
2010. http://bjs.ojp.usdoj.gov/content/pub/pdf/p09.pdf 43.,Non-OADS,/arxiv_data1/oa_pdf/47/67/bmjopen-2013-003153.PMC3752052.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003314).,Non-OADS,/arxiv_data1/oa_pdf/f3/e3/bmjopen-2013-003314.PMC3752054.pdf
These sample size calcula- tions were made using the Two-Arm Normal sample sizecalculator on the Southwest Oncology Group website http://www.swogstat.org/stat/public/two_normal.htm.,OADS,/arxiv_data1/oa_pdf/f3/e3/bmjopen-2013-003314.PMC3752054.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003265).,Non-OADS,/arxiv_data1/oa_pdf/8e/34/bmjopen-2013-003265.PMC3752055.pdf
"World Health Organization, 2012. http://www.who.int/mediacentre/factsheets/fs164/en/index.html.",Non-OADS,/arxiv_data1/oa_pdf/8e/34/bmjopen-2013-003265.PMC3752055.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003104).,Non-OADS,/arxiv_data1/oa_pdf/d5/72/bmjopen-2013-003104.PMC3752058.pdf
"Oakbrook Terrace, IL, 2002. http://www.jcaho.org/ (accessed 7 Mar 2013).",Non-OADS,/arxiv_data1/oa_pdf/d5/72/bmjopen-2013-003104.PMC3752058.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-002960).,Non-OADS,/arxiv_data1/oa_pdf/1f/1d/bmjopen-2013-002960.PMC3752059.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/1d/bmjopen-2013-002960.PMC3752059.pdf
"Sarasota: Biolife, LLC, Available  from : http://www.biolife.com  [Last updated 2012 Mar 5].",Non-OADS,/arxiv_data1/oa_pdf/0b/30/IDOJ-4-172.PMC3752468.pdf
Biolife LLC; Available from : http://www.biolife.com  [Last  updated 2012 Mar 5].,OADS,/arxiv_data1/oa_pdf/0b/30/IDOJ-4-172.PMC3752468.pdf
Available from: http://www.dermaweb.com/English/dermato/ aderma/index2.html.,Non-OADS,/arxiv_data1/oa_pdf/72/45/IDOJ-4-180.PMC3752470.pdf
(Facts about skin from New Zealand  Dermatological Society Incorporated) created 2005 (about 4 pages)  Available from: http://dermnetnz.org/nzds.html/.,Non-OADS,/arxiv_data1/oa_pdf/99/80/IDOJ-4-185.PMC3752471.pdf
Available from: http://www.grandrounds_e-med.com.,Non-OADS,/arxiv_data1/oa_pdf/99/80/IDOJ-4-185.PMC3752471.pdf
"Access this article online Quick Response Code: Website: www.idoj.in DOI:  10.4103/2229-5178.115542  ""This article is a response to the article http://www.idoj.in/article.asp?issn=2229- 5178;year=2013;volume=4;issue=2;spage=147;epage=148;aulast=Sanghavi""",Non-OADS,/arxiv_data1/oa_pdf/6f/5e/IDOJ-4-254.PMC3752496.pdf
"Access this article online Quick Response Code: Website: www.idoj.in DOI:  10.4103/2229-5178.115542  ""This article is a response to the article http://www.idoj.in/article.asp?issn=2229- 5178;year=2013;volume=4;issue=2;spage=147;epage=148;aulast=Sanghavi""",Non-OADS,/arxiv_data1/oa_pdf/89/51/IDOJ-4-255.PMC3752497.pdf
"World  J Gastroenterol 2009;15:1398-400.Access this article online Quick Response Code: Website:  www.idoj.in DOI:   10.4103/2229-5178.115543  ""This article is a response to the article http://www.idoj.in/article.",Non-OADS,/arxiv_data1/oa_pdf/89/51/IDOJ-4-255.PMC3752497.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c6/b6/srep02501.PMC3752609.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2501 | DOI: 10.1038/srep02501 8",Non-OADS,/arxiv_data1/oa_pdf/c6/b6/srep02501.PMC3752609.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6c/1f/srep02505.PMC3752611.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2505 | DOI: 10.1038/srep02505 5",Non-OADS,/arxiv_data1/oa_pdf/6c/1f/srep02505.PMC3752611.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/de/29/srep02509.PMC3752612.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2509 | DOI: 10.1038/srep02509 5",Non-OADS,/arxiv_data1/oa_pdf/de/29/srep02509.PMC3752612.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/18/de/srep02499.PMC3752615.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2499 | DOI: 10.1038/srep02499 6",Non-OADS,/arxiv_data1/oa_pdf/18/de/srep02499.PMC3752615.pdf
The data of water level were from the http://www.ctg.com.cn/inc/sqsk.php.,OADS,/arxiv_data1/oa_pdf/d0/c6/srep02500.PMC3752616.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2500 | DOI: 10.1038/srep02500 8",Non-OADS,/arxiv_data1/oa_pdf/d0/c6/srep02500.PMC3752616.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e9/1f/srep02506.PMC3752618.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2506 | DOI: 10.1038/srep02506 8",Non-OADS,/arxiv_data1/oa_pdf/e9/1f/srep02506.PMC3752618.pdf
"2011;39(5):1050-5, http://dx.doi.org/10.1097/CCM.0b013e31820eda29.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2000;1482(1-2):157-71, http://dx.doi.org/10.1016/S0167- 4838(00)00153-9.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2003;14(1):25-34, http://dx.doi.org/10.1016/S1359-6101(02)00054-0.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"1998;12(2):173-81, http://dx.doi.org/10.1111/j.1472-8206.1998.tb00938.x.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2007;104(49):19595-600, http://dx.doi.org/10.1073/ pnas.0709681104.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2006;48(3):326-31, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2007;35(8):1928-36, http://dx.doi.org/10.1097/01.CCM.0000277043.85378.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"1985;13(10):818- 29, http://dx.doi.org/10.1097/00003246-198510000-00009.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2010;25(1):101-7, http://dx.doi.org/10.2133/dmpk.25.101.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2007;8(1):91-108, http://dx.doi.org/10.2174/138920307779941497.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"1979.; 281(5733):677-8, http://dx.doi.org/10.1038/281677a0.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"1996;13(1):27-31, http://dx.doi.org/10.1007/BF01049676.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2002;28(11):1613-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2011;15(1):124, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2012;61(6):1584-91, http://dx.doi.org/10.2337/db11-0825.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2001;33(2):161-235, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"2010;44(6):1063-71, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/06/b2/cln-68-08-1134.PMC3752623.pdf
"1982;139(6):1111-15, http://dx.doi.org/10.2214/ajr.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2004;27(5):1047-1053, http://dx.doi.org/10.2337/diacare.27.5.1047.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2012;29(7):855-62, http://dx.doi.org/10.1111/j.1464-5491.2012.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2011;139(2):229-35, http://dx.doi.org/ 10.1017/S095026881000107X.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2004;27(5):1143-7, http://dx.doi.org/10.2337/ diacare.27.5.1143.CLINICS 2013;68(8):1109-1114 Mortality from renal abscess in diabetes Ko MC et al.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2002;19(6):539- 45, http://dx.doi.org/10.1016/S0924-8579(02)00090-0.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"1999;48(6):535-9, http://dx.doi.org/10.1099/00222615-48-6- 535.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"1997;11(3):735-50, http://dx.doi.org/10.1016/ S0891-5520(05)70383-4.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2005;40(4):628- 31, http://dx.doi.org/10.1086/427699.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2007;44(9):1194-201, http://dx.doi.org/10.1086/513201.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2010;38(2):539- 45, http://dx.doi.org/10.1097/CCM.0b013e3181c02726.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"1995;12(10):916-20, http://dx.doi.org/10.1111/j.1464-5491.1995.tb00396.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2003;26(2):510-3, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2003;2(Suppl 2:)2:S89-S93, http://dx.doi.org/10.1016/S0924-8579(03) 00228-0.",OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"1992;45(6):613-9, http://dx.doi.org/10.1016/0895-4356(92)90133-8.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2003;290(10):1345-50, http://dx.doi.org/10.1001/jama.290.10.",Non-OADS,/arxiv_data1/oa_pdf/72/df/cln-68-08-1109.PMC3752624.pdf
"2012;16(3):723-35, http://dx.doi.org/10.1007/ s11325-011-0567-0.",Non-OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"2006;12(6):409-13, http://dx.doi.org/10.1097/01.mcp.",Non-OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"1996;109(5):1269-75, http://dx.doi.org/10.1378/chest.109.5.1269.",Non-OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"2007;62(4):354-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"2011;140(6):1511- 6, http://dx.doi.org/10.1378/chest.10-2851.",Non-OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"2004;8(6):443-57, http://dx.doi.org/10.1016/ j.smrv.2004.04.002.",OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"2001;164(4):608-13, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"2002;165(6):773-80, http://dx.doi.org/10.1164/ajrccm.165.6.2003166.",Non-OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"2002;166(5):743-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"2004;170(6):656-64, http://dx.doi.org/10.1164/rccm.200311-1571OC.CPAP, OA and physical exercise on OSAS Schu¨tz TC et al.CLINICS 2013;68(8):1168-1174 1174",Non-OADS,/arxiv_data1/oa_pdf/3b/6a/cln-68-08-1168.PMC3752627.pdf
"2010;3(1):63- 81, http://dx.doi.org/10.1161/CIRCOUTCOMES.109.889576.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2010;38(1):101-8, http://dx.doi.org/10.1097/CCM.0b013e3181b432 82.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"1988;78(2):382-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"1993;21(7):1046- 50, http://dx.doi.org/10.1097/00003246-199307000-00022.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2009;37(4):1408-15, http://dx.doi.org/10.1097/ CCM.0b013e31819cedc9.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2006;102(2):542-8, http://dx.doi.org/10.1213/01.ane.0000195231.81076.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2011;82(9):1138-43, http://dx.doi.org/10.1016/j.resuscitation.2011.06.029.",OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2007;35(4):1161-4, http://dx.doi.org/10.1097/01.CCM.0000259377.64733.4C.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2010;11(1):139-41, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"1985;40(8):819, http://dx.doi.org/10.1111/j.1365- 2044.1985.tb11024.x.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2006;50(9):1125-30, http://dx.doi.org/ 10.1111/j.1399-6576.2006.01141.x.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"1999;27(9):1929-33, http://dx.doi.org/10.1097/00003246-199909000- 00035.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"1997;34(3):255-61, http://dx.doi.org/10.1016/S0300-9572(96)01066-0.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2010;81(1):42-6, http://dx.doi.org/10.1016/j.resuscitation.",OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2010;39(3):296-300, http://dx.doi.org/10.1016/j.jemermed.2008.10.",OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2010;160(7):1573- 6, http://dx.doi.org/10.1111/j.1476-5381.2010.00873.x.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"1996;24(10):1695-700, http://dx.doi.org/10.1097/ 00003246-199610000-00016.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"1994;22(2):282-90, http://dx.doi.org/10.1097/ 00003246-199402000-00020.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2006;68(1):151-3, http://dx.doi.org/10.1016/j.resuscitation.2005.06.016.",OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2010;44(10):1545-53, http://dx.doi.org/10.1345/aph.1P2 54.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2008;100(4):494-503, http://dx.doi.org/10.1093/bja/ aen017.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2009;37(3):876-81, http://dx.doi.org/10.1097/CCM.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2006;50(10):1271-6, http://dx.doi.org/10.1111/j.1399-6576.2006.01166.x.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"1998;63(14):1205-19, http://dx.doi.org/10.1016/S0024- 3205(98)00383-X.",Non-OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2000;287(2):113-6, http://dx.doi.org/10.1016/S0304-3940(00)01151-4.CLINICS 2013;68(8):1146-1151 Terlipressin and naloxone in cardiac arrest Martins HS et al.",OADS,/arxiv_data1/oa_pdf/c6/66/cln-68-08-1146.PMC3752630.pdf
"2009;15(12):1776-82, http://dx.doi.org/10.1002/lt.21955.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2012;44(4):959-61, http://dx.doi.org/10.1016/j.transproceed.2012.01.104.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2000;32(7):1626-7, http://dx.doi.org/10.1016/S0041- 1345(00)01444-5.",OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"1999; 34(9):1374-7, http://dx.doi.org/10.1016/S0022-3468(99)90014-3.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2010;16(3):364-74, http://dx.doi.org/10.1002/lt.21989.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2012;48(3):163-70, http://dx.doi.org/10.1159/000338622.13.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2011;43(1):194-5, http://dx.doi.org/10.1016/j.transproceed.2010.",OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2011;254(1):55-61, http://dx.doi.org/10.1097/ SLA.0b013e3182121eb7.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"1968; 8(4):151-60, http://dx.doi.org/10.1016/0022-4804(68)90077-2.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2006;43(5):921-7, http://dx.doi.org/10.1016/j.jvs.2006.01.018.",OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2004;34(12):1010-3, http://dx.doi.org/10.1007/s00595-004-2871-9.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2011;7(4):597-603, http://dx.doi.org/10.5114/aoms.2011.24128.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"1995;82(4):1026-60, http://dx.doi.org/10.1097/ 00000542-199504000-00027.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2012;19(1):52-5, http://dx.doi.org/10.1111/j.1399-3089.2011.00686.x.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"1999;67(2):321-7, http://dx.doi.org/10.1097/00007890-199901270-00024.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2011;24(8):797-804, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c2/d2/cln-68-08-1152.PMC3752631.pdf
"2009;17(2):100- 4, http://dx.doi.org/10.1097/JSA.0b013e3181a3d60e.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2001;387:22-40, http://dx.doi.org/10.1097/00003086-200106000-00005.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2001;387:8-17, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2003;327(406):75, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"1998;80(3):546-52, http://dx.doi.org/10.1302/0301-620X.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2008;36(11):2100- 9, http://dx.doi.org/10.1177/0363546508324176.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2008;29(3):358-66, http://dx.doi.org/10.3113/FAI.2008.0358.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2008;13(2):103-11, http://dx.doi.org/10.1016/j.math.2007.01.014.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2001;387:68-71, http://dx.doi.org/10.1097/ 00003086-200106000-00009.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2008;19(2):150-4, http://dx.doi.org/10.3113/FAI.2008.0150.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2009;64(2):97-103, http://dx.doi.org/10.1590/S1807-59322009000200006.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2005;125(1):6-9, http://dx.doi.org/10.1007/s00402-003-0591-z.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2002;288(11):1364-72, http://dx.doi.org/10.1001/jama.288.11.1364.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2007;81-82:183-208, http://dx.doi.org/ 10.1093/bmb/ldm005.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2007;8:36, http://dx.doi.org/10.1186/1471-2474-8-36.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2007;93(1-3):111-29, http://dx.doi.org/10.1016/j.pbiomolbio.2006.",OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2008;60(1):3-9, http://dx.doi.org/10.3138/physio/ 60/1/3.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2007;15(1):107, http://dx.doi.org/10.1007/s00167-006-0238-z.CLINICS 2013;68(8):1089-1095 A follow-up to plantar fasciitis treatment Grecco MV et al.",Non-OADS,/arxiv_data1/oa_pdf/07/dd/cln-68-08-1089.PMC3752632.pdf
"2001;47(3):173-80, http://dx.doi.org/10.1053/jhin.2000.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2000;356(9238):1307-12, http://dx.doi.org/ 10.1016/S0140-6736(00)02814-2.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2007;28(1):42- 9, http://dx.doi.org/10.1086/510809.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2011;32(5):481-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2008;47(6):760-7, http://dx.doi.org/10.1086/591134.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"1985;13(10):818- 29, http://dx.doi.org/10.1097/00003246-198510000-00009.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2000;21(9):588-91, http://dx.doi.org/10.1086/501808.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2000;21(11):718-23, http://dx.doi.org/10.1086/501721.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"1998;158(10):1127-32, http://dx.doi.org/10.1001/archinte.158.10.1127.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"1999;96(12):6908-13, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2008;8(12):751-62, http://dx.doi.org/10.1016/S1473-3099(08)70279-2.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2006 Sep 1;43 Suppl 2:S43-8, http://dx.doi.org/10.1086/504476.",OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2006;6:130, http://dx.doi.org/10.1186/1471-2334-6-130.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2007;45(5):1551-5, http://dx.doi.org/10.1128/JCM.02424-06.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2010;74(4):395-6, http://dx.doi.org/ 10.1016/j.jhin.2009.06.003.CLINICS 2013;68(8):1128-1133 Colonization by Acinetobacter and Pseudomonas DalBen MF et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/de/cln-68-08-1128.PMC3752633.pdf
"2007;67(4):367-72, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2008;108(2):275-80, http://dx.doi.org/10.3171/ JNS/2008/108/2/0275.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2006;104(1):79-84, http://dx.doi.org/10.3171/ jns.2006.104.1.79.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2003;107(2):110-6, http://dx.doi.org/10.1034/ j.1600-0404.2003.01340.x.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2009;71(2):161-5, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2008;63(6):1125- 9, http://dx.doi.org/10.1227/01.NEU.0000335782.60059.17.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"1925; 11:328, http://dx.doi.org/10.1001/archsurg.1925.01120150002001.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"1975; 25(7):669-75, http://dx.doi.org/10.1212/WNL.25.7.669.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2007;48(2):210-7, http://dx.doi.org/10.3349/ ymj.2007.48.2.210.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2009;49(9):379-85, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2011; 21(7):512-7, http://dx.doi.org/10.1016/j.numecd.2009.11.011.",OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2012;10(3):289-99, http://dx.doi.org/10.2174/ 157016112799959413.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2009;36(11):933-9, http://dx.doi.org/10.1111/j.1600-051X.2009.01481.x.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2007;96(5):258-63, http://dx.doi.org/10.1007/s00392- 007-0494-z.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2005;106(5):1525-31, http://dx.doi.org/10.1182/blood-2005- 04-1509.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"1997;275(5302):964-7, http://dx.doi.org/10.1126/science.275.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2002;96(5):877-84, http://dx.doi.org/10.3171/jns.2002.96.5.0877.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"1997;47(5):418-22, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2001;89(1):E1-7, http://dx.doi.org/10.1161/hh1301.093953.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2003;42(12):2073-80, http://dx.doi.org/10.1016/j.jacc.2003.07.025.",OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2005;56:79-101, http://dx.doi.org/10.1146/annurev.med.56.090203.104149.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2006;27(3):441-5, http://dx.doi.org/10.1183/09031936.06.00000706.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"ActaNeurochir.1998;140(1):51-5,http://dx.doi.org/10.1007/s007010050057.",OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2004;100(1):24-32, http://dx.doi.org/10.3171/jns.2004.100.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2008;73(3):186-93, http://dx.doi.org/10.1002/cyto.a.20480.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2005;22(5):518-28, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/cln-68-08-1084.PMC3752634.pdf
"2011;25(1):161- 79, http://dx.doi.org/10.1016/j.beem.2010.09.002.",OADS,/arxiv_data1/oa_pdf/ca/e0/cln-68-08-1079.PMC3752636.pdf
"2007;125(3):215-23, http://dx.doi.org/10.1016/j.clim.2007.08.008.",OADS,/arxiv_data1/oa_pdf/ca/e0/cln-68-08-1079.PMC3752636.pdf
"2011;102(6):402-16, http://dx.doi.org/10.1016/j.ad.2011.02.010.",OADS,/arxiv_data1/oa_pdf/ca/e0/cln-68-08-1079.PMC3752636.pdf
"2006;43(11):833- 42, http://dx.doi.org/10.1136/jmg.2006.042796.",Non-OADS,/arxiv_data1/oa_pdf/ca/e0/cln-68-08-1079.PMC3752636.pdf
"2000;17(6):440-6, http://dx.doi.org/10.1046/j.1525-1470.2000.",Non-OADS,/arxiv_data1/oa_pdf/ca/e0/cln-68-08-1079.PMC3752636.pdf
"2008;29(8):992-1006, http://dx.doi.org/10.1002/humu.",Non-OADS,/arxiv_data1/oa_pdf/ca/e0/cln-68-08-1079.PMC3752636.pdf
"2002;159(1):103-12, http://dx.doi.org/10.1083/jcb.200205017.",Non-OADS,/arxiv_data1/oa_pdf/ca/e0/cln-68-08-1079.PMC3752636.pdf
"2008;20(3):453-9, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ca/e0/cln-68-08-1079.PMC3752636.pdf
"2013;52(4):874-6, http://dx.doi.org/10.3109/0284186X.2012.716165.",Non-OADS,/arxiv_data1/oa_pdf/ca/e0/cln-68-08-1079.PMC3752636.pdf
"2013;68(3):425, http://dx.doi.org/10.6061/clinics/ 2013(03)LE04.",Non-OADS,/arxiv_data1/oa_pdf/98/a6/cln-68-08-1077.PMC3752637.pdf
"2013;309(13):1351-52, http://dx.doi.org/10.1001/jama.2013.393.",Non-OADS,/arxiv_data1/oa_pdf/98/a6/cln-68-08-1077.PMC3752637.pdf
"2011;306(8): 848-55, http://dx.doi.org/10.1001/jama.2011.1204.",Non-OADS,/arxiv_data1/oa_pdf/98/a6/cln-68-08-1077.PMC3752637.pdf
http://www.genome.gov/27540473.,OADS,/arxiv_data1/oa_pdf/98/a6/cln-68-08-1077.PMC3752637.pdf
"2012;13(6): 395-405, http://dx.doi.org/10.1038/nrg3208.",Non-OADS,/arxiv_data1/oa_pdf/98/a6/cln-68-08-1077.PMC3752637.pdf
"2008 ;118(2):e29-35, http://dx.doi.org/10.1161/CIRCULATI ONAHA.107.189624.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"Med Care.2000;38(12):1210-23, http://dx.doi.org/ 10.1097/00005650-200012000-00008.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"1996;10(6):667-73, http://dx.doi.org/10.1097/ 00002030-199606000-00013.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2004;18(2):81-98, http://dx.doi.org/10.1089/ 108729104322802515.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2000;29(6):373-86, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"Phys Ther.2008;88(2):156-75, http://dx.doi.org/10.2522/ptj.20070147.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2001; 15(18):2431- 40, http://dx.doi.org/10.1097/00002030-200112070-00011.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2000;283(6):763-70, http://dx.doi.org/10.1001/jama.283.6.763.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"1999;281(14):1282-90, http://dx.doi.org/10.1001/jama.281.14.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"1999; 84(4):1268-76, http://dx.doi.org/10.1210/jc.84.4.1268.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2003;14(2):30-40, http://dx.doi.org/10.1177/ 1055329002250992.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"Nurses AIDS Care 2002;13(2):33-45, http://dx.doi.org/10.1016/S1055-3290(06)60199-4.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"AIDS 2001;15(6):693-701, http://dx.doi.org/10.1097/00002030-200104130-00004.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"1999;31:973-9, http://dx.doi.org/10.1097/00005768-199907000-00009.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2008;17(3):377-85, http://dx.doi.org/10.1007/s11136-008-9319-4.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2004;18(3):465-73, http://dx.doi.org/10.1097/00002030-200402200-00013.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2004;89(5):2171-8, http://dx.doi.org/10.1210/jc.2003-031858.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2000;133(5):348-55, http://dx.doi.org/10.7326/0003-4819- 133-5-200009050-00010.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2012;26(8):2293-307, http://dx.doi.org/10.1519/JSC.0b013e31823a3e2d.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2004;34(8):487-99, http://dx.doi.org/10.2165/00007256-200434080-00001.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2001;104(14):1694-740, http://dx.doi.org/10.1161/hc3901.095960.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2003;35(3):456-64, http://dx.doi.org/10.1249/01.MSS.0000053727.63505.",Non-OADS,/arxiv_data1/oa_pdf/34/86/cln-68-08-1157.PMC3752639.pdf
"2011;37(9):1466-72, http://dx.doi.org/ 10.1007/s00134-011-2299-9.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"1993;21(2):279-91, http://dx.doi.org/10.1097/00003246-199302000-00022.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"1990;18(5):474-9, http://dx.doi.org/10.1097/00003246-199005000-00002.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"1999;229(2):163-71, http://dx.doi.org/10.1097/ 00000658-199902000-00001.5.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"Elsevier Inc.; 2012;27(2):159-66, http://dx.doi.org/10.1016/j.jcrc.2011.08.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"2009;302(21):2323-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"2009;37(3):222-32, http://dx.doi.org/10.1007/s15010-008-8203-z.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"2006;18(1):9-17, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"2002;28(2):108-21, http://dx.doi.org/10.1007/s00134-001-1143-z.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"2006;18(1):9-17, http://dx.doi.org/10.1590/S0103-507X2006000100003.",Non-OADS,/arxiv_data1/oa_pdf/11/c3/cln-68-08-1103.PMC3752640.pdf
"2008;89:195-205, http://dx.doi.org/10.1016/S0072-9752(07)01218-3.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2009;6(11):e1000180, http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2007;69(24):2197-204, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2009;21(4):622-30, http://dx.doi.org/10.1017/S1041610209009430.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2008;7(9):812-26, http://dx.doi.org/10.1016/S1474-4422(08)70169-8.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2006;6:2, http://dx.doi.org/10.1186/1471-2377-6-2.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2007;8(2):151-62, http://dx.doi.org/10.1007/s10561-006-9022-z.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2003;61(3A):601-6, http://dx.doi.org/10.1590/S0004-282X2003000400014.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2006;114(1):38-46, http://dx.doi.org/10.1111/j.1600-0404.2006.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2010;119(3):277-90, http://dx.doi.org/10.1007/ s00401-010-0652-7.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"1994;51(9):888-95, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2002;16(4):203-12, http://dx.doi.org/10.1097/00002093-200210000-00001.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2003;60(4):569-75, http://dx.doi.org/10.1001/archneur.60.4.569.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2009;49(1):146-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"1985;42(11):1097-105, http://dx.doi.org/10.1001/archneur.1985.0406010 0083029.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2001;56 (12):1690-6, http://dx.doi.org/10.1212/WNL.56.12.1690.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2010;299(1-2):136-8, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2013;18(1):79-85, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"1996;27(1):30-6, http://dx.doi.org/10.1161/01.STR.27.1.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"1997;49(3):690-4, http://dx.doi.org/10.1212/WNL.49.3.690.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2002;14(3):161-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2013;125(4):581-93, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2007;114(1):5- 22, http://dx.doi.org/10.1007/s00401-007-0237-2.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"1999; 58(4):376-88, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2011;709(10):832-40, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"1999;13(1):34-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/f7/cln-68-08-1140.PMC3752642.pdf
"2012;67(12):1427-31, http://dx.doi.org/10.6061/ clinics/2012(12)13.",Non-OADS,/arxiv_data1/oa_pdf/b4/a3/cln-68-08-1175.PMC3752643.pdf
"2011;49(12):4301- 3, http://dx.doi.org/10.1128/JCM.05602-11.",Non-OADS,/arxiv_data1/oa_pdf/b4/a3/cln-68-08-1175.PMC3752643.pdf
"2012;50(2):477-9, http://dx.doi.org/10.1128/JCM.05247-11.",Non-OADS,/arxiv_data1/oa_pdf/b4/a3/cln-68-08-1175.PMC3752643.pdf
"2008;12(4):540-6, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"2003;16(2):165-70, http://dx.doi.org/10.1097/00019052-200304000-00008.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"2006;64(2B):538-42, http://dx.doi.org/10.1590/ S0004-282X2006000300037.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"1993;34(3):453-68, http://dx.doi.org/10.1111/j.1528-1157.1993.tb02586.x.7.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"2002;43(11):1402-9, http://dx.doi.org/10.1046/j.1528-1157.2002.t01-1-26901.x.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"2005;4(1):21-31, http://dx.doi.org/ 10.1016/S1474-4422(04)00963-9.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"2013;27(2):113-9, http://dx.doi.org/10.1007/s40263-012-0006-1.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"2008;63(3):389-94, http://dx.doi.org/10.1590/S1807-59322008000300017.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"1982;300(5891):448-50, http://dx.doi.org/10.1038/300448a0.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"1982;218(4574):810- 2, http://dx.doi.org/10.1126/science.7134978.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"1985; 89(1):250-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"1994;102:261-73, http://dx.doi.org/10.1016/S0079- 6123(08)60545-2.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"2003;26(4):199-206, http://dx.doi.org/10.1016/S0166-2236(03)00068-7.",OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"2008;49(11):1908-24, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0a/21/cln-68-08-1074.PMC3752644.pdf
"10       http://www.medsci.org  1259  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1259 -1270.  doi: 10.7150/ ijms.6358  Research Paper   Flotillin -2 Expression in the Human Gut: from a Cell  Model to Human Tissue in Health and Inflammatory  Bowel Diseases  Annika Gauss1, Inga Buchholz1, Alexandra Zahn1, Gerd Schmitz2, Wolfgang Stremmel1, Joachim  Fuellekrug1, Robert Ehehalt1  1.",Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
10     http://www.medsci.org  1260  phagocytosis and interactions with the cytoskel e- ton.,Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
"10     http://www.medsci.org  1261  within the colon, colon samples  were taken from the  transverse colon in all patients.",Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
10       http://www.medsci.org  1262  Indirect immunofluorescence   Immunofluorescence was used to localize floti l- lin-2 and flotillin -1 in cultured cells and human inte s- tinal biopsies.,OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
"10     http://www.medsci.org  1263  Vectors  were subsequently transformed into E. coli,  and plasmids were isolated from E. coli cultures with  the NucleoSpin Plasmid Kit (Macherey -Nagel, Düren,  Germany).",Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
10     http://www.medsci.org  1264    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
10     http://www.medsci.org  1265  also found significant flotillin -1 enrichment in bas o- lateral enterocyte membranes ( Figure 6 ).,Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
"10       http://www.medsci.org  1266  Localization of flotillin -2 in enterocytes in IBD  patients compared to controls   Three colonic biopsies and three ileal biopsies (3  controls, 3 UC patients and 3 CD patients) were an a- lyzed by immunohistochemistry and compared to  each another.",Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
"10       http://www.medsci.org  1267  Expression of flotillin-2 at the protein level –   comparison between IBD and controls   At the translational level, real -time RT -PCR data  were confirmed by immunoblot analysis.",OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
10     http://www.medsci.org  1268  regulatory functions in T cell activation.,Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
"10     http://www.medsci.org  1269  The stronger expression of flotillin- 2 in the colon  compared to the ileum, even in healthy subjects, is  remarkable and raises the question as to whether fl o- tillin -2 possesses a special function in the colon.",Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
10     http://www.medsci.org  1270  24.,Non-OADS,/arxiv_data1/oa_pdf/45/99/ijmsv10p1259.PMC3752715.pdf
"10       http://www.medsci.org  1278  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1278 -1285.  doi: 10.7150/ ijms.6254  Research Paper   Sugammadex, a Neuromuscular Blockade Reversal  Agent, Causes Neuronal Apoptosis in Primary Cultures   José M. Palanca1, Diana Aguirre -Rueda2, Manuel V. Granell1, Martin Aldasoro2, Alma Garcia2, Antonio  Iradi2, Elena Obrador2, Maria Dolores Mauricio2, Jose Vila2, Anna Gil -Bisquert2 and Soraya L. Valles2  1.",Non-OADS,/arxiv_data1/oa_pdf/d5/a6/ijmsv10p1278.PMC3752716.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d5/a6/ijmsv10p1278.PMC3752716.pdf
"10     http://www.medsci.org  1279  for SUG included cough, dry mouth, temperature  changes, parasomia, paresthesia, movement during  surgery, mild erythemia, abdominal discomfort,  tachycardia, bradycardia, dizziness, increased creat i- nine phosphokinase, and increased B2 microglobinu- ria [3].",Non-OADS,/arxiv_data1/oa_pdf/d5/a6/ijmsv10p1278.PMC3752716.pdf
10     http://www.medsci.org  1280  mals used following the local ethics committees (Et h- ics Committee for Animal Research of the University  of Valencia) based on the local guidelines (Spanish  law 32/2007).,Non-OADS,/arxiv_data1/oa_pdf/d5/a6/ijmsv10p1278.PMC3752716.pdf
"10     http://www.medsci.org  1281  sub-cellular fractions were lyophilized using  freeze- drying equipment from SP Scientific (Gardiner,  NY).",OADS,/arxiv_data1/oa_pdf/d5/a6/ijmsv10p1278.PMC3752716.pdf
10     http://www.medsci.org  1282    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/d5/a6/ijmsv10p1278.PMC3752716.pdf
10     http://www.medsci.org  1283  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d5/a6/ijmsv10p1278.PMC3752716.pdf
10     http://www.medsci.org  1284  tivity [31].,Non-OADS,/arxiv_data1/oa_pdf/d5/a6/ijmsv10p1278.PMC3752716.pdf
10     http://www.medsci.org  1285  http://www.,Non-OADS,/arxiv_data1/oa_pdf/d5/a6/ijmsv10p1278.PMC3752716.pdf
"10       http://www.medsci.org  1286  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1286 -1294.  doi: 10.7150/ ijms.5985  Research Paper   Microcurrent E lectrical N erve S timulation Facilitates  Regrowth of Mouse Soleus Muscle   Yoshitaka Ohno1, Hiroto Fujiya2, Ayumi Goto3, Ayane Nakamura1, Yuka Nishiura1,Takao Sugiura4,  Yoshinobu Ohira5, Toshitada Yoshioka6, Katsumasa Goto1,3   1.",Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
"10     http://www.medsci.org  1287  MENS  has a reducing e ffect of signs and symptoms of  muscle  damage .4,5 However, molecular mechanism  for MENS -associated stimulation of the regenerative  potential of injured skeletal muscle is still unclear  because the regeneration of injured skeletal muscle is  complicated process.",Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
10       http://www.medsci.org  1288  Five mice of C group were assigned as the cage  control  and killed  immediately  before the initiation o f  HS.,Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
10     http://www.medsci.org  1289  at 4°C .,Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
10     http://www.medsci.org  1290  Discussion  The present study dem onstrated that the appl i- cation of MENS facilitated regrowth of atrophied s o- leus muscle induced by hindlimb unloading.,Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
10     http://www.medsci.org  1291    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
"10     http://www.medsci.org  1292    As unloading -induce d skeletal muscle atrophy  results i n muscle weakness, muscle inflammation,  muscle membrane lysis and necrosis occur  in reloa d- ed skeletal  muscle after unloading.29 In the present  study, necrotic region in soleus muscle was also ob- served at R1.",Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
"10     http://www.medsci.org  1293  Exploratory Research (24650411, KG) from the Japan  Society for the Promotion of Science, and the Science  Research Promotion Fund from the Promotion and  Mutual Aid Corporation for Private Schools of Japan  (KG).",Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
10     http://www.medsci.org  1294  45.,Non-OADS,/arxiv_data1/oa_pdf/44/0d/ijmsv10p1286.PMC3752717.pdf
"10       http://www.medsci.org  1307  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1307 -1313.  doi: 10.7150/ ijms.6430  Research Paper   Microbleeds and Silent Brain Infarctions Are Differently  Associated w ith Cognitive Dysfunction i n Patients w ith  Advanced Periventricular Leukoaraiosis  Min Fang1*, Chao Feng1*, Yu Xu2, Ting Hua2, Ai-Ping Jin1, Xue-Yuan Liu1  1.",Non-OADS,/arxiv_data1/oa_pdf/f4/89/ijmsv10p1307.PMC3752718.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f4/89/ijmsv10p1307.PMC3752718.pdf
10     http://www.medsci.org  1308  leukoaraiosis is believed to indicate a severe stage of  small vessel disease and predict cognitive dysfunction   or vascular dementia[3-6].,Non-OADS,/arxiv_data1/oa_pdf/f4/89/ijmsv10p1307.PMC3752718.pdf
10     http://www.medsci.org  1309  crobleeds were evaluated.,OADS,/arxiv_data1/oa_pdf/f4/89/ijmsv10p1307.PMC3752718.pdf
10       http://www.medsci.org  1310  Risk factors of cognitive impairment    Multiple linear models were constructed to  identify the independent risk factors of cognitive i m- pairment.,OADS,/arxiv_data1/oa_pdf/f4/89/ijmsv10p1307.PMC3752718.pdf
10     http://www.medsci.org  1311  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/f4/89/ijmsv10p1307.PMC3752718.pdf
10     http://www.medsci.org  1312  effec t on cognitive function than those in other loca- tions.,Non-OADS,/arxiv_data1/oa_pdf/f4/89/ijmsv10p1307.PMC3752718.pdf
10     http://www.medsci.org  1313  24.,Non-OADS,/arxiv_data1/oa_pdf/f4/89/ijmsv10p1307.PMC3752718.pdf
"10       http://www.medsci.org  1314  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1314 -1320.  doi: 10.7150/ ijms.6538  Research Paper   Antitumor Effect of Embryonic Stem Cells in a  Non- Small Cell Lung Cancer Model: Antitumor Factors  and Immune Responses   Wei Dong1,2*, Chen Qiu1*, Hongchang Shen1, Qi Liu1, and Jiajun Du1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/0b/35/ijmsv10p1314.PMC3752719.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/35/ijmsv10p1314.PMC3752719.pdf
"10     http://www.medsci.org  1315  type and help preventing tumorigenesis and metast a- sis [10, 11] .",Non-OADS,/arxiv_data1/oa_pdf/0b/35/ijmsv10p1314.PMC3752719.pdf
"10       http://www.medsci.org  1316  2.2 Increased p roliferation of lymphocytes  and  secretion of cytokines   To explore the specific changes in immune sy s- tem, we examined the proliferation of lymphocytes in  the peripheral circulation and spleen of all mice i n- duced by ESCs administration by flow cytometry and  IHC in our study (Fig.",Non-OADS,/arxiv_data1/oa_pdf/0b/35/ijmsv10p1314.PMC3752719.pdf
10     http://www.medsci.org  1317    Fig 4 .,Non-OADS,/arxiv_data1/oa_pdf/0b/35/ijmsv10p1314.PMC3752719.pdf
"10     http://www.medsci.org  1318  was also detected, these cytokines played an i m- portant role in regulating the antitumor immune r e- sponses and differentiation of cytotoxic T lympho- cytes [29-31].",Non-OADS,/arxiv_data1/oa_pdf/0b/35/ijmsv10p1314.PMC3752719.pdf
10     http://www.medsci.org  1319  tumors were exercised and weighed.,Non-OADS,/arxiv_data1/oa_pdf/0b/35/ijmsv10p1314.PMC3752719.pdf
10     http://www.medsci.org  1320  with minor and heavy tumor load.,Non-OADS,/arxiv_data1/oa_pdf/0b/35/ijmsv10p1314.PMC3752719.pdf
"10       http://www.medsci.org  1327  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1327 -1332.  doi: 10.7150/ ijms.6531  Research Paper   Optimal Dose  of Prophylactic D exmedetomidine for   Preventing P ostoperative Shivering   Yong -Shin Kim1, Yong -Il  Kim2, Kwon -Hui Seo1, Hye-Rim Kang1   1.",Non-OADS,/arxiv_data1/oa_pdf/0e/bc/ijmsv10p1327.PMC3752720.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0e/bc/ijmsv10p1327.PMC3752720.pdf
"10    http://www.medsci.org  1328  shivering, measures to prevent in the postoperative  period are important.",Non-OADS,/arxiv_data1/oa_pdf/0e/bc/ijmsv10p1327.PMC3752720.pdf
"10    http://www.medsci.org  1329  shaking , 3 = responds only after name is called loudly  and/or repeatedly , 4 = lethargic response to name  spoken in normal tone , 5 = responds readily to name  spoken .",Non-OADS,/arxiv_data1/oa_pdf/0e/bc/ijmsv10p1327.PMC3752720.pdf
10    http://www.medsci.org  1330  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/0e/bc/ijmsv10p1327.PMC3752720.pdf
"10    http://www.medsci.org  1331  Intraoperative hypothermia is the major risk  factor for post -anesthetic shivering, but shivering can  occur in patients who are normothermic at the end of  the surgery.13,14 In our study, tympanic temperatures  in the operation room started to decrease after indu c- tion and were lower than the baseline temperatures in  all groups.",Non-OADS,/arxiv_data1/oa_pdf/0e/bc/ijmsv10p1327.PMC3752720.pdf
10    http://www.medsci.org  1332  8.,Non-OADS,/arxiv_data1/oa_pdf/0e/bc/ijmsv10p1327.PMC3752720.pdf
"10       http://www.medsci.org  1333  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(10):1333-1343. doi: 10.7150/ ijms.5774   Research Paper   Allele Dependent Silencing of Collagen Type I Using  Small Interfering RNAs Targeting 3’UTR Indels – a  Novel Therapeutic Approach in Osteogenesis Impe r- fecta  Katarina  Lindahl1, Andreas Kindmark1, Navya Laxman1, Eva Åström2, Carl -Johan Rubin3, Östen  Ljunggre n1   1.",Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
"10     http://www.medsci.org  1334  fractures, with the most severe forms being perin a- tally lethal, often due to extreme bone fragility with  pulmonary hypoplasia and respiratory insufficie ncy.",Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
10     http://www.medsci.org  1335  been utilized in allele -preferential silencing of coll a- gen type I.,Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
Frequencies of heterozygotes for rs3840870 and rs3917  in differe nt populations   Population/   Ethnicity  Contributing   Alleles  rs3840870  (COL1A1 )  Heterozygotes  rs3917  (COL1A2 )  Heterozygotes   MrOS cohort  192 52% 46%  OI cohort  192 52% 48%  European origin°  120 47% 49%  Youruban Nigeria°  120 50% 17%  Chinese/Japanese°  120 49% 11%  Not stated [35] 240 46% N/A   European*  200 N/A  49%  Amerind*  50 N/A  49%  Japanese*  50 N/A  35%  African*  42 N/A  38%  °= Data from 1000 Genome s Project (http://www.1000genomes.org/)   *= Data from NCBI dbSNP  database  (http://www.ncbi.nlm.nih.gov/projects/SNP/)   Percentages of individuals with a heterozygous genotype of rs3840870 and rs3917  were genotyped in 96 Swedish healthy controls (subset of the MrOS cohort) and in  96 Swedish patients with OI and results a re presented here.,Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
10     http://www.medsci.org  1336  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
10     http://www.medsci.org  1337  using standard PCR conditions with an annealing  temperature of 60°C.,Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
10     http://www.medsci.org  1338  orescent light microscope where visible granulae in  the cytosol counted as a positive cell (Figure 3).,Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
10       http://www.medsci.org  1339    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
10     http://www.medsci.org  1340    Fig.,Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
10       http://www.medsci.org  1341  Discussion   Severe OI is a debilitating and potentially  life-threateni ng genetic disorder with no satisfactory  or curative treatment.,Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
"10     http://www.medsci.org  1342  on bone phenotype [27,33,34] .",Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
"In addition, the heteroz y- gote frequency for rs3840870 in COL1A1  was dete r- mined to be 46% in a published cohort of 120 unr e- lated contr ols [35] and data is also available for di f- ferent ethnicities in the 1000 Genomes Project   (http://www.1000genomes.org/) .",OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
"Allele frequencies  of non -insertion vs. insertion for rs3917 in COL1A2  are  also available in the National Centre for Biotechno l- ogy Info rmation (NCBI) dbSNP -database  (http://www.ncbi.nlm.nih.gov/projects/SNP/), and  in the 1000 Genomes Project and heterozygous gen o- type is between 11% and 49% in different populations.",OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
"10     http://www.medsci.org  1343  approach,  highly effective in vitro, and is a promising  step towards personalized RNAi therapy in severe OI.",Non-OADS,/arxiv_data1/oa_pdf/48/cd/ijmsv10p1333.PMC3752721.pdf
"10       http://www.medsci.org  1344  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1344 -1351.  doi: 10.7150/ ijms.4802  Research Paper   Prolidase , Matrix Metalloproteinases 1 and 13 Activity,  Oxidative -Antioxidative Status as  a Marker of Preterm  Premature  Rupture of Membranes and Chorioamni- onitis in Maternal Vaginal Washing Fluids  Hatice Ender Soydinc1, Muhammet Erdal Sak1, Osman Evliyaoglu2, Mehmet Sıddık Evsen1, Abdulkadi r  Turgut1, Ali Özler1, İsmail Yıldız3, Talip Gul1   1.",Non-OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
10       http://www.medsci.org  1345  Introduction  Premature rupture of membranes (PROM) is  described as the rupture of fetal membranes (amn i- orrhexis) prior to labor.,Non-OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
10     http://www.medsci.org  1346  came for routine prenatal visits were recruited to our  study.,Non-OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
"10     http://www.medsci.org  1347   For the enzymatic antioxidants, catalase activity  was measure d according to the method of Aebi, and  paraoxonase -1 (PON -1) activity was measured spe c- trophotometrically by a modified Eckerson method  (19, 20).",OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
10     http://www.medsci.org  1348  A multivariate logistic regression analysis was  performed for statistically significant parameters in  VWF.,OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
"10       http://www.medsci.org  1349  Table 6: Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values and likelihood ratios (LR) for the optimal cut -offs value  of the parameters for chorioamnionitis predicted   Variables  Sensitivity(%)  (95% CI)  Specificity(%)  (95% CI)  PPV(%)   (95%  CI) NPV(%)   (95% CI)  LR+   (95% CI)  LR-  (95% CI)   Prolidase >1052.7  73.33   (44.9 – 92.0)  93.10  (77.2 – 99.0)  84.6  (54.5 – 97.6)  87.1  (70.1 – 96.3)  10.63   (7.7 – 14.7)  0.29  (0.06 – 1.4)  MMP13 >56  93.33   (68.0 -98.9)  65.52   (45.7 -82.0)  58.3  (36.7 -77.9)  95  (75.1 -99.2)  2.71  (2.0-3.6) 0.10  (0.01 -0.7)  TOS >10.5  60.0  (32.3 -83.6)  72.41   (52.8 -87.2)  52.9  (27.9 -77.0)  77.8  (57.7 -91.3)  2.17  (1.4-3.5) 0.55  (0.2-1.3)  CI: confidence interval.",Non-OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
"10     http://www.medsci.org  1350  kidney, brain, heart, thymus, and uterus (28).",Non-OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
10     http://www.medsci.org  1351  University .,Non-OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
http://www.danielsoper.com/   statcalc3/  23.,OADS,/arxiv_data1/oa_pdf/62/50/ijmsv10p1344.PMC3752722.pdf
"10       http://www.medsci.org  1361  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1361 -1366.  doi: 10.7150/ ijms.6389  Research Paper   Predictors of C oronary and Carotid Atherosclerosis in  Patients with S evere Degenerative  Aortic Stenosis  Beata Bobrowska1, Wojciech Zasada1, Andrzej Surdacki1, Tomasz Rakowski1, Paweł Kleczyński1, Jolanta  Świerszcz1, Olga Kruszelnicka2, Renata Rajtar -Salwa1, Saleh Arif1, Danuta Sorysz1, Dariusz Dudek1, Jacek S.  Dubiel1  1.",Non-OADS,/arxiv_data1/oa_pdf/ea/a4/ijmsv10p1361.PMC3752723.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/a4/ijmsv10p1361.PMC3752723.pdf
"10     http://www.medsci.org  1362  only 40% of patients with severe aortic stenosis have  significant CAD and aortic stenosis is a bsent in the  majority of CAD patients, which suggests different pathogenesis of these diseases [8,9].",Non-OADS,/arxiv_data1/oa_pdf/ea/a4/ijmsv10p1361.PMC3752723.pdf
10     http://www.medsci.org  1363  or ICAS in the patients exposed to a factor of interest  compared to a reference group without this exposure.,Non-OADS,/arxiv_data1/oa_pdf/ea/a4/ijmsv10p1361.PMC3752723.pdf
10     http://www.medsci.org  1364  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/a4/ijmsv10p1361.PMC3752723.pdf
10     http://www.medsci.org  1365  Table  3.,Non-OADS,/arxiv_data1/oa_pdf/ea/a4/ijmsv10p1361.PMC3752723.pdf
"10     http://www.medsci.org  1366  dependent effect of coexistent CAD on ICAS, which  w a s  n o t  f o u n d  i n  t h e  p r e s e n t  s t u d y  [ 1 0 ] .",OADS,/arxiv_data1/oa_pdf/ea/a4/ijmsv10p1361.PMC3752723.pdf
http://www.acc.org/clinical/guidelines/stable/stable.pdf   13.,Non-OADS,/arxiv_data1/oa_pdf/ea/a4/ijmsv10p1361.PMC3752723.pdf
http://www.stat.gov.pl/gus   14.,OADS,/arxiv_data1/oa_pdf/ea/a4/ijmsv10p1361.PMC3752723.pdf
"10       http://www.medsci.org  1367  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1367 -1374.  doi: 10.7150/ ijms.6014  Research Paper   The Role of Serum Procalcitonin  Levels in Predicting  Ascitic Fluid Infection in Hospitalized Cirrhotic and  Non- cirrhotic Patients   Yesim Cekin1, Ayhan Hilmi Cekin2, Adil Duman2, Ustun Yilmaz3, Bayram Yesil3, Basak Oguz Yolcular4   1.",Non-OADS,/arxiv_data1/oa_pdf/27/ab/ijmsv10p1367.PMC3752724.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/ab/ijmsv10p1367.PMC3752724.pdf
"10     http://www.medsci.org  1368  rhosis indicates a poor prognosis with mortality of  approximately 40% at 1 year and 50% at 2 years with increased risk for other complications of liver disease, including refractory ascites, SBP, h yponatremia, or  hepatorenal syndrome (HRS) [1].",Non-OADS,/arxiv_data1/oa_pdf/27/ab/ijmsv10p1367.PMC3752724.pdf
"10     http://www.medsci.org  1369  drawn from the abdomen, the ‘skin’ needle was re- moved and replaced with a sterile needle to minimize the risk of skin flora growing in the cultures.",Non-OADS,/arxiv_data1/oa_pdf/27/ab/ijmsv10p1367.PMC3752724.pdf
"10     http://www.medsci.org  1370  Ascitic fluid analysis   Ascitic fluid analysis revealed WBC count  (cell/mm3) of 6035 ± 1738.4 in SBP, 2041 ± 450.4 in  culture -negative SBP, 368 ± 43.1 in bacterascites, 243 ±  23.8 in sterile ascites while 2685 ± 417.0 in malign a s- cites (Table 1).",OADS,/arxiv_data1/oa_pdf/27/ab/ijmsv10p1367.PMC3752724.pdf
10     http://www.medsci.org  1371  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/27/ab/ijmsv10p1367.PMC3752724.pdf
10     http://www.medsci.org  1372    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/27/ab/ijmsv10p1367.PMC3752724.pdf
10     http://www.medsci.org  1373  procalcitonin levels specific to cirrhosis related but  not to malignancy related ascites.,Non-OADS,/arxiv_data1/oa_pdf/27/ab/ijmsv10p1367.PMC3752724.pdf
10     http://www.medsci.org  1374  patients with ascites.,Non-OADS,/arxiv_data1/oa_pdf/27/ab/ijmsv10p1367.PMC3752724.pdf
10       http://www.medsci.org  1387  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1387 -1391.  doi: 10.7150/ ijms.6126  Research Paper   Can Mean Platelet Volume Serve a s a Marker f or  Prostatitis?,Non-OADS,/arxiv_data1/oa_pdf/5f/71/ijmsv10p1387.PMC3752725.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5f/71/ijmsv10p1387.PMC3752725.pdf
"10     http://www.medsci.org  1388  not yet fully understood and several mec hanisms  seem to be involved in its development and progres- sion, recent studies strongly suggest that BPH is an  immune inflammatory disease.",Non-OADS,/arxiv_data1/oa_pdf/5f/71/ijmsv10p1387.PMC3752725.pdf
10     http://www.medsci.org  1389  were performed by Independent Sample t -test.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/ijmsv10p1387.PMC3752725.pdf
"10     http://www.medsci.org  1390  and number; therefore, the total platelet mass, the  product of the MPV and platelet count is closely reg- ulated.",Non-OADS,/arxiv_data1/oa_pdf/5f/71/ijmsv10p1387.PMC3752725.pdf
10     http://www.medsci.org  1391  7.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/ijmsv10p1387.PMC3752725.pdf
"10      http://www.medsci.org  1392  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1392 -1398.  doi: 10.7150/ ijms.5645  Research Paper   Effect of Melatonin on the Proliferation and Differenti- ation of Chondrocytes from Rat Vertebral Body  Growth Plate In Vitro   Zhao -Ming Zhong1*, Tao Li2 *, Zi-Xing Xu3, Ting -Ting Meng4, Ji-Huan Zeng1, Shuai Zheng1, Wen- Bin Ye1,  Qian Wu1, and Jian-Ting Chen 1  1.",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/ijmsv10p1392.PMC3752726.pdf
10     http://www.medsci.org  1393  growth plate chondrocytes during the growth period  plays a key role in regulation of the development of  vertebral growth plate [5].,Non-OADS,/arxiv_data1/oa_pdf/4f/4a/ijmsv10p1392.PMC3752726.pdf
10     http://www.medsci.org  1394  merase chain reaction  (real-time PCR ).,Non-OADS,/arxiv_data1/oa_pdf/4f/4a/ijmsv10p1392.PMC3752726.pdf
"10     http://www.medsci.org  1395  differentiation, and Smad4, which is a common m e- diator in regulating the proliferation and differenti a- tion of chondrocytes.",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/ijmsv10p1392.PMC3752726.pdf
10     http://www.medsci.org  1396    Fig 4.,Non-OADS,/arxiv_data1/oa_pdf/4f/4a/ijmsv10p1392.PMC3752726.pdf
"10     http://www.medsci.org  1397  tion, as assessed by the decrease in the mRNA e x- pression of collagen type II and aggrecan.",Non-OADS,/arxiv_data1/oa_pdf/4f/4a/ijmsv10p1392.PMC3752726.pdf
10     http://www.medsci.org  1398  36.,Non-OADS,/arxiv_data1/oa_pdf/4f/4a/ijmsv10p1392.PMC3752726.pdf
"10       http://www.medsci.org  1412  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1412 -1421.  doi: 10.7150/ ijms.5630  Review  The Possible Mechanisms Underlying the Impairment of  HIF-1α Pathway Signaling in H yperglycemia and the  Beneficial E ffects of Certain T herapies   Haijuan Xiao1, Zhenyang Gu2, Guoxing Wang3, Tongfeng Zhao1  1.",Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
This  is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
"10     http://www.medsci.org  1413  degradation of HIF -1α is mediated by the hydroxyl a- tion of two prolyl residues (402 and 564) in the oxy- gen-dependent degradation domain (ODD) by the  specific prolyl hydroxylases (PHDs) [4], which require  oxygen and 2 -oxoglutarate, as co- substrates, and iron  (Fe2+) and ascorbate, as co -factors [5, 6].",Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
10     http://www.medsci.org  1414  poxia [29].,Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
10     http://www.medsci.org  1415  cose -induced MGO [38].,Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
10       http://www.medsci.org  1416    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
"10     http://www.medsci.org  1417  ty, in which the effect of hyperglycemia wa s mi m- icked by mannitol  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
"10     http://www.medsci.org  1418  ative role that ROS induced by high glucose plays in  HIF-1α level s [40, 41, 47], HIF -1α accumulation due to  an inhibition of PHD activity by ROS has been  re- ported by Köhl and colleagues [65].",Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
"10     http://www.medsci.org  1419  saturated fatty acid abundant in fish oil, upregulates  local HIF -1α expression and augments the HIF -1α  response in diabetic kidney disease by suppressing ROS generation and mitochondrial apoptosis and thereby ameliorating hyperglycemia -induced renal  tubula r injury and dysfunction [75].",Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
10     http://www.medsci.org  1420  2.,Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
10     http://www.medsci.org  1421  49.,Non-OADS,/arxiv_data1/oa_pdf/5e/09/ijmsv10p1412.PMC3752727.pdf
"Beste,1Katharina No ¨h,2Sebastian Niedenfu ¨ hr,2Tom A. Mendum,1Nathaniel D. Hawkins,3Jane L. Ward,3 Michael H. Beale,3Wolfgang Wiechert,2and Johnjoe McFadden1,* 1Department of Microbial and Cellular Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK 2Forschungszentrum Ju ¨lich, GmbH, IBG-1, Biotechnology and JARA-HPC, 52428 Ju ¨lich, Germany 3National Centre for Plant and Microbial Metabolomics, Rothamsted Research, Harpenden, Herts AL5 2JQ, UK *Correspondence: j.mcfadden@surrey.ac.uk http://dx.doi.org/10.1016/j.chembiol.2013.06.012 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/49/83/main.PMC3752972.pdf
"Second, multistart ﬂux estima-tions were run based on initial ﬂux space sampling as described elsewhere(optimization library: NAG C; [http://www.nag.co.uk ] with ﬂux sampling rate = 100 and maximal iteration number max_iter = 150; Dalman et al., 2013 ) to account for locality pitfalls of the nonlinear weighted least-squares ﬁtting problem.",Non-OADS,/arxiv_data1/oa_pdf/49/83/main.PMC3752972.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six tables and can be found with this article online at http://dx.doi.org/10.1016/j.chembiol.2013.06.012 .,OADS,/arxiv_data1/oa_pdf/49/83/main.PMC3752972.pdf
http://dx.doi.org/10.1371/journal.ppat.0010033 .,Non-OADS,/arxiv_data1/oa_pdf/49/83/main.PMC3752972.pdf
"We mined theNCBI Gene Expression Omnibus (GEO)database ( http://www.ncbi.nlm.nih.gov /geo/ ) for microarray data generated for P. aeruginosa grown under conditions relevant to the CF lung environment.These data sets revealed no differentialexpression of bqsRS in response to multi- ple environmental stimuli, including lowoxygen, pH, phosphate starvation, oxida-tive stress, bioﬁlm formation, and variousantibiotic treatments (see Table S2 in thesupplemental material).",OADS,/arxiv_data1/oa_pdf/b5/5b/mBio.00557-13.PMC3753050.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/b1/ccide-5-057.PMC3753052.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dentistry 2013:5 57–61Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  57RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCIDE.S3517 0Allergy related to dental implant   and its clinical significance TP Chaturvedi Faculty of Dental Sciences, Institute  of Medical Sciences, Banaras Hindu  University, varanasi, India Correspondence: TP Chaturvedi   Faculty of Dental Science, Institute  of Medical Sciences, Banaras Hindu  University, varanasi, India 221005   Tel +91 542 230 9296   Tel +91 542 236 8547   email deanheaddentistry@gmail.co mAbstract:  The oral cavity provides an ideal and unique environment for study of biological  processes involving metallic dental aids.",Non-OADS,/arxiv_data1/oa_pdf/fe/b1/ccide-5-057.PMC3753052.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/fe/b1/ccide-5-057.PMC3753052.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fe/b1/ccide-5-057.PMC3753052.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/fe/btt-7-189.PMC3753053.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2013:7 189–198Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  189Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S3494 2Treatment and management of myelofibrosis   in the era of JAK inhibitors Clodagh Keohane Deepti H Radia Claire N Harrison Department of Haematology, Guy’s  and St Thomas’ NHS Foundation Trust,   London, UK Correspondence: Claire N Harrison   Guy’s and St Thomas’ NHS Foundation  Trust, Guy’s Hospital, Great Maze Pond,  London Se1 9RT, UK   Tel +44 20 7188 2742   Fax +44 20 7188 2728   email claire.harrison@gstt.nhs.u kAbstract:  Myelofibrosis (MF) can present as a primary disorder or evolve from polycythemia  vera (PV) or essential thrombocythemia (ET) to post-PV MF or post-ET MF , respectively.",Non-OADS,/arxiv_data1/oa_pdf/42/fe/btt-7-189.PMC3753053.pdf
Available from: http://clinicaltrials.gov/show/ NCT01790295.,Non-OADS,/arxiv_data1/oa_pdf/42/fe/btt-7-189.PMC3753053.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/42/fe/btt-7-189.PMC3753053.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/42/fe/btt-7-189.PMC3753053.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced o r disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/18/93/eut053.PMC3753060.pdf
http://kouroukaken-kyukyusosei.Info/wpm/archivepdf/21/2_11a.Pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/18/93/eut053.PMC3753060.pdf
http://www.Qqzaidan.Jp/aed/aed.Htm 19.,Non-OADS,/arxiv_data1/oa_pdf/18/93/eut053.PMC3753060.pdf
http://www.Stat.Go.Jp/data/kokusei/2005/index.Htm.,OADS,/arxiv_data1/oa_pdf/18/93/eut053.PMC3753060.pdf
http://www.Fdma.Go.Jp/ neuter/topics/houdou/2212/221203_1houdou/01_houdoushiryou.Pdf).,Non-OADS,/arxiv_data1/oa_pdf/18/93/eut053.PMC3753060.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/d2/idr-6-087.PMC3753063.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2013:6 87–92Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  87ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S4880 9Phenotypic and molecular characteristics   of methicillin-resistant Staphylococcus aureus    isolates from ekiti state, nigeria Olugbenga adekunle  Olowe1  Olayinka Oluwatoyin  Kukoyi2  samuel sunday Taiwo1  Olusola Ojurongbe1  Oluyinka Oladele Opaleye1  Oloyede samuel Bolaji1  abiodun adebimpe  adegoke1  Olufunmilola Bamidele  Makanjuola1  David Olusoga Ogbolu3  Oyebode T erry alli3 1Department of Medical Microbiology  and Parasitology, college of health  sciences, ladoke akintola University  of T echnology, Ogbomoso, nigeria;   2Department of Microbiology, college  of sciences, afe Babalola University,   ado-ekiti, nigeria; 3Department  of Biomedical sciences, college of  health sciences, lautech, Osogbo,   nigeria correspondence: Olugbenga a Olowe   Department of Medical Microbiology   and Parasitology, college of health   sciences, ladoke akintola University   of Technology, PMB 4000,   Ogbomoso, nigeria   Tel +234 806 654 7206   email olowekunle@yahoo.co mIntroduction:  The characteristics and antimicrobial resistance profiles of Staphylococcus  aureus  differs according to geographical regions and in relation to antibiotic usage.",Non-OADS,/arxiv_data1/oa_pdf/f9/d2/idr-6-087.PMC3753063.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/f9/d2/idr-6-087.PMC3753063.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/d2/idr-6-087.PMC3753063.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/bb/dddt-7-771.PMC3753064.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 771–776Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  771RapiD CommuniC aTionopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S4597 9Clinical study of etomidate emulsion combined  with remifentanil in general anesthesia Digui Weng menghua Huang Runnian Jiang Rufu Zhan Chunni Yang Department of anesthesiology,   mindong Hospital affiliated to Fujian  medical university, Fuan, Fujian,   people’s Republic of China Correspondence: Digui Weng   Department of anesthesiology, mindong   Hospital Affiliated to Fujian Medical   university, Fuan, Fujian, 355000,   people’s Republic of China   Tel/Fax +86 137 0693 0791   Email wdgmdyy813@163.co mBackground:  The aim of this study was to investigate and evaluate the safety, recovery time,  and side effects of general anesthesia with different doses of etomidate emulsion combined  with remifentanil.",Non-OADS,/arxiv_data1/oa_pdf/1f/bb/dddt-7-771.PMC3753064.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1f/bb/dddt-7-771.PMC3753064.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/bb/dddt-7-771.PMC3753064.pdf
Available from: http://www.cnki.net/KCMS/ detail/detail.aspx?QueryID=36&CurRec=33&dbcode=CJFQ&dbna me=CJFD1112&filename=LCMZ201104034&urlid=&yx=&uid=W EEvREcwSlJHSldTTGJhYlMyYVVPcmFOVWRvWTJRUUFOL0Q zMFdxK3o5N01yNXlsclZRZ3ZKblJ2TmcrRDBJMg==&v=MDI4 - NjVMbWZZT1Z2RnkvblU3ck5LUzdHZExHNEg5RE1xNDlHWUlS OGVYMUx1eFlTN0RoMVQzcVRyV00xRnJDVVI =.,OADS,/arxiv_data1/oa_pdf/1f/bb/dddt-7-771.PMC3753064.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/hiv-5-215.PMC3753065.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS – Research and Palliative Care 2013:5 215–221HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  215ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S4636 4Serum selenium and skin diseases among  Nigerians with human immunodeficiency virus/ acquired immune deficiency syndrome Adeolu Oladayo Akinboro1 David Ayodele Mejiuni2 Olaniyi Onayemi3 Olugbenga Edward Ayodele4 Adeniran Samuel Atiba5 Gbenga Micheal Bamimore6 1Dermatology Unit, Department of  Internal Medicine, College of Health  Sciences, Osogbo, and LAUTECH  Teaching Hospital, Ogbomoso, Oyo  State, Nigeria; 2Bullsbrook Medical  Practice, Perth, WA, Australia;   3Department of Dermatology and  Venereology, College of Health  Science, Obafemi Awolowo University  and OAUTHC, Ile – Ife, Osun State,   Nigeria; 4Department of Internal  Medicine, College of Health Sciences,   Osogbo and LAUTECH Teaching  Hospital, Ogbomoso, Oyo State,   Nigeria; 5Department of Chemical  Pathology, College of Medicine,    Ekiti State University, and Ekiti State  University T eaching Hospital,    Ekiti State, Nigeria; 6Dermatology  Unit, Department of Internal  Medicine, LAUTECH Teaching  Hospital, Ogbomoso, Oyo State,   nigeria Correspondence: Adeolu Oladayo  Akinboro   Dermatology Unit, Department of   Internal Medicine, Ladoke Akintola   University of Technology, Ogbomoso   and LAUTECH Teaching Hospital,  Ibadan-Ilorin Road, PMB 4007,   Ogbomoso, Oyo State, Nigeria   Tel +234 813 6872 240   email deolusteve111@yahoo.co mBackground:  The role of selenium as an antioxidant micronutrient has garnered the unprec - edented focus of researchers in recent times.",Non-OADS,/arxiv_data1/oa_pdf/9d/7e/hiv-5-215.PMC3753065.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/9d/7e/hiv-5-215.PMC3753065.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/7e/hiv-5-215.PMC3753065.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/64/ijn-8-3129.PMC3753148.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3129–3139International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3129OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4773 1Nanostructured systems containing babassu  (Orbignya speciosa)  oil as a potential alternative  therapy for benign prostatic hyperplasia Valeria Pereira de sousa1 Joanne crean2 Vinícius raphael de   almeida Borges1 carlos rangel rodrigues1 lidia Tajber2 Fabio Boylan2 lucio Mendes cabral1 1Department of Pharmaceutics,   Faculty of Pharmacy, Federal  University of rio de Janeiro, rio de  Janeiro, Brazil; 2school of Pharmacy  and Pharmaceutical sciences and  Trinity Biomedical sciences Institute,   Trinity college Dublin, Dublin, Ireland correspondence: Valeria Pereira de  sousa   Department of Pharmaceutics, Faculty  of Pharmacy, Federal University of rio  de Janeiro ccs, Bl Bss, sala 15, Ilha do  Fundão, 21941-590, rio de Janeiro, Brazil   Tel +55 21 2564 7380   Fax +55 21 2564 7380   email valeria@pharma.ufrj.b rAbstract:  The oil of babassu tree nuts ( Orbignya speciosa ) is a potential alternative for treatment  and prophylaxis of benign prostatic hyperplasia.",Non-OADS,/arxiv_data1/oa_pdf/d5/64/ijn-8-3129.PMC3753148.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d5/64/ijn-8-3129.PMC3753148.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/64/ijn-8-3129.PMC3753148.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/d5/64/ijn-8-3129.PMC3753148.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/ac/ijn-8-3161.PMC3753149.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3161–3169International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3161OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4997 2Evaluation of protective efficacy using   a nonstructural protein Ns1 in DNa vaccine– loaded microspheres against dengue 2 virus Shih-shiung Huang1 I-hsun li2,3 Po-da Hong1 Ming-kung Yeh1,2 1Biomedical Engineering Program,   graduate Institute of applied science  and T echnology, and Department of  Materials Science and Engineering,   National Taiwan University of Science  and T echnology, Taiwan; 2school of  Pharmacy, National Defence Medical  center and Bureau of Pharmaceutical  Affairs, Military of National Defence  Medical Affairs Bureau, Taipei, Taiwan;   3Department of Pharmacy Practice,   Tri-service general hospital, National  Defense Medical center, Taipei, Taiwan Correspondence: Ming-kung Yeh   School of Pharmacy, National Defence  Medical center, Taipei, No 161, sec 6,  Ming-chung E Rd, Taipei City 11490,  Taipei, Taiwan   Tel +886 2 2371 1112   Fax +886 2 2371 2734   email mkyeh2004@gmail.co mAbstract:  Dengue virus results in dengue fever or severe dengue hemorrhagic fever/dengue  shock syndrome in humans.",Non-OADS,/arxiv_data1/oa_pdf/c7/ac/ijn-8-3161.PMC3753149.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c7/ac/ijn-8-3161.PMC3753149.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/ac/ijn-8-3161.PMC3753149.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/e0/ijn-8-2859.PMC3753151.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 2859–2869International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2859OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4796 7T ernary nanoparticles composed of cationic solid  lipid nanoparticles, protamine, and DNa for gene  delivery sai-Nan he1 Yun-long li1,2 Jing-Jing Yan2 Wei Zhang2 Y ong-Zhong Du2 he-Y ong Yu1 Fu-Qiang hu2 hong Yuan2 1Women’s hospital, 2college of  Pharmaceutical sciences, school  of Medicine, Zhejiang University,   hangzhou, People’s republic of china correspondence: hong Yuan   college of Pharmaceutical sciences,  Zhejiang University, 866 Yuhangtang  road, hangzhou 310058, People’s  republic of china   Tel +86 571 8820 8439   Fax +86 571 8820 8439   email yuanhong70@zju.edu.c n    he-Yong Yu   Women’s hospital, school of Medicine,  Zhejiang University, 2 Xueshi road,  hangzhou 310006, People’s republic of  china   Tel +86 571 8706 1501   Fax +86 571 8706 1501   email yuhy@zju.edu.c nBackground:  The objective of this research was to design an effective gene delivery system  composed of cationic solid lipid nanoparticles (SLNs), protamine, and Deoxyribonucleic  acid DNA.",Non-OADS,/arxiv_data1/oa_pdf/e3/e0/ijn-8-2859.PMC3753151.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e3/e0/ijn-8-2859.PMC3753151.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/e0/ijn-8-2859.PMC3753151.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/17/ott-6-1129.PMC3753152.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1129–1138OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1129Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S4914 8arsenic trioxide inhibits viability of pancreatic   cancer stem cells in culture and in a xenograft  model via binding to shh-gli Jin-bin han1,2 Feng sang3 Jin-jia chang1,4 Y ong-qiang hua1,2 Wei-dong shi1,2 li-hua Tang1,2 lu-ming liu1,2 1Department of integrative Oncology,   Fudan University shanghai cancer  center, shanghai, 2Department of  Oncology, shanghai Medical college,   Fudan University, shanghai, 3The  center for aiDs research of the  First affiliated hospital of henan  University of TcM, Zhengzhou,   4Department of Medical Oncology,   Fudan University shanghai cancer  center, shanghai, People’s republic  of china correspondence: lu-ming liu   Department of integrative Oncology,   Fudan University shanghai cancer   center, 270 Dong an road, shanghai,   200032, People’s republic of china   Tel +86 216 417 5590 3636   Fax +86 216 404 9440   email llm1010@163.co mObjective:  Overexpression of the sonic hedgehog (SHH) signaling pathway is an essential  characteristic of pancreatic cancer stem cells (PCSCs) and arsenic trioxide (ATO) is described  as a SHH inhibitor.",Non-OADS,/arxiv_data1/oa_pdf/9d/17/ott-6-1129.PMC3753152.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9d/17/ott-6-1129.PMC3753152.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/17/ott-6-1129.PMC3753152.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/82/ijn-8-3071.PMC3753153.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3071–3091International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3071RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S4718 6Critical evaluation of biodegradable polymers  used in nanodrugs edgar Marin1–3 Maria Isabel Briceño2 Catherina Caballero- George1 1Unit of Pharmacology, Center of  Biodiversity and Drug Discovery,   Institute of Scientific Research and  High T echnology Services, 2Nano  Dispersions T echnology, Panama,   Republic of Panama; 3Department of  Biotechnology, Archaria Nagarjuna  University, Guntur, India Correspondence: Catherina Caballero- George   Institute of Scientific Research and High  Technology Services, Building 219 City  of Knowledge, Clayton, PO 0843-01103,  Panama, Republic of Panama   Tel +507 517 0700   Fax +507 517 0701   email c.caballerogeorge@gmail.co mAbstract:  Use of biodegradable polymers for biomedical applications has increased in recent  decades due to their biocompatibility, biodegradability, flexibility, and minimal side effects.",Non-OADS,/arxiv_data1/oa_pdf/30/82/ijn-8-3071.PMC3753153.pdf
"International Journal of Nanomedicine 2013:8submit your manuscript | www.dovepress.co m Dove press Dove press 3085Biodegradable polymers in nanodrugs Table 5 List of biodegradable polymers approved by the US Food and Drug Administration for use in the preparation of nanodrugs  updated to September 2012 ( http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm ) Polymer Route, dosage form CAS number Acrylates copolymer TD, controlled-release patch _ Acrylic acid-isooctyl acrylate copolymer TD, controlled-release film _ Ammonio methacrylate copolymer O, tablet _ Ammonio methacrylate copolymer type A O, extended-release capsule 33434241 Ammonio methacrylate copolymer type B O, extended-release tablet 33434241 Butyl ester of vinyl methyl ether/maleic anhydride copolymer   (125,000 molecular weight)T, solution 25119680 Carbomer homopolymer type A (allyl pentaerythritol crosslinked) O, extended-release tablet 138757683 Carbomer homopolymer type B (allyl sucrose crosslinked) T, gel _ Carboxy vinyl copolymer T, gel _ Cellulosic polymers O, capsule, enteric-coated pellets _ Dimethylaminoethyl methacrylate-butyl methacrylate-methyl   methacrylate copolymerO, sustained-action capsule _ Dimethylsiloxane/methylvinylsiloxane copolymer I, pellet, implant _ Divinylbenzene styrene copolymer OPH, suspension, drops _ ethyl acrylate-methacrylic acid copolymer O, delayed-action, coated, hard gelatin capsule _ ethyl acrylate and methyl methacrylate copolymer   (2:1; 750,000 molecular weight)O, capsule, enteric-coated pellets _ ethylene vinyl acetate copolymer I, rod _ ethylene-propylene copolymer TD, controlled-release film _ ethylene-vinyl acetate copolymer (28% vinyl acetate) v, insert _ Glycerin polymer solution i-137 O, tablet _ Glycerin polymer solution im-137 O, tablet _ Hydrogel polymer v, extended-release insert _ Ink/polyethylene terephthalate/aluminum/polyethylene/sodium   polymethacrylate/ethylene vinyl acetate copolymerTD, controlled-release film _ Isooctyl acrylate/acrylamide/vinyl acetate copolymer,   Kollidon® vA 64 polymerO, tablet, film-coated _ Methacrylic acid-ethyl acrylate copolymer (1:1) type A O, capsule 25212888 Methacrylic acid-methyl methacrylate copolymer (1:1) O, capsule 25086151 Methacrylic acid-methyl methacrylate copolymer (1:2) O, tablet 25086151 Methacrylic acid copolymer O, capsule _ Methacrylic acid copolymer type A O, sustained-action, coated tablet 25086151 Methacrylic acid copolymer type B O, extended-release capsule 25086151 Methacrylic acid copolymer type C O, sustained-action tablet 25212888 Octadecene-1/maleic acid copolymer T, lotion _ PeG-22 methyl ether/dodecyl glycol copolymer T, cream, augmented _ PeG-45/dodecyl glycol copolymer T, cream, augmented _ Polyester polyamine copolymer TD, controlled-release film _ Poly(ethylene glycol) 1,000 O, R, RP, and v; concentrate, solution, tablet, film-coated,   suppository, aerosol, metered, emulsion, aerosol foam25322683 Poly(ethylene glycol) 1,450 O, T, and U; solution, suspension, extended-release tablet,   film-coated, topical, ointment, suppository25322683 Poly(ethylene glycol) 1,500 O and T; tablet, ointment 25322683 Poly(ethylene glycol) 1,540 D and R; gel, paste, solution, tablet, coated, ointment 25322683 Poly(ethylene glycol) 200 IM, O, and T; injection, capsule, solution, tablet   extended-release, ointment112607 Poly(ethylene glycol) 20,000 O, hard gelatin capsule, delayed-action, enteric-coated tablet 25322683 Poly(ethylene glycol) 200,000 O, extended-release tablet _ Poly(ethylene glycol) 2,000,000 O, tablet _ Poly(ethylene glycol) 300 IV, IM, OPH, and T; injection, film-coated tablet 2615158 Poly(ethylene glycol) 300–1,600 O, tablet, delayed-action, enteric-coated _ Poly(ethylene glycol) 300–1,600 T, ointment _ Poly(ethylene glycol) 3,350 IA, IL, IM, N, SC, and T; injection, solution, spray,   soft gelatin capsule, extended-release tablet, ointment25322683 (Continued )",Non-OADS,/arxiv_data1/oa_pdf/30/82/ijn-8-3071.PMC3753153.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/30/82/ijn-8-3071.PMC3753153.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/82/ijn-8-3071.PMC3753153.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/a6/4a/jmdh-6-303.PMC3753154.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2013:6 303–310Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  303Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S4907 5Over-the-counter suboptimal dispensing   of antibiotics in Uganda Jackson K Mukonzo1,2 Proscovia M namuwenge1 gildo Okure3 Benjamin Mwesige1 Olivia K namusisi4 David Mukanga4 1center for Operational research  africa, Kampala, Uganda; 2Department  of Pharmacology and Therapeutics,   3school of Public Health, Makerere  University, Kampala, Uganda; 4african  Field epidemiologist network,   Kampala, Uganda correspondence: Jackson K Mukonzo   Department of Pharmacology and  Therapeutics, college of Health sciences,   Makerere University, Kampala University   road, PO Box 7072, Kampala, Uganda   Tel +256 77 259 3168   email mukojack@yahoo.co.u kBackground:  Overuse and misuse of antibiotics is a serious global problem.",Non-OADS,/arxiv_data1/oa_pdf/a6/4a/jmdh-6-303.PMC3753154.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/a6/4a/jmdh-6-303.PMC3753154.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/4a/jmdh-6-303.PMC3753154.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/5c/ijn-8-3141.PMC3753155.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3141–3150International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3141OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4770 8Preparation and characteristics of lipid  nanoemulsion formulations loaded   with doxorubicin sai-Ping Jiang1,2,* sai-Nan he3,* Yun-long li2,3 Da-lin Feng2 Xiao-Yang lu1 Y ong-Zhong Du2 he-Y ong Yu3 Fu-Qiang hu2 hong Yuan2 1Department of Pharmacy,    The First affiliated hospital, college  of Medicine, Zhejiang University,   hangzhou, 2college of Pharmaceutical  sciences, Zhejiang University,   hangzhou, 3Women’s hospital, school  of Medicine, Zhejiang University,   hangzhou, People’s republic of china *These authors contributed equally  to this work correspondence: hong Yuan   college of Pharmaceutical sciences,  Zhejiang University, 866 Yuhangtang  road, hangzhou 310058,   People’s republic of china   Tel +86 571 8820 84 39   Fax +86 571 8820 84 39   email yuanhong70@zju.edu.c nPurpose:  Safe and effective lipid nanoemulsion (LNE) formulations for the antitumor delivery  of doxorubicin is designed.",Non-OADS,/arxiv_data1/oa_pdf/87/5c/ijn-8-3141.PMC3753155.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/87/5c/ijn-8-3141.PMC3753155.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/5c/ijn-8-3141.PMC3753155.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/cc/tcrm-9-329.PMC3753169.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 329–340Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  329Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S4713 8Options for treating postherpetic neuralgia   in the medically complicated patient Patricia Bruckenthal1 Robert L Barkin2,3 1Department of Graduate Studies in  Advanced Practice Nursing, Stony  Brook University School of Nursing,   Stony Brook, NY, USA; 2Department  of Anesthesiology, Family Medicine,   and Pharmacology, Rush University  Medical College, Chicago, iL, USA;   3Department of Anesthesiology,   Northshore University Health System  Pain Centers, Skokie and evanston  Hospitals, Skokie and evanston,    iL, USA Correspondence: Patricia Bruckenthal   Stony Brook University School of Nursing,  Department of Graduate   Studies in Advanced Practice Nursing,   Stony Brook University, HSC L2,   Room 209, Stony Brook,   NY 11794-8240, USA   Tel +1 631 444 3268   Fax +1 631 444 3136   email patricia.bruckenthal@stonybrook.ed uAbstract:  Patients with postherpetic neuralgia (PHN) are often of advanced age or  immunocompromised and likely to have $1 comorbid medical condition for which they  receive $1 medication (polypharmacy).",Non-OADS,/arxiv_data1/oa_pdf/16/cc/tcrm-9-329.PMC3753169.pdf
"Available from: http://medicine.iupui.edu/flockhart/table.ht m. Accessed  June 20, 2012.",Non-OADS,/arxiv_data1/oa_pdf/16/cc/tcrm-9-329.PMC3753169.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/16/cc/tcrm-9-329.PMC3753169.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/cc/tcrm-9-329.PMC3753169.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/44/dddt-7-841.PMC3753171.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 841–847Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  841Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S4727 2Bioequivalence study of two formulations   of candesartan cilexetil tablet in healthy   subjects under fasting conditions raymond r Tjandrawinata1 effi setiawati2 Danang agung Yunaidi2 ronal simanjuntak2 iwan Dwi santoso2 liana W susanto1 1Dexa laboratories of Biomolecular  sciences (DlBs), cikarang, indonesia;   2Bioavailability and Bioequivalence  laboratory, PT equilab international,   Jakarta, indonesia correspondence: raymond r  Tjandrawinata   Dexa laboratories of Biomolecular  sciences, Dexa Medica group,   indonesia, industri selatan V,   Block PP no 7, Kawasan industri   Jababeka ii, cikarang 17550, indonesia   Tel +62 218 984 1901   Fax +62 218 984 1905   email raymond@dexa-medica.co mIntroduction:  The present study was conducted to compare the bioavailability of two   candesartan cilexetil 16 mg table t formulations (test and reference formulations).",Non-OADS,/arxiv_data1/oa_pdf/17/44/dddt-7-841.PMC3753171.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/17/44/dddt-7-841.PMC3753171.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/44/dddt-7-841.PMC3753171.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/17/44/dddt-7-841.PMC3753171.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/63/0a/cpaa-5-029.PMC3753206.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2013:5 (Suppl 1) 29–45Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  29Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S4923 1immunocytokines: a review of molecules in clinical  development for cancer therapy Thomas List Dario Neri Department of Chemistry and Applied  Biosciences, Swiss Federal institute  of T echnology (eTH Zürich), Zurich,   Switzerland Correspondence: Dario Neri   Department of Chemistry and Applied   Biosciences, Swiss Federal institute   of Technology (eTH Zürich),   wolfgang-Pauli-Strasse 10, CH-8093   Zurich, Switzerland   Tel +41 44 6337401   email neri@pharma.ethz.c hAbstract:  The concept of therapeutically enhancing the immune system’ s responsiveness to  tumors is long standing.",Non-OADS,/arxiv_data1/oa_pdf/63/0a/cpaa-5-029.PMC3753206.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/63/0a/cpaa-5-029.PMC3753206.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0a/cpaa-5-029.PMC3753206.pdf
DOI:http://dx.doi.org/10.5770/cgj.16.98EDITORIAL © 2013 Author(s).,Non-OADS,/arxiv_data1/oa_pdf/f8/5b/cgj-16-104.PMC3753207.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/5b/cgj-16-104.PMC3753207.pdf
"This belief may result in behaviours which predispose to frailty, such a lower levels Acceptance of Disability and the Risk of Frailty* Philip D. St. John, MD, MPH, FRCPC ,1  Patrick R. Montgomery, MD, FRCPC2 1Section of Geriatric Medicine, Department of Medicine, and the Centre on Aging,   University of Manitoba, Winnipeg, MB; 2Vancouver Island Health Authority, Victoria, BC DOI:http://dx.doi.org/10.5770/cgj.16.69ORIGINAL RESEARCH © 2013 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/28/e4/cgj-16-105.PMC3753208.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/e4/cgj-16-105.PMC3753208.pdf
"(6) Improving the Quality of Care for Older Adults   Using Evidence-Informed Clinical Care Pathways  Jayna M. Holroyd-Leduc, MD, FRCPC1,2, Vanessa Steinke, MHA2, Debbie Elliott, RN, BScN, MEd, CMSN(C)2,   Katherine Mullin, RN, MN, ONC(C)2, Kevin Elder, RN2, Stella Callender, RN, ONC(C)2,   and Kevin A. Hildebrand, MD, FRCSC1,2 1University of Calgary, Calgary, AB; 2Alberta Health Services, Calgary, AB DOI:http://dx.doi.org/10.5770/cgj.16.62ORIGINAL RESEARCH © 2013 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/82/a7/cgj-16-111.PMC3753209.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/a7/cgj-16-111.PMC3753209.pdf
"In 1996, Pereles and Russell(6) interviewed  family physicians in Calgary who reported that geriatric Medical Problems Referred to a Care of the   Elderly Physician: Insight for Future  Geriatrics CME Robert Lam, ms, md, ccfp,1 Anna Gallinaro, ma,1 Jenna Adleman, bsc, msc, (md Candidate 2014)2  1Department of Family & Community Medicine,  Toronto Western Hospital, University Health Network, Toronto, ON;  2University of Toronto, Toronto, ON DOI:http://dx.doi.org/10.5770/cgj.16.58ORIGINAL RESEARCH © 2013 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ee/b1/cgj-16-114.PMC3753210.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/b1/cgj-16-114.PMC3753210.pdf
"Major method - ological limitations of this body of research were uncovered including (1) lack of justification of sample size leaving studies open to Type II error (i.e., false negative findings), and (2) excessive focus on associations rather than clinically useful cut-off scores.Key words: Trail Making Test, Trails B, driving, fitness-to-drive, cut-off Introduct Ion  Physicians in most Canadian jurisdictions are legally man - dated to report medical findings that could impact on fitness-to-drive ( http://www.cma.ca/driversguide ).",Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
"There were Systematic review of the evidence for Trails B   cut-off scores in assessing fitness-to-drive Mononita Roy, MD, FRCPC ,1,2  Frank Molnar, MSc, MDCM, FRCPC1-6 1Division of Geriatric Medicine, The University of Ottawa, Ottawa, ON; 2The Ottawa Hospital, Ottawa, ON; 3The Bruyere  Research Institute, Ottawa, ON; 4The Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON;  5The Regional Geriatric Program of Eastern Ontario, The Ottawa Hospital, Ottawa, ON; 6CanDRIVE: a CIHR Institute of  Aging funded New Emerging Team, Ottawa Hospital Research Institute, Ottawa, ON DOI:http://dx.doi.org/10.5770/cgj.16.76SYSTEMIC REVIEWS/META-ANAL YSIS © 2013 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
"CANADIAN GERIATRICS JOURNAL, VOLUME 16, ISSUE 3, SEPTEMBER 2013ROY: TRAILS B CUT -OFFS IN ASSESSING DRIVING FITNESS 139 For a review of considerations in applying in-office  tests to the assessment of fitness-to-drive, please see page  11 of  http://www.canadiangeriatrics.ca/default/index.cfm/linkservid/0D194943-EF73-7DAB-77450BB92BFF239A/showMeta/0/.",Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
"(7) Furthermore, tests such as Trails B can  be employed within a more detailed assessment process, as described in http://www.cfp.ca/content/56/11/1123.full.pdf+html?sid=6ddf379a-874a-4d6f-9c64-02c6bf939312 .",Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
Avail - able from: http://www.ccmta.ca/english/pdf/medical_admin _ process_part_1_may2011.pdf  4.,Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
Available from: http://www.dft.gov.uk/dvla/medical/medical_advisory_information/ reviewofdm.aspx  5.,Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
Avail - able from: http://www.nhtsa.dot.gov/people/injury/olddrive/ OlderDriversBook 6.,Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
Available from: http://www.canadian   geriatrics.ca/default/index.cfm/linkservid/0D194943-EF73- 7DAB-77450BB92BFF239A/showMeta/0/  8.,Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
Available from: http://onlinelibrary.wiley.com/doi/10.1111/ j.1532-5415.2006.00967.x/pdf  23.,Non-OADS,/arxiv_data1/oa_pdf/e3/4b/cgj-16-120.PMC3753211.pdf
"Something of a pragmatic reply to the question of what do  we do now comes in the chapter by Alina Solomon and Miia Kivipelto, in their summary of the 2010 National Institutes of Health report on AD prevention (http://www.ahrq.gov/clinic/tp/alzcogtp.htm ).",Non-OADS,/arxiv_data1/oa_pdf/71/60/cgj-16-143.PMC3753212.pdf
"The experience has not gone well, and the almost inevitable next step (to combine biomarkers) so far is demonstrating chiefly that improvement in sensitivity is bought only by declining specificity, and vice versa.Book Review: Chronic Medical Disease &   Cognitive Aging: Toward a Healthy Body   and Brain , edited by Kristine Yaffe   (New Y ork Oxford University Press, 2013) Kenneth Rockwood, MD, FRCPC, FRCP, FCAHS Department of Medicine (Geriatric Medicine & Neurology), Dalhousie University and Centre for Health Care  of the Elderly, Capital District Health Authority, Halifax, NS, Canada DOI:http://dx.doi.org/10.5770/cgj.16.88REVIEW © 2013 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/71/60/cgj-16-143.PMC3753212.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/60/cgj-16-143.PMC3753212.pdf
"Int J Geriatr  Psychiatry  1998;13:405–9.Corrigendum: The Practice of Geriatrics:   Specialized Geriatric Programs and Home Visits David B. Hogan, MD, FRCPC, FACP Department of Medicine, University of Calgary, Calgary, Alberta  DOI:http://dx.doi.org/10.5770/cgj.16.94CORRIGENDA © 2013 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ab/0d/cgj-16-145.PMC3753213.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/0d/cgj-16-145.PMC3753213.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/b y-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/1d/ijbsv09p0728.PMC3753409.pdf
http://cancergenome.nih.gov.,Non-OADS,/arxiv_data1/oa_pdf/0f/1d/ijbsv09p0728.PMC3753409.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a3/0a/ijbsv09p0743.PMC3753410.pdf
"Bioinformatic analysis of miR -34c-5p target  genes   Putative miR- 34c-5p targets were predicted u s- ing several different  algorithms, including TargetScan  (http://www.targetscan.org/),  Pictar (http://pictar.",OADS,/arxiv_data1/oa_pdf/a3/0a/ijbsv09p0743.PMC3753410.pdf
An interaction between miR -34c-5p  and the 3’ UTR of  its target gene was predicted by  RNAhybrid  (http://bibiserv.tech fak.uni- bielefeld.,OADS,/arxiv_data1/oa_pdf/a3/0a/ijbsv09p0743.PMC3753410.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0c/32/ijbsv09p0753.PMC3753411.pdf
"10       http://www.medsci.org  1271  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1271 -1277.  doi: 10.7150/ ijms.6597  Research Paper   Heat Shock Protein27 Expression and Cell Differentia- tion in Ameloblastomas  Muneteru Fujita1, Keisuke Nakano1,4, Akiyoshi Funato2, Yoshihiko Sugita2,5, Katsutoshi Kubo2,5,  Hatsuhiko Maeda2,5, Norimasa Okafuji3, Hiromasa Hasegawa1,4 and Toshiyuki Kawakami1  1.",Non-OADS,/arxiv_data1/oa_pdf/55/3f/ijmsv10p1271.PMC3753412.pdf
This is an open- access arti cle distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/55/3f/ijmsv10p1271.PMC3753412.pdf
10     http://www.medsci.org  1272  phology as well as cell differentiation in the tumor  nests were analyzed.,OADS,/arxiv_data1/oa_pdf/55/3f/ijmsv10p1271.PMC3753412.pdf
10     http://www.medsci.org  1273  follicular type showed positive reaction to HSP27  particularly the sites with squamous metaplasia  which was strongly reflected in the marginal cells of  the parenchyma  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/55/3f/ijmsv10p1271.PMC3753412.pdf
10       http://www.medsci.org  1274  Table 2 shows the quantitative results of IHC.,OADS,/arxiv_data1/oa_pdf/55/3f/ijmsv10p1271.PMC3753412.pdf
10       http://www.medsci.org  1275    Fig 2 .,Non-OADS,/arxiv_data1/oa_pdf/55/3f/ijmsv10p1271.PMC3753412.pdf
10     http://www.medsci.org  1276    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/55/3f/ijmsv10p1271.PMC3753412.pdf
10     http://www.medsci.org  1277  stained with pHSP27.,Non-OADS,/arxiv_data1/oa_pdf/55/3f/ijmsv10p1271.PMC3753412.pdf
"10       http://www.medsci.org  1295  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1295 -1300.  doi: 10.7150/ ijms.6619  Research Paper   Heart Rate Significantly Influences the Relationship  between Atrial Fibrillation and Arterial Stiffness  Chun -Yuan Chu1, Tsung -Hsien Lin1,3, Po-Chao Hsu1, Wen -Hsien Lee1,2, Hung -Hao Lee1, Cheng -An Chiu1,  Ho-Ming Su1,2,3, Chee- Siong Lee1,3, Hsueh -Wei Yen1,3, Wen- Chol Voon1,3, Wen- Ter Lai1,3, Sheng -Hsiung  Sheu1,3  1.",Non-OADS,/arxiv_data1/oa_pdf/c2/21/ijmsv10p1295.PMC3753413.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/21/ijmsv10p1295.PMC3753413.pdf
"10     http://www.medsci.org  1296  many noninvasive methods  have been developed,  and they usually require  expertise techniques  [14].",Non-OADS,/arxiv_data1/oa_pdf/c2/21/ijmsv10p1295.PMC3753413.pdf
"10     http://www.medsci.org  1297  test, respectively.",Non-OADS,/arxiv_data1/oa_pdf/c2/21/ijmsv10p1295.PMC3753413.pdf
10     http://www.medsci.org  1298  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/c2/21/ijmsv10p1295.PMC3753413.pdf
"10     http://www.medsci.org  1299  confounding factors, including age and SB P, this a s- sociation remained significant.",Non-OADS,/arxiv_data1/oa_pdf/c2/21/ijmsv10p1295.PMC3753413.pdf
"10     http://www.medsci.org  1300  Conclusions    This study  demonstrated the presence of  AF  was associated with  increased baPWV in a multivar i- ate model, but this association  became insignificant  after further adjustment for HR, which suggested HR  could significantly influence the relationship between  AF and baPWV .",OADS,/arxiv_data1/oa_pdf/c2/21/ijmsv10p1295.PMC3753413.pdf
"10       http://www.medsci.org  1301  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1301 -1306.  doi: 10.7150/ ijms.6607  Research Paper   Lentivirus -based RNA Silencing of Nemo- like K inase  (NLK) Inhibits the CAL 27 Human Adenosquamos  Carcinoma Cells Proliferation and Blocks G0/G1 Phase  to S P hase  Bin Zhang1,2, Ke Yi Li2, Hai Ying  Chen3, Shao Dong Pan3, Shuang Feng  Chen3, Wei Feng  Zhang2, Chun  Peng  Xia2, Li Cheng  Jiang2, Xian  Bin Liu2, Feng Jun  Zhao3, Dao Ying  Yuan2, Le Xin Wang2,4, Ya Ping   Wu3,5, Shu Wei  Liu1  1.",Non-OADS,/arxiv_data1/oa_pdf/b2/80/ijmsv10p1301.PMC3753414.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b2/80/ijmsv10p1301.PMC3753414.pdf
"10     http://www.medsci.org  1302  Recent studies have revealed that many molecules are  deeply involved in the oral squamous cell carcinoma  formation and metastasis (4-7), which provide the  genetic therapeutic targets for treatment of this kind  of can cer.",Non-OADS,/arxiv_data1/oa_pdf/b2/80/ijmsv10p1301.PMC3753414.pdf
10     http://www.medsci.org  1303  osystems).,Non-OADS,/arxiv_data1/oa_pdf/b2/80/ijmsv10p1301.PMC3753414.pdf
10     http://www.medsci.org  1304  number per colony was dramatically reduced (Figure  2B).,Non-OADS,/arxiv_data1/oa_pdf/b2/80/ijmsv10p1301.PMC3753414.pdf
10     http://www.medsci.org  1305      Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/b2/80/ijmsv10p1301.PMC3753414.pdf
"10     http://www.medsci.org  1306  Abbreviations   NLK: Nemo -like kinase; MTT: 3 -(4,5-  Dimethylthiazol -2-yl)-2,5-Diphenyltetrazolium  Bro- mide; T -cell factor : TCF; APC: adenomatous polyposis  coli gene product; RT -PCR: real -time reverse tra n- scription -polymerase chain reaction; siRNA: small  interfering double stranded RNA; shRNA : short  hairpin; LV-shNLK : Lentivirus/shRNA -NLK;   LV-shCon:  Letivirus/shRNA -Control .",Non-OADS,/arxiv_data1/oa_pdf/b2/80/ijmsv10p1301.PMC3753414.pdf
"10       http://www.medsci.org  1321  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1321 -1326.  doi: 10.7150/ ijms.6631  Research Paper   Promotion of Transplanted Bone Marrow -derived Cell  Migration into the Periodontal Tissues due to Orth o- dontic Mechanical Stress  Mihoko Tomida1, Hidetsugu Tsujigiwa2, Keisuke Nakano3, Rina Muraoka4, Takami Nakamura1, Nori- masa Okafuji3, Hitoshi Nagatsuka2, Toshiyuki Kawakami3  1.",Non-OADS,/arxiv_data1/oa_pdf/5e/79/ijmsv10p1321.PMC3753415.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5e/79/ijmsv10p1321.PMC3753415.pdf
"10     http://www.medsci.org  1322  organs  namely , retinal vessels,  myoblasts, hepatocy tes  in the liver, Purkinje neurons, cardiac muscle in the  heart, and airway epithelial cells  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/5e/79/ijmsv10p1321.PMC3753415.pdf
10     http://www.medsci.org  1323  Germany).,Non-OADS,/arxiv_data1/oa_pdf/5e/79/ijmsv10p1321.PMC3753415.pdf
"10     http://www.medsci.org  1324  fat cartilage, bone, muscle , tendon, ligament and fat   [29].",Non-OADS,/arxiv_data1/oa_pdf/5e/79/ijmsv10p1321.PMC3753415.pdf
10       http://www.medsci.org  1325    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/5e/79/ijmsv10p1321.PMC3753415.pdf
10     http://www.medsci.org  1326  16.,Non-OADS,/arxiv_data1/oa_pdf/5e/79/ijmsv10p1321.PMC3753415.pdf
"10       http://www.medsci.org  1352  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1352 -1360. doi: 10.7150/ ijms.6714  Research Paper  Clustering  Patterns of Comorbidities Associated with  In-Hospital Death in Hospitalizations of US Adult s with  Venous Thromboembolism   James Tsai1, Althea M. Grant1, J. Michael Soucie1, Amy Helwig2, Hussain R. Yusuf1, Sheree L. Boulet3,  Nimia L. Reyes1, Hani K. Atrash1  1.",Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
"10       http://www.medsci.org  1353  Introduction  Venous thromboembolism (VTE), presenting  clinically as pulmonary embolism or deep vein  thrombosis, and its long -term sequelae of  post -thrombotic syndrome and chronic thromboe m- bolic pulmonary hypertension are significant sources  of mortality, morbidity, dis ability, and impaired  health -related quality of life in the world [1 -4].",Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
"10     http://www.medsci.org  1354  sex, vital status, length of hospital stay, or status of  primary expected payer, 153,124 unweighted hosp i- talizations were included in the analyses.",OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
"10     http://www.medsci.org  1355  with 80 years and older, male, Asian or other  race/ethnicity, or “non -operating room procedure.”  Additionally, the case -fatality rates were higher  among subgroups of patients whose primary e x- pected payer was Medicare or who had at least 5  comorbidities than among those with other insurance  payers or with fewer number of como rbidities (P <  0.001) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
10     http://www.medsci.org  1356    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
10     http://www.medsci.org  1357  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
10     http://www.medsci.org  1358  a.,Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
10     http://www.medsci.org  1359  cross -sectional study design cannot establish such a  relationship.,Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call -to -action -on-dvt-2008.pdf .,Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
10     http://www.medsci.org  1360  15.,Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
Introduction to the HCUP Nationwide Inpatient Sample (NIS);   Healthcare Cost and Utilization Project (HCUP);  2009.  http://www.hcup -us.ahrq.gov/db/nation/nis/NIS_Introduction_2009.,OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
http://www.hcup -us.ahrq.gov/nisoverview.jsp .,Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
Procedure Classes 2012. http://www.hcup -us.ahrq.gov/   toolssoftware/procedure/procedure.jsp .,OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
http://www.hcup -us.ahrq.gov/db/vars/orproc/nisnote.jsp .,OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
"Comorbidity Software, Version 3.7.   http://www.hcup -us.ahrq.gov/toolssoftware/comorbidity/comorbidit y.jsp.",OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
http://www.rwjf.org/files/research/50968chronic.care.chartbook.pdf .,Non-OADS,/arxiv_data1/oa_pdf/60/bc/ijmsv10p1352.PMC3753416.pdf
"10       http://www.medsci.org  1375  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1375 -1386.  doi: 10.7150/ ijms.6855  Research Paper   Effect of Antisense Oligodeoxynucleotides Glucose  Transporter- 1 on Enhancement of Radiosensitivity of  Laryngeal Carcinoma   Sen- Xiang Yan1, Xing -Mei Luo1, Shui -Hong Zhou2 , Yang -Yang Bao2, Jun Fan3, Zhong -Jie Lu1, Xin -Biao  Liao1, Ya-Ping Huang3, Ting -Ting Wu2, Qin -Ying Wang 2  1.",Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
10     http://www.medsci.org  1376  The exact mechanism of the radioresistance of  laryngeal carcinoma remains unclear.,Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
"10     http://www.medsci.org  1377  (+) was transfected into Hep -2 cells using the  Lipofectamine 2000 reagent (Invitrogen Co., Ltd.,  USA).",Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
"10     http://www.medsci.org  1378  was first denatured at 94°C for 3 min, followed by 30  cycles at 94°C for 1 min, 57°C for 30 s, and 72°C for 30  s; and a final extension period at 72°C for 10 min.",Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
10     http://www.medsci.org  1379  pre-denatured at 65 °C for 10 min.,Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
"10       http://www.medsci.org  1380  After transfection of GLUT -1 AS -ODNs, MTS  assay showed the survival rates of radiation  groups(2Gy,4Gy,8Gy,12Gy)were gradually reduced  with the prolongation of culture time(p<0.05,Figure  1C); At the same time, cell survival rates were signi f- icantly reduced along with the increasing of radiation dose(p<0.05,  Figure 1D ).",Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
"10       http://www.medsci.org  1381  24h after radiation, western blotting showed e x- pression of GLUT -1 protein in 2Gy, 4Gy and 12Gy  group was higher than that in the control group b e- fore transfection ( p<0.05 , Figure 3A,3B), the expre s- sion of GLUT -1protein in 12Gy group was highest in  all groups( p<0.05 ,Figure 3A,3B) whereas, the expres- sion of GLUT -1protein in 8Gy was lowest in all  groups( p<0.05 , Figure 3A,3B ).",Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
10     http://www.medsci.org  1382      Figure 4:  The change of cell cycle after radiation.,Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
"10       http://www.medsci.org  1383  Effect of GLUT -1 AS-ODNs on tumor growth  in vivo after irradiation   The volumes of xenograft  tumor after 8Gy rad i- ation plus transfection of GLUT -1 AS -ODNs were  significant decreased when mouse were sacrificed  compared to 8Gy radiation alone, reducing  mean tumor volume > 30% by 12 day s after the initiation of   treatment.",Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
"10       http://www.medsci.org  1384  Real -time RT -PCR revealed that the expressions  of GLUT -1 mRNA after 8Gy radiation plus transfe c- tion of GLUT -1 AS -ODNs were significant decreased  compared to 8Gy radiation alone (0.3960 ±0.0456  vs  1.0137 ±0.1176, p<0.001, Figure  6B).",OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
"10     http://www.medsci.org  1385  study, we found that a cle ar arrest of cells in the  G2/M phase depending on radiation dose, which  indicated entry into mitosis had been delayed.",Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
10     http://www.medsci.org  1386  expression with the biological behaviors.,Non-OADS,/arxiv_data1/oa_pdf/59/5a/ijmsv10p1375.PMC3753417.pdf
"10       http://www.medsci.org  1399  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1399 -1405.  doi: 10.7150/ ijms.6652  Research Paper   Differences of Circulating Inflammatory Markers b e- tween Large - and Small Vessel Disease in Patients with  Acute Ischemic Stroke   Lili Zeng1,2#, Xiaosong He2,3#, Jianrong Liu1, Ling Wang1, Sui qing Weng1, Yong ting Wang2,3, Shengdi Chen1  and Guo -Yuan Yang1,2,3   1.",Non-OADS,/arxiv_data1/oa_pdf/e1/f9/ijmsv10p1399.PMC3753418.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e1/f9/ijmsv10p1399.PMC3753418.pdf
"10     http://www.medsci.org  1400  results in stenosis or occlusion of intra or extracranial  large arteries, the instable plaque, artery to artery  embolism and hypo -perfusion.",Non-OADS,/arxiv_data1/oa_pdf/e1/f9/ijmsv10p1399.PMC3753418.pdf
"10     http://www.medsci.org  1401  ble 1,  p>0.05).",Non-OADS,/arxiv_data1/oa_pdf/e1/f9/ijmsv10p1399.PMC3753418.pdf
"10       http://www.medsci.org  1402  CRP was the only inflammatory mediator,  which correlated to noncardioembolic stroke  subtype.",Non-OADS,/arxiv_data1/oa_pdf/e1/f9/ijmsv10p1399.PMC3753418.pdf
10     http://www.medsci.org  1403  Table 3  Circulating inflammatory markers between large - and small vessel disease in patients with acute ischemic stroke within 1- 3 days  of onset.,Non-OADS,/arxiv_data1/oa_pdf/e1/f9/ijmsv10p1399.PMC3753418.pdf
"10     http://www.medsci.org  1404      DISCUSSIONS   Our study demonstrated that among a panel of  inflammatory markers, CRP was the only one, which  can distinguish large - from small vessel disease in  acute ischemia stroke patients with 85.7% sensitivity.",Non-OADS,/arxiv_data1/oa_pdf/e1/f9/ijmsv10p1399.PMC3753418.pdf
10     http://www.medsci.org  1405  drugs e.g.,Non-OADS,/arxiv_data1/oa_pdf/e1/f9/ijmsv10p1399.PMC3753418.pdf
"10       http://www.medsci.org  1406  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1406 -1411. doi: 10.7150/ ijms.6565  Research Paper  Identification and Determination of Antibiotic Susce p- tibilities of Brucella Strains  Isolated from Patients i n Van,  Turkey  by Conventional and Molecular Methods  Mehmet Parlak1, Hüseyin Güdücüoğlu2, Yasemin Bayram2, Aytekin Çıkman3, Cenk Aypak4, Selçuk  Kılıç5, Mustafa Berktaş2   1.",Non-OADS,/arxiv_data1/oa_pdf/c5/8e/ijmsv10p1406.PMC3753419.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c5/8e/ijmsv10p1406.PMC3753419.pdf
"10     http://www.medsci.org  1407  America and Central Asia with 500,000 new cases  reported every year.2-4 Although the prevalenc e of  brucellosis has decreased in many developed cou n- tries due to various eradication programs, it still r e- mains an important endemic disease in Turkey, where  10,000 human brucellosis cases are reported annua l- ly.5,6 The most common symptoms of brucellosis are  recurring fever, chills, shivering, fatigue, body aches,  joint and back pain, anorexia and weakness.",Non-OADS,/arxiv_data1/oa_pdf/c5/8e/ijmsv10p1406.PMC3753419.pdf
"10     http://www.medsci.org  1408  Turkey) for biovar differenti ation of B. melitensis   biovar 1, 2 and 3 in a single PCR tube.17 For this pu r- pose, 2 μl of DNA extract was added to 45 μl of a m- plification mixture, and 40 PCR cycles were pe r- formed.",Non-OADS,/arxiv_data1/oa_pdf/c5/8e/ijmsv10p1406.PMC3753419.pdf
10     http://www.medsci.org  1409  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/8e/ijmsv10p1406.PMC3753419.pdf
10     http://www.medsci.org  1410  pin.,Non-OADS,/arxiv_data1/oa_pdf/c5/8e/ijmsv10p1406.PMC3753419.pdf
10     http://www.medsci.org  1411  14.,Non-OADS,/arxiv_data1/oa_pdf/c5/8e/ijmsv10p1406.PMC3753419.pdf
"10       http://www.medsci.org  1422  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(10): 1422 -1429.  doi: 10.7150/ ijms.6809  Research Paper   PITX2c Loss- of-Function Mutations Responsible for  Congenital Atrial Septal Defects  Fang Yuan1#, Lan Zhao2#, Juan Wang3, Wei Zhang4, Xin Li5, Xing -Biao  Qiu1, Ruo-Gu Li1, Ying -Jia Xu1, Lei  Xu1, Xing -Kai Qu1, Wei -Yi Fang1, Yi-Qing Yang1,6   1.",Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
10     http://www.medsci.org  1423  having cardiovascular abnormalities [1].,Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
"10     http://www.medsci.org  1424  Genotyping  for PITX2c   Genomic DNA from all participants was e x- tracted from blood lymphocytes with  Wizard G e- nomic DNA Purification Kit ( Promega, Madison, WI,  USA ).",Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
"NC_000004) , which was at the National  Center for Biotechnical Information (NCBI;  http://www.ncbi.nlm.nih.gov/) .",OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
"With the help of  on-line Primer 3 software  (http://frodo.wi.mit.edu ),  the primer pairs used to amplify the whole coding  region and  splice junction sites of PITX2c  by poly- merase chain reaction (PCR) were designed as prev i- ously described [33] .",OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
"Addition ally, for an  identified sequence variant , the Exome Variant Server  (EVS; http://evs.gs.washington.edu/EVS)  and  NCBI’s  single nucleotide polymorphism (SNP;  http://www.ncbi.nlm.nih.gov /SNP ) online dat a- bases were queried to confirm its nov elty.",OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
"Prediction of the c ausative  potential of a  PITX2c  sequence variation   The disease- causing potential of a  PITX2c  se- quence vari ation was predicted by MutationTaster (an  online program at http://www.mutationtaster.org), which automatically g ave a probability for the vari a-tion to be either a pathogenic mutation  or a benign   polymorphism .",Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
"In addition, another online program PolyPhen- 2  (http://genetics.bwh.harvard.edu/pph2 ) was also  used to evaluate the causative likeliness of a  variant.",OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
10     http://www.medsci.org  1425  activation of Firefly luciferase relative to Renilla lu- ciferase.,Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
10       http://www.medsci.org  1426    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
"10     http://www.medsci.org  1427  and M119T -mutant PITX2c ( 2 μg ) activated the ANF   promoter by ~ 10-fold, ~4-fold and ~2-fold increase,  respectively, when compared with the empty pla s- mid.",Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
"10     http://www.medsci.org  1428  xenopus, while the  fourth isoform, PITX2 d, which  lacks  the amino -terminal domain and most of  the  homeodomain, has only been observed  in humans.",Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
10     http://www.medsci.org  1429  8.,Non-OADS,/arxiv_data1/oa_pdf/1f/86/ijmsv10p1422.PMC3753420.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/99/5c/ijbsv09p0759.PMC3753440.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/15/ijbsv09p0766.PMC3753441.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/a6/ijbsv09p0778.PMC3753442.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f1/12/ijbsv09p0792.PMC3753443.pdf
"Stability of the eight candidate reference genes were  comprehensively evaluated using algorithm s geNorm   version  3.5 ( http://medgen.ugent.be/~jvdesomp/   genorm /) [9], NormFinder  version 0.953  (http ://www.mdl.dk/ publicationsnormfinder.htm)  [10], BestKeeper  (http://www.wzw.tum.de/gene -  quantification/bestkeeper.html) [11], and the compar- ative ΔCt method  [29].",OADS,/arxiv_data1/oa_pdf/f1/12/ijbsv09p0792.PMC3753443.pdf
"Finally, we compared and  ranked the tested candidates based on a web -based  analysis tool RefF inder  (http://www.leonxie.com/  referencegene.php) [30].",OADS,/arxiv_data1/oa_pdf/f1/12/ijbsv09p0792.PMC3753443.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f7/79/ijbsv09p0803.PMC3753444.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3 .0/).,Non-OADS,/arxiv_data1/oa_pdf/38/06/ijbsv09p0811.PMC3753445.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/58/a5/ijbsv09p0818.PMC3753446.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/62/ijbsv09p0830.PMC3753447.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a7/db/ijbsv09p0842.PMC3753448.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003203).,Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"World Health Organization, 2008. http://www.who.int/social_determinants/thecommission/finalreport/en/index.html (accessed Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Canberra: ABS, 2012. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/1301.0~2012~Main% 20Features~Downloads~96 (accessed May 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Canberra: AIHW, 2008. http://www.aihw.gov.au/publication-detail/?id=6442468076 (accessed May 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Canberra: AIHW, 2010. http://www.aihw.gov.au/publication-detail/?id=6442468376&tab=2 (accessed May2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Canberra: ABS, 2012. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3303.02010?OpenDocument(accessed Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Canberra: AIHW, 2012. http://www.aihw.gov.au/publication-detail/?id=10737421466&tab=2 (accessed May 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Canberra: ABS, 2011. http://www.abs.gov.au/ausstats/abs@.nsf/mf/1345.4 (accessed Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Adelaide: Population Research & Outcome Studies Unit —SA Health; and Greater Green Triangle, University Department of Rural Health, Flinders University and Deakin University 2010. http://www.greaterhealth.org (accessed Jun 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"National HeartFoundation of Australia; 2009. http://www.heartfoundation.org.au/ 8 Tideman P, Taylor AW, Janus E, et al.BMJ Open 2013; 3:e003203.",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Canberra:ABS, 2009. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3228.0.55.0012009?OpenDocument#Publications(accessed Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Canberra: ABS, 2010. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/1216.0July% 202010?OpenDocument (accessed Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"2039.0).Canberra: ABS, 2006. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/2039.02006?OpenDocument (accessed Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
"Canberra: AIHW, 2007. http://www.aihw.gov.au/search/?q=The+burden+of+disease+and +injury+in+Australia+2003 (accessed Jun 2012).",Non-OADS,/arxiv_data1/oa_pdf/06/22/bmjopen-2013-003203.PMC3753472.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003342).,Non-OADS,/arxiv_data1/oa_pdf/74/61/bmjopen-2013-003342.PMC3753473.pdf
"We sampled systematic reviews from two specialised databases: those published in theCochrane Database of Systematic Reviews (n=100) in the Cochrane Library (http://www.cochranelibrary.org) and those from the Database of Reviews of Effects (DARE)(n=100) through the Centre for Reviews and Dissemination, University of York (http://www.crd.york.",OADS,/arxiv_data1/oa_pdf/74/61/bmjopen-2013-003342.PMC3753473.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCE 1.,Non-OADS,/arxiv_data1/oa_pdf/74/61/bmjopen-2013-003342.PMC3753473.pdf
2012. http://www.effectivehealthcare.hrq.gov.,Non-OADS,/arxiv_data1/oa_pdf/74/61/bmjopen-2013-003342.PMC3753473.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org and http://www.cochrane-handbook.org 17.",OADS,/arxiv_data1/oa_pdf/74/61/bmjopen-2013-003342.PMC3753473.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003328).,Non-OADS,/arxiv_data1/oa_pdf/a6/26/bmjopen-2013-003328.PMC3753474.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003352).,Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
"For a pro ﬁle of patients identi ﬁed using these alternative denominators, see http://www.nuf ﬁeldtrust.org.uk/.",Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
A detailed business case analysis with mean emer- gency inpatient costs in the next 12 months within each risk vigintile level is available via http://www.nufﬁeldtrust.org.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
"Our analysis is somewhat limited by the small number of sites involved, whichmight cause somewhat greater variability in regression coefﬁcients (regression coef ﬁcients for each of the ﬁve four-site models are available at http://www.nufﬁeldtrust.org.uk/).",Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
"Kings Fund, February, 2006. http://www.kingsfund.org.uk/sites/files/kf/field/field_document/PARR-case-finding-algorithms-feb06.pdf (last accessed 4 Jun 2013).",Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
"Kings Fund, Dec 2006. http://www.kingsfund.org.uk/sites/files/kf/field/field_document/PARR-combined-predictive-model-final-report-dec06.pdf (lastaccessed 4 Jun 2013).",Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
"Wales Predictive Model: Final Report and Technical Documentation, 2008. http://www.nliah.com/portal/microsites/Uploads/Resources/k5cma8PPy.pdf (last accessed 4 Jun 2013).",Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
10. http://systems.hscic.gov.uk/data/uktc/readcodes (last accessed 14 May 2013).,OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
11. http://www.connectingforhealth.nhs.uk/systemsandservices/sus (last accessed 14 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
October 2008. http://csrc.nist.gov/publications/fips/fips180-3/fips180-3_final.pdf last (accessed 30 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/f5/ec/bmjopen-2013-003352.PMC3753475.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003335).,Non-OADS,/arxiv_data1/oa_pdf/79/be/bmjopen-2013-003335.PMC3753476.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/79/be/bmjopen-2013-003335.PMC3753476.pdf
http://www.cred.be/sites/default/files/ADSR_2011.pdf (accessed 30 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/79/be/bmjopen-2013-003335.PMC3753476.pdf
"http://handbook.cochrane.org Johnsen AS, Fattah S, Sollid SJM, et al.BMJ Open 2013; 3:e003335.",OADS,/arxiv_data1/oa_pdf/79/be/bmjopen-2013-003335.PMC3753476.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003217).,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/bmjopen-2013-003217.PMC3753479.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/bmjopen-2013-003217.PMC3753479.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003547).,Non-OADS,/arxiv_data1/oa_pdf/d9/a6/bmjopen-2013-003547.PMC3753480.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/a6/bmjopen-2013-003547.PMC3753480.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003400).,Non-OADS,/arxiv_data1/oa_pdf/84/df/bmjopen-2013-003400.PMC3753481.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/84/df/bmjopen-2013-003400.PMC3753481.pdf
Report of a WHO consultation [eLetter] February 1998. http://www.who.int/csr/resources/publications/bse/WHO_EMC_ZDI_98_9/en/ 14.,OADS,/arxiv_data1/oa_pdf/84/df/bmjopen-2013-003400.PMC3753481.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003402).,Non-OADS,/arxiv_data1/oa_pdf/b9/ec/bmjopen-2013-003402.PMC3753482.pdf
"Information regarding this access will be made availableon the study website http://www.bris.ac.uk/social-community-medicine/ projects/afl Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/b9/ec/bmjopen-2013-003402.PMC3753482.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b9/ec/bmjopen-2013-003402.PMC3753482.pdf
2010. http://www.communities.gov.uk/communities/research/indicesdeprivation/deprivation10/ (accessed 2 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/b9/ec/bmjopen-2013-003402.PMC3753482.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:217-224 Identification of Novel Drug Targets for the Treatment  of Diabetic Retinopathy Akiyoshi Uemura Division of Vascular Biology, Kobe University Graduate School of Medicine, Kobe, Japan Vision loss in diabetic retinopathy (DR) is attributable to retinal vascular disorders that result in macular edema and neoangio - genesis.",Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
This article will review the experimental model  systems utilizing mouse retinas and discuss perspectives on  new drug discovery for the treatment of DR.Review Complication http://dx.doi.org/10.4093/dmj.2013.37.4.217 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
"218Uemura A Diabetes Metab J 2013;37:217-224 http://e-dmj.orgANGIOPOIETINS AS DRUG TARGETS FOR  RETINAL EDEMA Pericyte dropout in retinal vessels In DR, impairment of retinal vascular integrity causes elevated  vascular permeability, which subsequently leads to fluid accu - mulation in extracellular spaces and swelling of retinal neu - rons and glial cells in the macula (Fig.",Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
219Novel drug targets for diabetic retinopathy Diabetes Metab J 2013;37:217-224 http://e-dmj.orgnot been experimentally confirmed in diabetic animal models.,Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
"220Uemura A Diabetes Metab J 2013;37:217-224 http://e-dmj.orgIn response to hypoxia, retinal neurons, and glial cells secrete a  series of proangiogenic growth factors, including VEGF, which  leads to the formation of new blood vessels from pre-existing  ones.",Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
"221Novel drug targets for diabetic retinopathy Diabetes Metab J 2013;37:217-224 http://e-dmj.orgcytes, which migrate into the retina from the optic nerve prior  to the onset of retinal vascular development [32].",Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
"222Uemura A Diabetes Metab J 2013;37:217-224 http://e-dmj.orgti-VEGF drugs suppress not only the extraretinal neoangio - genesis but also the desirable regeneration of intraretinal ves - sels, resulting in the deterioration of retinal ischemia [40].",Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
223Novel drug targets for diabetic retinopathy Diabetes Metab J 2013;37:217-224 http://e-dmj.orgformed endothelial network and is regulated by PDGF-B and  VEGF.,Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
224Uemura A Diabetes Metab J 2013;37:217-224 http://e-dmj.orgdiates a neuron-astrocyte interaction in the developing retina.,Non-OADS,/arxiv_data1/oa_pdf/94/f3/dmj-37-217.PMC3753485.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:225-232 Effects of Exercise Alone on Insulin Sensitivity and  Glucose Tolerance in Obese Y outh SoJung Lee1, Y oonMyung Kim2 1Division of Weight Management and Wellness, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA, 2University College, Y onsei University International Campus, Incheon, Korea As with the dramatic increases in childhood obesity over the past decades, the incidence of type 2 diabetes has increased among  children and adolescents in the United States.",Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
Although cross-sectional studies re -Review Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2013.37.4.225 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
"Diabetes Metab J 2013;37:225-232 http://e-dmj.orgport the beneficial effects of physical activity [18] or having a  high cardiorespiratory fitness [19] on insulin sensitivity in  children and adolescents, whether engaging in exercise alone  is effective in improving insulin sensitivity is not firmly estab - lished.",Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
"227 Exercise and insulin resistance Diabetes Metab J 2013;37:225-232 http://e-dmj.org At present, we are aware of one randomized controlled trial  that examined the effect of different doses of aerobic training  on insulin resistance in the pediatric population.",Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
"Diabetes Metab J 2013;37:225-232 http://e-dmj.orgEvidence from randomized controlled trials [29,32] suggests  that progressive resistance training is effective in improving insulin sensitivity in previously sedentary obese adolescent  boys.",Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
"229 Exercise and insulin resistance Diabetes Metab J 2013;37:225-232 http://e-dmj.orgweek resistance training alone (2 days/wk, 60 min/session) on  insulin sensitivity in overweight Hispanic adolescent boys.",Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
Diabetes Metab J 2013;37:225-232 http://e-dmj.orgvivo insulin sensitivity has not been firmly established.,Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
231 Exercise and insulin resistance Diabetes Metab J 2013;37:225-232 http://e-dmj.org169:122-31.,Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
Diabetes Metab J 2013;37:225-232 http://e-dmj.orgimprove adiposity and insulin resistance in overweight Latino  adolescents.,Non-OADS,/arxiv_data1/oa_pdf/aa/b6/dmj-37-225.PMC3753486.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/97/dmj-37-233.PMC3753487.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:233-239 Diabetes Epidemics in Korea: Reappraise Nationwide  Survey of Diabetes “Diabetes in Korea 2007” Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus of Korean Diabetes Association, Ie Byung Park1,   Jaiyong Kim2, Dae Jung Kim3, Choon Hee Chung4, Jee-Y oung Oh5, Seok Won Park6, Juneyoung Lee7, Kyung Mook Choi8,   Kyung Wan Min9, Jeong Hyun Park10, Hyun Shik Son11, Chul Woo Ahn12, Hwayoung Kim2, Sunhee Lee2, Im Bong Lee2,   Injeoung Choi2, Sei Hyun Baik8 1Department of Endocrinology of Metabolism, Gachon University of Medicine and Science, Incheon,  2Health Insurance Review & Assessment Service, Seoul,  3Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon,  4Department of Internal Medicine, Y onsei University Wonju College of Medicine, Wonju,  5Division of Endocrinology and Metabolism, Ewha Womans University School of Medicine, Seoul,  6Department of Internal Medicine, CHA University, Seongnam,  7Department of Biostatistics, Korea University College of Medicine, Seoul,  8Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul,  9Department of Internal Medicine, Eulji University School of Medicine, Seoul,  10Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan,  11Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Uijeongbu,  12Department of Internal Medicine, Y onsei University College of Medicine, Seoul, Korea There are many studies on the prevalence, clinical characteristics, and economic burden of diabetes across the past four decades  in Korea.",Non-OADS,/arxiv_data1/oa_pdf/90/97/dmj-37-233.PMC3753487.pdf
"In 2006,  the Committee formed a collaborative agreement with Health Review Epidemiology http://dx.doi.org/10.4093/dmj.2013.37.4.233 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/90/97/dmj-37-233.PMC3753487.pdf
"Diabetes Metab J 2013;37:233-239 http://e-dmj.orgInsurance Review & Assessment Service (HIRA), which is one  of the several government agency collecting national health  insurance data: since then, the name of the joint task force  changed to Task Force Team for Basic Statistical Study of Ko - rean Diabetes Mellitus (KDA-TFT for BSS) in 2006.",Non-OADS,/arxiv_data1/oa_pdf/90/97/dmj-37-233.PMC3753487.pdf
"235Reappraise nationwide survey of diabetes in Korea 2007 Diabetes Metab J 2013;37:233-239 http://e-dmj.orglion by the year 2010 (7.08% of the estimated total population),  4.55 million (8.97%) by 2020, and 5.45 million (10.85%) by  2030 (Figs.",Non-OADS,/arxiv_data1/oa_pdf/90/97/dmj-37-233.PMC3753487.pdf
"Diabetes Metab J 2013;37:233-239 http://e-dmj.orgCOMPLICATIONS To evaluate the foot disease, end-stage renal disease (ESRD) and  ophthalmologic disease, we chose subjects different from the  aforementioned data.",Non-OADS,/arxiv_data1/oa_pdf/90/97/dmj-37-233.PMC3753487.pdf
237Reappraise nationwide survey of diabetes in Korea 2007 Diabetes Metab J 2013;37:233-239 http://e-dmj.orgsuch education.,Non-OADS,/arxiv_data1/oa_pdf/90/97/dmj-37-233.PMC3753487.pdf
Diabetes Metab J 2013;37:233-239 http://e-dmj.orgcost in the entire adult population.,Non-OADS,/arxiv_data1/oa_pdf/90/97/dmj-37-233.PMC3753487.pdf
239Reappraise nationwide survey of diabetes in Korea 2007 Diabetes Metab J 2013;37:233-239 http://e-dmj.org13.,Non-OADS,/arxiv_data1/oa_pdf/90/97/dmj-37-233.PMC3753487.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:240-248 Intestinal and Hepatic Niemann-Pick C1-Like 1 Sung-Woo Park Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine,  Seoul, Korea Polytopic transmembrane protein, Niemann-Pick C1-Like 1 (NPC1L1) is localized at the apical membrane of enterocytes and  the canalicular membrane of hepatocytes.",Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
Like its ho -Sulwon Lecture 2012 Others http://dx.doi.org/10.4093/dmj.2013.37.4.240 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
"241Intestinal and hepatic NPC1L1  Diabetes Metab J 2013;37:240-248 http://e-dmj.orgmologue, NPC1L1 is a polytopic transmembrane protein con - sisting of 13 transmembrane domains, N-terminal domain  (NTD) and N-linked glycosylation sites [9].",Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
242Park SW Diabetes Metab J 2013;37:240-248 http://e-dmj.orglesterol compared to phytosterols.,Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
243Intestinal and hepatic NPC1L1  Diabetes Metab J 2013;37:240-248 http://e-dmj.orgpatients.,Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
244Park SW Diabetes Metab J 2013;37:240-248 http://e-dmj.orgmibe or NPC1L1 deletion has beneficial impacts on NAFLD  by insulin sensitivity.,Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
245Intestinal and hepatic NPC1L1  Diabetes Metab J 2013;37:240-248 http://e-dmj.orghepatic biliary cholesterol secretion.,Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
246Park SW Diabetes Metab J 2013;37:240-248 http://e-dmj.orghog signaling in disorders of cholesterol biosynthesis.,Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
247Intestinal and hepatic NPC1L1  Diabetes Metab J 2013;37:240-248 http://e-dmj.org47.,Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
248Park SW Diabetes Metab J 2013;37:240-248 http://e-dmj.orgweight loss diet.,Non-OADS,/arxiv_data1/oa_pdf/d8/3e/dmj-37-240.PMC3753488.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/32/dmj-37-249.PMC3753489.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:249-251 Diabetes Mellitus and Tuberculosis Bo Kyung Koo Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea Corresponding author: Bo Kyung Koo Department of Internal Medicine, Boramae Medical Center, Seoul National  University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu,   Seoul 156-707, Korea E-mail: bokyungkoomd@gmail.comIndia experiences a rapidly increasing prevalence of both dia - betes mellitus [1] and tuberculosis [2].",Non-OADS,/arxiv_data1/oa_pdf/6f/32/dmj-37-249.PMC3753489.pdf
[3] showed that Editorial Epidemiology http://dx.doi.org/10.4093/dmj.2013.37.4.249 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/6f/32/dmj-37-249.PMC3753489.pdf
"250Koo BK Diabetes Metab J 2013;37:249-251 http://e-dmj.orgamong 4,118 patients with diabetes, 111 subjects (2.7%) had  tuberculosis, which was a somewhat low rate considering the  high prevalence of tuberculosis in India.",Non-OADS,/arxiv_data1/oa_pdf/6f/32/dmj-37-249.PMC3753489.pdf
Available from: http://www.who.int/tb/publications/global_re - port/en/ (cited 2013 Jun 20).,OADS,/arxiv_data1/oa_pdf/6f/32/dmj-37-249.PMC3753489.pdf
251Diabetes mellitus and tuberculosis Diabetes Metab J 2013;37:249-251 http://e-dmj.org696-700.,Non-OADS,/arxiv_data1/oa_pdf/6f/32/dmj-37-249.PMC3753489.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:252-261 Serum Adiponectin and Type 2 Diabetes: A 6-Y ear  Follow-Up Cohort Study Sun Ha Jee1, Chul Woo Ahn2, Jong Suk Park2, Chang Gyu Park3, Hyon-Suk Kim4, Sang-Hak Lee5, Sungha Park5,   Myoungsook Lee6, Chang Beom Lee7, Hye Soon Park8, Heejin Kimm1, Sung Hee Choi9, Jidong Sung10, Seungjoon Oh11,   Hyojee Joung12, Sung Rae Kim13, Ho-Joong Y oun14, Sun Mi Kim15, Hong Soo Lee16, Y ejin Mok1, Eunmi Choi1, Y oung Duk Yun17,  Soo-Jin Baek17, Jaeseong Jo1, Kap Bum Huh18 1Institute for Health Promotion, Department of Epidemiology and Health Promotion, Y onsei University Graduate School of Public Health, Seoul, 2Division of Endocrinology, Department of Internal Medicine, Y onsei University College of Medicine, Seoul,  3Cardiovascular Center, Korea University Guro Hospital, Korea University College of Medicine, Seoul, 4Department of Laboratory Medicine, 5Cardiology Division, Department of Internal Medicine, Y onsei University College of Medicine, Seoul, 6Department of Food and Nutrition, Sungshin Women’s University College of Human Ecology, Seoul, 7Department of Endocrinology and Metabolism, Hanyang University College of Medicine, Seoul, 8Department of Family Medicine, University of Ulsan College of Medicine, Seoul, 9Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 10 Division of Cardiology, Department of Medicine, and Cardiac and Vascular Center, Center for Health Promotion, Sungkyunkwan University School of  Medicine, Seoul, 11Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, 12Division of Public Health Nutrition, Seoul National University School of Public Health and Institute of Health and Environment, Seoul, 13 Department of Endocrinology and Metabolism, 14Division of Cardiology, Department of Internal Medicine, The Catholic University of Korea College of  Medicine, Seoul, 15Department of Family Medicine, Korea University College of Medicine, Seoul, 16Department of Family Medicine, Ewha Womans University School of Medicine, Seoul, 17National Health Insurance Service, Seoul, 18Huh’s Diabetes Center and the 21th Century Diabetes and Vascular Research Institute, Seoul, Korea Background:  Studies on factors which may predict the risk of diabetes are scarce.",Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
"19, 2013Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2013.37.4.252 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
"253 Adiponectin and diabetes in Korea Diabetes Metab J 2013;37:252-261 http://e-dmj.orgINTRODUCTION With an increasing number of diabetic patients, the complica - tion of diabetes has been deemed a social problem.",Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
Diabetes Metab J 2013;37:252-261 http://e-dmj.orgpump were listed in the medication database at the Health In - surance Review & Assessment Service.,Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
255 Adiponectin and diabetes in Korea Diabetes Metab J 2013;37:252-261 http://e-dmj.orgtes.,Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
Diabetes Metab J 2013;37:252-261 http://e-dmj.orgdiabetes.,Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
257 Adiponectin and diabetes in Korea Diabetes Metab J 2013;37:252-261 http://e-dmj.orging Cox proportional hazard modeling.,Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
Diabetes Metab J 2013;37:252-261 http://e-dmj.orgTable 5.,Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
259 Adiponectin and diabetes in Korea Diabetes Metab J 2013;37:252-261 http://e-dmj.orgit could have clinically significant meanings of diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
"Diabetes Metab J 2013;37:252-261 http://e-dmj.orgthrough two distinct receptors termed adiponectin receptor 1  and adiponectin receptor 2 [8,16].",Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
261 Adiponectin and diabetes in Korea Diabetes Metab J 2013;37:252-261 http://e-dmj.orgY .,Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
2013 Feb 6. http://dx.doi.org/10.1007/ s12020-013-9890-5.,Non-OADS,/arxiv_data1/oa_pdf/9c/60/dmj-37-252.PMC3753490.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:262-269 Diabetic Retinopathy and Endothelial Dysfunction in  Patients with Type 2 Diabetes Mellitus Jae-Seung Yun1, Seung-Hyun Ko1, Ji-Hoon Kim2, Kun-Woong Moon2, Y ong-Moon Park3,4, Ki-Dong Y oo2, Yu-Bae Ahn1 Divisions of 1Endocrinology and Metabolism, 2Cardiology, Department of Internal Medicine, 3Department of Preventive Medicine, St. Vincent’s Hospital,   The Catholic University of Korea College of Medicine, Suwon, Korea   4Department of Epidemiology and Biostatistics, Arnold School of Public health, University of South Carolina, Columbia, SC, USA Background:  We investigated the relationship between endothelial dysfunction and diabetic retinopathy (DR) in patients with  type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
"Arguably, the most  critical mediator of endothelium-derived molecules is nitric  oxide (NO) [3], and the earliest and most important marker of Original Article Complications http://dx.doi.org/10.4093/dmj.2013.37.4.262 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
263 Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus Diabetes Metab J 2013;37:262-269 http://e-dmj.orgendothelial dysfunction is represented by a reduction in NO  bioactivity.,Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
Diabetes Metab J 2013;37:262-269 http://e-dmj.orgcontinuously recorded electrocardiogram.,Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
265 Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus Diabetes Metab J 2013;37:262-269 http://e-dmj.orgwas not statistically significant.,Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
Diabetes Metab J 2013;37:262-269 http://e-dmj.orgthat fenofibrate can also improve endothelial function of type  2 diabetic patients [22].,Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
"267 Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus Diabetes Metab J 2013;37:262-269 http://e-dmj.orglikely to have DR than those with a high response to %FMD,  but the intermediate-response %FMD group did not demon - strate statistical significance.",Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
"Diabetes Metab J 2013;37:262-269 http://e-dmj.orgACKNOWLEDGMENTS This work was supported by a grant (Y .B.A., 2009) from the  Korean Diabetes Association.",Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
269 Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus Diabetes Metab J 2013;37:262-269 http://e-dmj.orgproves endothelial function in the brachial artery and forearm  resistance arterioles of statin-treated type 2 diabetic patients.,Non-OADS,/arxiv_data1/oa_pdf/86/34/dmj-37-262.PMC3753491.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:270-277 Association of Estrogen Receptor α Genes PvuII and  XbaI Polymorphisms with Type 2 Diabetes Mellitus in  the Inpatient Population of a Hospital in Southern Iran Farzaneh Mohammadi1, Mohammad Pourahmadi2, Mohadeseh Mosalanejad1, Houshang Jamali1,   Mohamed Amin Ghobadifar3, Saeideh Erfanian4 1Department of Biology, Jahrom Branch, Islamic Azad University,  2Department of Anatomy, 3Student Research Committee, 4Research Laboratory, Jahrom University of Medical Sciences, Jahrom, Iran  Background:  Estrogen plays a fundamental role in the pathogenesis of type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
"Estrogen shows its physiological effect via the estro - gen receptors (ERs) which might prevent osteoporosis, meno -Original Article Genetics http://dx.doi.org/10.4093/dmj.2013.37.4.270 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
"271PvuII and XbaI polymorphisms genes and type 2 diabetes mellitus Diabetes Metab J 2013;37:270-277 http://e-dmj.orgpause syndrome, diabetes, arteriosclerosis, etc.",Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
"Diabetes Metab J 2013;37:270-277 http://e-dmj.orgA/G, rs9340799, respectively.",Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
273PvuII and XbaI polymorphisms genes and type 2 diabetes mellitus Diabetes Metab J 2013;37:270-277 http://e-dmj.orgPvuII (pp vs. Pp+PP) in both sexes revealed that there was no  significantly association in men ( P=0.89) and women ( P=  0.12).,Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
"Diabetes Metab J 2013;37:270-277 http://e-dmj.orgXX, and Xx genotypes than in those with pp and xx genotypes.",Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
275PvuII and XbaI polymorphisms genes and type 2 diabetes mellitus Diabetes Metab J 2013;37:270-277 http://e-dmj.org Sex steroids apparently have a considerable role in insulin  resistance risk.,Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
Diabetes Metab J 2013;37:270-277 http://e-dmj.orgwith T2DM in inpatient men and women population.,Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
277PvuII and XbaI polymorphisms genes and type 2 diabetes mellitus Diabetes Metab J 2013;37:270-277 http://e-dmj.org19.,Non-OADS,/arxiv_data1/oa_pdf/7c/e0/dmj-37-270.PMC3753492.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:278-285 The Role of Skeletal Muscle in Development of  Nonalcoholic Fatty Liver Disease Jun Sung Moon*, Ji Sung Y oon*, Kyu Chang Won, Hyoung Woo Lee Department of Internal Medicine, Y eungnam University College of Medicine, Daegu, Korea Background:  Nonalcoholic fatty liver disease (NAFLD) is closely correlated with abnormal accumulation of visceral fat, but the  role of skeletal muscle remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
"Moreover,  higher FLI scores are correlated with an elevated risk for dia - betes [12], early carotid atherosclerosis [10], coronary artery Original Article Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2013.37.4.278 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
"279Skeletal muscle prevents fatty liver Diabetes Metab J 2013;37:278-285 http://e-dmj.orgdisease [13], and all-cause mortality [11].",Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
"Diabetes Metab J 2013;37:278-285 http://e-dmj.orgbody composition of all subjects using the Inbody 720 (Biospace,  Seoul, Korea), a multifrequency impedance body composition  analyzer.",Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
281Skeletal muscle prevents fatty liver Diabetes Metab J 2013;37:278-285 http://e-dmj.orgverse correlation between SMM and VFA in the low FLI group  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
Diabetes Metab J 2013;37:278-285 http://e-dmj.orgthere was an inverse correlation between SMM and VFA.,OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
283Skeletal muscle prevents fatty liver Diabetes Metab J 2013;37:278-285 http://e-dmj.orgthe highest risk of NAFLD.,Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
"Diabetes Metab J 2013;37:278-285 http://e-dmj.orgor CT were currently gold standard tests for evaluating SMM  [38], these methods were limited to epidemiologic studies in  terms of cost and time.",Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
285Skeletal muscle prevents fatty liver Diabetes Metab J 2013;37:278-285 http://e-dmj.orgfindings from the National Health and Nutrition Examination  Survey III.,Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
FEBS J. Epub 2013 May 13. http://dx.doi.org/10.1111/ febs.12338.,Non-OADS,/arxiv_data1/oa_pdf/ea/19/dmj-37-278.PMC3753493.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/81/dmj-37-286.PMC3753494.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:286-290 Effect of Granulocyte Colony-Stimulating Factor on  the Peripheral Nerves in Streptozotocin-Induced  Diabetic Rat Kyung Ae Lee1, Kyung Taek Park2, Hea Min Yu3, Heung Y ong Jin1, Hong Sun Baek1, Tae Sun Park1 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital,   Chonbuk National University Medical School, Jeonju, 2Y eolin Hospital, Department of Internal Medicine, Jeonju, 3 Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine, Eulji University Hospital,   Eulji University School of Medicine, Daejeon, Korea There are controversial reports about the effect of granulocyte colony-stimulating factor (G-CSF) in peripheral nerve protection.",Non-OADS,/arxiv_data1/oa_pdf/f2/81/dmj-37-286.PMC3753494.pdf
To induce Brief Report Complications http://dx.doi.org/10.4093/dmj.2013.37.4.286 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/f2/81/dmj-37-286.PMC3753494.pdf
